data_2rng_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rng _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.454 ' HB2' ' CG2' ' A' ' 7' ' ' ILE . 46.1 Cg_endo . . . . . 0 C--O 1.215 -0.648 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.58 -24.78 33.77 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.654 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -53.51 -54.83 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.79 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 10.0 m-30 -48.48 -26.82 2.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 110.172 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 15.7 mt -71.84 139.15 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.391 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 49.06 35.93 19.85 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -123.72 -161.84 1.01 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.542 -0.975 . . . . 0.0 110.515 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.596 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 5.6 m -153.93 93.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 69' ' ' VAL . 2.9 m -88.76 -171.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.062 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -100.58 -163.6 28.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.4 Cg_endo -72.83 -48.82 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.963 1.507 . . . . 0.0 110.458 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 t -62.78 -52.09 64.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG2' ' OD1' ' A' ' 41' ' ' ASP . 79.5 t -58.31 -45.85 89.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 110.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.603 ' CZ3' ' NH2' ' A' ' 37' ' ' ARG . 22.2 t90 -50.35 -63.92 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.917 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.03 -36.14 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 52.1 t80 -62.21 -60.97 2.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.463 HD12 HD12 ' A' ' 35' ' ' ILE . 2.6 tt -49.47 -34.55 17.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 64.1 t -60.39 -51.04 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.152 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.88 76.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.433 -0.792 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -0.935 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -126.34 -88.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 176.18 166.0 32.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.88 -19.32 60.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -1.147 . . . . 0.0 110.562 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -62.94 1.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.115 -0.991 . . . . 0.0 109.949 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -64.54 -21.02 66.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.327 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.462 HG21 HD23 ' A' ' 21' ' ' LEU . 38.0 t -75.86 -32.44 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.49 -0.756 . . . . 0.0 109.755 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 m -93.29 -14.99 26.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.057 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.07 -24.67 21.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.016 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -82.18 9.34 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.2 t-20 59.34 72.6 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 110.652 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 21' ' ' LEU . 22.4 mt -119.45 120.38 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.627 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 12' ' ' THR . 10.1 mtm180 -101.19 149.07 24.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.569 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.603 ' NH2' ' CZ3' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -100.22 152.26 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.823 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.82 172.47 9.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.167 -0.958 . . . . 0.0 110.405 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 1.2 p -50.92 -27.31 7.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.477 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 5.1 m -172.06 -173.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.574 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 2.6 m-20 -55.12 -22.83 18.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 17.6 t-20 -87.8 107.73 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.5 p80 -147.33 -175.98 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -95.2 148.73 22.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 10.4 p -139.9 -176.08 4.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.935 . . . . 0.0 110.458 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' CYS . . . 45.84 43.17 9.75 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.3 -157.66 53.45 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.54 44.44 1.04 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.045 -1.267 . . . . 0.0 109.598 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -117.33 -34.37 4.34 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.292 -0.88 . . . . 0.0 111.342 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.02 165.22 12.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.233 -1.46 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 3.5 m95 -140.32 171.37 14.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.608 -0.937 . . . . 0.0 108.948 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.496 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.1 t -113.99 123.4 49.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 111.565 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' NH2' ' HB3' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -135.1 156.65 48.65 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' ARG . 80.0 p -46.58 -41.42 14.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.86 -1.15 . . . . 0.0 109.027 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -142.63 178.27 7.74 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.537 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 10.8 m -122.15 165.69 15.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.895 -1.128 . . . . 0.0 110.153 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -79.93 175.36 10.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -73.47 -39.45 64.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 0.0 110.646 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -2.74 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.139 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.36 -174.66 3.06 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 5.8 p90 -146.72 -159.7 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 64' ' ' THR . 45.1 t -125.44 104.85 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.627 -0.671 . . . . 0.0 109.594 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 75' ' ' CYS . 9.7 p30 -51.69 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -44.07 -25.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.706 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.35 -48.5 41.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 111.085 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.654 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 60.0 m-85 -89.28 -4.66 58.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 111.408 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -51.08 -23.1 2.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.147 . . . . 0.0 108.693 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 7' ' ' ILE . . . -72.01 -66.08 0.69 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.624 -0.672 . . . . 0.0 110.538 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 13' ' ' VAL . 13.2 p -44.08 -30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.078 -1.013 . . . . 0.0 109.67 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -65.47 -63.76 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.109 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.0 -132.6 11.08 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -51.88 -34.55 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.168 . . . . 0.0 110.06 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.35 -174.01 4.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -130.72 128.57 41.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.848 . . . . 0.0 109.877 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.515 ' CB ' ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -79.03 99.38 6.86 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.94 -1.1 . . . . 0.0 108.804 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 5.6 m -79.56 160.99 26.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 1.1 mtp180 -151.0 170.93 18.15 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 110.144 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.38 117.02 33.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.641 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 49.2 Cg_endo . . . . . 0 N--CA 1.485 0.994 0 N-CA-C 110.032 -0.795 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.18 -43.45 2.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.86 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.506 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -54.11 -39.43 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.641 ' CD1' ' CG ' ' A' ' 5' ' ' PRO . 47.3 m-85 -59.93 -31.78 70.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 66.1 mt -72.87 143.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.454 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.98 35.26 63.37 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 69' ' ' VAL . . . -127.77 -162.57 1.18 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -1.065 . . . . 0.0 110.646 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 4.7 m -150.35 89.87 1.61 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.53 ' HA ' HG22 ' A' ' 69' ' ' VAL . 3.1 m -83.19 -163.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.018 -1.051 . . . . 0.0 110.336 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.92 -165.62 21.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -73.16 -44.29 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.313 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -65.01 -49.88 68.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.121 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.508 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 44.4 t -60.64 -49.81 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.587 ' CZ3' ' CG2' ' A' ' 35' ' ' ILE . 46.4 t-105 -46.26 -63.87 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.97 -43.06 6.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -59.62 -66.64 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 ' CD1' HD12 ' A' ' 35' ' ' ILE . 4.8 tt -40.78 -49.17 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.489 -0.757 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.5 t -48.75 -50.96 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.39 64.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.399 -0.813 . . . . 0.0 109.868 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.18 -42.2 94.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 110.016 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.617 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -125.93 -87.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.972 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 173.4 163.58 27.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.71 60.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -1.132 . . . . 0.0 110.612 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -62.63 1.32 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.14 -0.975 . . . . 0.0 109.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.617 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -61.13 -25.33 66.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.552 HG12 ' CZ2' ' A' ' 18' ' ' TRP . 20.1 t -68.64 -34.0 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 m -77.09 -44.27 31.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.82 65.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -88.62 23.06 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.964 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 62.7 t-20 39.82 70.78 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.423 -0.798 . . . . 0.0 110.646 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.587 ' CG2' ' CZ3' ' A' ' 18' ' ' TRP . 14.8 mt -115.16 130.16 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.716 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 10.2 mtt180 -114.86 148.96 37.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.416 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.567 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 6.6 mtp180 -99.47 149.14 23.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.473 -0.767 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -122.95 159.47 28.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.112 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.3 m -45.08 -25.09 0.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 39' ' ' SER . 44.6 m -167.47 -171.99 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.113 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.1 m-20 -64.22 -14.85 58.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 11.2 t-20 -93.53 109.72 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.5 p80 -146.55 -175.69 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.584 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.9 p -88.66 127.24 35.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.681 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.9 p -117.32 178.1 4.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.575 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.06 33.14 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.357 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.63 -149.37 36.6 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -87.6 29.12 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.129 -1.218 . . . . 0.0 109.963 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -108.4 -32.12 7.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.218 -0.926 . . . . 0.0 110.855 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.8 164.68 15.68 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.584 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 9.4 m95 -138.46 178.59 7.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.456 -1.026 . . . . 0.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.3 t -115.6 113.43 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.889 -1.132 . . . . 0.0 110.707 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -131.58 157.32 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -56.21 -52.77 63.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.966 -1.083 . . . . 0.0 108.76 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' N ' ' OG ' ' A' ' 54' ' ' SER . 1.1 tttt -138.81 139.58 38.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 2.0 t -103.87 168.33 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.449 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.4 m-85 -79.62 168.09 19.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -38.16 86.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.786 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.86 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.995 -1.066 . . . . 0.0 109.739 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.3 mt-10 -124.05 179.3 4.91 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.358 -0.839 . . . . 0.0 109.998 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.6 p90 -135.29 -166.53 1.85 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.809 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 64' ' ' THR . 28.6 t -112.31 88.24 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.461 -0.774 . . . . 0.0 109.933 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 75' ' ' CYS . 51.8 t0 -37.14 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.377 0.608 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.75 -28.29 60.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -69.91 -44.11 70.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 22.3 m-85 -92.12 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 111.001 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.86 -20.64 3.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.025 -1.047 . . . . 0.0 108.924 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -70.03 -71.49 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.575 -0.703 . . . . 0.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.532 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 7.2 p -44.28 -28.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.066 -1.021 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.532 ' N ' HG12 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -63.05 -59.39 4.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 110.271 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -134.47 11.76 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -31.85 12.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -1.194 . . . . 0.0 109.859 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.7 m-85 -91.58 -179.63 5.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 110.115 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 2.1 m-85 -122.95 140.57 52.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.765 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.1 t -79.53 98.25 6.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.085 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 10.9 t -78.58 163.77 25.23 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.04 . . . . 0.0 110.198 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 44.4 mtp180 -159.12 176.08 12.69 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.406 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -94.84 109.89 21.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.162 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.637 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 47.5 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.484 -1.006 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.23 -44.14 2.91 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -53.58 -49.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.357 -0.839 . . . . 0.0 110.049 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CD1' ' CG ' ' A' ' 5' ' ' PRO . 41.7 m-85 -47.13 -33.67 5.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 109.742 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 73.8 mt -72.17 124.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.294 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 72.95 29.94 64.17 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -120.33 -163.12 0.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.476 -1.014 . . . . 0.0 110.766 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.602 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 4.2 m -153.66 99.77 2.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.875 . . . . 0.0 109.84 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 10.4 m -95.38 168.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.224 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -75.65 -162.62 11.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -75.47 -49.08 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.028 1.541 . . . . 0.0 110.35 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 t -60.46 -54.22 48.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 110.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 76.3 t -58.33 -45.67 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.628 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 27.3 t90 -51.56 -66.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.64 -34.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.735 . . . . 0.0 110.289 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 56.4 t80 -64.05 -62.29 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.582 HD12 ' CD2' ' A' ' 8' ' ' TYR . 1.4 tt -52.36 -26.22 11.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 26' ' ' GLY . 72.8 t -69.94 -50.55 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.731 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.08 -26.62 50.31 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.219 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 tp -73.91 -50.59 19.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.518 -0.739 . . . . 0.0 110.669 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.566 ' CG2' ' N ' ' A' ' 26' ' ' GLY . 2.1 m -113.05 -44.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.462 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 129.2 169.0 12.48 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -67.57 -26.74 66.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.901 -1.353 . . . . 0.0 110.479 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 -54.97 14.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB1' HG23 ' A' ' 25' ' ' VAL . . . -64.05 -40.76 97.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.87 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.526 ' CG2' HD23 ' A' ' 21' ' ' LEU . 54.7 t -68.29 -25.26 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 110.181 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 40.2 m -86.67 -22.41 26.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.2 -19.59 26.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -86.46 17.11 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.22 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 60.8 t-20 55.4 67.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 110.603 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.52 ' CD1' HD13 ' A' ' 21' ' ' LEU . 65.2 mt -120.35 110.06 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.457 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -91.77 152.83 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.661 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.628 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 1.4 mtp180 -94.76 157.18 16.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 109.691 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -132.03 163.58 28.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.432 ' C ' ' OG ' ' A' ' 40' ' ' SER . 84.1 p -53.33 -31.91 46.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.44 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.432 ' OG ' ' C ' ' A' ' 39' ' ' SER . 2.1 m -164.74 -179.8 6.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -49.68 -23.42 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.082 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.9 t30 -87.7 110.42 20.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.1 p80 -150.12 177.85 9.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 5.2 p -81.49 130.41 35.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.46 -0.775 . . . . 0.0 109.62 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 p -121.97 173.85 7.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 0.0 110.424 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 48.37 40.24 14.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.124 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 -149.25 49.23 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -87.21 23.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.138 -1.213 . . . . 0.0 109.864 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -100.84 -34.62 9.74 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 0.0 111.051 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.37 166.57 14.92 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.987 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.59 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.4 m95 -140.99 171.07 14.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -1.07 . . . . 0.0 109.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 4.4 t -106.07 108.79 20.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.59 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -130.41 157.45 42.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.211 -0.93 . . . . 0.0 109.938 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -63.93 -52.75 58.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.965 . . . . 0.0 109.021 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.4 tttt -128.75 174.66 9.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.503 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 58.2 m -150.34 170.08 19.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.867 -1.145 . . . . 0.0 110.747 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 15.7 m-85 -81.97 -176.06 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.476 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -80.37 -46.95 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.25 -0.906 . . . . 0.0 110.646 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' ARG . 1.5 t-80 -46.46 -23.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 109.153 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mt-10 -118.67 175.35 5.77 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.456 -0.777 . . . . 0.0 109.445 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.8 p90 -139.94 -167.26 2.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.543 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 64' ' ' THR . 49.8 t -110.96 89.45 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.636 -0.665 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 16.8 t0 -40.6 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.49 -0.756 . . . . 0.0 110.42 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.25 -24.93 30.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.566 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.475 ' O ' HD12 ' A' ' 7' ' ' ILE . 18.6 t80 -68.74 -51.99 35.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.526 -0.734 . . . . 0.0 110.714 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 9.1 m-85 -81.58 -4.98 57.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.161 -0.962 . . . . 0.0 111.414 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.7 p -49.6 -21.5 1.02 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.057 -1.027 . . . . 0.0 109.979 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' HD11 ' A' ' 7' ' ' ILE . . . -66.09 -69.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 110.602 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 70' ' ' CYS . 9.9 p -49.07 -26.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.056 . . . . 0.0 109.476 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.539 ' N ' HG13 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -68.2 -44.29 76.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -124.32 6.5 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.58 74.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -1.209 . . . . 0.0 110.045 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 80.4 m-85 -81.22 -178.99 7.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 54' ' ' SER . 1.1 m-85 -125.36 138.92 54.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.32 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 16.4 t -81.85 101.06 9.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.145 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 76.9 m -79.49 175.0 11.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 9.2 mtp180 -160.52 179.8 8.29 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 110.054 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.2 85.5 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 51.3 Cg_endo . . . . . 0 C--O 1.215 -0.669 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -88.83 -23.6 22.78 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 110.164 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.632 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.41 -57.16 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 110.995 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.582 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.2 m-30 -48.32 -25.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.018 -1.051 . . . . 0.0 110.169 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.0 mt -73.17 128.37 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 58.05 32.79 67.49 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -117.46 -159.21 0.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.515 -0.991 . . . . 0.0 110.601 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.614 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 2.8 m -153.13 91.05 1.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 109.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 5.9 m -90.66 164.62 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 110.506 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -89.69 -158.02 33.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.8 Cg_endo -74.42 -42.78 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.912 1.48 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -63.81 -57.75 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 110.089 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.9 t -58.51 -49.67 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.73 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.535 ' CH2' ' CG1' ' A' ' 30' ' ' VAL . 56.4 t-105 -46.52 -66.4 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.705 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.44 -38.11 1.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.485 -0.759 . . . . 0.0 110.33 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 6.4 t80 -63.36 -64.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.474 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 1.8 tt -46.68 -51.28 16.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.325 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.458 ' HA ' HG23 ' A' ' 30' ' ' VAL . 78.3 t -48.77 -52.87 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.69 44.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.108 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.76 -41.88 92.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.604 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -126.21 -86.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 175.7 170.03 38.06 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.43 -22.07 66.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 110.607 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.58 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.045 -1.034 . . . . 0.0 109.838 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.604 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.95 -22.28 66.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.204 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.535 ' CG1' ' CH2' ' A' ' 18' ' ' TRP . 24.1 t -73.54 -35.72 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.466 -0.771 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 9.9 m -78.65 -34.27 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.967 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.17 -23.89 59.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.49 4.88 12.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 59.5 t-20 59.05 68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.446 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.449 HD11 ' HB1' ' A' ' 33' ' ' ALA . 25.8 mt -117.57 109.95 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -83.45 143.71 30.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.55 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.06 150.88 23.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.789 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.85 162.14 24.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.54 -26.33 20.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.311 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.532 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 2.5 m -170.44 -170.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 16' ' ' SER . 15.2 m-20 -62.5 -13.9 35.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.902 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.5 m-20 -99.61 102.82 14.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.0 p80 -141.47 175.38 9.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.414 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.586 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.3 p -79.17 129.59 34.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p -122.32 176.74 5.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.421 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.68 37.83 7.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.3 -148.62 45.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 14.8 p30 -87.84 26.64 1.29 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.168 -1.195 . . . . 0.0 109.912 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -105.63 -29.23 10.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.23 21.1 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.391 -1.385 . . . . 0.0 109.893 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 6.7 m95 -137.67 170.9 15.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.46 -1.023 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -105.75 115.89 31.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.667 -1.27 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -133.39 155.22 49.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.78 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -55.56 -56.97 14.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.891 -1.131 . . . . 0.0 108.754 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.79 -165.15 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 1.2 m -163.64 173.38 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.728 -1.233 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.51 -179.3 6.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.501 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -40.31 20.31 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.163 -0.961 . . . . 0.0 110.359 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.63 -16.88 4.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.54 178.19 4.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.477 -0.765 . . . . 0.0 109.539 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 4.4 p90 -144.39 -164.66 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.8 t -126.01 98.31 4.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -48.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.47 -26.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.67 . . . . 0.0 110.47 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 63' ' ' ASP . 12.2 t80 -68.77 -52.47 30.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -81.21 -10.18 59.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 111.005 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -49.35 -22.85 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.05 -1.031 . . . . 0.0 109.357 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -66.92 -69.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 9.8 p -45.7 -30.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 109.624 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.51 -53.99 50.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.09 -139.39 14.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -50.49 -23.17 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -1.108 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.467 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 12.2 m-85 -94.27 -170.54 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.541 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 37.0 m-85 -129.32 133.47 47.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 109.732 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 7.5 t -79.98 101.94 8.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 109.212 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.7 m -78.7 167.21 21.54 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.875 -1.141 . . . . 0.0 110.376 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 2.4 mtp180 -160.87 167.44 26.67 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.91 102.46 13.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.204 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.628 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 47.7 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 109.932 -0.834 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.18 -44.71 11.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.442 -0.786 . . . . 0.0 110.238 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.619 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -51.46 -41.86 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.286 -0.884 . . . . 0.0 110.483 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 5' ' ' PRO . 28.3 m-85 -60.57 -33.73 73.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.179 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -71.97 138.5 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.118 -0.989 . . . . 0.0 109.514 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.96 33.95 81.11 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -127.48 -162.25 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.519 -0.989 . . . . 0.0 110.543 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.611 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 2.3 m -151.15 98.43 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.237 -0.914 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.519 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 2.9 m -93.22 -175.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.12 -164.56 37.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -72.62 -41.9 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.966 1.509 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -67.67 -47.34 69.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 47.6 t -62.64 -37.94 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.571 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 13.3 t90 -57.33 -58.9 6.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -50.45 -39.41 47.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 3.9 t80 -57.72 -65.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 HD21 ' CG2' ' A' ' 30' ' ' VAL . 4.1 tt -41.98 -44.38 3.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.506 -0.747 . . . . 0.0 109.987 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.458 ' HA ' HG23 ' A' ' 30' ' ' VAL . 71.7 t -55.27 -48.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.28 76.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -59.57 -41.12 89.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.605 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.94 -88.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.405 -0.81 . . . . 0.0 110.199 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.574 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 176.76 163.92 29.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.41 -20.59 56.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.603 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.24 1.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.094 -1.004 . . . . 0.0 109.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.605 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.93 -22.0 66.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.537 ' CG2' HD21 ' A' ' 21' ' ' LEU . 26.0 t -71.39 -33.58 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.8 m -86.25 -26.71 24.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.84 -18.87 49.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.892 . . . . 0.0 109.782 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.65 23.32 2.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 62.5 t-20 43.36 71.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 21' ' ' LEU . 65.2 mt -121.59 112.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.454 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -95.71 148.88 22.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.681 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.571 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm-85 -89.69 159.12 17.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.51 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 110.005 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 1.8 m -42.82 -26.73 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.908 . . . . 0.0 110.08 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' ALA . 3.2 m -174.43 -171.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 110.073 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD2' ' HG3' ' A' ' 72' ' ' ARG . 70.6 m-20 -57.51 -17.24 12.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 t-20 -91.25 108.64 20.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.327 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.611 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.4 p80 -151.65 179.72 8.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.208 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -81.09 148.04 29.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.864 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 7.8 p -141.28 -178.47 5.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.569 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 47.42 42.7 14.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 -154.88 48.54 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.424 -1.87 . . . . 0.0 108.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -84.05 42.91 0.9 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.112 -1.228 . . . . 0.0 109.665 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -119.31 -35.33 3.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.2 -0.938 . . . . 0.0 111.252 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -127.11 171.21 18.72 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.319 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 17.5 m95 -138.63 179.13 6.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.983 . . . . 0.0 109.405 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.0 t -112.59 118.5 35.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.812 -1.18 . . . . 0.0 110.769 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -130.47 158.3 40.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.663 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -53.39 -47.84 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.049 -1.032 . . . . 0.0 109.146 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 140.93 44.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 15.5 m -77.48 159.38 29.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 110.097 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -80.59 -171.43 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.418 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -43.23 39.3 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.12 3.85 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 9.3 mt-10 -129.35 162.74 27.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 0.0 109.958 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 24.3 p90 -129.36 -178.83 4.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.522 ' CG2' ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -91.42 92.84 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.332 0.587 . . . . 0.0 109.474 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' OD2' ' CG ' ' A' ' 77' ' ' ARG . 1.5 m-20 -51.52 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.694 . . . . 0.0 109.782 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -51.7 -22.65 3.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 0.0 110.683 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -70.02 -56.93 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 111.043 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.619 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 4.0 m-85 -86.06 -3.47 58.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 111.374 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.57 -23.03 1.45 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.581 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.33 -71.97 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.656 -0.653 . . . . 0.0 110.757 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 70' ' ' CYS . 9.8 p -44.24 -27.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.521 ' N ' HG12 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -63.5 -63.35 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.265 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.15 -112.29 4.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG3' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mtt180 -62.66 -50.2 72.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -1.162 . . . . 0.0 110.093 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 20.2 m-85 -79.89 -173.05 3.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.951 . . . . 0.0 110.006 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -126.56 139.23 53.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.799 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 t -79.6 107.3 12.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 0.0 108.735 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 10.3 m -97.45 157.57 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.793 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.545 ' CG ' ' OD2' ' A' ' 63' ' ' ASP . 8.5 mtp180 -142.63 -175.36 4.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.724 -0.61 . . . . 0.0 109.801 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.8 p -110.6 94.88 5.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.26 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.545 ' HD2' ' CD2' ' A' ' 8' ' ' TYR . 45.3 Cg_endo . . . . . 0 C--O 1.215 -0.655 0 N-CA-C 110.027 -0.797 . . . . 0.0 110.027 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.469 ' CB ' ' OH ' ' A' ' 65' ' ' TYR . . . -61.67 -43.34 99.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.016 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.627 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -50.39 -54.24 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.62 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.545 ' CD2' ' HD2' ' A' ' 5' ' ' PRO . 8.8 m-30 -51.57 -31.03 23.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.972 . . . . 0.0 110.369 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 58.3 mt -71.95 129.41 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 60.14 31.66 73.79 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -114.55 -162.47 0.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -1.028 . . . . 0.0 110.668 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.601 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 1.8 m -154.68 97.89 2.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 109.758 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HA ' HG23 ' A' ' 69' ' ' VAL . 3.5 m -93.77 172.78 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.099 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -85.82 -159.59 32.35 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 48.9 Cg_endo -74.74 -46.58 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.015 1.534 . . . . 0.0 110.5 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -67.65 -50.43 57.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.53 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.0 t -57.22 -45.78 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.992 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.581 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 11.3 t90 -52.17 -61.45 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.623 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.89 -37.97 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.4 t80 -60.29 -53.75 53.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.985 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 22' ' ' VAL . 1.6 tt -57.63 -55.57 33.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.11 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.462 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.4 t -44.01 -61.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.065 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.19 -41.26 17.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -59.95 -41.44 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.609 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -126.4 -88.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 177.05 166.18 33.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.94 -19.25 60.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.13 . . . . 0.0 110.699 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.17 -64.25 1.01 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.019 -1.051 . . . . 0.0 109.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.52 -21.74 65.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.214 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' A' ' 22' ' ' VAL . 24.5 t -73.65 -34.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.454 -0.778 . . . . 0.0 109.714 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.0 m -87.8 -19.64 27.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 109.899 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.21 -22.1 28.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.837 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.01 23.51 2.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.88 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.435 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 37.8 t-20 42.54 76.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 110.355 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.6 110.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 109.701 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -93.22 144.44 25.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.907 . . . . 0.0 110.589 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 2.7 mtm180 -82.93 166.0 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 0.0 109.708 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -139.05 161.87 36.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.01 . . . . 0.0 110.266 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.475 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -51.19 -36.48 41.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.296 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.479 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 16.5 m -164.72 -179.07 5.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 38.6 m-20 -46.63 -30.89 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.588 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 17.2 t-20 -84.96 110.56 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.7 p80 -147.27 175.91 10.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.073 -1.017 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.585 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 17.9 p -78.23 127.54 32.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.426 -0.797 . . . . 0.0 109.749 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 p -120.49 168.43 11.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.006 -1.059 . . . . 0.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 53.22 50.0 18.66 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.551 -0.718 . . . . 0.0 109.303 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.17 -149.94 25.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -86.18 36.49 0.68 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.171 -1.193 . . . . 0.0 110.065 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 3.5 mtt180 -113.57 -33.13 5.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -127.28 168.03 19.51 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.0 m95 -142.22 170.79 15.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -117.73 113.68 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.777 -1.202 . . . . 0.0 110.684 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -132.7 163.56 28.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.353 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.445 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 24.8 p -50.57 -48.17 57.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.897 -1.127 . . . . 0.0 108.508 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.74 179.83 5.33 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.641 0.734 . . . . 0.0 110.562 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 20.9 m -121.63 168.99 11.14 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.037 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -79.82 -173.62 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.5 -36.82 21.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.245 -0.909 . . . . 0.0 110.25 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -78.98 5.22 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 46.6 mt-10 -128.83 -175.68 3.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 7.5 p90 -141.12 -162.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 109.833 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' THR . 53.2 t -111.69 89.08 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.122 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 14.2 t0 -41.64 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 0.0 110.213 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -57.84 -27.1 62.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.207 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.469 ' OH ' ' CB ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -68.6 -49.51 58.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 110.605 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.4 m-85 -83.76 -9.28 58.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.945 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -22.57 1.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.039 -1.038 . . . . 0.0 109.537 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 7' ' ' ILE . . . -66.96 -70.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 110.303 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 13' ' ' VAL . 10.6 p -45.74 -25.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.998 -1.064 . . . . 0.0 109.341 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.482 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -62.78 -67.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.781 . . . . 0.0 110.048 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.4 -96.13 2.0 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -56.77 7.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.422 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.588 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 24.6 m-85 -89.27 -168.99 2.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.091 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 1.3 m-85 -123.34 149.64 44.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.84 . . . . 0.0 109.73 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 15.7 t -86.03 100.88 12.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 0.0 109.765 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.2 m -79.34 163.56 24.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 3.4 mtp180 -153.95 176.88 11.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 t -104.67 94.37 5.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.171 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.155 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.597 ' CG ' ' CE2' ' A' ' 8' ' ' TYR . 47.8 Cg_endo . . . . . 0 C--O 1.216 -0.61 0 N-CA-C 109.937 -0.832 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -84.68 -16.74 40.82 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.421 -0.799 . . . . 0.0 110.287 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -55.91 -47.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -0.869 . . . . 0.0 110.737 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CE2' ' CG ' ' A' ' 5' ' ' PRO . 22.8 m-85 -52.37 -24.42 7.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.476 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 70.2 mt -60.37 136.51 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.715 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 46.31 34.92 6.58 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -113.15 -167.48 1.2 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.509 -0.994 . . . . 0.0 110.671 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.595 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.7 m -150.06 88.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.546 HG11 ' CG2' ' A' ' 69' ' ' VAL . 3.0 m -83.16 -165.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.35 -163.46 17.8 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -73.11 -45.45 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -67.59 -49.14 64.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.099 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 91.1 t -58.91 -48.0 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.579 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 7.8 t-105 -50.81 -59.35 4.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.732 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.46 -39.67 7.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.095 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 68.1 t80 -63.62 -63.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.335 -0.853 . . . . 0.0 110.145 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -42.37 -54.44 3.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.211 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.1 t -48.02 -50.2 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' TYR . . . -51.11 -43.46 61.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 110.161 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -66.14 -36.12 82.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.593 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.04 -88.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 171.59 167.72 32.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.59 62.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -1.171 . . . . 0.0 110.524 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -63.66 1.1 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.053 -1.03 . . . . 0.0 109.914 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.19 -22.46 65.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.909 . . . . 0.0 109.297 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.7 t -73.61 -31.46 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.486 -0.759 . . . . 0.0 109.979 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -87.83 -26.83 22.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.225 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -25.38 43.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -83.64 6.59 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 110.353 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 46.8 t-20 58.32 79.3 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -0.92 . . . . 0.0 110.619 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 40.0 mt -118.84 136.97 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.466 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -110.18 151.2 27.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 110.575 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.5 OUTLIER -100.95 143.05 31.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.0 109.887 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.88 152.2 37.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.406 ' C ' ' OG ' ' A' ' 40' ' ' SER . 9.6 m -42.39 -27.08 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -163.4 -176.02 4.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.196 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.5 -12.21 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.34 103.44 15.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 12' ' ' THR . 6.1 p80 -142.62 -178.56 5.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.615 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -92.92 147.22 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.802 . . . . 0.0 110.002 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.0 p -137.26 178.59 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 110.313 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 46.97 46.55 15.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.884 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.22 -153.11 48.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.66 42.88 0.94 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.054 -1.262 . . . . 0.0 109.604 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.4 mmm180 -109.44 -39.0 5.32 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 111.21 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.21 164.12 18.91 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.761 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.615 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.3 m95 -134.76 167.75 20.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.066 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 4.7 t -106.71 117.52 34.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.77 -1.206 . . . . 0.0 111.272 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mtt-85 -129.24 153.05 48.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.208 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.16 -48.98 64.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.09 . . . . 0.0 109.257 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.2 tttt -138.44 177.5 7.83 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 16.3 m -149.96 169.98 19.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.823 -1.173 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -80.03 -175.02 4.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.404 -0.81 . . . . 0.0 110.562 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 -43.36 14.64 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.324 -0.86 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.51 -20.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.688 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.88 174.35 5.98 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 9.2 p90 -138.96 -165.1 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.95 -1.094 . . . . 0.0 110.376 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 64' ' ' THR . 16.6 t -124.95 103.63 12.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 75' ' ' CYS . 14.8 p30 -47.91 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.85 -25.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.414 -0.803 . . . . 0.0 110.505 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' ASP . 12.8 t80 -71.34 -48.05 52.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.625 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 40.7 m-85 -90.2 -4.1 57.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 111.292 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -22.97 2.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 108.587 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.567 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -71.67 -64.48 0.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.671 -0.643 . . . . 0.0 110.485 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.546 ' CG2' HG11 ' A' ' 13' ' ' VAL . 10.1 p -44.96 -30.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.997 -1.064 . . . . 0.0 109.552 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.521 ' N ' HG13 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -66.3 -58.31 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.147 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.98 -121.7 7.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -63.73 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -1.214 . . . . 0.0 110.166 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.7 m-30 -87.73 -174.96 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.884 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 39.8 m-85 -128.31 126.82 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.969 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -79.71 97.33 6.53 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.881 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 65.2 m -79.71 169.13 18.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 110.959 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.585 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -160.41 170.57 20.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.0 109.898 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.6 m -97.93 103.43 15.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.507 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 5.5 tpt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.292 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.8 Cg_endo . . . . . 0 C--O 1.215 -0.65 0 N-CA-C 109.834 -0.871 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -81.23 -24.11 37.61 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -51.33 -59.6 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.6 m-85 -45.97 -28.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 109.845 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.0 mt -69.55 131.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.482 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.46 32.15 57.68 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -122.02 -162.93 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.984 . . . . 0.0 110.517 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.6 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 1.7 m -153.82 99.02 2.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 0.0 110.099 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.541 HG13 ' CG2' ' A' ' 69' ' ' VAL . 2.8 m -89.96 -175.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.999 -1.063 . . . . 0.0 110.187 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 13' ' ' VAL . . . -95.04 -160.94 34.01 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.1 Cg_endo -73.41 -47.87 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.963 1.507 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -48.0 73.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 15.9 t -58.98 -47.11 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.981 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.625 ' CE3' ' CD ' ' A' ' 37' ' ' ARG . 6.0 t90 -50.45 -60.76 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.56 -34.87 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.277 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 13.8 t80 -64.49 -66.07 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 1.1 tt -50.34 -24.97 3.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 26' ' ' GLY . 24.3 t -73.36 -42.36 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.792 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.81 69.88 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 24' ' ' LEU . 7.3 tp -77.93 -47.34 18.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.53 -0.732 . . . . 0.0 110.407 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 26' ' ' GLY . 2.5 m -113.33 -42.78 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 110.448 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.567 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 120.36 170.06 14.15 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.13 69.46 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.915 -1.344 . . . . 0.0 110.427 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.16 -52.07 57.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.211 -0.931 . . . . 0.0 110.05 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.528 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . . . -64.03 -44.6 92.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.515 ' CG2' HD22 ' A' ' 21' ' ' LEU . 74.2 t -62.66 -26.31 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.792 . . . . 0.0 110.231 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -83.85 -31.59 25.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.01 . . . . 0.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.23 -17.55 49.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.01 8.11 34.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 57.1 t-20 58.78 72.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.253 -0.905 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 8' ' ' TYR . 5.7 mt -126.2 113.78 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.829 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 12' ' ' THR . 25.1 mtm-85 -99.62 156.26 17.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.712 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.625 ' CD ' ' CE3' ' A' ' 18' ' ' TRP . 8.2 mtp180 -100.4 158.37 15.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.94 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -127.83 -174.6 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.317 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 40' ' ' SER . 9.7 t -60.67 -23.59 64.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.474 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.9 m -178.09 -169.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.3 m-20 -56.6 -24.08 45.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 110.091 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 31.0 t-20 -89.61 110.68 21.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.882 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.6 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.3 p80 -147.28 -176.03 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.107 -0.996 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.576 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -85.16 126.81 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 109.664 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 p -128.87 170.84 12.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 56.55 31.44 19.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.44 44.63 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 34.49 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.085 -1.244 . . . . 0.0 109.848 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.5 mmt85 -113.29 -36.14 5.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.396 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.17 160.08 23.26 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.419 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.576 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 19.5 m95 -131.47 175.29 9.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.598 -0.942 . . . . 0.0 108.646 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -118.9 116.54 26.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.724 -1.235 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -131.62 171.13 13.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.545 -0.722 . . . . 0.0 109.452 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -55.35 -47.62 75.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.054 -1.029 . . . . 0.0 109.228 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 7.4 tttt -135.03 177.05 8.11 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.522 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 17.6 m -119.21 175.93 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.944 -1.097 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 65.1 m-85 -79.75 -176.42 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 110.239 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -39.79 22.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.131 -0.981 . . . . 0.0 110.5 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.577 ' CD2' ' HG3' ' A' ' 60' ' ' GLU . 31.8 p-80 -79.04 7.16 7.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.577 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 7.9 mt-10 -124.42 -170.46 2.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 3.3 p90 -152.43 -161.34 1.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 64' ' ' THR . 47.8 t -123.15 99.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 46.0 p30 -52.11 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.892 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.72 -25.6 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -0.764 . . . . 0.0 110.982 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 28.4 t80 -66.25 -53.13 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.055 -1.028 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 14.7 m-85 -83.16 -11.67 57.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 110.995 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -46.7 -24.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . . . -67.21 -71.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 110.561 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.541 ' CG2' HG13 ' A' ' 13' ' ' VAL . 7.2 p -42.27 -28.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.522 ' N ' HG13 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -64.2 -69.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.168 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.08 -119.94 6.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -27.18 68.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -1.169 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.1 m-85 -99.5 177.05 5.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.201 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 16.0 m-85 -121.02 138.01 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.958 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.487 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 41.1 t -79.51 100.59 7.8 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 108.837 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 9.4 m -79.35 160.84 26.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.17 . . . . 0.0 110.139 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.567 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -159.98 173.46 15.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.52 -0.737 . . . . 0.0 110.22 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 p -103.41 112.81 25.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 110.217 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.578 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.89 -0.85 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HA ' HD13 ' A' ' 9' ' ' ILE . . . -118.54 -22.07 7.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.88 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -55.7 -52.05 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 110.397 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.578 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.2 m-85 -46.22 -25.97 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.877 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.5 mt -61.28 126.85 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.186 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 58.0 32.94 67.53 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -113.18 -162.53 0.81 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.666 -0.902 . . . . 0.0 110.872 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.605 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 3.1 m -157.25 97.04 1.61 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.528 ' HA ' HG23 ' A' ' 69' ' ' VAL . 3.6 m -95.22 174.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.996 -1.065 . . . . 0.0 110.21 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.88 -163.09 37.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 48.2 Cg_endo -74.14 -51.53 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.046 1.551 . . . . 0.0 110.522 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -49.76 76.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 48.6 t -58.93 -47.6 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.581 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 9.9 t-105 -51.73 -58.13 7.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.802 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.36 -39.85 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.131 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.69 -58.13 9.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.461 HD22 HG23 ' A' ' 30' ' ' VAL . 1.5 tt -51.05 -34.12 28.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.121 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 24.4 t -63.65 -47.97 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.44 -40.71 68.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.753 . . . . 0.0 109.823 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.3 -39.78 95.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.603 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -132.46 -88.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.002 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.56 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 172.52 166.37 30.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.9 -20.45 65.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 110.446 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -61.54 1.73 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.112 -0.992 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.603 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.05 -28.74 70.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG23 HD22 ' A' ' 21' ' ' LEU . 37.8 t -70.27 -30.99 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.4 -0.812 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.3 m -76.55 -36.0 57.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.4 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.37 4.63 12.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.288 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 42.2 t-20 57.9 74.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.505 ' O ' ' CZ3' ' A' ' 18' ' ' TRP . 49.1 mt -122.26 121.73 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.5 mtt85 -101.11 150.29 23.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.86 159.61 16.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 110.077 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.58 151.13 51.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -42.98 -26.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.9 m -172.36 -173.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 110.007 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -57.85 -17.31 15.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.224 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.1 t-20 -89.25 98.12 11.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.469 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.605 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.8 p80 -142.49 176.53 8.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 110.53 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.6 p -81.82 130.48 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.783 . . . . 0.0 109.847 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.91 174.64 6.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 48.69 46.31 21.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 109.084 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.09 -151.99 41.15 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.4 40.46 0.84 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -1.208 . . . . 0.0 109.752 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 10.4 mtp180 -112.46 -38.64 4.6 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.985 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -126.1 168.98 18.09 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.133 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.582 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -136.13 172.19 13.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -1.028 . . . . 0.0 109.861 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.4 t -104.41 112.37 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.76 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 7.2 mtt-85 -127.96 142.46 51.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.858 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.44 ' N ' ' CD2' ' A' ' 73' ' ' TYR . 2.1 p -51.89 -46.39 64.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.011 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -137.16 175.67 9.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 11.8 m -153.65 170.69 20.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.891 -1.131 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -79.74 177.57 8.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -79.61 -42.68 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -22.19 0.72 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.304 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.77 -175.69 2.73 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.51 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 3.1 p90 -147.38 -164.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 34.6 t -128.54 98.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -50.15 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.826 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.05 -26.7 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.579 -0.7 . . . . 0.0 110.26 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.483 ' O ' HD11 ' A' ' 7' ' ' ILE . 14.8 t80 -65.6 -49.79 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.578 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.4 m-85 -86.56 -3.09 58.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 111.562 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -17.28 6.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.016 -1.053 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -70.87 -56.67 5.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.95 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.528 HG23 ' HA ' ' A' ' 13' ' ' VAL . 7.9 p -61.11 -27.79 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.969 -1.082 . . . . 0.0 109.469 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -64.57 -49.05 72.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 -137.2 14.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -48.67 -31.56 6.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 109.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 54' ' ' SER . 8.6 m-85 -87.95 -177.83 5.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.006 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 46.8 m-85 -125.81 136.6 53.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 10.7 t -79.47 97.72 6.52 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.034 -1.041 . . . . 0.0 108.755 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 74.1 m -79.01 166.43 22.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.03 -1.044 . . . . 0.0 110.501 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.51 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 17.5 mtp180 -161.19 176.16 11.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.323 0.582 . . . . 0.0 109.83 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 78' ' ' SER . 11.5 p -108.08 104.53 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.505 -0.747 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.2 -179.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HB2' ' CG2' ' A' ' 7' ' ' ILE . 45.0 Cg_endo . . . . . 0 C--O 1.216 -0.609 0 N-CA-C 110.255 -0.71 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.93 -23.27 28.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.443 -0.786 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.615 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -60.01 -38.23 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.687 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 9.7 m-30 -64.05 -18.79 64.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 9.4 mt -81.05 124.12 38.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.162 -0.961 . . . . 0.0 109.016 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 68.56 31.82 74.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -119.62 -163.08 0.96 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.468 -1.019 . . . . 0.0 110.752 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.61 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 11.3 m -155.29 95.37 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' NE2' ' A' ' 43' ' ' HIS . 4.3 m -90.18 171.5 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -83.77 -161.18 31.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 46.7 Cg_endo -74.26 -45.07 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.911 1.479 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.1 m -66.75 -55.49 14.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.496 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 84.1 t -56.09 -45.56 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.577 ' CE3' ' CG ' ' A' ' 37' ' ' ARG . 22.8 t-105 -51.16 -62.99 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.19 -38.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.143 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.9 t80 -63.68 -60.21 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.106 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 1.2 tt -47.89 -55.37 9.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 30' ' ' VAL . 41.3 t -44.15 -56.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.78 -42.74 47.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -53.29 -42.94 67.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 109.988 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.606 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -127.99 -86.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 109.936 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.564 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 176.33 166.1 33.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -61.22 -19.93 62.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -1.145 . . . . 0.0 110.449 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -63.4 1.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -64.8 -20.17 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 26' ' ' GLY . 29.6 t -77.85 -33.6 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.477 -0.764 . . . . 0.0 109.892 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 43.7 m -80.89 -33.16 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.52 -23.49 46.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.28 4.88 11.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 59.4 t-20 60.78 63.98 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.654 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.462 HD13 ' HA ' ' A' ' 30' ' ' VAL . 54.8 mt -113.78 128.39 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.368 -0.832 . . . . 0.0 109.481 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -110.25 145.27 37.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 110.488 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.577 ' CG ' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -90.31 154.38 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 109.761 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -129.54 171.0 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.253 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 t -58.76 -33.3 70.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -159.92 178.94 9.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.567 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 41.6 m-20 -52.33 -33.31 42.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 15.2 t-20 -82.71 99.81 9.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.7 p80 -136.25 177.01 8.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.409 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -75.25 141.66 43.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.977 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 10.9 p -131.79 178.78 6.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 44.16 44.88 6.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.229 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.03 -156.75 51.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' ASN . 22.9 t30 -84.33 41.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.963 -1.316 . . . . 0.0 109.959 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.35 -33.36 3.89 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.149 -0.969 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -121.19 173.84 15.68 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.831 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 16.5 m95 -150.73 161.35 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.424 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 86.4 m -96.5 104.57 16.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.12 . . . . 0.0 109.971 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 6.0 mtt180 -120.23 151.5 39.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 109.976 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.493 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -57.56 -52.84 63.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 109.122 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.38 172.98 10.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 94.6 m -149.5 168.09 24.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.785 -1.197 . . . . 0.0 110.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -79.91 176.22 9.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.731 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -75.34 -44.5 44.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -48.01 -21.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -118.3 174.29 6.32 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.417 -0.802 . . . . 0.0 109.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 11.2 p90 -134.4 -167.65 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.975 . . . . 0.0 110.227 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 64' ' ' THR . 17.9 t -113.97 89.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.73 . . . . 0.0 109.981 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.1 t0 -39.82 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.363 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -52.91 -23.34 6.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 110.591 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.08 -44.01 55.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 20.3 m-85 -89.83 -9.93 47.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 111.622 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -22.17 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.787 -1.196 . . . . 0.0 109.049 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.46 ' HB3' HG23 ' A' ' 7' ' ' ILE . . . -68.91 -52.62 27.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.488 -0.757 . . . . 0.0 110.645 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 70' ' ' CYS . 9.7 p -60.0 -34.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.887 -1.133 . . . . 0.0 110.32 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.557 ' N ' HG13 ' A' ' 69' ' ' VAL . 61.6 m -60.4 -51.68 68.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.955 -1.091 . . . . 0.0 109.682 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.93 -102.78 2.91 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HD2' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -76.57 -5.27 46.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -1.151 . . . . 0.0 109.881 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.65 178.09 4.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 1.1 m-85 -120.5 137.85 54.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 109.755 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 11.3 t -79.69 94.29 5.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.967 -1.083 . . . . 0.0 109.352 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.5 m -77.78 170.75 16.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.003 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.9 mtp180 -160.27 -177.5 6.3 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.244 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 m -110.19 91.15 3.54 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.192 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.473 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 10.3 tpt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.607 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 50.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.29 -41.33 3.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.627 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.651 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -57.64 -38.19 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.451 -0.781 . . . . 0.0 110.443 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.607 ' CD1' ' CG ' ' A' ' 5' ' ' PRO . 45.2 m-85 -62.71 -25.04 67.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.282 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 61.3 mt -73.4 143.72 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 49.51 36.58 24.4 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -122.23 -164.32 1.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.523 -0.986 . . . . 0.0 110.549 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.614 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 3.2 m -152.1 91.77 1.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.032 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.534 HG12 ' CG2' ' A' ' 69' ' ' VAL . 2.7 m -89.14 162.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.111 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.65 -166.68 9.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.1 Cg_endo -73.37 -39.41 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.999 1.526 . . . . 0.0 110.448 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -51.25 43.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.38 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.471 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 48.0 t -57.62 -46.5 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.549 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 35.2 t-105 -49.8 -61.14 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.45 -44.3 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.283 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -58.12 -66.81 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.849 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.529 HD22 ' CG1' ' A' ' 25' ' ' VAL . 5.7 tt -40.52 -56.19 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 110.12 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 21' ' ' LEU . 47.2 t -42.44 -55.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.878 . . . . 0.0 110.061 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.18 -44.85 33.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.27 -49.94 74.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.15 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -117.02 -88.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 175.82 165.71 32.16 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.73 -20.13 63.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -1.129 . . . . 0.0 110.54 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.13 -63.29 1.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.149 -0.969 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -61.91 -19.14 62.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.223 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.487 HG21 ' CD2' ' A' ' 21' ' ' LEU . 10.9 t -75.09 -39.83 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.48 -0.762 . . . . 0.0 109.743 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.5 m -77.8 -28.8 50.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.4 -24.22 42.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 34' ' ' ASN . . . -80.0 5.55 13.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.467 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.1 t-20 58.79 69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.444 ' CG2' ' CZ3' ' A' ' 18' ' ' TRP . 11.0 mt -119.3 135.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mtp180 -115.42 149.84 37.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.549 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 10.8 mtp85 -98.46 143.96 28.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 109.839 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -115.57 164.11 14.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.8 p -48.35 -27.79 2.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.4 m -165.01 -168.32 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 78.9 m-20 -64.32 -22.14 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.296 -0.877 . . . . 0.0 110.166 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.6 t30 -88.58 110.54 20.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.0 p80 -148.72 175.92 10.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.4 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.619 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -79.99 139.07 37.15 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -130.47 176.93 7.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 110.439 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.36 39.45 12.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.76 -151.98 46.86 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -87.44 24.17 1.72 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.171 -1.193 . . . . 0.0 109.972 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -105.65 -28.83 10.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 110.797 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.39 164.53 15.39 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.002 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.619 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 9.3 m95 -142.52 174.41 10.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.44 -1.035 . . . . 0.0 109.701 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 5.6 t -109.23 113.16 25.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 2.3 mtt180 -133.43 143.99 49.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -46.61 -39.31 10.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.971 -1.081 . . . . 0.0 108.766 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 4.7 tttt -135.86 171.1 14.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.518 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 6.3 m -119.73 177.06 5.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.18 -169.16 2.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -84.45 -42.46 15.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.422 -0.799 . . . . 0.0 110.215 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -72.2 -1.2 14.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 17.9 mt-10 -126.65 -179.92 5.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.917 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.541 ' CD1' ' HB2' ' A' ' 79' ' ' ARG . 8.1 p90 -139.74 -162.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.07 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 64' ' ' THR . 47.8 t -110.87 88.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.1 t0 -40.71 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.581 -0.699 . . . . 0.0 110.25 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 4.3 p -57.69 -34.64 69.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.378 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -63.54 -46.38 86.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.651 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 18.1 m-85 -86.57 -6.88 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 111.059 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -50.33 -22.29 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.951 -1.093 . . . . 0.0 109.064 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -67.59 -71.59 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.549 -0.72 . . . . 0.0 110.579 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.75 -29.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -61.01 -65.76 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 110.354 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.96 -115.81 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -61.6 -49.98 74.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -1.203 . . . . 0.0 109.915 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.454 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.6 m-85 -80.0 -177.22 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 2.7 m-85 -121.3 142.27 50.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.483 -0.76 . . . . 0.0 109.096 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.5 t -79.59 100.88 8.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.429 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 33.3 m -78.94 165.87 23.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -157.13 176.67 12.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.85 . . . . 0.0 110.344 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.43 96.59 6.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.541 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.204 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HB2' HG22 ' A' ' 7' ' ' ILE . 48.6 Cg_endo . . . . . 0 C--O 1.215 -0.672 0 N-CA-C 109.859 -0.862 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.16 -36.75 34.65 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -50.7 -47.88 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 110.717 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.483 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 7.8 m-30 -50.68 -34.93 28.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 110.301 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 43.4 mt -69.9 115.6 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.88 28.61 58.59 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 8' ' ' TYR . . . -115.94 -162.65 0.85 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.967 . . . . 0.0 110.71 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.61 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 4.0 m -153.35 93.78 1.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' HG21 ' A' ' 69' ' ' VAL . 3.9 m -93.41 169.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 110.201 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -79.43 -154.95 9.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 49.1 Cg_endo -76.8 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.007 1.53 . . . . 0.0 110.441 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 t -53.21 -50.89 63.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.47 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 21.9 t -59.91 -46.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.118 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.624 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 11.3 t90 -49.47 -65.5 0.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.517 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.02 -41.55 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.395 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 36.6 t80 -59.33 -62.45 1.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.924 . . . . 0.0 109.87 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 25' ' ' VAL . 1.7 tt -43.92 -52.73 6.68 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.393 -0.817 . . . . 0.0 109.811 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 25' ' ' VAL . 40.5 t -52.4 -42.67 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.786 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.86 -45.11 59.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.342 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.86 -27.38 62.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.488 -0.757 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.577 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -124.18 -91.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.682 . . . . 0.0 110.293 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' HG21 ' A' ' 30' ' ' VAL . . . 167.26 -170.57 41.61 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.462 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -75.87 -52.65 9.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.32 . . . . 0.0 110.306 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.56 74.16 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.943 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . . . -69.45 -49.93 50.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 109.782 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.513 ' CG2' HD22 ' A' ' 21' ' ' LEU . 25.0 t -62.88 -21.77 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 19.2 m -79.78 -40.62 28.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.08 -17.21 60.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.19 25.05 2.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.9 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.439 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 46.0 t-20 41.87 67.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 8' ' ' TYR . 16.2 mm -110.21 112.5 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.659 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 5.3 mtt180 -97.6 139.47 33.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.893 . . . . 0.0 110.295 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.624 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -89.52 155.69 19.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.73 157.98 44.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.04 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -45.1 -33.27 2.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.516 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -166.92 -156.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 110.262 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' OD2' ' HD3' ' A' ' 72' ' ' ARG . 59.6 m-20 -71.73 -5.86 37.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.507 -0.746 . . . . 0.0 110.044 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 2.3 t30 -102.57 102.57 12.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.2 p80 -146.03 -175.46 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.454 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.576 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.1 p -86.95 129.49 34.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.443 -0.785 . . . . 0.0 109.568 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.45 177.63 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.426 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 48.03 45.35 19.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 -156.01 52.79 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 19.7 p30 -86.24 34.94 0.63 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.013 -1.286 . . . . 0.0 110.009 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -115.9 -30.6 6.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.131 -0.98 . . . . 0.0 110.788 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -117.92 163.74 12.82 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.483 -1.342 . . . . 0.0 109.773 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.576 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 7.5 m95 -140.23 177.06 8.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.0 109.367 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.484 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 6.2 t -114.55 115.07 26.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 110.928 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -131.91 159.28 39.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 55' ' ' LYS . 5.9 p -57.89 -52.67 64.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.988 -1.07 . . . . 0.0 108.965 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' N ' ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -140.69 139.69 34.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -105.05 163.6 12.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.235 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.63 -164.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' HIS . 8.9 ttp180 -80.64 -43.74 19.99 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.44 ' C ' ' HG2' ' A' ' 60' ' ' GLU . 1.3 m-70 -45.78 -24.49 0.38 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.8 mm-40 -125.91 179.56 5.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.385 -0.822 . . . . 0.0 110.023 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.0 p90 -137.86 -163.11 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.594 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 64' ' ' THR . 25.4 t -113.77 87.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 109.927 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.3 t0 -38.26 90.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.694 -0.629 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.98 -25.34 43.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.467 ' O ' HD11 ' A' ' 7' ' ' ILE . 8.4 t80 -70.8 -51.32 27.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 46' ' ' ALA . 10.9 m-85 -81.44 -6.45 58.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 111.23 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -18.93 2.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.11 -47.02 63.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.9 . . . . 0.0 110.988 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.54 HG11 ' N ' ' A' ' 70' ' ' CYS . 7.9 p -71.54 -24.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.501 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.54 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -66.99 -57.33 7.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.452 -0.78 . . . . 0.0 110.267 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.31 -125.75 8.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.46 ' HD3' ' OD2' ' A' ' 41' ' ' ASP . 5.2 mpt_? -52.51 -36.65 55.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.84 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 39.5 m-85 -90.87 -173.42 3.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.46 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 3.0 m-85 -129.65 142.34 50.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 10.5 t -79.6 99.32 7.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.556 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 8.0 t -79.05 165.41 23.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.129 -0.982 . . . . 0.0 109.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 5.4 mtp180 -157.5 171.93 19.48 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.784 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 79' ' ' ARG . 1.1 m -107.55 76.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 78' ' ' SER . 6.6 ttt-85 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.152 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.596 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.9 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 110.028 -0.797 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -80.44 -21.97 41.62 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.403 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -52.57 -54.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.66 -28.88 3.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 17.3 mt -64.86 123.91 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.75 29.34 74.47 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -116.92 -162.77 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -1.009 . . . . 0.0 110.429 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.595 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.2 m -151.95 95.09 2.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.012 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' HG23 ' A' ' 69' ' ' VAL . 3.2 m -88.87 179.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 110.118 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -94.52 -161.81 34.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.31 -45.68 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.016 1.535 . . . . 0.0 110.318 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -53.1 50.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.454 HG12 ' HB ' ' A' ' 13' ' ' VAL . 10.7 t -58.55 -47.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -0.946 . . . . 0.0 109.856 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.551 ' CZ2' HG12 ' A' ' 30' ' ' VAL . 59.6 t-105 -48.09 -66.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.96 -38.35 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.27 -49.66 76.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' CD1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -60.38 -28.13 67.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . 48.5 t -66.79 -48.75 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 110.0 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.98 92.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.838 . . . . 0.0 109.914 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.45 -41.94 97.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 110.177 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.615 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -130.52 -50.87 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.254 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 30' ' ' VAL . . . 137.02 163.99 9.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -66.2 -9.41 31.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -1.182 . . . . 0.0 110.856 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 -67.64 0.66 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.968 -1.083 . . . . 0.0 109.707 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.615 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.77 -20.08 64.63 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 108.668 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.551 HG12 ' CZ2' ' A' ' 18' ' ' TRP . 14.4 t -70.82 -37.23 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.606 -0.684 . . . . 0.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.7 m -85.04 -25.03 27.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.36 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.866 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.05 25.92 2.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.771 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.456 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 5.8 t-20 40.21 75.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 0.0 110.6 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.56 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 64.3 mt -124.34 118.34 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.768 . . . . 0.0 109.455 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.3 mtt180 -96.91 156.68 16.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 110.512 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 8.9 mtp180 -107.27 139.47 41.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -117.73 164.56 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -42.7 -26.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.356 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.438 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -172.34 -162.42 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 70' ' ' CYS . 54.2 m-20 -66.61 -8.44 27.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.882 . . . . 0.0 110.302 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -94.7 101.99 13.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.516 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 12' ' ' THR . 2.6 p80 -143.55 -179.78 6.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.581 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -88.1 120.92 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 109.66 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 9.3 p -116.51 -178.75 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 110.76 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.493 ' HB1' ' CZ ' ' A' ' 77' ' ' ARG . . . 49.13 41.58 19.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.457 -0.777 . . . . 0.0 108.957 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.57 -153.74 51.0 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.96 36.55 0.67 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.057 -1.26 . . . . 0.0 109.771 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -117.77 -30.74 5.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.418 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -124.64 160.23 19.25 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.893 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.581 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 25.2 m95 -132.18 174.68 9.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.318 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.7 t -107.44 112.53 25.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.421 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -127.77 143.2 51.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.894 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -49.52 -46.45 48.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 108.624 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -125.67 -175.84 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 86.6 m -150.9 160.32 43.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.992 -1.067 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -80.56 171.53 14.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 110.365 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -38.97 67.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -13.68 11.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.733 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -120.88 169.93 9.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 109.557 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 15.5 p90 -132.09 -178.01 4.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.913 -1.117 . . . . 0.0 111.102 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 75.6 t -99.61 94.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.294 0.568 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -47.96 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -50.46 -25.4 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 111.027 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.03 -48.6 43.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.17 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.625 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 32.0 m-85 -89.79 -4.86 57.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.07 -1.019 . . . . 0.0 111.41 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -49.91 -22.89 1.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.942 -1.099 . . . . 0.0 109.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB2' HG23 ' A' ' 7' ' ' ILE . . . -70.99 -65.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.447 -0.783 . . . . 0.0 110.541 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.526 HG23 ' HA ' ' A' ' 13' ' ' VAL . 9.3 p -46.69 -26.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.948 -1.095 . . . . 0.0 109.59 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.526 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -68.63 -64.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -124.14 8.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -24.36 22.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.147 . . . . 0.0 109.953 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.446 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.2 m-85 -102.0 -179.41 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 110.143 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 8.9 m-85 -123.57 130.84 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.131 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.526 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 7.5 t -79.81 105.99 11.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.037 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 66.6 m -102.09 170.07 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.666 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 16.7 mtp180 -149.73 -172.8 4.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.348 0.594 . . . . 0.0 109.559 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 79' ' ' ARG . 5.6 p -115.73 80.42 1.44 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HB2' HG23 ' A' ' 7' ' ' ILE . 47.4 Cg_endo . . . . . 0 N--CA 1.481 0.763 0 N-CA-C 110.429 -0.643 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.86 -27.73 20.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -54.36 -49.65 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 110.442 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.574 ' CD2' HD11 ' A' ' 21' ' ' LEU . 8.5 m-30 -46.6 -29.46 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 109.946 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -66.91 113.83 3.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.211 -0.93 . . . . 0.0 109.547 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 73.13 27.81 67.65 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -110.65 -164.77 0.94 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.527 -0.984 . . . . 0.0 110.619 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.628 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 54.9 m -155.01 100.09 2.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 110.034 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 3.1 m -97.5 163.85 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.104 -0.998 . . . . 0.0 110.036 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.19 -164.73 11.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.2 Cg_endo -73.69 -47.5 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.4 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.02 51.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 81.6 t -60.59 -50.71 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.575 ' CE2' ' HD2' ' A' ' 37' ' ' ARG . 26.8 t-105 -45.17 -66.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.626 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -41.55 -42.33 2.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.474 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.6 t80 -60.73 -65.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.574 HD11 ' CD2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -41.75 -44.33 3.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 110.356 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.46 ' HA ' HG23 ' A' ' 30' ' ' VAL . 84.9 t -54.69 -49.52 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.81 69.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.65 -46.22 91.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.605 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -120.13 -87.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.562 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 177.16 170.21 39.29 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.8 -22.62 67.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -1.102 . . . . 0.0 110.711 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -61.94 1.58 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.605 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.17 -26.49 68.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 33.9 t -71.42 -34.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.751 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 16.9 m -85.32 -20.47 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.905 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -20.52 31.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.85 25.01 2.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.831 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.427 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 49.0 t-20 41.5 74.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.815 . . . . 0.0 110.445 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.533 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 13.5 mt -118.43 120.34 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 7.3 mmt180 -99.09 147.85 24.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 110.474 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HD2' ' CE2' ' A' ' 18' ' ' TRP . 17.5 mtp180 -101.38 136.58 40.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.409 -0.807 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -110.44 160.06 16.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 110.233 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -48.62 -25.7 1.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.917 . . . . 0.0 110.313 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.404 ' OG ' ' C ' ' A' ' 39' ' ' SER . 0.7 OUTLIER -160.07 -176.6 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 56.9 m-20 -62.17 -16.65 54.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 19.8 t-20 -90.4 107.62 19.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.628 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.6 p80 -143.77 175.54 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 110.561 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.577 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 2.2 p -78.68 130.41 35.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.736 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.57 179.34 4.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 47.7 41.76 14.33 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.159 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.56 -153.22 51.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 1.8 m-20 -84.47 41.33 0.83 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.164 -1.198 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.96 -36.51 3.4 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -122.71 166.3 15.21 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.094 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.577 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 11.1 m95 -135.74 172.07 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -1.033 . . . . 0.0 109.649 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.455 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 5.7 t -105.35 111.62 24.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 1.2 mtt180 -129.14 145.14 51.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.451 ' OG ' ' CE1' ' A' ' 73' ' ' TYR . 23.5 m -46.68 -40.44 13.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.033 . . . . 0.0 108.614 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.83 168.52 19.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 7.8 m -117.22 173.67 6.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.899 -1.125 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -79.62 -169.85 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.074 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -87.57 -42.47 12.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.09 -1.22 11.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.229 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 9.2 mt-10 -121.65 -170.88 2.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.7 p90 -150.26 -162.94 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.889 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 64' ' ' THR . 53.9 t -120.35 94.37 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -51.88 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.739 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -42.77 -25.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.691 -0.631 . . . . 0.0 110.598 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.475 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.9 t80 -66.55 -50.07 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 111.287 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.9 m-85 -87.0 -5.76 58.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 111.761 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 t -55.27 -18.27 5.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.854 -1.153 . . . . 0.0 109.663 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . . . -70.25 -49.33 51.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 111.044 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 7.0 p -68.47 -27.93 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.133 . . . . 0.0 109.224 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.97 -53.58 55.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.52 -123.37 6.88 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -42.79 71.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -1.106 . . . . 0.0 109.971 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 22.6 m-30 -85.96 -178.19 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.947 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 10.3 m-85 -121.05 143.23 49.17 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.447 -0.783 . . . . 0.0 109.236 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 t -79.28 99.72 7.21 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.131 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.7 m -79.3 162.87 25.34 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.145 -0.972 . . . . 0.0 110.153 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 1.6 mtp180 -159.2 -176.21 5.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.512 -0.742 . . . . 0.0 110.275 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.464 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -118.31 83.59 2.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.756 . . . . 0.0 110.27 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--O 1.215 -0.661 0 N-CA-C 110.041 -0.792 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.445 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -83.16 -27.17 30.27 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.506 -0.746 . . . . 0.0 110.425 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -56.04 -38.03 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.582 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.43 ' O ' HG12 ' A' ' 35' ' ' ILE . 10.8 m-30 -64.93 -27.29 68.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.281 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 9' ' ' ILE . 49.4 mt -70.09 129.18 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.255 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 63.16 32.02 82.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -123.06 -162.14 1.01 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 110.555 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.604 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 8.4 m -153.2 101.05 2.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 69' ' ' VAL . 3.2 m -99.84 157.43 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 0.0 110.284 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.87 -162.0 5.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.7 Cg_endo -74.57 -40.54 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.018 1.536 . . . . 0.0 110.428 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.3 m -62.81 -58.93 5.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 84.5 t -59.26 -50.53 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.776 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.633 ' CE3' ' CG ' ' A' ' 37' ' ' ARG . 23.7 t-105 -45.09 -64.14 0.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 0.0 109.745 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.15 -44.55 5.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.719 . . . . 0.0 110.387 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 62.4 t80 -57.81 -62.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 25' ' ' VAL . 2.0 tt -44.28 -56.16 4.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.813 . . . . 0.0 109.998 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' LEU . 84.7 t -43.07 -44.55 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.78 -56.31 23.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.202 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.5 tp -49.44 -46.45 47.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.945 . . . . 0.0 110.028 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.611 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -116.37 -89.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.797 . . . . 0.0 110.079 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 173.28 165.27 29.9 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.79 59.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 110.626 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.05 -62.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.105 -0.997 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.611 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.21 -21.38 66.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.493 ' CG2' HD21 ' A' ' 21' ' ' LEU . 24.8 t -74.62 -35.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.471 -0.768 . . . . 0.0 109.885 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -83.57 -26.32 30.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.92 -15.75 38.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.01 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.02 25.1 2.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.773 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.438 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 50.0 t-20 47.36 68.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.552 -0.718 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.566 HG21 ' CZ3' ' A' ' 18' ' ' TRP . 57.6 mt -122.62 126.15 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.415 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 73.1 mtt180 -109.1 146.75 33.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.493 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CG ' ' CE3' ' A' ' 18' ' ' TRP . 0.9 OUTLIER -93.32 144.37 25.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.513 -0.742 . . . . 0.0 109.647 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -116.39 155.0 29.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.969 . . . . 0.0 110.401 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -45.66 -27.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -0.85 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -165.07 -163.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -70.45 -12.69 61.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.332 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.4 OUTLIER -94.57 103.75 15.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.7 p80 -143.42 177.0 8.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 110.336 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.596 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 84.9 p -82.37 131.89 35.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.44 -0.788 . . . . 0.0 109.569 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.9 p -124.27 175.68 6.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 110.62 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 51.11 36.51 15.71 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -150.36 51.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.25 42.64 0.89 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.263 . . . . 0.0 109.827 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.2 mtt180 -117.23 -38.31 3.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -0.911 . . . . 0.0 111.084 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -127.44 171.38 18.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.398 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.596 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 7.2 m95 -137.33 172.78 12.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.535 -0.979 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.46 110.69 22.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.158 . . . . 0.0 111.024 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -128.46 145.45 51.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.4 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 30.1 t -53.09 -53.16 54.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.884 -1.135 . . . . 0.0 108.316 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -124.87 178.4 5.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.455 0.645 . . . . 0.0 110.047 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' CD ' ' A' ' 53' ' ' ARG . 5.3 m -155.63 171.22 20.34 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.817 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -79.72 178.31 8.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.689 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -47.3 15.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -48.59 -21.04 0.51 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 109.64 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -110.5 178.17 4.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 109.705 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.5 p90 -144.18 -164.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.054 -1.029 . . . . 0.0 110.297 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 64' ' ' THR . 39.3 t -127.82 98.02 4.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 1.0 OUTLIER -50.03 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.782 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.6 -26.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.674 -0.641 . . . . 0.0 110.458 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.5 t80 -66.79 -49.39 66.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 111.04 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.646 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 12.4 m-85 -85.77 -8.15 58.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 111.15 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.7 p -49.08 -22.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.921 -1.112 . . . . 0.0 109.017 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.424 ' CB ' HG23 ' A' ' 7' ' ' ILE . . . -65.36 -70.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 12' ' ' THR . 9.8 p -47.43 -29.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.907 -1.121 . . . . 0.0 109.845 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -63.95 -46.19 85.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.32 -132.82 11.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.1 mmt85 -57.07 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -1.19 . . . . 0.0 110.132 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 8.8 m-85 -84.26 -173.26 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 15.9 m-85 -128.39 134.49 48.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 110.078 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.0 t -79.73 97.11 6.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 108.635 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 70.9 m -79.21 166.29 22.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 110.581 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.525 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 13.6 mtp180 -160.77 177.56 10.31 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.217 0.532 . . . . 0.0 109.666 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 t -106.94 106.58 17.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -111.72 -35.61 5.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 110.036 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.01 -50.28 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.57 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.532 ' CE1' ' HB3' ' A' ' 68' ' ' ALA . 15.9 m-30 -48.58 -31.76 7.06 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.887 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 41.7 mt -67.31 113.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.75 27.14 61.33 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -113.11 -164.4 0.92 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.552 -0.969 . . . . 0.0 110.6 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.62 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.0 m -155.89 103.08 2.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 69' ' ' VAL . 4.0 m -98.62 -175.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.21 -160.32 32.5 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.84 -43.64 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.01 1.532 . . . . 0.0 110.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.9 p -65.44 -53.75 38.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG11 ' HB ' ' A' ' 13' ' ' VAL . 60.1 t -59.9 -48.81 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 109.968 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.579 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 14.3 t-105 -48.58 -60.38 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.858 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.07 -42.47 13.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.256 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.4 t80 -59.69 -65.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.468 ' CD1' HD13 ' A' ' 35' ' ' ILE . 3.9 tt -42.58 -43.94 3.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 18' ' ' TRP . 40.1 t -54.34 -50.08 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.96 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.5 -45.66 66.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.27 -41.66 84.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.362 -0.836 . . . . 0.0 109.898 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.605 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.64 -88.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.975 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 172.51 163.99 27.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -18.32 53.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.7 1.07 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.05 -1.031 . . . . 0.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.605 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -61.22 -25.64 67.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.12 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.451 HG21 HD22 ' A' ' 21' ' ' LEU . 37.3 t -68.75 -33.27 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.491 -0.756 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -77.5 -46.67 21.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.26 -17.77 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.27 23.31 2.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.432 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 35.5 t-20 40.69 69.84 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 35' ' ' ILE . 21.2 mt -118.34 122.04 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.468 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.1 mtp180 -104.15 148.79 25.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 110.59 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 5.5 mtt85 -91.93 154.3 18.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.546 -0.721 . . . . 0.0 109.771 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.34 160.62 36.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -44.42 -35.03 2.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.557 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.447 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -164.17 -165.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.404 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -64.37 -11.38 32.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.559 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 24.2 t-20 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.111 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.0 p80 -144.16 177.61 8.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.487 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.589 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.5 p -76.32 131.36 39.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -0.778 . . . . 0.0 109.699 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.51 173.96 8.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.985 -1.072 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 49.83 38.79 16.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.179 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.64 -149.44 51.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -85.14 40.91 0.85 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.098 -1.237 . . . . 0.0 109.706 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.9 mmt180 -113.77 -37.2 4.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.341 -0.849 . . . . 0.0 110.843 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -130.86 173.6 20.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.128 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.589 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -140.17 171.43 14.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.397 -1.061 . . . . 0.0 109.223 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.2 t -106.38 120.5 42.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.791 -1.193 . . . . 0.0 111.287 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.454 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 3.4 mtt-85 -132.95 156.21 47.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.464 -0.772 . . . . 0.0 108.922 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -48.53 -50.05 33.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 107.964 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.66 179.86 5.89 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 4.1 m -127.64 159.92 33.2 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.789 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -79.97 -177.0 5.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.41 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.48 -39.13 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.898 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -12.87 13.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.554 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 77' ' ' ARG . 5.3 mt-10 -124.56 -164.83 1.3 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.427 -0.796 . . . . 0.0 109.933 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.8 p90 -155.44 -162.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.709 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 64' ' ' THR . 78.4 t -119.86 95.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.473 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -53.04 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.334 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -44.17 -24.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.672 -0.643 . . . . 0.0 110.627 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.466 ' O ' HD11 ' A' ' 7' ' ' ILE . 11.8 t80 -66.81 -50.85 61.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 111.164 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 46' ' ' ALA . 8.0 m-85 -86.69 -5.6 59.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.108 -0.995 . . . . 0.0 111.724 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -54.68 -18.29 4.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.875 -1.141 . . . . 0.0 109.573 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . . . -69.33 -51.81 33.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG2' HG13 ' A' ' 13' ' ' VAL . 8.1 p -66.71 -26.84 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 109.414 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -65.26 -44.5 87.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.871 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.08 -128.04 8.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -53.01 -34.02 54.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -1.097 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.559 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.4 m-30 -88.46 -174.62 4.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.001 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -130.17 135.97 48.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.957 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.3 t -79.36 101.25 8.0 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 108.958 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.0 m -83.09 162.31 21.38 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.054 -1.029 . . . . 0.0 109.817 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.42 ' O ' ' CD ' ' A' ' 60' ' ' GLU . 10.0 mtp180 -157.14 -175.84 5.64 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.27 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -119.58 81.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 110.142 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 78' ' ' SER . 1.8 mtm-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.594 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 47.6 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.97 -20.86 32.15 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.663 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -51.84 -57.54 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 111.119 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.2 m-85 -48.07 -27.28 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.063 -1.023 . . . . 0.0 110.236 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 12.4 mt -69.1 128.72 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 57.47 32.05 63.96 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -118.65 -163.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.526 -0.985 . . . . 0.0 110.431 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.608 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 25.4 m -151.81 94.46 1.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.133 -0.979 . . . . 0.0 110.291 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' ' 69' ' ' VAL . 3.3 m -86.24 -168.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.854 -1.154 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.19 -161.46 24.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.13 -45.63 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.805 1.423 . . . . 0.0 110.142 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 p -65.71 -49.3 68.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.3 t -59.34 -48.63 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.827 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.475 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 52.4 t-105 -48.42 -65.63 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.76 -33.2 4.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.808 . . . . 0.0 110.382 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 47.8 t80 -67.95 -70.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 1.5 tt -43.65 -30.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' GLY . 30.6 t -63.29 -57.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.77 -31.56 39.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.963 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.08 -51.74 55.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.308 -0.87 . . . . 0.0 110.43 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 29' ' ' ALA . 2.0 m -114.99 -49.0 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.766 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . 147.1 163.83 10.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.36 -48.3 35.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.239 . . . . 0.0 110.68 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.71 76.24 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 25' ' ' VAL . . . -61.36 -52.13 65.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.317 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.507 ' CG2' HD22 ' A' ' 21' ' ' LEU . 24.1 t -50.02 -31.55 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.724 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -41.63 71.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.108 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.83 63.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.98 5.0 12.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER 59.05 69.09 0.75 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.36 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.454 HD11 HD12 ' A' ' 21' ' ' LEU . 34.3 mt -119.37 134.56 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.5 OUTLIER -109.04 146.04 34.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 110.59 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 7.7 mtp180 -95.18 142.34 27.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -118.5 156.58 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.6 t -42.17 -27.08 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.514 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 25.4 m -164.83 -170.59 2.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.28 -8.38 24.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.085 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 38.7 t-20 -96.52 104.9 16.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.6 p80 -143.45 -176.64 5.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -95.94 146.88 24.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 109.567 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 p -136.36 -177.71 4.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 47.31 37.93 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.089 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.97 -158.77 46.78 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.34 44.21 1.01 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.235 . . . . 0.0 109.709 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -119.14 -34.63 3.82 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.18 -0.95 . . . . 0.0 111.388 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -116.09 163.99 12.31 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.425 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.7 m95 -137.64 173.57 11.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.439 -1.036 . . . . 0.0 109.505 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 5.7 t -116.09 118.01 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.923 -1.11 . . . . 0.0 111.366 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.45 ' NH1' ' CG ' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -133.81 159.0 41.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.488 -0.758 . . . . 0.0 109.13 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -45.12 43.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.95 -1.094 . . . . 0.0 108.88 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 3.1 tttt -138.12 176.8 8.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.532 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 7.1 m -122.4 171.99 8.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.905 -1.122 . . . . 0.0 110.271 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -85.63 -178.6 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -44.0 41.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -67.51 -4.06 10.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 110.21 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -123.37 176.48 6.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.472 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 6.2 p90 -139.41 -160.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.24 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 64' ' ' THR . 76.4 t -125.26 103.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.559 -0.713 . . . . 0.0 109.899 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 9.5 p30 -53.44 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -45.53 -25.34 0.43 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.439 -0.788 . . . . 0.0 110.742 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -73.51 -47.41 41.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.812 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.663 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 32.2 m-85 -85.18 -7.21 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.905 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -49.66 -23.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 109.156 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' A' ' 7' ' ' ILE . . . -70.96 -66.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.516 -0.74 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.543 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 13.0 p -44.25 -31.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.517 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -63.92 -67.86 0.4 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.186 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.54 -124.08 7.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -57.94 -32.18 67.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -1.191 . . . . 0.0 110.042 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 21.3 m-30 -94.38 175.03 6.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.462 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.451 ' HB3' HG11 ' A' ' 62' ' ' VAL . 22.0 m-85 -115.79 133.25 56.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.737 . . . . 0.0 109.168 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -79.23 102.55 8.61 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.916 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 7.8 m -79.26 161.87 26.04 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 0.0 109.948 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.472 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 24.3 mtp180 -155.78 -169.7 3.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.339 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.23 114.93 29.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 110.298 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.292 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.5 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.369 -0.666 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -88.11 -26.12 22.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.429 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -51.86 -51.59 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.2 -0.938 . . . . 0.0 110.855 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.574 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 14.4 m-30 -51.84 -29.21 18.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 21.2 mt -69.1 131.52 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.74 33.17 59.43 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.436 -1.865 . . . . 0.0 108.436 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -119.31 -163.06 0.95 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.606 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 3.9 m -152.22 95.86 2.11 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.013 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 69' ' ' VAL . 2.6 m -92.3 174.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.274 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.92 38.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -73.75 -48.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.987 1.519 . . . . 0.0 110.402 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 1.1 p -59.94 -51.09 71.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 96.6 t -61.24 -52.1 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' VAL . 32.1 t-105 -44.59 -65.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.71 -41.21 3.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 11.4 t80 -61.46 -65.67 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.878 . . . . 0.0 110.241 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.468 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 1.7 tt -42.81 -36.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 64.9 t -60.47 -51.99 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.943 . . . . 0.0 109.819 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.83 51.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.73 -38.6 91.71 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.602 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -131.99 -87.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.331 -0.856 . . . . 0.0 109.989 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 175.08 169.06 36.49 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 110.63 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.14 1.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.149 -0.969 . . . . 0.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.602 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.01 -21.94 66.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.166 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 27.9 t -73.3 -30.99 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.842 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -85.41 -32.05 22.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.07 -24.76 58.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.165 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -79.64 5.98 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 58.3 t-20 58.41 72.77 0.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 8' ' ' TYR . 35.5 mt -122.51 129.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.548 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 13.8 mtt180 -108.97 140.37 42.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm105 -84.2 156.93 21.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -130.92 164.79 24.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -50.85 -27.69 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.4 m -172.38 -170.8 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD1' HG23 ' A' ' 17' ' ' VAL . 6.8 m-20 -58.37 -15.3 10.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -95.13 106.21 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.606 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.7 p80 -147.64 177.01 9.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 110.339 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.622 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -80.14 147.85 31.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.841 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.12 173.89 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.334 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 51.08 36.52 15.63 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.38 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.94 -153.64 48.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -85.65 36.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.066 -1.255 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.23 -30.52 5.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.52 164.58 15.49 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.484 -1.341 . . . . 0.0 109.767 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.622 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 7.9 m95 -143.47 172.64 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 109.572 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 4.6 t -108.38 112.7 25.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.788 -1.195 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 2.0 mtt-85 -128.4 153.38 47.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -52.35 -46.15 65.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 0.0 109.033 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.06 147.85 49.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.499 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 4.0 m -97.44 163.25 12.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.69 -179.25 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.244 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -38.26 51.14 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.218 -0.926 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -68.69 -6.48 26.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.264 -0.898 . . . . 0.0 109.77 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' OE2' ' C ' ' A' ' 77' ' ' ARG . 5.9 mt-10 -126.63 -176.6 3.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -140.76 -166.74 2.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.366 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' THR . 54.7 t -108.92 90.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.526 -0.734 . . . . 0.0 109.975 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 23.7 t0 -41.49 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.1 p -57.53 -31.02 65.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.833 . . . . 0.0 110.568 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -67.29 -48.29 68.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.722 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.637 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 28.3 m-85 -86.28 -6.9 58.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 111.089 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -21.45 4.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.858 -1.151 . . . . 0.0 109.164 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -69.95 -66.84 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.597 -0.689 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.1 p -46.65 -31.05 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.917 -1.115 . . . . 0.0 109.333 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -59.95 -69.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 0.0 109.949 179.361 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.66 -106.41 2.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -53.31 56.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -1.095 . . . . 0.0 110.06 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.489 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 23.7 m-85 -83.94 -169.25 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.424 ' CE2' ' O ' ' A' ' 54' ' ' SER . 7.3 m-85 -126.95 141.95 51.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -0.835 . . . . 0.0 109.476 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.4 t -79.62 97.75 6.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.363 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 16.5 m -78.85 164.14 24.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 9.3 mtp180 -154.35 -177.16 6.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 110.406 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 p -101.37 89.63 3.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.13 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.594 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.6 Cg_endo . . . . . 0 C--O 1.216 -0.605 0 N-CA-C 109.744 -0.906 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.87 -20.94 34.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 110.36 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.637 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.7 -53.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 111.042 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.9 m-85 -49.13 -26.27 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -69.65 136.16 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 52.04 33.28 36.75 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.31 -159.56 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.55 -0.971 . . . . 0.0 110.497 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.603 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 5.2 m -154.19 95.54 1.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 110.307 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.541 ' HA ' HG21 ' A' ' 69' ' ' VAL . 3.0 m -91.47 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.956 -1.09 . . . . 0.0 110.147 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -162.09 28.39 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -74.08 -51.18 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.944 1.497 . . . . 0.0 110.415 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 2.3 p -60.66 -49.2 78.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.155 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.491 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 26.7 t -59.41 -46.67 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.079 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -50.29 -62.77 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.58 -36.82 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.063 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.7 t80 -60.63 -55.06 37.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -55.23 -36.12 65.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HA ' HG22 ' A' ' 30' ' ' VAL . 25.9 t -60.06 -52.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.2 -40.43 67.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.129 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.73 -38.82 89.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.92 -88.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 177.17 164.94 31.69 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -21.81 62.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 110.675 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.79 1.27 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.083 -1.011 . . . . 0.0 110.057 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.24 -21.81 66.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.389 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 44.8 t -74.46 -33.29 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 0.0 110.068 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.7 m -88.8 -21.4 23.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.28 -25.23 31.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -80.59 7.46 9.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.201 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 52.2 t-20 58.43 74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.27 -0.893 . . . . 0.0 110.534 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 2.7 mt -124.38 110.41 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.469 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 2.3 mmt85 -87.3 157.24 19.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.402 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.5 mtm180 -102.17 150.7 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 110.018 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.99 154.55 39.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' ALA . 50.9 m -43.82 -26.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.208 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -166.23 -162.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -72.28 -11.88 60.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.75 106.16 18.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.2 p80 -145.85 175.22 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.177 -0.952 . . . . 0.0 110.454 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.588 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.4 p -80.96 124.45 29.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 0.0 109.823 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.0 p -115.3 -177.59 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.115 -0.991 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.538 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.93 39.36 5.47 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.452 -0.78 . . . . 0.0 109.301 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.71 -150.08 48.94 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 14.4 p30 -87.29 31.38 0.73 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.095 -1.239 . . . . 0.0 110.012 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.92 -28.96 6.86 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.251 -0.905 . . . . 0.0 110.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.97 162.64 14.03 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.925 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.588 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 8.4 m95 -139.55 167.42 22.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.449 -1.03 . . . . 0.0 109.325 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 6.3 t -107.79 108.92 20.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.868 -1.145 . . . . 0.0 111.1 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -130.06 158.96 38.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.836 . . . . 0.0 109.06 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -48.4 51.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.946 -1.097 . . . . 0.0 108.249 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -124.28 -171.24 2.29 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.686 0.755 . . . . 0.0 110.525 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 11.4 m -131.52 164.33 26.03 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.958 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.0 m-85 -79.63 164.76 23.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.153 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -63.56 -44.62 93.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -4.77 13.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.868 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 17.1 mt-10 -123.0 -178.51 3.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.915 . . . . 0.0 110.145 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -139.65 -163.57 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 64' ' ' THR . 70.9 t -111.38 89.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 29.9 t0 -40.63 91.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.185 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -57.27 -30.51 64.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.563 -179.477 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.81 -48.61 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 110.818 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.637 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 22.9 m-85 -83.88 -8.76 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 111.12 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -24.35 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.974 -1.079 . . . . 0.0 109.415 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -67.22 -71.36 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 13' ' ' VAL . 9.9 p -44.18 -29.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.116 -0.99 . . . . 0.0 109.841 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.41 -64.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.57 -116.07 5.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -60.8 -50.98 71.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.451 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 12.4 m-30 -79.91 -175.16 4.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.966 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -122.31 144.83 48.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 t -81.59 97.05 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 109.382 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.468 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 21.8 m -79.39 164.09 24.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.194 -0.941 . . . . 0.0 109.753 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.2 mtp180 -151.16 -179.25 7.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 0.0 110.53 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.473 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 54.4 p -116.59 87.35 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.269 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.2 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -113.48 -29.82 7.06 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.636 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -51.97 -55.28 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.367 -0.833 . . . . 0.0 110.815 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 21.2 m-85 -48.15 -29.33 3.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 6' ' ' ALA . 33.1 mt -68.57 129.22 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.422 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.66 32.01 72.74 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 8' ' ' TYR . . . -122.42 -162.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.983 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.616 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 5.0 m -153.79 100.07 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.534 HG12 ' CG2' ' A' ' 69' ' ' VAL . 2.9 m -93.73 173.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.115 -0.991 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -161.44 35.11 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 46.8 Cg_endo -74.27 -49.67 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.964 1.507 . . . . 0.0 110.39 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -50.19 74.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.23 -0.919 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 55.4 t -61.59 -51.0 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.555 ' CZ3' HG21 ' A' ' 35' ' ' ILE . 57.1 t-105 -44.56 -65.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.703 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HA ' HG23 ' A' ' 22' ' ' VAL . . . -43.53 -43.27 5.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 67.2 t80 -56.89 -64.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.867 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 2.1 tt -44.08 -38.61 3.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 19' ' ' ALA . 15.6 t -54.99 -55.97 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.1 -43.56 64.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.1 tp -55.28 -43.82 75.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.248 -0.908 . . . . 0.0 110.157 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.602 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.6 -88.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.238 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 177.08 166.83 34.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.22 -20.88 63.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -1.148 . . . . 0.0 110.588 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -63.62 1.1 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.031 -1.043 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.602 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.45 -18.49 63.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.174 -0.953 . . . . 0.0 109.208 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 24.2 t -75.98 -32.02 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.468 -0.77 . . . . 0.0 109.729 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.0 m -93.03 -17.1 24.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.34 -24.0 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 34' ' ' ASN . . . -83.18 10.36 8.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 61.9 t-20 58.81 74.07 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.603 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.555 HG21 ' CZ3' ' A' ' 18' ' ' TRP . 7.0 mt -125.1 125.27 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.858 . . . . 0.0 109.605 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.9 mtt180 -107.2 146.35 31.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -89.63 154.24 20.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -126.71 161.53 27.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.368 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -51.7 -26.71 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.392 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 39' ' ' SER . 3.7 m -165.32 -177.18 4.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.9 m-20 -56.41 -24.57 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.574 ' OD1' ' CD2' ' A' ' 73' ' ' TYR . 4.0 t30 -86.81 110.94 20.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.616 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.2 p80 -147.85 175.25 11.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.626 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -77.69 138.79 39.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.347 -0.846 . . . . 0.0 109.689 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.3 p -131.37 178.8 6.44 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.83 36.43 8.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.28 -147.74 46.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -87.13 31.6 0.71 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.198 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -115.03 -31.84 5.93 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.236 -0.915 . . . . 0.0 111.032 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -122.81 165.75 15.4 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.162 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.626 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.7 m95 -144.74 169.71 17.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.461 -1.023 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 5.8 t -109.61 113.33 26.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.829 -1.17 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.8 OUTLIER -132.52 160.96 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 109.126 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -50.84 -50.5 56.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.859 -1.151 . . . . 0.0 108.269 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -124.72 -178.98 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.528 0.68 . . . . 0.0 110.492 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 12.4 m -125.05 166.33 16.57 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.975 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -79.7 171.37 15.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.11 -0.994 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -39.41 71.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.207 -0.933 . . . . 0.0 110.17 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -71.21 -2.99 17.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 13.0 mt-10 -126.39 -172.35 2.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 6.2 p90 -144.52 -164.15 1.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' THR . 54.3 t -110.3 89.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.502 -0.749 . . . . 0.0 109.969 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 30.1 t0 -41.86 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.21 -28.67 65.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' OH ' ' HB1' ' A' ' 6' ' ' ALA . 16.4 t80 -68.86 -49.23 60.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 110.526 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 17.7 m-85 -82.91 -8.56 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 t -51.09 -21.71 2.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.987 -1.07 . . . . 0.0 109.115 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -67.49 -68.97 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 110.294 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' HG12 ' A' ' 13' ' ' VAL . 10.8 p -46.35 -30.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 109.35 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.522 ' N ' HG13 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -60.15 -70.93 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 110.415 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.2 -115.5 5.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -61.0 -39.8 91.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -1.165 . . . . 0.0 109.995 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 29.3 m-85 -92.26 -177.69 4.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.877 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -122.3 145.87 47.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 0.0 109.642 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 8.7 t -85.08 99.24 10.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.64 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 18.3 m -78.36 163.89 25.29 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 109.667 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.0 mtp180 -154.09 -175.58 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 110.658 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -111.87 102.08 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.149 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.272 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.596 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.7 Cg_endo . . . . . 0 C--O 1.215 -0.66 0 N-CA-C 109.921 -0.838 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -80.62 -20.96 42.01 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.631 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.92 -56.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.9 -179.643 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.3 m-85 -47.6 -25.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.0 110.004 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 8.3 mt -69.15 125.49 27.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 60.2 31.41 73.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -118.72 -160.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.447 -1.031 . . . . 0.0 110.759 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.605 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 5.8 m -156.26 104.33 2.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG12 ' CG2' ' A' ' 69' ' ' VAL . 3.4 m -99.03 169.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.154 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 -163.89 21.54 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.497 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.5 Cg_endo -73.73 -46.1 0.35 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.051 1.553 . . . . 0.0 110.281 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -52.43 56.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.503 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 59.6 t -57.63 -41.36 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.568 ' CD2' ' HD2' ' A' ' 37' ' ' ARG . 43.0 t-105 -54.22 -66.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.14 -0.975 . . . . 0.0 109.633 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.27 -33.97 1.77 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.707 . . . . 0.0 110.334 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 74.2 t80 -65.13 -65.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.117 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 35' ' ' ILE . 1.6 tt -44.7 -35.8 2.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.441 ' HA ' HG21 ' A' ' 30' ' ' VAL . 21.7 t -60.96 -48.24 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.21 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.459 -0.776 . . . . 0.0 109.968 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 tp -60.71 -42.98 98.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -121.7 -88.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 110.163 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 175.64 165.77 32.16 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.32 -19.25 61.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -1.132 . . . . 0.0 110.486 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -63.11 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.884 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.4 -19.7 64.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.514 HG13 ' CZ2' ' A' ' 18' ' ' TRP . 38.2 t -75.78 -32.03 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.442 -0.786 . . . . 0.0 109.856 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.2 m -89.37 -23.21 22.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.18 -24.9 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -81.07 8.38 8.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 61.2 t-20 59.21 74.73 0.43 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.562 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 67.9 mt -125.19 128.4 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.437 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mmt180 -109.99 146.32 35.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.568 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 6.6 mtp180 -92.79 148.86 21.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.82 173.69 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.097 -1.002 . . . . 0.0 110.328 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 t -51.29 -37.02 45.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.33 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.497 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.2 m -161.2 -162.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.346 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.2 m-20 -67.47 -18.55 65.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.405 -0.809 . . . . 0.0 110.344 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -91.75 92.19 8.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.273 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.605 ' CE1' ' O ' ' A' ' 12' ' ' THR . 2.7 p80 -127.49 -178.6 4.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.159 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -88.95 117.64 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 46' ' ' ALA . 21.4 p -104.11 -175.47 2.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.439 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 77' ' ' ARG . . . 43.98 39.57 2.8 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.446 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.63 -150.23 50.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 34.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.153 -1.204 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -117.93 -28.63 5.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.319 -0.863 . . . . 0.0 110.924 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -126.53 165.17 19.83 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.165 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 30.2 m95 -138.61 176.16 8.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.044 . . . . 0.0 109.956 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 m -105.66 102.41 11.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 5.3 mtt180 -122.21 137.71 54.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.147 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.559 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -49.25 -41.2 36.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 108.977 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.44 144.13 51.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 4.4 m -103.62 166.8 10.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.038 -1.038 . . . . 0.0 110.048 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -79.9 167.8 20.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.417 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -41.03 90.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.22 -6.18 17.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 15.5 mt-10 -126.18 178.04 6.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 109.887 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.583 ' CE1' ' HB2' ' A' ' 77' ' ' ARG . 12.6 p90 -133.49 -170.32 2.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.277 179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 64' ' ' THR . 41.8 t -107.48 87.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 32.0 t0 -40.49 91.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.617 -0.677 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.2 -27.73 55.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.572 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' OH ' ' HB1' ' A' ' 6' ' ' ALA . 19.7 t80 -70.43 -50.35 39.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.886 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.631 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 24.0 m-85 -82.7 -8.0 59.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 111.065 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 -21.39 3.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.017 -1.052 . . . . 0.0 109.308 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -69.96 -51.16 34.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.552 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 7.6 p -64.24 -31.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.95 -1.094 . . . . 0.0 110.495 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.509 ' N ' HG12 ' A' ' 69' ' ' VAL . 57.8 m -62.74 -52.3 63.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.944 -1.097 . . . . 0.0 109.466 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 -119.56 5.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.09 -23.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 110.11 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -116.67 178.44 4.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.559 ' CE2' ' O ' ' A' ' 54' ' ' SER . 1.6 m-85 -115.73 147.22 41.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 8.8 t -79.5 95.91 5.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 0.0 109.58 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 77' ' ' ARG . 31.3 m -78.66 160.98 27.24 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.957 -1.09 . . . . 0.0 109.355 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.583 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 43.4 mtp180 -157.83 -172.52 3.97 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.359 -0.838 . . . . 0.0 110.591 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 7.6 t -114.87 96.31 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.611 -0.681 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.481 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.6 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.425 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.24 -21.49 9.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.781 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.651 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -56.09 -44.9 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.454 -0.778 . . . . 0.0 110.807 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.607 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.3 m-85 -55.86 -24.17 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.987 . . . . 0.0 110.758 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 54.3 mt -61.18 127.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 54.7 32.58 54.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -112.29 -170.83 1.73 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.504 -0.997 . . . . 0.0 110.645 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.587 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.2 m -145.75 90.13 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.546 HG12 ' CG2' ' A' ' 69' ' ' VAL . 3.1 m -82.99 175.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.04 -1.038 . . . . 0.0 109.826 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.83 -166.49 42.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 44.0 Cg_endo -72.21 -46.49 0.51 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.976 1.514 . . . . 0.0 110.185 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -47.57 82.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 57.1 t -59.5 -51.81 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.581 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 36.4 t-105 -44.43 -66.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 109.824 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.71 -39.76 2.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.844 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 38.9 t80 -62.44 -64.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.363 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -42.74 -52.0 5.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 30' ' ' VAL . 73.2 t -47.65 -50.89 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.78 -46.53 59.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 tp -60.58 -38.87 86.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.844 . . . . 0.0 110.036 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.603 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -126.99 -89.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 173.55 171.25 37.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.38 -19.18 65.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -1.169 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.95 -63.13 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.07 -1.018 . . . . 0.0 109.945 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.603 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.84 -21.87 66.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 24.6 t -74.0 -33.48 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.726 . . . . 0.0 109.929 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 m -85.31 -27.01 26.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.009 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.02 -25.93 48.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.948 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -81.46 3.25 25.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.025 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.472 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.2 t-20 58.73 77.95 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.59 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.578 HG21 ' CZ3' ' A' ' 18' ' ' TRP . 2.6 mt -121.43 140.76 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.505 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 5.5 mtt180 -117.49 153.82 32.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.567 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 19.0 mtp-105 -109.04 134.3 51.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -109.44 173.82 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 40' ' ' SER . 77.9 p -49.58 -27.48 4.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.5 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 39.0 m -167.71 -166.08 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -65.83 -10.17 35.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.472 ' OD1' ' CG ' ' A' ' 73' ' ' TYR . 2.8 m-20 -96.31 105.58 17.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.9 p80 -145.71 -179.85 6.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -0.977 . . . . 0.0 110.647 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.625 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -91.64 148.31 22.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.443 -0.786 . . . . 0.0 109.521 179.627 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 9.3 p -141.27 -177.32 5.07 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 110.611 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.3 43.54 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.27 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.69 -161.04 53.92 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -83.82 41.33 0.79 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.031 -1.276 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -119.38 -31.16 4.71 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.64 158.76 14.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.223 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.625 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.1 m95 -140.05 169.05 18.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -1.028 . . . . 0.0 109.189 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 4.6 t -112.45 115.91 29.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.786 -1.197 . . . . 0.0 110.893 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 0.9 OUTLIER -132.44 161.38 33.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.349 -0.844 . . . . 0.0 109.25 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -46.08 66.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.985 -1.072 . . . . 0.0 108.856 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.52 163.19 30.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 10.9 m -103.73 170.22 8.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 110.265 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 21.5 m-85 -87.39 -178.88 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.2 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -75.23 -38.47 60.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.333 -0.854 . . . . 0.0 110.008 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.54 0.74 13.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -132.36 177.9 7.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 9.7 p90 -138.89 -168.83 2.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' THR . 26.2 t -104.07 89.63 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.64 -0.663 . . . . 0.0 109.828 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.489 ' OD2' ' CD ' ' A' ' 77' ' ' ARG . 16.8 t0 -42.64 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.8 p -58.08 -32.74 68.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -44.89 80.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.651 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 37.8 m-85 -89.1 -5.99 57.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.963 -179.347 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 t -50.51 -22.5 1.97 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.013 -1.055 . . . . 0.0 108.766 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . . . -70.61 -67.78 0.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 13' ' ' VAL . 12.9 p -44.71 -28.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.018 -1.051 . . . . 0.0 109.671 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.531 ' N ' HG11 ' A' ' 69' ' ' VAL . 1.1 m -67.08 -62.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.453 -0.78 . . . . 0.0 110.449 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.7 -114.81 4.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -69.04 -34.0 74.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' CG ' ' OD1' ' A' ' 42' ' ' ASN . 61.7 m-85 -87.79 179.72 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 7.0 m-85 -121.89 129.55 52.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -0.853 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -79.46 99.61 7.3 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.04 -1.038 . . . . 0.0 108.816 179.376 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.9 m -78.38 163.83 25.33 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.903 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 10.1 mtp180 -148.02 176.55 10.09 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 110.31 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 t -103.93 88.5 3.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 6.7 ttm180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.6 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.4 Cg_endo . . . . . 0 C--O 1.215 -0.672 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.507 ' HA ' ' CD1' ' A' ' 9' ' ' ILE . . . -80.22 -22.48 41.77 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -51.37 -55.11 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -179.663 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.25 -30.76 5.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 6' ' ' ALA . 65.0 mt -67.99 135.23 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 54.43 33.55 53.69 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.154 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -125.51 -160.28 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.513 -0.992 . . . . 0.0 110.417 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.584 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 3.6 m -155.18 92.57 1.44 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.952 . . . . 0.0 110.451 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.539 ' HA ' HG23 ' A' ' 69' ' ' VAL . 2.9 m -84.21 -147.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 110.28 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -125.58 -161.31 10.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.22 -47.27 0.32 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.992 1.522 . . . . 0.0 110.542 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -55.64 11.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 64.2 t -53.71 -39.74 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.578 ' CD2' ' HD2' ' A' ' 37' ' ' ARG . 25.9 t90 -55.99 -61.87 2.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.76 -38.23 3.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -66.16 -44.2 84.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' VAL . 1.3 tt -65.1 -27.89 69.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 110.27 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.51 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 85.9 t -71.37 -42.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 110.281 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.7 tp -72.92 -69.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 110.794 -179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.623 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 14.9 p -88.43 -26.48 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 110.702 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 25' ' ' VAL . . . 119.72 161.37 11.57 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 22' ' ' VAL . . . -63.42 -63.2 1.25 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -1.121 . . . . 0.0 110.318 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.2 -34.25 31.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.992 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.623 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.6 -43.67 96.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.483 HG12 HD12 ' A' ' 35' ' ' ILE . 49.8 t -60.84 -39.76 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m -71.47 -23.45 61.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.19 -20.8 31.75 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.391 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.11 9.14 29.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.513 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 1.3 t-20 59.13 68.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.383 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.483 HD12 HG12 ' A' ' 30' ' ' VAL . 3.3 mt -120.13 110.81 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.652 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.1 mtm105 -92.04 160.11 15.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.555 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.578 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 8.4 mtp-105 -110.54 151.52 27.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.83 -172.46 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 4.9 t -71.92 -2.76 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 170.65 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.076 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -71.24 -9.65 58.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.7 t-20 -97.39 100.48 11.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.133 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.0 p80 -142.22 176.78 8.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.112 -0.993 . . . . 0.0 110.501 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.5 p -78.51 129.74 35.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.16 175.64 6.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 110.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.81 42.74 20.49 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.73 -150.65 49.74 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -86.17 38.57 0.77 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.103 -1.234 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.3 mtm-85 -116.96 -35.35 4.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.171 -0.956 . . . . 0.0 111.013 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -125.45 165.49 18.58 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.501 -1.333 . . . . 0.0 109.931 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.9 m95 -136.77 175.0 10.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.443 -1.034 . . . . 0.0 109.673 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.453 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 5.6 t -107.97 120.09 41.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.976 -1.078 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -139.02 144.89 39.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.36 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.47 ' CB ' ' HD3' ' A' ' 55' ' ' LYS . 1.4 m -45.78 -38.73 7.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.954 -1.092 . . . . 0.0 108.479 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.8 -162.83 1.27 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.455 ' SG ' HG21 ' A' ' 62' ' ' VAL . 20.7 m -143.4 179.06 7.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.928 -1.108 . . . . 0.0 110.37 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.93 -176.12 5.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.028 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -84.26 -38.46 20.46 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 9.58 7.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 11.1 mt-10 -124.06 -168.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.6 p90 -154.4 -160.09 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.896 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 64' ' ' THR . 66.2 t -122.5 96.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.683 -0.636 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.473 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -52.69 89.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 109.796 -179.63 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -43.08 -24.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.58 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 63' ' ' ASP . 26.6 t80 -67.32 -55.13 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.83 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.3 m-85 -81.95 -9.92 59.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.195 -0.941 . . . . 0.0 110.982 -179.286 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 t -48.25 -23.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.094 -1.004 . . . . 0.0 109.215 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -67.54 -71.5 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.722 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 13' ' ' VAL . 9.3 p -43.33 -29.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 109.668 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.528 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -62.44 -58.67 6.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.471 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.69 -136.91 12.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.47 -27.69 4.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -1.166 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -93.71 179.18 5.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.152 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.525 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 10.9 m-85 -122.68 137.29 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 178.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 t -78.76 103.35 8.65 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.969 -1.082 . . . . 0.0 108.818 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.5 m -79.58 163.06 24.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.523 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 26.3 mtp180 -160.08 -170.24 2.78 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.534 -0.729 . . . . 0.0 110.274 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.69 114.9 21.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.826 . . . . 0.0 110.22 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.174 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HB2' HG23 ' A' ' 7' ' ' ILE . 46.4 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.95 -28.44 27.81 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -54.75 -50.47 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 110.366 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.538 ' CD2' HD11 ' A' ' 21' ' ' LEU . 9.9 m-30 -46.97 -27.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 49.1 mt -64.19 118.55 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.562 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 65.06 30.65 78.5 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -178.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -106.52 -161.57 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.51 -0.994 . . . . 0.0 110.809 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.611 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 4.3 m -156.35 92.28 1.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.539 ' HA ' HG23 ' A' ' 69' ' ' VAL . 3.4 m -93.74 169.75 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.288 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.97 -161.68 36.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.6 Cg_endo -74.09 -38.79 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.024 1.539 . . . . 0.0 110.414 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.94 -53.96 22.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 110.142 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.531 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.6 t -58.48 -46.86 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.986 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.44 ' CZ3' HG23 ' A' ' 35' ' ' ILE . 28.3 t-105 -49.06 -65.2 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.646 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.48 -40.91 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 110.263 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 54.0 t80 -59.24 -58.0 10.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.538 HD11 ' CD2' ' A' ' 8' ' ' TYR . 2.8 tt -51.73 -36.2 46.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 40.8 t -58.4 -49.29 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.085 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.16 82.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.178 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 tp -57.14 -44.71 83.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.609 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.39 -88.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.265 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.575 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 176.02 166.93 34.16 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -20.34 63.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -1.192 . . . . 0.0 110.637 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.57 -64.24 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.081 -1.012 . . . . 0.0 109.779 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -60.76 -23.5 65.02 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.024 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.521 ' CG2' HD22 ' A' ' 21' ' ' LEU . 21.9 t -67.43 -37.02 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.443 -0.786 . . . . 0.0 109.533 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.2 m -85.26 -23.85 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.22 -23.05 54.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.6 24.76 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 30.7 t-20 41.23 75.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 30' ' ' VAL . 53.1 mt -117.2 126.47 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.496 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -100.78 146.06 27.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.564 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -91.5 146.91 23.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.83 . . . . 0.0 109.693 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.45 152.91 42.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' ALA . 18.2 t -42.27 -27.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.211 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.436 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m -171.65 -165.03 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -65.23 -12.91 56.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 30.9 t-20 -95.8 103.38 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.575 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.611 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.5 p80 -145.77 -179.9 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.363 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.578 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.4 p -84.66 133.33 34.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.694 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.0 p -122.06 174.78 6.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 50.0 33.09 6.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.323 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 -144.93 43.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.87 40.65 0.82 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.025 -1.28 . . . . 0.0 109.976 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -113.11 -40.37 3.96 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 110.989 -179.412 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.478 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -131.6 172.37 20.9 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.271 -1.443 . . . . 0.0 110.573 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.578 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.3 m95 -136.22 177.18 8.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.895 . . . . 0.0 109.356 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -107.62 115.07 29.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' NH1' ' HB2' ' A' ' 51' ' ' TRP . 1.6 mtt180 -132.16 142.95 49.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.729 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 2.1 t -48.1 -43.15 30.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.883 -1.135 . . . . 0.0 108.834 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.11 50.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 6.3 m -101.85 162.2 13.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.952 -1.092 . . . . 0.0 110.331 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -79.98 167.34 20.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.887 . . . . 0.0 110.478 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -67.01 -39.55 87.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -63.91 -9.89 17.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.918 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 13.3 mt-10 -126.48 179.15 5.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.212 -0.93 . . . . 0.0 109.817 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 13.4 p90 -130.58 -169.45 2.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -0.96 . . . . 0.0 110.34 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 64' ' ' THR . 41.9 t -111.08 88.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 62' ' ' VAL . 3.7 t70 -38.56 91.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.43 0.633 . . . . 0.0 110.477 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.85 -29.54 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 110.049 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.467 ' O ' HD12 ' A' ' 7' ' ' ILE . 51.2 t80 -68.48 -53.51 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.435 -0.79 . . . . 0.0 110.462 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 46' ' ' ALA . 11.6 m-85 -80.09 -4.26 52.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 111.489 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -16.62 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.944 -1.097 . . . . 0.0 109.626 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -73.19 -45.99 53.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.003 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 13' ' ' VAL . 10.0 p -71.63 -26.28 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.935 -1.103 . . . . 0.0 109.343 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -65.28 -50.91 63.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.77 . . . . 0.0 109.83 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.12 -131.04 10.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -33.67 9.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -1.074 . . . . 0.0 109.798 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 8.9 m-85 -92.83 -177.63 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.857 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 6.8 m-85 -126.69 140.77 52.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 8.6 t -79.48 97.25 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.568 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 14.2 m -79.23 163.26 25.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.981 . . . . 0.0 110.069 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.636 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 6.5 mmm180 -153.59 -172.43 4.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 110.242 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 29.3 p -120.17 81.03 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.489 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.169 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HB2' ' CG2' ' A' ' 7' ' ' ILE . 47.2 Cg_endo . . . . . 0 C--O 1.214 -0.698 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.49 -20.31 37.05 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.547 -0.72 . . . . 0.0 110.22 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.638 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -57.73 -39.18 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.879 . . . . 0.0 110.457 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.565 ' CD2' HD13 ' A' ' 21' ' ' LEU . 12.8 m-30 -63.14 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.518 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.8 mt -72.44 126.55 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 109.281 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.79 31.01 79.36 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -118.54 -163.08 0.93 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.501 -0.999 . . . . 0.0 110.711 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.606 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 1.8 m -154.85 99.54 2.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -0.894 . . . . 0.0 109.835 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.527 HG13 ' CG2' ' A' ' 69' ' ' VAL . 3.1 m -94.72 178.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.991 -1.068 . . . . 0.0 110.445 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.12 -161.74 37.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 45.6 Cg_endo -73.33 -46.52 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.985 1.519 . . . . 0.0 110.509 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -47.78 74.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.317 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.514 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 14.9 t -58.8 -46.05 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.447 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 7.7 t90 -52.66 -55.67 20.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.55 59.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.605 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.19 -59.06 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.92 . . . . 0.0 110.302 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.565 HD13 ' CD2' ' A' ' 8' ' ' TYR . 1.6 tt -52.04 -36.31 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.791 . . . . 0.0 110.366 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 26' ' ' GLY . 46.8 t -62.73 -48.58 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.11 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.85 -34.76 68.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.54 -39.15 77.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.376 -0.828 . . . . 0.0 110.371 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.612 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -128.71 -52.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.425 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . 134.85 164.19 10.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -65.2 -7.99 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -1.087 . . . . 0.0 110.884 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.947 -1.096 . . . . 0.0 109.817 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.612 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -64.74 -19.25 65.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.855 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.52 ' CG2' HD22 ' A' ' 21' ' ' LEU . 18.2 t -75.21 -32.83 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.9 m -87.26 -27.01 23.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.044 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.94 -19.91 36.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -84.57 9.18 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 110.156 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER 59.05 72.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.345 -0.847 . . . . 0.0 110.624 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 8' ' ' TYR . 38.0 mt -124.96 114.54 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 109.692 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.8 mtt-85 -98.67 152.11 19.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 4.1 mtm180 -93.68 159.59 15.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -134.52 164.02 28.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.18 -25.31 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.459 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -179.54 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.293 -179.865 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 62.1 m-20 -65.97 -10.45 39.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -98.33 100.19 11.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.351 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.606 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.0 p80 -143.25 175.04 10.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.943 . . . . 0.0 110.451 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.572 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 5.7 p -80.38 125.63 30.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.403 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.97 177.44 4.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.07 44.03 18.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.47 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.42 -152.13 51.49 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -86.75 36.14 0.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.061 -1.258 . . . . 0.0 109.989 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -31.2 5.11 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.225 -0.922 . . . . 0.0 110.859 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.487 ' CA ' ' HG2' ' A' ' 77' ' ' ARG . . . -118.78 163.46 13.17 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.061 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.572 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 8.1 m95 -140.84 165.92 26.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -1.082 . . . . 0.0 109.839 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.5 t -104.37 107.95 19.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 0.0 110.787 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -128.29 149.93 50.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -0.898 . . . . 0.0 109.622 179.351 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 65.8 p -55.99 -49.87 72.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 109.035 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -130.49 173.57 10.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 57.1 m -148.6 172.04 15.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -79.54 -170.29 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.506 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -45.28 10.69 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.338 -0.852 . . . . 0.0 110.332 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.7 -20.31 1.2 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 109.517 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -113.58 170.77 8.0 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.395 -0.816 . . . . 0.0 109.832 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.9 p90 -133.85 -168.33 2.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 0.0 110.145 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 64' ' ' THR . 62.6 t -111.76 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.546 -0.721 . . . . 0.0 110.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.2 t0 -40.21 91.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 110.19 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' VAL . 2.8 p -55.13 -33.98 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 110.505 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.93 -46.79 83.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.78 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.638 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 27.4 m-85 -87.2 -6.48 58.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 0.0 111.021 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -21.96 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.053 . . . . 0.0 108.904 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -69.67 -66.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 0.0 110.53 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.538 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 9.7 p -48.54 -26.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.077 . . . . 0.0 109.603 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' N ' HG13 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -65.39 -63.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 110.231 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -114.94 5.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -61.06 -47.98 83.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -1.181 . . . . 0.0 110.027 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.46 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 22.5 m-85 -82.69 -178.45 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 2.0 m-85 -121.23 138.82 54.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.7 t -79.68 98.49 6.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.762 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 96.1 m -79.06 173.16 12.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.955 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.5 mtp180 -160.55 179.88 8.22 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.482 -0.761 . . . . 0.0 110.276 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.68 117.49 34.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.159 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.522 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 2.0 m-20 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.671 0.272 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 1' ' ' ASN . 47.2 Cg_endo -74.15 126.42 10.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.867 1.456 . . . . 0.0 110.476 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -166.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.253 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 5' ' ' PRO . 1.6 mm -52.67 146.46 17.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' HG23 ' A' ' 4' ' ' ILE . 46.1 Cg_endo -76.09 164.08 31.92 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.093 1.575 . . . . 0.0 110.053 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.58 -24.78 33.77 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.654 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -53.51 -54.83 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.79 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 10.0 m-30 -48.48 -26.82 2.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 110.172 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 15.7 mt -71.84 139.15 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.391 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 49.06 35.93 19.85 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -123.72 -161.84 1.01 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.542 -0.975 . . . . 0.0 110.515 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.596 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 5.6 m -153.93 93.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 69' ' ' VAL . 2.9 m -88.76 -171.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.062 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -100.58 -163.6 28.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.4 Cg_endo -72.83 -48.82 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.963 1.507 . . . . 0.0 110.458 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 t -62.78 -52.09 64.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG2' ' OD1' ' A' ' 41' ' ' ASP . 79.5 t -58.31 -45.85 89.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 110.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.603 ' CZ3' ' NH2' ' A' ' 37' ' ' ARG . 22.2 t90 -50.35 -63.92 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.917 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.03 -36.14 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 52.1 t80 -62.21 -60.97 2.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.463 HD12 HD12 ' A' ' 35' ' ' ILE . 2.6 tt -49.47 -34.55 17.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 64.1 t -60.39 -51.04 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.152 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.88 76.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.433 -0.792 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -0.935 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -126.34 -88.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 176.18 166.0 32.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.88 -19.32 60.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -1.147 . . . . 0.0 110.562 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -62.94 1.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.115 -0.991 . . . . 0.0 109.949 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -64.54 -21.02 66.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.327 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.462 HG21 HD23 ' A' ' 21' ' ' LEU . 38.0 t -75.86 -32.44 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.49 -0.756 . . . . 0.0 109.755 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 m -93.29 -14.99 26.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.057 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.07 -24.67 21.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.016 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -82.18 9.34 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.2 t-20 59.34 72.6 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 110.652 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 21' ' ' LEU . 22.4 mt -119.45 120.38 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.627 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 12' ' ' THR . 10.1 mtm180 -101.19 149.07 24.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.569 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.603 ' NH2' ' CZ3' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -100.22 152.26 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.823 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.82 172.47 9.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.167 -0.958 . . . . 0.0 110.405 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 1.2 p -50.92 -27.31 7.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.477 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 5.1 m -172.06 -173.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 2.6 m-20 -55.12 -22.83 18.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 17.6 t-20 -87.8 107.73 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.5 p80 -147.33 -175.98 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -95.2 148.73 22.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 10.4 p -139.9 -176.08 4.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.935 . . . . 0.0 110.458 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' CYS . . . 45.84 43.17 9.75 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.3 -157.66 53.45 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.54 44.44 1.04 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.045 -1.267 . . . . 0.0 109.598 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -117.33 -34.37 4.34 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.292 -0.88 . . . . 0.0 111.342 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.02 165.22 12.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.233 -1.46 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 3.5 m95 -140.32 171.37 14.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.608 -0.937 . . . . 0.0 108.948 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.496 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.1 t -113.99 123.4 49.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 111.565 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' NH2' ' HB3' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -135.1 156.65 48.65 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' ARG . 80.0 p -46.58 -41.42 14.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.86 -1.15 . . . . 0.0 109.027 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -142.63 178.27 7.74 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.537 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 10.8 m -122.15 165.69 15.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.895 -1.128 . . . . 0.0 110.153 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -79.93 175.36 10.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -73.47 -39.45 64.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 0.0 110.646 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -2.74 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.139 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.36 -174.66 3.06 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 5.8 p90 -146.72 -159.7 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 64' ' ' THR . 45.1 t -125.44 104.85 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.627 -0.671 . . . . 0.0 109.594 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 75' ' ' CYS . 9.7 p30 -51.69 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -44.07 -25.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.706 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.35 -48.5 41.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 111.085 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.654 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 60.0 m-85 -89.28 -4.66 58.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 111.408 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -51.08 -23.1 2.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.147 . . . . 0.0 108.693 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 7' ' ' ILE . . . -72.01 -66.08 0.69 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.624 -0.672 . . . . 0.0 110.538 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 13' ' ' VAL . 13.2 p -44.08 -30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.078 -1.013 . . . . 0.0 109.67 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -65.47 -63.76 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.109 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.0 -132.6 11.08 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -51.88 -34.55 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.168 . . . . 0.0 110.06 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.35 -174.01 4.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -130.72 128.57 41.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.848 . . . . 0.0 109.877 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.515 ' CB ' ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -79.03 99.38 6.86 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.94 -1.1 . . . . 0.0 108.804 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 5.6 m -79.56 160.99 26.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 1.1 mtp180 -151.0 170.93 18.15 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 110.144 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.38 117.02 33.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.716 0.293 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.42 112.04 3.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.115 1.587 . . . . 0.0 110.391 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 4' ' ' ILE . 3.1 tm? -114.23 134.19 55.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' A' ' 21' ' ' LEU . 5.0 mm -48.79 146.3 5.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.44 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.641 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 49.2 Cg_endo -70.56 -157.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.14 1.6 . . . . 0.0 110.032 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.18 -43.45 2.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.86 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.506 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -54.11 -39.43 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.641 ' CD1' ' CG ' ' A' ' 5' ' ' PRO . 47.3 m-85 -59.93 -31.78 70.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 66.1 mt -72.87 143.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.454 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.98 35.26 63.37 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 69' ' ' VAL . . . -127.77 -162.57 1.18 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -1.065 . . . . 0.0 110.646 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 4.7 m -150.35 89.87 1.61 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.53 ' HA ' HG22 ' A' ' 69' ' ' VAL . 3.1 m -83.19 -163.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.018 -1.051 . . . . 0.0 110.336 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.92 -165.62 21.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -73.16 -44.29 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.313 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -65.01 -49.88 68.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.121 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.508 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 44.4 t -60.64 -49.81 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.587 ' CZ3' ' CG2' ' A' ' 35' ' ' ILE . 46.4 t-105 -46.26 -63.87 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.97 -43.06 6.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -59.62 -66.64 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD2' HD12 ' A' ' 4' ' ' ILE . 4.8 tt -40.78 -49.17 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.489 -0.757 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.5 t -48.75 -50.96 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.39 64.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.399 -0.813 . . . . 0.0 109.868 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.18 -42.2 94.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 110.016 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.617 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -125.93 -87.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.972 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 173.4 163.58 27.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.71 60.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -1.132 . . . . 0.0 110.612 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -62.63 1.32 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.14 -0.975 . . . . 0.0 109.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.617 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -61.13 -25.33 66.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG12 ' CZ2' ' A' ' 18' ' ' TRP . 20.1 t -68.64 -34.0 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 m -77.09 -44.27 31.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.82 65.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -88.62 23.06 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.964 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 62.7 t-20 39.82 70.78 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.423 -0.798 . . . . 0.0 110.646 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.587 ' CG2' ' CZ3' ' A' ' 18' ' ' TRP . 14.8 mt -115.16 130.16 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.716 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 10.2 mtt180 -114.86 148.96 37.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.416 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.567 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 6.6 mtp180 -99.47 149.14 23.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.473 -0.767 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -122.95 159.47 28.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.112 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.3 m -45.08 -25.09 0.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 39' ' ' SER . 44.6 m -167.47 -171.99 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.113 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.1 m-20 -64.22 -14.85 58.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 11.2 t-20 -93.53 109.72 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.5 p80 -146.55 -175.69 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.584 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.9 p -88.66 127.24 35.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.681 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.9 p -117.32 178.1 4.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.575 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.06 33.14 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.357 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.63 -149.37 36.6 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -87.6 29.12 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.129 -1.218 . . . . 0.0 109.963 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -108.4 -32.12 7.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.218 -0.926 . . . . 0.0 110.855 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.8 164.68 15.68 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.584 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 9.4 m95 -138.46 178.59 7.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.456 -1.026 . . . . 0.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.3 t -115.6 113.43 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.889 -1.132 . . . . 0.0 110.707 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -131.58 157.32 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -56.21 -52.77 63.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.966 -1.083 . . . . 0.0 108.76 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' N ' ' OG ' ' A' ' 54' ' ' SER . 1.1 tttt -138.81 139.58 38.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 2.0 t -103.87 168.33 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.449 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.4 m-85 -79.62 168.09 19.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -38.16 86.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.786 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.86 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.995 -1.066 . . . . 0.0 109.739 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.3 mt-10 -124.05 179.3 4.91 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.358 -0.839 . . . . 0.0 109.998 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.6 p90 -135.29 -166.53 1.85 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.809 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 64' ' ' THR . 28.6 t -112.31 88.24 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.461 -0.774 . . . . 0.0 109.933 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 75' ' ' CYS . 51.8 t0 -37.14 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.377 0.608 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.75 -28.29 60.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -69.91 -44.11 70.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 22.3 m-85 -92.12 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 111.001 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.86 -20.64 3.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.025 -1.047 . . . . 0.0 108.924 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -70.03 -71.49 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.575 -0.703 . . . . 0.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.532 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 7.2 p -44.28 -28.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.066 -1.021 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.532 ' N ' HG12 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -63.05 -59.39 4.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 110.271 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -134.47 11.76 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -31.85 12.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -1.194 . . . . 0.0 109.859 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.7 m-85 -91.58 -179.63 5.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 110.115 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 2.1 m-85 -122.95 140.57 52.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.765 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.1 t -79.53 98.25 6.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.085 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 10.9 t -78.58 163.77 25.23 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.04 . . . . 0.0 110.198 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 44.4 mtp180 -159.12 176.08 12.69 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.406 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -94.84 109.89 21.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.162 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 118.75 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.998 1.525 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 tt -110.0 46.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' A' ' 21' ' ' LEU . 7.5 mm -81.81 148.73 62.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.637 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 47.5 Cg_endo -72.03 -158.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.004 1.528 . . . . 0.0 109.484 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.23 -44.14 2.91 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -53.58 -49.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.357 -0.839 . . . . 0.0 110.049 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CD1' ' CG ' ' A' ' 5' ' ' PRO . 41.7 m-85 -47.13 -33.67 5.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 109.742 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 73.8 mt -72.17 124.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.294 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 72.95 29.94 64.17 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -120.33 -163.12 0.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.476 -1.014 . . . . 0.0 110.766 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.602 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 4.2 m -153.66 99.77 2.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.875 . . . . 0.0 109.84 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 10.4 m -95.38 168.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.224 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -75.65 -162.62 11.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -75.47 -49.08 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.028 1.541 . . . . 0.0 110.35 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 t -60.46 -54.22 48.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 110.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 76.3 t -58.33 -45.67 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.628 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 27.3 t90 -51.56 -66.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.64 -34.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.735 . . . . 0.0 110.289 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 56.4 t80 -64.05 -62.29 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.582 HD12 ' CD2' ' A' ' 8' ' ' TYR . 1.4 tt -52.36 -26.22 11.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 26' ' ' GLY . 72.8 t -69.94 -50.55 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.731 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.08 -26.62 50.31 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.219 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 tp -73.91 -50.59 19.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.518 -0.739 . . . . 0.0 110.669 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.566 ' CG2' ' N ' ' A' ' 26' ' ' GLY . 2.1 m -113.05 -44.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.462 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 129.2 169.0 12.48 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -67.57 -26.74 66.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.901 -1.353 . . . . 0.0 110.479 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 -54.97 14.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB1' HG23 ' A' ' 25' ' ' VAL . . . -64.05 -40.76 97.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.87 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.526 ' CG2' HD23 ' A' ' 21' ' ' LEU . 54.7 t -68.29 -25.26 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 110.181 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 40.2 m -86.67 -22.41 26.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.2 -19.59 26.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -86.46 17.11 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.22 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 60.8 t-20 55.4 67.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 110.603 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.52 ' CD1' HD13 ' A' ' 21' ' ' LEU . 65.2 mt -120.35 110.06 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.457 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -91.77 152.83 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.661 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.628 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 1.4 mtp180 -94.76 157.18 16.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 109.691 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -132.03 163.58 28.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.432 ' C ' ' OG ' ' A' ' 40' ' ' SER . 84.1 p -53.33 -31.91 46.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.44 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.432 ' OG ' ' C ' ' A' ' 39' ' ' SER . 2.1 m -164.74 -179.8 6.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -49.68 -23.42 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.082 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.9 t30 -87.7 110.42 20.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.1 p80 -150.12 177.85 9.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 5.2 p -81.49 130.41 35.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.46 -0.775 . . . . 0.0 109.62 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 p -121.97 173.85 7.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 0.0 110.424 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 48.37 40.24 14.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.124 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 -149.25 49.23 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -87.21 23.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.138 -1.213 . . . . 0.0 109.864 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -100.84 -34.62 9.74 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 0.0 111.051 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.37 166.57 14.92 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.987 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.59 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.4 m95 -140.99 171.07 14.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -1.07 . . . . 0.0 109.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 4.4 t -106.07 108.79 20.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.59 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -130.41 157.45 42.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.211 -0.93 . . . . 0.0 109.938 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -63.93 -52.75 58.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.965 . . . . 0.0 109.021 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.4 tttt -128.75 174.66 9.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.503 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 58.2 m -150.34 170.08 19.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.867 -1.145 . . . . 0.0 110.747 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 15.7 m-85 -81.97 -176.06 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.476 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -80.37 -46.95 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.25 -0.906 . . . . 0.0 110.646 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' ARG . 1.5 t-80 -46.46 -23.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 109.153 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mt-10 -118.67 175.35 5.77 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.456 -0.777 . . . . 0.0 109.445 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.8 p90 -139.94 -167.26 2.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.543 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 64' ' ' THR . 49.8 t -110.96 89.45 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.636 -0.665 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 16.8 t0 -40.6 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.49 -0.756 . . . . 0.0 110.42 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.25 -24.93 30.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.566 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.475 ' O ' HD12 ' A' ' 7' ' ' ILE . 18.6 t80 -68.74 -51.99 35.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.526 -0.734 . . . . 0.0 110.714 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.591 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 9.1 m-85 -81.58 -4.98 57.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.161 -0.962 . . . . 0.0 111.414 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.7 p -49.6 -21.5 1.02 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.057 -1.027 . . . . 0.0 109.979 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' HD11 ' A' ' 7' ' ' ILE . . . -66.09 -69.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 110.602 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 70' ' ' CYS . 9.9 p -49.07 -26.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.056 . . . . 0.0 109.476 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.539 ' N ' HG13 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -68.2 -44.29 76.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -124.32 6.5 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.58 74.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -1.209 . . . . 0.0 110.045 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 80.4 m-85 -81.22 -178.99 7.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' A' ' 54' ' ' SER . 1.1 m-85 -125.36 138.92 54.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.32 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 16.4 t -81.85 101.06 9.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.145 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 76.9 m -79.49 175.0 11.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 9.2 mtp180 -160.52 179.8 8.29 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 110.054 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.2 85.5 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.782 0.325 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.47 160.46 44.45 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.09 1.574 . . . . 0.0 110.495 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.09 -177.39 2.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' CD1' HD22 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -55.08 156.53 7.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 109.974 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 51.3 Cg_endo -77.26 169.64 20.97 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.154 1.607 . . . . 0.0 110.169 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -88.83 -23.6 22.78 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 110.164 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.632 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.41 -57.16 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 110.995 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.582 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.2 m-30 -48.32 -25.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.018 -1.051 . . . . 0.0 110.169 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.0 mt -73.17 128.37 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 58.05 32.79 67.49 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -117.46 -159.21 0.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.515 -0.991 . . . . 0.0 110.601 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.614 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 2.8 m -153.13 91.05 1.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 109.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 5.9 m -90.66 164.62 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 110.506 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -89.69 -158.02 33.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.8 Cg_endo -74.42 -42.78 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.912 1.48 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -63.81 -57.75 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 110.089 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.9 t -58.51 -49.67 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.73 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.535 ' CH2' ' CG1' ' A' ' 30' ' ' VAL . 56.4 t-105 -46.52 -66.4 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.705 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.44 -38.11 1.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.485 -0.759 . . . . 0.0 110.33 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 6.4 t80 -63.36 -64.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.532 HD22 ' CD1' ' A' ' 4' ' ' ILE . 1.8 tt -46.68 -51.28 16.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.325 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.458 ' HA ' HG23 ' A' ' 30' ' ' VAL . 78.3 t -48.77 -52.87 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.69 44.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.108 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.76 -41.88 92.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.604 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -126.21 -86.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 175.7 170.03 38.06 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.43 -22.07 66.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 110.607 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.58 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.045 -1.034 . . . . 0.0 109.838 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.604 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.95 -22.28 66.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.204 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.535 ' CG1' ' CH2' ' A' ' 18' ' ' TRP . 24.1 t -73.54 -35.72 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.466 -0.771 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 9.9 m -78.65 -34.27 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.967 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.17 -23.89 59.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.49 4.88 12.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 59.5 t-20 59.05 68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.446 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.449 HD11 ' HB1' ' A' ' 33' ' ' ALA . 25.8 mt -117.57 109.95 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -83.45 143.71 30.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.55 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.06 150.88 23.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.789 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.85 162.14 24.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.54 -26.33 20.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.311 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.532 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 2.5 m -170.44 -170.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 16' ' ' SER . 15.2 m-20 -62.5 -13.9 35.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.902 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.5 m-20 -99.61 102.82 14.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.0 p80 -141.47 175.38 9.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.414 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.586 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.3 p -79.17 129.59 34.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p -122.32 176.74 5.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.421 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.68 37.83 7.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.3 -148.62 45.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 14.8 p30 -87.84 26.64 1.29 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.168 -1.195 . . . . 0.0 109.912 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -105.63 -29.23 10.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.23 21.1 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.391 -1.385 . . . . 0.0 109.893 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 6.7 m95 -137.67 170.9 15.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.46 -1.023 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -105.75 115.89 31.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.667 -1.27 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -133.39 155.22 49.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.78 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -55.56 -56.97 14.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.891 -1.131 . . . . 0.0 108.754 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.79 -165.15 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 1.2 m -163.64 173.38 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.728 -1.233 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.51 -179.3 6.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.501 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -40.31 20.31 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.163 -0.961 . . . . 0.0 110.359 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.63 -16.88 4.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.54 178.19 4.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.477 -0.765 . . . . 0.0 109.539 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 4.4 p90 -144.39 -164.66 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.8 t -126.01 98.31 4.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -48.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.47 -26.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.67 . . . . 0.0 110.47 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 63' ' ' ASP . 12.2 t80 -68.77 -52.47 30.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -81.21 -10.18 59.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 111.005 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -49.35 -22.85 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.05 -1.031 . . . . 0.0 109.357 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -66.92 -69.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 9.8 p -45.7 -30.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 109.624 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.51 -53.99 50.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.09 -139.39 14.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -50.49 -23.17 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -1.108 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.467 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 12.2 m-85 -94.27 -170.54 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.541 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 37.0 m-85 -129.32 133.47 47.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 109.732 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 7.5 t -79.98 101.94 8.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 109.212 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.7 m -78.7 167.21 21.54 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.875 -1.141 . . . . 0.0 110.376 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.493 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 2.4 mtp180 -160.87 167.44 26.67 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.91 102.46 13.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.204 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.66 152.75 48.34 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.106 1.582 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.0 -179.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -67.25 150.51 97.85 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.628 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 47.7 Cg_endo -73.31 170.02 20.87 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.164 1.613 . . . . 0.0 109.932 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.18 -44.71 11.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.442 -0.786 . . . . 0.0 110.238 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.619 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -51.46 -41.86 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.286 -0.884 . . . . 0.0 110.483 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.628 ' CD1' ' HG2' ' A' ' 5' ' ' PRO . 28.3 m-85 -60.57 -33.73 73.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.179 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -71.97 138.5 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.118 -0.989 . . . . 0.0 109.514 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.96 33.95 81.11 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -127.48 -162.25 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.519 -0.989 . . . . 0.0 110.543 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.611 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 2.3 m -151.15 98.43 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.237 -0.914 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.519 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 2.9 m -93.22 -175.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.12 -164.56 37.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -72.62 -41.9 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.966 1.509 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -67.67 -47.34 69.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 47.6 t -62.64 -37.94 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.571 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 13.3 t90 -57.33 -58.9 6.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -50.45 -39.41 47.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 3.9 t80 -57.72 -65.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD21 ' CG2' ' A' ' 30' ' ' VAL . 4.1 tt -41.98 -44.38 3.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.506 -0.747 . . . . 0.0 109.987 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.458 ' HA ' HG23 ' A' ' 30' ' ' VAL . 71.7 t -55.27 -48.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.28 76.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -59.57 -41.12 89.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.605 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.94 -88.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.405 -0.81 . . . . 0.0 110.199 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.574 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 176.76 163.92 29.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.41 -20.59 56.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.603 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.24 1.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.094 -1.004 . . . . 0.0 109.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.605 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.93 -22.0 66.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.537 ' CG2' HD21 ' A' ' 21' ' ' LEU . 26.0 t -71.39 -33.58 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.8 m -86.25 -26.71 24.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.84 -18.87 49.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.892 . . . . 0.0 109.782 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.65 23.32 2.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 62.5 t-20 43.36 71.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 21' ' ' LEU . 65.2 mt -121.59 112.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.454 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -95.71 148.88 22.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.681 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.571 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm-85 -89.69 159.12 17.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.51 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 110.005 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 1.8 m -42.82 -26.73 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.908 . . . . 0.0 110.08 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' ALA . 3.2 m -174.43 -171.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 110.073 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD2' ' HG3' ' A' ' 72' ' ' ARG . 70.6 m-20 -57.51 -17.24 12.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 t-20 -91.25 108.64 20.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.327 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.611 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.4 p80 -151.65 179.72 8.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.208 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -81.09 148.04 29.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.864 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 7.8 p -141.28 -178.47 5.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.569 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 47.42 42.7 14.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 -154.88 48.54 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.424 -1.87 . . . . 0.0 108.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -84.05 42.91 0.9 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.112 -1.228 . . . . 0.0 109.665 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -119.31 -35.33 3.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.2 -0.938 . . . . 0.0 111.252 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -127.11 171.21 18.72 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.319 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 17.5 m95 -138.63 179.13 6.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.983 . . . . 0.0 109.405 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.0 t -112.59 118.5 35.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.812 -1.18 . . . . 0.0 110.769 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -130.47 158.3 40.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.663 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -53.39 -47.84 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.049 -1.032 . . . . 0.0 109.146 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 140.93 44.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 15.5 m -77.48 159.38 29.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 110.097 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -80.59 -171.43 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.418 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -43.23 39.3 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.12 3.85 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 9.3 mt-10 -129.35 162.74 27.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 0.0 109.958 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 24.3 p90 -129.36 -178.83 4.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.522 ' CG2' ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -91.42 92.84 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.332 0.587 . . . . 0.0 109.474 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' OD2' ' CG ' ' A' ' 77' ' ' ARG . 1.5 m-20 -51.52 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.694 . . . . 0.0 109.782 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -51.7 -22.65 3.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 0.0 110.683 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -70.02 -56.93 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 111.043 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.619 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 4.0 m-85 -86.06 -3.47 58.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 111.374 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.57 -23.03 1.45 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.581 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.33 -71.97 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.656 -0.653 . . . . 0.0 110.757 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 70' ' ' CYS . 9.8 p -44.24 -27.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.521 ' N ' HG12 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -63.5 -63.35 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.265 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.15 -112.29 4.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG3' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mtt180 -62.66 -50.2 72.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -1.162 . . . . 0.0 110.093 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 20.2 m-85 -79.89 -173.05 3.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.951 . . . . 0.0 110.006 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -126.56 139.23 53.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.799 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 t -79.6 107.3 12.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 0.0 108.735 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 10.3 m -97.45 157.57 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.793 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.545 ' CG ' ' OD2' ' A' ' 63' ' ' ASP . 8.5 mtp180 -142.63 -175.36 4.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.724 -0.61 . . . . 0.0 109.801 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.8 p -110.6 94.88 5.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.26 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.815 0.341 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.429 ' HG2' HD21 ' A' ' 24' ' ' LEU . 46.5 Cg_endo -73.26 109.38 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.971 1.511 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 4' ' ' ILE . 2.6 tm? -42.83 136.41 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.245 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.503 ' N ' HD11 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -42.67 142.14 1.42 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 0.0 110.116 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.545 ' HD2' ' CD2' ' A' ' 8' ' ' TYR . 45.3 Cg_endo -76.05 162.47 34.37 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.056 1.556 . . . . 0.0 110.027 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.469 ' CB ' ' OH ' ' A' ' 65' ' ' TYR . . . -61.67 -43.34 99.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.016 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.627 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -50.39 -54.24 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.62 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.545 ' CD2' ' HD2' ' A' ' 5' ' ' PRO . 8.8 m-30 -51.57 -31.03 23.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.972 . . . . 0.0 110.369 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 58.3 mt -71.95 129.41 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 60.14 31.66 73.79 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -114.55 -162.47 0.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -1.028 . . . . 0.0 110.668 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.601 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 1.8 m -154.68 97.89 2.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 109.758 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HA ' HG23 ' A' ' 69' ' ' VAL . 3.5 m -93.77 172.78 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.099 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -85.82 -159.59 32.35 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 48.9 Cg_endo -74.74 -46.58 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.015 1.534 . . . . 0.0 110.5 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -67.65 -50.43 57.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.53 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.0 t -57.22 -45.78 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.992 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.581 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 11.3 t90 -52.17 -61.45 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.623 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.89 -37.97 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.4 t80 -60.29 -53.75 53.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.985 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.493 HD21 ' CD1' ' A' ' 4' ' ' ILE . 1.6 tt -57.63 -55.57 33.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.11 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.462 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.4 t -44.01 -61.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.065 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.19 -41.26 17.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' A' ' 2' ' ' PRO . 11.0 tp -59.95 -41.44 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.609 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -126.4 -88.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 177.05 166.18 33.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.94 -19.25 60.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.13 . . . . 0.0 110.699 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.17 -64.25 1.01 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.019 -1.051 . . . . 0.0 109.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.52 -21.74 65.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.214 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' A' ' 22' ' ' VAL . 24.5 t -73.65 -34.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.454 -0.778 . . . . 0.0 109.714 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.0 m -87.8 -19.64 27.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 109.899 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.21 -22.1 28.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.837 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.01 23.51 2.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.88 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.435 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 37.8 t-20 42.54 76.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 110.355 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.6 110.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 109.701 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -93.22 144.44 25.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.907 . . . . 0.0 110.589 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 2.7 mtm180 -82.93 166.0 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 0.0 109.708 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -139.05 161.87 36.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.01 . . . . 0.0 110.266 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.475 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -51.19 -36.48 41.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.296 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.479 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 16.5 m -164.72 -179.07 5.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 38.6 m-20 -46.63 -30.89 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.588 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 17.2 t-20 -84.96 110.56 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.7 p80 -147.27 175.91 10.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.073 -1.017 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.585 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 17.9 p -78.23 127.54 32.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.426 -0.797 . . . . 0.0 109.749 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 p -120.49 168.43 11.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.006 -1.059 . . . . 0.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 53.22 50.0 18.66 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.551 -0.718 . . . . 0.0 109.303 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.17 -149.94 25.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -86.18 36.49 0.68 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.171 -1.193 . . . . 0.0 110.065 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 3.5 mtt180 -113.57 -33.13 5.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -127.28 168.03 19.51 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.0 m95 -142.22 170.79 15.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -117.73 113.68 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.777 -1.202 . . . . 0.0 110.684 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -132.7 163.56 28.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.353 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.445 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 24.8 p -50.57 -48.17 57.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.897 -1.127 . . . . 0.0 108.508 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.74 179.83 5.33 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.641 0.734 . . . . 0.0 110.562 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 20.9 m -121.63 168.99 11.14 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.037 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -79.82 -173.62 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.5 -36.82 21.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.245 -0.909 . . . . 0.0 110.25 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -78.98 5.22 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 46.6 mt-10 -128.83 -175.68 3.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 7.5 p90 -141.12 -162.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 109.833 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' THR . 53.2 t -111.69 89.08 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.122 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 14.2 t0 -41.64 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 0.0 110.213 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -57.84 -27.1 62.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.207 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.469 ' OH ' ' CB ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -68.6 -49.51 58.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 110.605 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.4 m-85 -83.76 -9.28 58.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.945 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -22.57 1.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.039 -1.038 . . . . 0.0 109.537 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 7' ' ' ILE . . . -66.96 -70.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 110.303 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 13' ' ' VAL . 10.6 p -45.74 -25.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.998 -1.064 . . . . 0.0 109.341 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.482 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -62.78 -67.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.781 . . . . 0.0 110.048 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.4 -96.13 2.0 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -56.77 7.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.422 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.588 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 24.6 m-85 -89.27 -168.99 2.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.091 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 1.3 m-85 -123.34 149.64 44.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.84 . . . . 0.0 109.73 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 15.7 t -86.03 100.88 12.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 0.0 109.765 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.2 m -79.34 163.56 24.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 3.4 mtp180 -153.95 176.88 11.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 t -104.67 94.37 5.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.171 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.155 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.802 0.334 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.6 124.87 10.13 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.016 1.535 . . . . 0.0 110.46 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -134.78 160.79 37.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.518 ' CD1' ' HG ' ' A' ' 21' ' ' LEU . 1.2 mm -43.03 148.55 0.58 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.597 ' CG ' ' CE2' ' A' ' 8' ' ' TYR . 47.8 Cg_endo -75.09 166.73 28.48 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.01 1.531 . . . . 0.0 109.937 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -84.68 -16.74 40.82 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.421 -0.799 . . . . 0.0 110.287 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -55.91 -47.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -0.869 . . . . 0.0 110.737 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CE2' ' CG ' ' A' ' 5' ' ' PRO . 22.8 m-85 -52.37 -24.42 7.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.476 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 70.2 mt -60.37 136.51 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.715 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 46.31 34.92 6.58 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -113.15 -167.48 1.2 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.509 -0.994 . . . . 0.0 110.671 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.595 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.7 m -150.06 88.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.546 HG11 ' CG2' ' A' ' 69' ' ' VAL . 3.0 m -83.16 -165.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.35 -163.46 17.8 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -73.11 -45.45 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -67.59 -49.14 64.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.099 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 91.1 t -58.91 -48.0 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.579 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 7.8 t-105 -50.81 -59.35 4.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.732 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.46 -39.67 7.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.095 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 68.1 t80 -63.62 -63.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.335 -0.853 . . . . 0.0 110.145 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -42.37 -54.44 3.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.211 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.1 t -48.02 -50.2 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' TYR . . . -51.11 -43.46 61.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 110.161 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -66.14 -36.12 82.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.593 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.04 -88.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 171.59 167.72 32.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.59 62.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -1.171 . . . . 0.0 110.524 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -63.66 1.1 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.053 -1.03 . . . . 0.0 109.914 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.19 -22.46 65.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.909 . . . . 0.0 109.297 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.7 t -73.61 -31.46 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.486 -0.759 . . . . 0.0 109.979 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -87.83 -26.83 22.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.225 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -25.38 43.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -83.64 6.59 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 110.353 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 46.8 t-20 58.32 79.3 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -0.92 . . . . 0.0 110.619 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 40.0 mt -118.84 136.97 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.466 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -110.18 151.2 27.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 110.575 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.5 OUTLIER -100.95 143.05 31.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.0 109.887 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.88 152.2 37.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.406 ' C ' ' OG ' ' A' ' 40' ' ' SER . 9.6 m -42.39 -27.08 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -163.4 -176.02 4.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.196 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.5 -12.21 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.34 103.44 15.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 12' ' ' THR . 6.1 p80 -142.62 -178.56 5.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.615 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -92.92 147.22 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.802 . . . . 0.0 110.002 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.0 p -137.26 178.59 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 110.313 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 46.97 46.55 15.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.884 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.22 -153.11 48.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.66 42.88 0.94 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.054 -1.262 . . . . 0.0 109.604 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.4 mmm180 -109.44 -39.0 5.32 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 111.21 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.21 164.12 18.91 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.761 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.615 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.3 m95 -134.76 167.75 20.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.066 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 4.7 t -106.71 117.52 34.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.77 -1.206 . . . . 0.0 111.272 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mtt-85 -129.24 153.05 48.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.208 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.16 -48.98 64.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.09 . . . . 0.0 109.257 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.2 tttt -138.44 177.5 7.83 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 16.3 m -149.96 169.98 19.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.823 -1.173 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -80.03 -175.02 4.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.404 -0.81 . . . . 0.0 110.562 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 -43.36 14.64 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.324 -0.86 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.51 -20.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.688 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.88 174.35 5.98 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 9.2 p90 -138.96 -165.1 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.95 -1.094 . . . . 0.0 110.376 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 64' ' ' THR . 16.6 t -124.95 103.63 12.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 75' ' ' CYS . 14.8 p30 -47.91 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.85 -25.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.414 -0.803 . . . . 0.0 110.505 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' ASP . 12.8 t80 -71.34 -48.05 52.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.625 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 40.7 m-85 -90.2 -4.1 57.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 111.292 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -22.97 2.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 108.587 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.567 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -71.67 -64.48 0.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.671 -0.643 . . . . 0.0 110.485 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.546 ' CG2' HG11 ' A' ' 13' ' ' VAL . 10.1 p -44.96 -30.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.997 -1.064 . . . . 0.0 109.552 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.521 ' N ' HG13 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -66.3 -58.31 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.147 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.98 -121.7 7.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -63.73 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -1.214 . . . . 0.0 110.166 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.7 m-30 -87.73 -174.96 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.884 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 39.8 m-85 -128.31 126.82 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.969 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -79.71 97.33 6.53 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.881 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 65.2 m -79.71 169.13 18.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 110.959 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.585 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -160.41 170.57 20.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.0 109.898 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.6 m -97.93 103.43 15.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.507 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 5.5 tpt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.292 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.52 138.06 26.32 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.853 1.449 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 -163.08 0.94 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.473 HG21 ' HD2' ' A' ' 5' ' ' PRO . 1.5 mm -55.11 147.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.8 Cg_endo -75.66 164.46 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.077 1.567 . . . . 0.0 109.834 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -81.23 -24.11 37.61 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.644 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -51.33 -59.6 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.6 m-85 -45.97 -28.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 109.845 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.0 mt -69.55 131.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.482 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.46 32.15 57.68 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -122.02 -162.93 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.984 . . . . 0.0 110.517 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.6 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 1.7 m -153.82 99.02 2.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 0.0 110.099 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.541 HG13 ' CG2' ' A' ' 69' ' ' VAL . 2.8 m -89.96 -175.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.999 -1.063 . . . . 0.0 110.187 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 13' ' ' VAL . . . -95.04 -160.94 34.01 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.1 Cg_endo -73.41 -47.87 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.963 1.507 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -48.0 73.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 15.9 t -58.98 -47.11 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.981 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.625 ' CE3' ' CD ' ' A' ' 37' ' ' ARG . 6.0 t90 -50.45 -60.76 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.56 -34.87 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.277 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 13.8 t80 -64.49 -66.07 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 1.1 tt -50.34 -24.97 3.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 26' ' ' GLY . 24.3 t -73.36 -42.36 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.792 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.81 69.88 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 24' ' ' LEU . 7.3 tp -77.93 -47.34 18.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.53 -0.732 . . . . 0.0 110.407 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 26' ' ' GLY . 2.5 m -113.33 -42.78 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 110.448 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.567 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 120.36 170.06 14.15 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.13 69.46 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.915 -1.344 . . . . 0.0 110.427 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.16 -52.07 57.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.211 -0.931 . . . . 0.0 110.05 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.528 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . . . -64.03 -44.6 92.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.515 ' CG2' HD22 ' A' ' 21' ' ' LEU . 74.2 t -62.66 -26.31 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.792 . . . . 0.0 110.231 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -83.85 -31.59 25.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.01 . . . . 0.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.23 -17.55 49.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.01 8.11 34.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 57.1 t-20 58.78 72.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.253 -0.905 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 8' ' ' TYR . 5.7 mt -126.2 113.78 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.829 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 12' ' ' THR . 25.1 mtm-85 -99.62 156.26 17.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.712 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.625 ' CD ' ' CE3' ' A' ' 18' ' ' TRP . 8.2 mtp180 -100.4 158.37 15.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.94 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -127.83 -174.6 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.317 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 40' ' ' SER . 9.7 t -60.67 -23.59 64.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.474 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.9 m -178.09 -169.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.3 m-20 -56.6 -24.08 45.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 110.091 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 31.0 t-20 -89.61 110.68 21.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.882 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.6 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.3 p80 -147.28 -176.03 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.107 -0.996 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.576 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -85.16 126.81 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 109.664 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 p -128.87 170.84 12.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 56.55 31.44 19.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.44 44.63 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 34.49 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.085 -1.244 . . . . 0.0 109.848 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.5 mmt85 -113.29 -36.14 5.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.396 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.17 160.08 23.26 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.419 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.576 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 19.5 m95 -131.47 175.29 9.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.598 -0.942 . . . . 0.0 108.646 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -118.9 116.54 26.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.724 -1.235 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -131.62 171.13 13.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.545 -0.722 . . . . 0.0 109.452 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -55.35 -47.62 75.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.054 -1.029 . . . . 0.0 109.228 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 7.4 tttt -135.03 177.05 8.11 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.522 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 17.6 m -119.21 175.93 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.944 -1.097 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 65.1 m-85 -79.75 -176.42 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 110.239 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -39.79 22.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.131 -0.981 . . . . 0.0 110.5 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.577 ' CD2' ' HG3' ' A' ' 60' ' ' GLU . 31.8 p-80 -79.04 7.16 7.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.577 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 7.9 mt-10 -124.42 -170.46 2.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 3.3 p90 -152.43 -161.34 1.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 64' ' ' THR . 47.8 t -123.15 99.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.491 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 46.0 p30 -52.11 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.892 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.72 -25.6 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -0.764 . . . . 0.0 110.982 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 28.4 t80 -66.25 -53.13 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.055 -1.028 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 14.7 m-85 -83.16 -11.67 57.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 110.995 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -46.7 -24.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . . . -67.21 -71.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 110.561 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.541 ' CG2' HG13 ' A' ' 13' ' ' VAL . 7.2 p -42.27 -28.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.522 ' N ' HG13 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -64.2 -69.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.168 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.08 -119.94 6.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -27.18 68.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -1.169 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.1 m-85 -99.5 177.05 5.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.201 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 16.0 m-85 -121.02 138.01 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.958 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.487 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 41.1 t -79.51 100.59 7.8 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 108.837 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 9.4 m -79.35 160.84 26.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.17 . . . . 0.0 110.139 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.567 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -159.98 173.46 15.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.52 -0.737 . . . . 0.0 110.22 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 p -103.41 112.81 25.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 110.217 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.802 0.334 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.61 135.02 21.25 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.07 1.563 . . . . 0.0 110.521 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.99 -170.26 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.119 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.492 HG21 ' HD2' ' A' ' 5' ' ' PRO . 2.6 mm -45.23 145.54 1.8 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.578 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 Cg_endo -73.11 -159.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.17 1.616 . . . . 0.0 109.89 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HA ' HD13 ' A' ' 9' ' ' ILE . . . -118.54 -22.07 7.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.88 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -55.7 -52.05 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 110.397 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.578 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.2 m-85 -46.22 -25.97 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.877 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.5 mt -61.28 126.85 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.186 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 58.0 32.94 67.53 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -113.18 -162.53 0.81 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.666 -0.902 . . . . 0.0 110.872 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.605 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 3.1 m -157.25 97.04 1.61 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' HA ' HG23 ' A' ' 69' ' ' VAL . 3.6 m -95.22 174.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.996 -1.065 . . . . 0.0 110.21 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.88 -163.09 37.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 48.2 Cg_endo -74.14 -51.53 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.046 1.551 . . . . 0.0 110.522 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -49.76 76.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 48.6 t -58.93 -47.6 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.581 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 9.9 t-105 -51.73 -58.13 7.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.802 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.36 -39.85 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.131 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.69 -58.13 9.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.461 HD22 HG23 ' A' ' 30' ' ' VAL . 1.5 tt -51.05 -34.12 28.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.121 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 24.4 t -63.65 -47.97 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.44 -40.71 68.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.753 . . . . 0.0 109.823 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.3 -39.78 95.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.603 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -132.46 -88.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.002 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.56 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 172.52 166.37 30.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.9 -20.45 65.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 110.446 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -61.54 1.73 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.112 -0.992 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.603 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.05 -28.74 70.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG23 HD22 ' A' ' 21' ' ' LEU . 37.8 t -70.27 -30.99 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.4 -0.812 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.3 m -76.55 -36.0 57.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.4 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.37 4.63 12.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.288 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 42.2 t-20 57.9 74.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.505 ' O ' ' CZ3' ' A' ' 18' ' ' TRP . 49.1 mt -122.26 121.73 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.5 mtt85 -101.11 150.29 23.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.86 159.61 16.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 110.077 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.58 151.13 51.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -42.98 -26.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.9 m -172.36 -173.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 110.007 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -57.85 -17.31 15.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.224 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.1 t-20 -89.25 98.12 11.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.469 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.605 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.8 p80 -142.49 176.53 8.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 110.53 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.6 p -81.82 130.48 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.783 . . . . 0.0 109.847 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.91 174.64 6.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 48.69 46.31 21.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 109.084 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.09 -151.99 41.15 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.4 40.46 0.84 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -1.208 . . . . 0.0 109.752 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 10.4 mtp180 -112.46 -38.64 4.6 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.985 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -126.1 168.98 18.09 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.133 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.582 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -136.13 172.19 13.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -1.028 . . . . 0.0 109.861 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.4 t -104.41 112.37 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.76 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 7.2 mtt-85 -127.96 142.46 51.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.858 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.44 ' N ' ' CD2' ' A' ' 73' ' ' TYR . 2.1 p -51.89 -46.39 64.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.011 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -137.16 175.67 9.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 11.8 m -153.65 170.69 20.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.891 -1.131 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -79.74 177.57 8.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -79.61 -42.68 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -22.19 0.72 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.304 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.77 -175.69 2.73 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.51 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 3.1 p90 -147.38 -164.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 34.6 t -128.54 98.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -50.15 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.826 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.05 -26.7 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.579 -0.7 . . . . 0.0 110.26 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.483 ' O ' HD11 ' A' ' 7' ' ' ILE . 14.8 t80 -65.6 -49.79 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.578 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.4 m-85 -86.56 -3.09 58.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 111.562 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -17.28 6.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.016 -1.053 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -70.87 -56.67 5.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.95 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.528 HG23 ' HA ' ' A' ' 13' ' ' VAL . 7.9 p -61.11 -27.79 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.969 -1.082 . . . . 0.0 109.469 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -64.57 -49.05 72.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 -137.2 14.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -48.67 -31.56 6.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 109.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 54' ' ' SER . 8.6 m-85 -87.95 -177.83 5.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.006 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 46.8 m-85 -125.81 136.6 53.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 10.7 t -79.47 97.72 6.52 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.034 -1.041 . . . . 0.0 108.755 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 74.1 m -79.01 166.43 22.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.03 -1.044 . . . . 0.0 110.501 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.51 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 17.5 mtp180 -161.19 176.16 11.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.323 0.582 . . . . 0.0 109.83 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 78' ' ' SER . 11.5 p -108.08 104.53 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.505 -0.747 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.2 -179.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.35 161.07 45.41 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.51 . . . . 0.0 110.419 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -164.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -65.8 151.6 94.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.136 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 4' ' ' ILE . 45.0 Cg_endo -74.86 164.73 32.92 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.144 1.602 . . . . 0.0 110.255 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.93 -23.27 28.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.443 -0.786 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.615 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -60.01 -38.23 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.687 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 8' ' ' TYR . 9.7 m-30 -64.05 -18.79 64.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 9.4 mt -81.05 124.12 38.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.162 -0.961 . . . . 0.0 109.016 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 68.56 31.82 74.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -119.62 -163.08 0.96 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.468 -1.019 . . . . 0.0 110.752 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.61 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 11.3 m -155.29 95.37 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' NE2' ' A' ' 43' ' ' HIS . 4.3 m -90.18 171.5 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -83.77 -161.18 31.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 46.7 Cg_endo -74.26 -45.07 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.911 1.479 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.1 m -66.75 -55.49 14.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.496 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 84.1 t -56.09 -45.56 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.577 ' CE3' ' CG ' ' A' ' 37' ' ' ARG . 22.8 t-105 -51.16 -62.99 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.19 -38.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.143 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.9 t80 -63.68 -60.21 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.106 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.542 ' CD2' HD11 ' A' ' 4' ' ' ILE . 1.2 tt -47.89 -55.37 9.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 30' ' ' VAL . 41.3 t -44.15 -56.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.78 -42.74 47.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -53.29 -42.94 67.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 109.988 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.606 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -127.99 -86.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 109.936 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.564 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 176.33 166.1 33.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -61.22 -19.93 62.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -1.145 . . . . 0.0 110.449 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -63.4 1.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -64.8 -20.17 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 26' ' ' GLY . 29.6 t -77.85 -33.6 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.477 -0.764 . . . . 0.0 109.892 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 43.7 m -80.89 -33.16 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.52 -23.49 46.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.28 4.88 11.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 59.4 t-20 60.78 63.98 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.654 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.462 HD13 ' HA ' ' A' ' 30' ' ' VAL . 54.8 mt -113.78 128.39 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.368 -0.832 . . . . 0.0 109.481 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -110.25 145.27 37.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 110.488 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.577 ' CG ' ' CE3' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -90.31 154.38 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 109.761 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -129.54 171.0 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.253 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 t -58.76 -33.3 70.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -159.92 178.94 9.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.567 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 41.6 m-20 -52.33 -33.31 42.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 15.2 t-20 -82.71 99.81 9.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.7 p80 -136.25 177.01 8.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.409 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -75.25 141.66 43.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.977 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 10.9 p -131.79 178.78 6.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 44.16 44.88 6.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.229 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.03 -156.75 51.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' ASN . 22.9 t30 -84.33 41.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.963 -1.316 . . . . 0.0 109.959 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.35 -33.36 3.89 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.149 -0.969 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -121.19 173.84 15.68 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.831 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 16.5 m95 -150.73 161.35 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.424 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 86.4 m -96.5 104.57 16.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.12 . . . . 0.0 109.971 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 6.0 mtt180 -120.23 151.5 39.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 109.976 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.493 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -57.56 -52.84 63.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 109.122 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.38 172.98 10.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 94.6 m -149.5 168.09 24.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.785 -1.197 . . . . 0.0 110.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -79.91 176.22 9.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.731 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -75.34 -44.5 44.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -48.01 -21.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -118.3 174.29 6.32 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.417 -0.802 . . . . 0.0 109.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 11.2 p90 -134.4 -167.65 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.975 . . . . 0.0 110.227 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 64' ' ' THR . 17.9 t -113.97 89.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.73 . . . . 0.0 109.981 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.1 t0 -39.82 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.363 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -52.91 -23.34 6.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 110.591 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.08 -44.01 55.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 20.3 m-85 -89.83 -9.93 47.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 111.622 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -22.17 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.787 -1.196 . . . . 0.0 109.049 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.46 ' HB3' HG23 ' A' ' 7' ' ' ILE . . . -68.91 -52.62 27.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.488 -0.757 . . . . 0.0 110.645 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 70' ' ' CYS . 9.7 p -60.0 -34.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.887 -1.133 . . . . 0.0 110.32 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.557 ' N ' HG13 ' A' ' 69' ' ' VAL . 61.6 m -60.4 -51.68 68.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.955 -1.091 . . . . 0.0 109.682 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.93 -102.78 2.91 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HD2' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -76.57 -5.27 46.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -1.151 . . . . 0.0 109.881 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.65 178.09 4.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 1.1 m-85 -120.5 137.85 54.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 109.755 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 11.3 t -79.69 94.29 5.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.967 -1.083 . . . . 0.0 109.352 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.5 m -77.78 170.75 16.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.003 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.9 mtp180 -160.27 -177.5 6.3 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.244 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 m -110.19 91.15 3.54 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.192 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.473 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 10.3 tpt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.532 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 5.0 m-20 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 1' ' ' ASN . 46.2 Cg_endo -72.17 160.33 47.57 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.858 1.452 . . . . 0.0 110.466 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER 55.89 160.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 110.364 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 21' ' ' LEU . 2.6 mm -56.81 144.12 67.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.607 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 50.4 Cg_endo -72.86 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.243 1.654 . . . . 0.0 109.835 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.29 -41.33 3.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.627 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.651 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -57.64 -38.19 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.451 -0.781 . . . . 0.0 110.443 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.607 ' CD1' ' CG ' ' A' ' 5' ' ' PRO . 45.2 m-85 -62.71 -25.04 67.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.282 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 61.3 mt -73.4 143.72 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 49.51 36.58 24.4 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' HB1' HG21 ' A' ' 69' ' ' VAL . . . -122.23 -164.32 1.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.523 -0.986 . . . . 0.0 110.549 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.614 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 3.2 m -152.1 91.77 1.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.032 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.534 HG12 ' CG2' ' A' ' 69' ' ' VAL . 2.7 m -89.14 162.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.111 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.65 -166.68 9.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.1 Cg_endo -73.37 -39.41 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.999 1.526 . . . . 0.0 110.448 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -51.25 43.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.38 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.471 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 48.0 t -57.62 -46.5 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.549 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 35.2 t-105 -49.8 -61.14 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.45 -44.3 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.283 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -58.12 -66.81 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.849 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.529 HD22 ' CG1' ' A' ' 25' ' ' VAL . 5.7 tt -40.52 -56.19 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 110.12 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 21' ' ' LEU . 47.2 t -42.44 -55.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.878 . . . . 0.0 110.061 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.18 -44.85 33.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.27 -49.94 74.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.15 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -117.02 -88.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 175.82 165.71 32.16 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.73 -20.13 63.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -1.129 . . . . 0.0 110.54 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.13 -63.29 1.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.149 -0.969 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -61.91 -19.14 62.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.223 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.487 HG21 ' CD2' ' A' ' 21' ' ' LEU . 10.9 t -75.09 -39.83 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.48 -0.762 . . . . 0.0 109.743 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.5 m -77.8 -28.8 50.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.4 -24.22 42.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 34' ' ' ASN . . . -80.0 5.55 13.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.467 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.1 t-20 58.79 69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.444 ' CG2' ' CZ3' ' A' ' 18' ' ' TRP . 11.0 mt -119.3 135.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mtp180 -115.42 149.84 37.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.549 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 10.8 mtp85 -98.46 143.96 28.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 109.839 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -115.57 164.11 14.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.8 p -48.35 -27.79 2.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.4 m -165.01 -168.32 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 78.9 m-20 -64.32 -22.14 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.296 -0.877 . . . . 0.0 110.166 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.6 t30 -88.58 110.54 20.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.0 p80 -148.72 175.92 10.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.4 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.619 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -79.99 139.07 37.15 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -130.47 176.93 7.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 110.439 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.36 39.45 12.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.76 -151.98 46.86 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -87.44 24.17 1.72 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.171 -1.193 . . . . 0.0 109.972 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -105.65 -28.83 10.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 110.797 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.39 164.53 15.39 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.002 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.619 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 9.3 m95 -142.52 174.41 10.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.44 -1.035 . . . . 0.0 109.701 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 5.6 t -109.23 113.16 25.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 2.3 mtt180 -133.43 143.99 49.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -46.61 -39.31 10.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.971 -1.081 . . . . 0.0 108.766 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 4.7 tttt -135.86 171.1 14.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.518 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 6.3 m -119.73 177.06 5.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.18 -169.16 2.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -84.45 -42.46 15.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.422 -0.799 . . . . 0.0 110.215 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -72.2 -1.2 14.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 17.9 mt-10 -126.65 -179.92 5.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.917 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' CD1' ' HB2' ' A' ' 79' ' ' ARG . 8.1 p90 -139.74 -162.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.07 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 64' ' ' THR . 47.8 t -110.87 88.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.1 t0 -40.71 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.581 -0.699 . . . . 0.0 110.25 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 4.3 p -57.69 -34.64 69.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.378 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -63.54 -46.38 86.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.651 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 18.1 m-85 -86.57 -6.88 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 111.059 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -50.33 -22.29 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.951 -1.093 . . . . 0.0 109.064 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -67.59 -71.59 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.549 -0.72 . . . . 0.0 110.579 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.75 -29.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -61.01 -65.76 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 110.354 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.96 -115.81 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -61.6 -49.98 74.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -1.203 . . . . 0.0 109.915 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.454 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.6 m-85 -80.0 -177.22 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 2.7 m-85 -121.3 142.27 50.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.483 -0.76 . . . . 0.0 109.096 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.5 t -79.59 100.88 8.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.429 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 33.3 m -78.94 165.87 23.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.527 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -157.13 176.67 12.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.85 . . . . 0.0 110.344 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.43 96.59 6.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.541 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.204 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.775 0.322 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.25 118.42 5.52 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.998 1.525 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -175.96 2.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 110.148 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.523 HD11 ' CG1' ' A' ' 25' ' ' VAL . 1.9 mt -74.89 144.47 79.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HB2' HG22 ' A' ' 7' ' ' ILE . 48.6 Cg_endo -79.5 165.44 22.97 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.142 1.601 . . . . 0.0 109.859 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.16 -36.75 34.65 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -50.7 -47.88 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 110.717 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.483 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 7.8 m-30 -50.68 -34.93 28.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 110.301 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 43.4 mt -69.9 115.6 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.88 28.61 58.59 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 8' ' ' TYR . . . -115.94 -162.65 0.85 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.967 . . . . 0.0 110.71 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.61 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 4.0 m -153.35 93.78 1.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' HG21 ' A' ' 69' ' ' VAL . 3.9 m -93.41 169.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 110.201 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -79.43 -154.95 9.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 49.1 Cg_endo -76.8 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.007 1.53 . . . . 0.0 110.441 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 t -53.21 -50.89 63.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.47 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 21.9 t -59.91 -46.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.118 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.624 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 11.3 t90 -49.47 -65.5 0.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.517 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.02 -41.55 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.395 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 36.6 t80 -59.33 -62.45 1.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.924 . . . . 0.0 109.87 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 25' ' ' VAL . 1.7 tt -43.92 -52.73 6.68 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.393 -0.817 . . . . 0.0 109.811 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 25' ' ' VAL . 40.5 t -52.4 -42.67 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.786 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.86 -45.11 59.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.342 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.86 -27.38 62.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.488 -0.757 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.577 ' CG2' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -124.18 -91.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.682 . . . . 0.0 110.293 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' HG21 ' A' ' 30' ' ' VAL . . . 167.26 -170.57 41.61 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.462 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -75.87 -52.65 9.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.32 . . . . 0.0 110.306 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.56 74.16 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.943 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 25' ' ' VAL . . . -69.45 -49.93 50.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 109.782 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.513 ' CG2' HD22 ' A' ' 21' ' ' LEU . 25.0 t -62.88 -21.77 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 19.2 m -79.78 -40.62 28.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.08 -17.21 60.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.19 25.05 2.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.9 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 46.0 t-20 41.87 67.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 8' ' ' TYR . 16.2 mm -110.21 112.5 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.659 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 5.3 mtt180 -97.6 139.47 33.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.893 . . . . 0.0 110.295 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.624 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -89.52 155.69 19.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.73 157.98 44.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.04 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -45.1 -33.27 2.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.516 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -166.92 -156.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 110.262 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' OD2' ' HD3' ' A' ' 72' ' ' ARG . 59.6 m-20 -71.73 -5.86 37.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.507 -0.746 . . . . 0.0 110.044 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 2.3 t30 -102.57 102.57 12.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.2 p80 -146.03 -175.46 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.454 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.576 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.1 p -86.95 129.49 34.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.443 -0.785 . . . . 0.0 109.568 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.45 177.63 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.426 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 48.03 45.35 19.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 -156.01 52.79 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 19.7 p30 -86.24 34.94 0.63 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.013 -1.286 . . . . 0.0 110.009 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -115.9 -30.6 6.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.131 -0.98 . . . . 0.0 110.788 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -117.92 163.74 12.82 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.483 -1.342 . . . . 0.0 109.773 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.576 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 7.5 m95 -140.23 177.06 8.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.0 109.367 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.484 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 6.2 t -114.55 115.07 26.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 110.928 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -131.91 159.28 39.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 55' ' ' LYS . 5.9 p -57.89 -52.67 64.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.988 -1.07 . . . . 0.0 108.965 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' N ' ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -140.69 139.69 34.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -105.05 163.6 12.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.235 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.63 -164.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' HIS . 8.9 ttp180 -80.64 -43.74 19.99 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.44 ' C ' ' HG2' ' A' ' 60' ' ' GLU . 1.3 m-70 -45.78 -24.49 0.38 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.8 mm-40 -125.91 179.56 5.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.385 -0.822 . . . . 0.0 110.023 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.0 p90 -137.86 -163.11 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.594 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 64' ' ' THR . 25.4 t -113.77 87.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 109.927 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.3 t0 -38.26 90.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.694 -0.629 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.98 -25.34 43.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.467 ' O ' HD11 ' A' ' 7' ' ' ILE . 8.4 t80 -70.8 -51.32 27.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 46' ' ' ALA . 10.9 m-85 -81.44 -6.45 58.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 111.23 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -18.93 2.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.11 -47.02 63.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.9 . . . . 0.0 110.988 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.54 HG11 ' N ' ' A' ' 70' ' ' CYS . 7.9 p -71.54 -24.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.501 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.54 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -66.99 -57.33 7.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.452 -0.78 . . . . 0.0 110.267 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.31 -125.75 8.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.46 ' HD3' ' OD2' ' A' ' 41' ' ' ASP . 5.2 mpt_? -52.51 -36.65 55.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.84 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 39.5 m-85 -90.87 -173.42 3.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.46 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 3.0 m-85 -129.65 142.34 50.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 10.5 t -79.6 99.32 7.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.556 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 8.0 t -79.05 165.41 23.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.129 -0.982 . . . . 0.0 109.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 5.4 mtp180 -157.5 171.93 19.48 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.784 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 79' ' ' ARG . 1.1 m -107.55 76.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 78' ' ' SER . 6.6 ttt-85 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.152 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.511 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.9 t30 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 1' ' ' ASN . 48.0 Cg_endo -75.91 -176.59 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.872 1.459 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER 52.12 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -0.849 . . . . 0.0 110.279 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.471 HG22 ' HD2' ' A' ' 5' ' ' PRO . 2.1 mm -89.87 144.71 31.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.596 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.9 Cg_endo -78.05 162.78 28.73 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.098 1.578 . . . . 0.0 110.028 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -80.44 -21.97 41.62 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.403 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -52.57 -54.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.66 -28.88 3.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 17.3 mt -64.86 123.91 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.75 29.34 74.47 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -116.92 -162.77 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -1.009 . . . . 0.0 110.429 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.595 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.2 m -151.95 95.09 2.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.012 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' HG23 ' A' ' 69' ' ' VAL . 3.2 m -88.87 179.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 110.118 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -94.52 -161.81 34.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.31 -45.68 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.016 1.535 . . . . 0.0 110.318 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -53.1 50.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.454 HG12 ' HB ' ' A' ' 13' ' ' VAL . 10.7 t -58.55 -47.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -0.946 . . . . 0.0 109.856 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.551 ' CZ2' HG12 ' A' ' 30' ' ' VAL . 59.6 t-105 -48.09 -66.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.96 -38.35 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.27 -49.66 76.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' CD1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -60.38 -28.13 67.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . 48.5 t -66.79 -48.75 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 110.0 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.98 92.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.838 . . . . 0.0 109.914 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.45 -41.94 97.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 110.177 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.615 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -130.52 -50.87 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.254 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 30' ' ' VAL . . . 137.02 163.99 9.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -66.2 -9.41 31.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -1.182 . . . . 0.0 110.856 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 -67.64 0.66 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.968 -1.083 . . . . 0.0 109.707 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.615 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.77 -20.08 64.63 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 108.668 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.551 HG12 ' CZ2' ' A' ' 18' ' ' TRP . 14.4 t -70.82 -37.23 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.606 -0.684 . . . . 0.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.7 m -85.04 -25.03 27.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.36 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.866 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.05 25.92 2.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.771 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.456 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 5.8 t-20 40.21 75.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 0.0 110.6 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.56 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 64.3 mt -124.34 118.34 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.768 . . . . 0.0 109.455 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.3 mtt180 -96.91 156.68 16.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 110.512 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 8.9 mtp180 -107.27 139.47 41.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -117.73 164.56 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -42.7 -26.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.356 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.438 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -172.34 -162.42 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 70' ' ' CYS . 54.2 m-20 -66.61 -8.44 27.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.882 . . . . 0.0 110.302 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -94.7 101.99 13.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.516 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 12' ' ' THR . 2.6 p80 -143.55 -179.78 6.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.581 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -88.1 120.92 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 109.66 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 9.3 p -116.51 -178.75 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 110.76 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.493 ' HB1' ' CZ ' ' A' ' 77' ' ' ARG . . . 49.13 41.58 19.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.457 -0.777 . . . . 0.0 108.957 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.57 -153.74 51.0 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.96 36.55 0.67 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.057 -1.26 . . . . 0.0 109.771 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -117.77 -30.74 5.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.418 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -124.64 160.23 19.25 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.893 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.581 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 25.2 m95 -132.18 174.68 9.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.318 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.7 t -107.44 112.53 25.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.421 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -127.77 143.2 51.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.894 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -49.52 -46.45 48.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 108.624 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -125.67 -175.84 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 86.6 m -150.9 160.32 43.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.992 -1.067 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -80.56 171.53 14.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 110.365 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -38.97 67.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -13.68 11.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.733 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -120.88 169.93 9.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 109.557 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 15.5 p90 -132.09 -178.01 4.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.913 -1.117 . . . . 0.0 111.102 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 75.6 t -99.61 94.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.294 0.568 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -47.96 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -50.46 -25.4 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 111.027 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.03 -48.6 43.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.17 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.625 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 32.0 m-85 -89.79 -4.86 57.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.07 -1.019 . . . . 0.0 111.41 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -49.91 -22.89 1.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.942 -1.099 . . . . 0.0 109.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB2' HG23 ' A' ' 7' ' ' ILE . . . -70.99 -65.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.447 -0.783 . . . . 0.0 110.541 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.526 HG23 ' HA ' ' A' ' 13' ' ' VAL . 9.3 p -46.69 -26.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.948 -1.095 . . . . 0.0 109.59 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.526 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -68.63 -64.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -124.14 8.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -24.36 22.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.147 . . . . 0.0 109.953 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.446 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.2 m-85 -102.0 -179.41 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 110.143 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 8.9 m-85 -123.57 130.84 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.131 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.526 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 7.5 t -79.81 105.99 11.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.037 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 66.6 m -102.09 170.07 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.666 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 16.7 mtp180 -149.73 -172.8 4.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.348 0.594 . . . . 0.0 109.559 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 79' ' ' ARG . 5.6 p -115.73 80.42 1.44 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.79 0.328 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.07 135.47 21.02 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.021 1.537 . . . . 0.0 110.493 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -172.18 3.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.522 HD13 ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -54.9 160.15 3.18 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.94 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HB2' HG23 ' A' ' 7' ' ' ILE . 47.4 Cg_endo -75.35 166.57 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.86 -27.73 20.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -54.36 -49.65 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 110.442 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.574 ' CD2' HD11 ' A' ' 21' ' ' LEU . 8.5 m-30 -46.6 -29.46 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 109.946 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -66.91 113.83 3.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.211 -0.93 . . . . 0.0 109.547 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 73.13 27.81 67.65 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -110.65 -164.77 0.94 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.527 -0.984 . . . . 0.0 110.619 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.628 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 54.9 m -155.01 100.09 2.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 110.034 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 3.1 m -97.5 163.85 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.104 -0.998 . . . . 0.0 110.036 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.19 -164.73 11.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.2 Cg_endo -73.69 -47.5 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.4 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.02 51.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 81.6 t -60.59 -50.71 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.575 ' CE2' ' HD2' ' A' ' 37' ' ' ARG . 26.8 t-105 -45.17 -66.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.626 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -41.55 -42.33 2.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.474 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.6 t80 -60.73 -65.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.574 HD11 ' CD2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -41.75 -44.33 3.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 110.356 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.46 ' HA ' HG23 ' A' ' 30' ' ' VAL . 84.9 t -54.69 -49.52 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.81 69.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.65 -46.22 91.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.605 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -120.13 -87.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.562 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 177.16 170.21 39.29 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 31' ' ' THR . . . -64.8 -22.62 67.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -1.102 . . . . 0.0 110.711 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -61.94 1.58 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.605 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.17 -26.49 68.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 33.9 t -71.42 -34.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.751 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 27' ' ' ALA . 16.9 m -85.32 -20.47 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.905 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -20.52 31.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.85 25.01 2.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.831 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.427 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 49.0 t-20 41.5 74.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.815 . . . . 0.0 110.445 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.533 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 13.5 mt -118.43 120.34 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 7.3 mmt180 -99.09 147.85 24.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 110.474 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HD2' ' CE2' ' A' ' 18' ' ' TRP . 17.5 mtp180 -101.38 136.58 40.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.409 -0.807 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -110.44 160.06 16.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 110.233 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -48.62 -25.7 1.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.917 . . . . 0.0 110.313 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.404 ' OG ' ' C ' ' A' ' 39' ' ' SER . 0.7 OUTLIER -160.07 -176.6 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 56.9 m-20 -62.17 -16.65 54.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 19.8 t-20 -90.4 107.62 19.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.628 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.6 p80 -143.77 175.54 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 110.561 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.577 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 2.2 p -78.68 130.41 35.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.736 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.57 179.34 4.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 47.7 41.76 14.33 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.159 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.56 -153.22 51.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 1.8 m-20 -84.47 41.33 0.83 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.164 -1.198 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.96 -36.51 3.4 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -122.71 166.3 15.21 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.094 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.577 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 11.1 m95 -135.74 172.07 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -1.033 . . . . 0.0 109.649 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.455 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 5.7 t -105.35 111.62 24.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 1.2 mtt180 -129.14 145.14 51.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.451 ' OG ' ' CE1' ' A' ' 73' ' ' TYR . 23.5 m -46.68 -40.44 13.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.033 . . . . 0.0 108.614 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.83 168.52 19.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 7.8 m -117.22 173.67 6.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.899 -1.125 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -79.62 -169.85 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.074 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -87.57 -42.47 12.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.09 -1.22 11.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.229 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 9.2 mt-10 -121.65 -170.88 2.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.7 p90 -150.26 -162.94 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.889 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 64' ' ' THR . 53.9 t -120.35 94.37 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -51.88 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.739 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -42.77 -25.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.691 -0.631 . . . . 0.0 110.598 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.475 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.9 t80 -66.55 -50.07 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 111.287 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.9 m-85 -87.0 -5.76 58.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 111.761 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 t -55.27 -18.27 5.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.854 -1.153 . . . . 0.0 109.663 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 7' ' ' ILE . . . -70.25 -49.33 51.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 111.044 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 7.0 p -68.47 -27.93 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.133 . . . . 0.0 109.224 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.97 -53.58 55.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.52 -123.37 6.88 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -42.79 71.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -1.106 . . . . 0.0 109.971 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 22.6 m-30 -85.96 -178.19 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.947 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 10.3 m-85 -121.05 143.23 49.17 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.447 -0.783 . . . . 0.0 109.236 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 t -79.28 99.72 7.21 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.131 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.7 m -79.3 162.87 25.34 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.145 -0.972 . . . . 0.0 110.153 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 1.6 mtp180 -159.2 -176.21 5.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.512 -0.742 . . . . 0.0 110.275 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.464 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -118.31 83.59 2.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.756 . . . . 0.0 110.27 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.39 -160.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.927 1.488 . . . . 0.0 110.495 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -159.57 41.93 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.538 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.48 HD12 HG21 ' A' ' 4' ' ' ILE . 1.7 mm -51.72 145.87 15.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD2' HG21 ' A' ' 4' ' ' ILE . 46.0 Cg_endo -77.04 163.87 30.29 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.066 1.561 . . . . 0.0 110.041 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.445 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -83.16 -27.17 30.27 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.506 -0.746 . . . . 0.0 110.425 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -56.04 -38.03 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.582 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.43 ' O ' HG12 ' A' ' 35' ' ' ILE . 10.8 m-30 -64.93 -27.29 68.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.281 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 9' ' ' ILE . 49.4 mt -70.09 129.18 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.255 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 63.16 32.02 82.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -123.06 -162.14 1.01 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 110.555 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.604 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 8.4 m -153.2 101.05 2.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 69' ' ' VAL . 3.2 m -99.84 157.43 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 0.0 110.284 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.87 -162.0 5.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.7 Cg_endo -74.57 -40.54 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.018 1.536 . . . . 0.0 110.428 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.3 m -62.81 -58.93 5.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 84.5 t -59.26 -50.53 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.776 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.633 ' CE3' ' CG ' ' A' ' 37' ' ' ARG . 23.7 t-105 -45.09 -64.14 0.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 0.0 109.745 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.15 -44.55 5.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.719 . . . . 0.0 110.387 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 62.4 t80 -57.81 -62.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 25' ' ' VAL . 2.0 tt -44.28 -56.16 4.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.813 . . . . 0.0 109.998 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' LEU . 84.7 t -43.07 -44.55 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.78 -56.31 23.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.202 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.513 ' CD2' HD21 ' A' ' 3' ' ' LEU . 13.5 tp -49.44 -46.45 47.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.945 . . . . 0.0 110.028 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.611 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -116.37 -89.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.797 . . . . 0.0 110.079 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 173.28 165.27 29.9 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.79 59.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 110.626 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.05 -62.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.105 -0.997 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.611 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.21 -21.38 66.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.493 ' CG2' HD21 ' A' ' 21' ' ' LEU . 24.8 t -74.62 -35.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.471 -0.768 . . . . 0.0 109.885 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -83.57 -26.32 30.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.92 -15.75 38.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.01 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.02 25.1 2.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.773 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.438 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 50.0 t-20 47.36 68.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.552 -0.718 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.566 HG21 ' CZ3' ' A' ' 18' ' ' TRP . 57.6 mt -122.62 126.15 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.415 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 73.1 mtt180 -109.1 146.75 33.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.493 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CG ' ' CE3' ' A' ' 18' ' ' TRP . 0.9 OUTLIER -93.32 144.37 25.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.513 -0.742 . . . . 0.0 109.647 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.545 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -116.39 155.0 29.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.969 . . . . 0.0 110.401 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -45.66 -27.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -0.85 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -165.07 -163.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -70.45 -12.69 61.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.332 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.4 OUTLIER -94.57 103.75 15.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.7 p80 -143.42 177.0 8.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 110.336 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.596 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 84.9 p -82.37 131.89 35.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.44 -0.788 . . . . 0.0 109.569 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.9 p -124.27 175.68 6.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 110.62 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 51.11 36.51 15.71 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -150.36 51.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.25 42.64 0.89 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.263 . . . . 0.0 109.827 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.2 mtt180 -117.23 -38.31 3.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -0.911 . . . . 0.0 111.084 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -127.44 171.38 18.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.398 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.596 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 7.2 m95 -137.33 172.78 12.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.535 -0.979 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.46 110.69 22.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.158 . . . . 0.0 111.024 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -128.46 145.45 51.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.4 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 30.1 t -53.09 -53.16 54.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.884 -1.135 . . . . 0.0 108.316 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -124.87 178.4 5.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.455 0.645 . . . . 0.0 110.047 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' CD ' ' A' ' 53' ' ' ARG . 5.3 m -155.63 171.22 20.34 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.817 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -79.72 178.31 8.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.689 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -47.3 15.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -48.59 -21.04 0.51 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 109.64 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -110.5 178.17 4.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 109.705 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.5 p90 -144.18 -164.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.054 -1.029 . . . . 0.0 110.297 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 64' ' ' THR . 39.3 t -127.82 98.02 4.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 1.0 OUTLIER -50.03 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.782 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.6 -26.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.674 -0.641 . . . . 0.0 110.458 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.5 t80 -66.79 -49.39 66.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 111.04 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.646 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 12.4 m-85 -85.77 -8.15 58.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 111.15 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.7 p -49.08 -22.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.921 -1.112 . . . . 0.0 109.017 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.424 ' CB ' HG23 ' A' ' 7' ' ' ILE . . . -65.36 -70.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 12' ' ' THR . 9.8 p -47.43 -29.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.907 -1.121 . . . . 0.0 109.845 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -63.95 -46.19 85.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.32 -132.82 11.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.1 mmt85 -57.07 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -1.19 . . . . 0.0 110.132 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 8.8 m-85 -84.26 -173.26 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 15.9 m-85 -128.39 134.49 48.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 110.078 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.0 t -79.73 97.11 6.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 108.635 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 70.9 m -79.21 166.29 22.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 110.581 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.525 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 13.6 mtp180 -160.77 177.56 10.31 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.217 0.532 . . . . 0.0 109.666 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 t -106.94 106.58 17.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.783 0.325 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.19 124.69 9.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.973 1.512 . . . . 0.0 110.395 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -164.78 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.515 HD11 ' CD2' ' A' ' 21' ' ' LEU . 4.2 mm -79.84 144.41 59.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.965 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 4' ' ' ILE . 45.6 Cg_endo -72.27 -159.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.072 1.564 . . . . 0.0 109.805 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -111.72 -35.61 5.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 110.036 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.01 -50.28 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.57 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.532 ' CE1' ' HB3' ' A' ' 68' ' ' ALA . 15.9 m-30 -48.58 -31.76 7.06 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.887 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 41.7 mt -67.31 113.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.75 27.14 61.33 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -113.11 -164.4 0.92 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.552 -0.969 . . . . 0.0 110.6 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.62 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.0 m -155.89 103.08 2.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 69' ' ' VAL . 4.0 m -98.62 -175.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.21 -160.32 32.5 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.84 -43.64 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.01 1.532 . . . . 0.0 110.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.9 p -65.44 -53.75 38.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG11 ' HB ' ' A' ' 13' ' ' VAL . 60.1 t -59.9 -48.81 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 109.968 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.579 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 14.3 t-105 -48.58 -60.38 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.858 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.07 -42.47 13.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.256 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.4 t80 -59.69 -65.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' CD2' HD11 ' A' ' 4' ' ' ILE . 3.9 tt -42.58 -43.94 3.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 18' ' ' TRP . 40.1 t -54.34 -50.08 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.96 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.5 -45.66 66.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.27 -41.66 84.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.362 -0.836 . . . . 0.0 109.898 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.605 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.64 -88.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.975 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 172.51 163.99 27.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -18.32 53.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.7 1.07 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.05 -1.031 . . . . 0.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.605 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -61.22 -25.64 67.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.12 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.451 HG21 HD22 ' A' ' 21' ' ' LEU . 37.3 t -68.75 -33.27 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.491 -0.756 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -77.5 -46.67 21.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.26 -17.77 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.27 23.31 2.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 35.5 t-20 40.69 69.84 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 35' ' ' ILE . 21.2 mt -118.34 122.04 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.468 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.1 mtp180 -104.15 148.79 25.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 110.59 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.579 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 5.5 mtt85 -91.93 154.3 18.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.546 -0.721 . . . . 0.0 109.771 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.34 160.62 36.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -44.42 -35.03 2.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.557 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.447 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -164.17 -165.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.404 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -64.37 -11.38 32.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.559 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 24.2 t-20 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.111 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.0 p80 -144.16 177.61 8.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.487 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.589 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.5 p -76.32 131.36 39.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -0.778 . . . . 0.0 109.699 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.51 173.96 8.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.985 -1.072 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 49.83 38.79 16.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.179 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.64 -149.44 51.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -85.14 40.91 0.85 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.098 -1.237 . . . . 0.0 109.706 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.9 mmt180 -113.77 -37.2 4.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.341 -0.849 . . . . 0.0 110.843 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -130.86 173.6 20.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.128 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.589 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -140.17 171.43 14.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.397 -1.061 . . . . 0.0 109.223 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.2 t -106.38 120.5 42.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.791 -1.193 . . . . 0.0 111.287 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.454 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 3.4 mtt-85 -132.95 156.21 47.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.464 -0.772 . . . . 0.0 108.922 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -48.53 -50.05 33.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 107.964 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.66 179.86 5.89 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 4.1 m -127.64 159.92 33.2 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.789 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -79.97 -177.0 5.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.41 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.48 -39.13 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.898 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -12.87 13.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.554 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 77' ' ' ARG . 5.3 mt-10 -124.56 -164.83 1.3 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.427 -0.796 . . . . 0.0 109.933 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.8 p90 -155.44 -162.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.709 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 64' ' ' THR . 78.4 t -119.86 95.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.473 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -53.04 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.334 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -44.17 -24.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.672 -0.643 . . . . 0.0 110.627 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.466 ' O ' HD11 ' A' ' 7' ' ' ILE . 11.8 t80 -66.81 -50.85 61.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 111.164 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 46' ' ' ALA . 8.0 m-85 -86.69 -5.6 59.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.108 -0.995 . . . . 0.0 111.724 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -54.68 -18.29 4.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.875 -1.141 . . . . 0.0 109.573 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . . . -69.33 -51.81 33.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG2' HG13 ' A' ' 13' ' ' VAL . 8.1 p -66.71 -26.84 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 109.414 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -65.26 -44.5 87.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.871 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.08 -128.04 8.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -53.01 -34.02 54.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -1.097 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.559 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.4 m-30 -88.46 -174.62 4.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.001 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -130.17 135.97 48.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.957 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.3 t -79.36 101.25 8.0 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 108.958 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.0 m -83.09 162.31 21.38 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.054 -1.029 . . . . 0.0 109.817 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.42 ' O ' ' CD ' ' A' ' 60' ' ' GLU . 10.0 mtp180 -157.14 -175.84 5.64 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.27 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -119.58 81.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 110.142 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 78' ' ' SER . 1.8 mtm-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.775 0.321 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.41 -174.46 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.13 1.595 . . . . 0.0 110.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.16 -166.36 1.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.471 HG21 ' HD2' ' A' ' 5' ' ' PRO . 1.7 mm -72.3 145.19 87.84 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.594 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 47.6 Cg_endo -78.54 163.57 26.77 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.18 1.621 . . . . 0.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.97 -20.86 32.15 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.663 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -51.84 -57.54 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 111.119 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.2 m-85 -48.07 -27.28 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.063 -1.023 . . . . 0.0 110.236 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 12.4 mt -69.1 128.72 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 57.47 32.05 63.96 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -118.65 -163.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.526 -0.985 . . . . 0.0 110.431 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.608 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 25.4 m -151.81 94.46 1.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.133 -0.979 . . . . 0.0 110.291 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HA ' HG22 ' A' ' 69' ' ' VAL . 3.3 m -86.24 -168.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.854 -1.154 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.19 -161.46 24.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.13 -45.63 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.805 1.423 . . . . 0.0 110.142 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 p -65.71 -49.3 68.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.3 t -59.34 -48.63 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.827 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.475 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 52.4 t-105 -48.42 -65.63 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.76 -33.2 4.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.808 . . . . 0.0 110.382 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 47.8 t80 -67.95 -70.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 1.5 tt -43.65 -30.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' GLY . 30.6 t -63.29 -57.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.77 -31.56 39.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.963 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.08 -51.74 55.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.308 -0.87 . . . . 0.0 110.43 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 29' ' ' ALA . 2.0 m -114.99 -49.0 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.766 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . 147.1 163.83 10.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.36 -48.3 35.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.239 . . . . 0.0 110.68 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.71 76.24 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 25' ' ' VAL . . . -61.36 -52.13 65.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.317 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.507 ' CG2' HD22 ' A' ' 21' ' ' LEU . 24.1 t -50.02 -31.55 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.724 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -41.63 71.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.108 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.83 63.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.98 5.0 12.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER 59.05 69.09 0.75 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.36 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.454 HD11 HD12 ' A' ' 21' ' ' LEU . 34.3 mt -119.37 134.56 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.5 OUTLIER -109.04 146.04 34.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 110.59 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 7.7 mtp180 -95.18 142.34 27.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -118.5 156.58 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.6 t -42.17 -27.08 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.514 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 25.4 m -164.83 -170.59 2.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.28 -8.38 24.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.085 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 38.7 t-20 -96.52 104.9 16.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.6 p80 -143.45 -176.64 5.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -95.94 146.88 24.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 109.567 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 p -136.36 -177.71 4.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 47.31 37.93 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.089 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.97 -158.77 46.78 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.34 44.21 1.01 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.235 . . . . 0.0 109.709 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -119.14 -34.63 3.82 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.18 -0.95 . . . . 0.0 111.388 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -116.09 163.99 12.31 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.425 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.7 m95 -137.64 173.57 11.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.439 -1.036 . . . . 0.0 109.505 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 5.7 t -116.09 118.01 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.923 -1.11 . . . . 0.0 111.366 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.45 ' NH1' ' CG ' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -133.81 159.0 41.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.488 -0.758 . . . . 0.0 109.13 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -45.12 43.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.95 -1.094 . . . . 0.0 108.88 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 3.1 tttt -138.12 176.8 8.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.532 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 7.1 m -122.4 171.99 8.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.905 -1.122 . . . . 0.0 110.271 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -85.63 -178.6 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -44.0 41.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -67.51 -4.06 10.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 110.21 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -123.37 176.48 6.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.472 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 6.2 p90 -139.41 -160.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.24 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 64' ' ' THR . 76.4 t -125.26 103.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.559 -0.713 . . . . 0.0 109.899 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 9.5 p30 -53.44 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -45.53 -25.34 0.43 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.439 -0.788 . . . . 0.0 110.742 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -73.51 -47.41 41.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.812 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.663 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 32.2 m-85 -85.18 -7.21 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.905 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -49.66 -23.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 109.156 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' A' ' 7' ' ' ILE . . . -70.96 -66.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.516 -0.74 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.543 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 13.0 p -44.25 -31.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.517 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -63.92 -67.86 0.4 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.186 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.54 -124.08 7.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -57.94 -32.18 67.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -1.191 . . . . 0.0 110.042 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 21.3 m-30 -94.38 175.03 6.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.462 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.451 ' HB3' HG11 ' A' ' 62' ' ' VAL . 22.0 m-85 -115.79 133.25 56.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.737 . . . . 0.0 109.168 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -79.23 102.55 8.61 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.916 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 7.8 m -79.26 161.87 26.04 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 0.0 109.948 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.472 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 24.3 mtp180 -155.78 -169.7 3.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.339 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.23 114.93 29.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 110.298 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.292 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.769 0.319 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.58 161.72 43.29 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.977 1.514 . . . . 0.0 110.597 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.03 -169.86 1.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.558 ' CD1' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.18 158.9 43.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.409 -179.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' N ' HG21 ' A' ' 4' ' ' ILE . 47.5 Cg_endo -75.76 167.97 25.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.172 1.617 . . . . 0.0 110.369 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -88.11 -26.12 22.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.429 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -51.86 -51.59 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.2 -0.938 . . . . 0.0 110.855 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.574 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 14.4 m-30 -51.84 -29.21 18.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 21.2 mt -69.1 131.52 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.74 33.17 59.43 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.436 -1.865 . . . . 0.0 108.436 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -119.31 -163.06 0.95 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.606 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 3.9 m -152.22 95.86 2.11 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.013 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 69' ' ' VAL . 2.6 m -92.3 174.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.274 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.92 38.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -73.75 -48.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.987 1.519 . . . . 0.0 110.402 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 1.1 p -59.94 -51.09 71.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 96.6 t -61.24 -52.1 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' VAL . 32.1 t-105 -44.59 -65.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.71 -41.21 3.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 11.4 t80 -61.46 -65.67 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.878 . . . . 0.0 110.241 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.558 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 1.7 tt -42.81 -36.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 64.9 t -60.47 -51.99 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.943 . . . . 0.0 109.819 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.83 51.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.451 HD22 HG13 ' A' ' 4' ' ' ILE . 9.5 tp -63.73 -38.6 91.71 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.602 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -131.99 -87.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.331 -0.856 . . . . 0.0 109.989 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 175.08 169.06 36.49 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 110.63 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.14 1.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.149 -0.969 . . . . 0.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.602 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.01 -21.94 66.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.166 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 27.9 t -73.3 -30.99 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.842 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -85.41 -32.05 22.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.07 -24.76 58.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.165 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -79.64 5.98 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 58.3 t-20 58.41 72.77 0.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 8' ' ' TYR . 35.5 mt -122.51 129.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.548 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 13.8 mtt180 -108.97 140.37 42.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm105 -84.2 156.93 21.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -130.92 164.79 24.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -50.85 -27.69 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.4 m -172.38 -170.8 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD1' HG23 ' A' ' 17' ' ' VAL . 6.8 m-20 -58.37 -15.3 10.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -95.13 106.21 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.606 ' CE1' ' O ' ' A' ' 12' ' ' THR . 5.7 p80 -147.64 177.01 9.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 110.339 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.622 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -80.14 147.85 31.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.841 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.12 173.89 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.334 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 51.08 36.52 15.63 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.38 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.94 -153.64 48.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -85.65 36.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.066 -1.255 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.23 -30.52 5.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.446 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.52 164.58 15.49 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.484 -1.341 . . . . 0.0 109.767 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.622 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 7.9 m95 -143.47 172.64 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 109.572 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 4.6 t -108.38 112.7 25.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.788 -1.195 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 2.0 mtt-85 -128.4 153.38 47.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -52.35 -46.15 65.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 0.0 109.033 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.06 147.85 49.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.499 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 4.0 m -97.44 163.25 12.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.69 -179.25 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.244 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -38.26 51.14 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.218 -0.926 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -68.69 -6.48 26.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.264 -0.898 . . . . 0.0 109.77 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' OE2' ' C ' ' A' ' 77' ' ' ARG . 5.9 mt-10 -126.63 -176.6 3.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -140.76 -166.74 2.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.366 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' THR . 54.7 t -108.92 90.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.526 -0.734 . . . . 0.0 109.975 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 23.7 t0 -41.49 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.1 p -57.53 -31.02 65.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.833 . . . . 0.0 110.568 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -67.29 -48.29 68.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.722 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.637 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 28.3 m-85 -86.28 -6.9 58.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 111.089 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -21.45 4.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.858 -1.151 . . . . 0.0 109.164 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -69.95 -66.84 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.597 -0.689 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 13' ' ' VAL . 14.1 p -46.65 -31.05 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.917 -1.115 . . . . 0.0 109.333 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -59.95 -69.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 0.0 109.949 179.361 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.66 -106.41 2.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -53.31 56.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -1.095 . . . . 0.0 110.06 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.489 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 23.7 m-85 -83.94 -169.25 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.424 ' CE2' ' O ' ' A' ' 54' ' ' SER . 7.3 m-85 -126.95 141.95 51.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -0.835 . . . . 0.0 109.476 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.4 t -79.62 97.75 6.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.363 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 16.5 m -78.85 164.14 24.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 9.3 mtp180 -154.35 -177.16 6.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 110.406 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 p -101.37 89.63 3.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.13 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 24.3 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.797 0.332 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 46.8 Cg_endo -72.78 172.12 15.94 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.054 1.555 . . . . 0.0 110.415 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -174.68 42.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.491 ' CD1' ' HG ' ' A' ' 21' ' ' LEU . 1.9 mm -64.04 145.84 97.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.594 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.6 Cg_endo -76.73 166.47 27.05 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.118 1.589 . . . . 0.0 109.744 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.87 -20.94 34.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 110.36 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.637 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.7 -53.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 111.042 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.9 m-85 -49.13 -26.27 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -69.65 136.16 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 52.04 33.28 36.75 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.31 -159.56 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.55 -0.971 . . . . 0.0 110.497 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.603 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 5.2 m -154.19 95.54 1.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 110.307 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.541 ' HA ' HG21 ' A' ' 69' ' ' VAL . 3.0 m -91.47 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.956 -1.09 . . . . 0.0 110.147 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -162.09 28.39 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -74.08 -51.18 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.944 1.497 . . . . 0.0 110.415 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 2.3 p -60.66 -49.2 78.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.155 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.491 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 26.7 t -59.41 -46.67 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.079 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -50.29 -62.77 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.58 -36.82 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.063 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.7 t80 -60.63 -55.06 37.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.491 ' HG ' ' CD1' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -55.23 -36.12 65.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HA ' HG22 ' A' ' 30' ' ' VAL . 25.9 t -60.06 -52.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.2 -40.43 67.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.129 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 4' ' ' ILE . 10.2 tp -61.73 -38.82 89.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.61 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.92 -88.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 177.17 164.94 31.69 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -21.81 62.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 110.675 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.79 1.27 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.083 -1.011 . . . . 0.0 110.057 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.24 -21.81 66.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.389 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 44.8 t -74.46 -33.29 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 0.0 110.068 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.7 m -88.8 -21.4 23.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.28 -25.23 31.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -80.59 7.46 9.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.201 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 52.2 t-20 58.43 74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.27 -0.893 . . . . 0.0 110.534 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 2.7 mt -124.38 110.41 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.469 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 2.3 mmt85 -87.3 157.24 19.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.402 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.5 mtm180 -102.17 150.7 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 110.018 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.99 154.55 39.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' ALA . 50.9 m -43.82 -26.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.208 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -166.23 -162.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -72.28 -11.88 60.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.75 106.16 18.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.2 p80 -145.85 175.22 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.177 -0.952 . . . . 0.0 110.454 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.588 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.4 p -80.96 124.45 29.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 0.0 109.823 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.0 p -115.3 -177.59 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.115 -0.991 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.538 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.93 39.36 5.47 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.452 -0.78 . . . . 0.0 109.301 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.71 -150.08 48.94 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 14.4 p30 -87.29 31.38 0.73 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.095 -1.239 . . . . 0.0 110.012 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.92 -28.96 6.86 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.251 -0.905 . . . . 0.0 110.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.97 162.64 14.03 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.925 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.588 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 8.4 m95 -139.55 167.42 22.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.449 -1.03 . . . . 0.0 109.325 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 6.3 t -107.79 108.92 20.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.868 -1.145 . . . . 0.0 111.1 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -130.06 158.96 38.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.836 . . . . 0.0 109.06 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -48.4 51.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.946 -1.097 . . . . 0.0 108.249 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -124.28 -171.24 2.29 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.686 0.755 . . . . 0.0 110.525 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.522 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 11.4 m -131.52 164.33 26.03 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.958 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.0 m-85 -79.63 164.76 23.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.153 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -63.56 -44.62 93.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -4.77 13.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.868 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 17.1 mt-10 -123.0 -178.51 3.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.915 . . . . 0.0 110.145 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -139.65 -163.57 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 64' ' ' THR . 70.9 t -111.38 89.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 29.9 t0 -40.63 91.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.185 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -57.27 -30.51 64.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.563 -179.477 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.81 -48.61 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 110.818 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.637 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 22.9 m-85 -83.88 -8.76 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 111.12 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -24.35 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.974 -1.079 . . . . 0.0 109.415 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -67.22 -71.36 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 13' ' ' VAL . 9.9 p -44.18 -29.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.116 -0.99 . . . . 0.0 109.841 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.41 -64.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.57 -116.07 5.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -60.8 -50.98 71.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.451 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 12.4 m-30 -79.91 -175.16 4.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.966 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -122.31 144.83 48.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 t -81.59 97.05 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 109.382 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.468 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 21.8 m -79.39 164.09 24.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.194 -0.941 . . . . 0.0 109.753 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.2 mtp180 -151.16 -179.25 7.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 0.0 110.53 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.473 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 54.4 p -116.59 87.35 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.269 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.4 t-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 1' ' ' ASN . 48.3 Cg_endo -75.34 141.09 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.901 1.474 . . . . 0.0 110.473 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.51 -169.26 2.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 5' ' ' PRO . 4.0 mm -62.42 144.32 95.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.2 Cg_endo -72.4 -158.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.183 1.622 . . . . 0.0 109.701 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -113.48 -29.82 7.06 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.636 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -51.97 -55.28 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.367 -0.833 . . . . 0.0 110.815 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 21.2 m-85 -48.15 -29.33 3.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 6' ' ' ALA . 33.1 mt -68.57 129.22 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.422 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.66 32.01 72.74 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 8' ' ' TYR . . . -122.42 -162.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.983 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.616 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 5.0 m -153.79 100.07 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.534 HG12 ' CG2' ' A' ' 69' ' ' VAL . 2.9 m -93.73 173.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.115 -0.991 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -161.44 35.11 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 46.8 Cg_endo -74.27 -49.67 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.964 1.507 . . . . 0.0 110.39 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -50.19 74.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.23 -0.919 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 55.4 t -61.59 -51.0 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.555 ' CZ3' HG21 ' A' ' 35' ' ' ILE . 57.1 t-105 -44.56 -65.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.703 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HA ' HG23 ' A' ' 22' ' ' VAL . . . -43.53 -43.27 5.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 67.2 t80 -56.89 -64.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.867 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 2.1 tt -44.08 -38.61 3.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 19' ' ' ALA . 15.6 t -54.99 -55.97 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.1 -43.56 64.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 4' ' ' ILE . 12.1 tp -55.28 -43.82 75.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.248 -0.908 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.602 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.6 -88.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.238 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 177.08 166.83 34.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.22 -20.88 63.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -1.148 . . . . 0.0 110.588 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -63.62 1.1 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.031 -1.043 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.602 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.45 -18.49 63.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.174 -0.953 . . . . 0.0 109.208 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 24.2 t -75.98 -32.02 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.468 -0.77 . . . . 0.0 109.729 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.0 m -93.03 -17.1 24.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.34 -24.0 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 34' ' ' ASN . . . -83.18 10.36 8.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 61.9 t-20 58.81 74.07 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.603 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.555 HG21 ' CZ3' ' A' ' 18' ' ' TRP . 7.0 mt -125.1 125.27 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.858 . . . . 0.0 109.605 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.9 mtt180 -107.2 146.35 31.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -89.63 154.24 20.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -126.71 161.53 27.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.368 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -51.7 -26.71 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.392 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 39' ' ' SER . 3.7 m -165.32 -177.18 4.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.9 m-20 -56.41 -24.57 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.574 ' OD1' ' CD2' ' A' ' 73' ' ' TYR . 4.0 t30 -86.81 110.94 20.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.616 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.2 p80 -147.85 175.25 11.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.626 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -77.69 138.79 39.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.347 -0.846 . . . . 0.0 109.689 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.3 p -131.37 178.8 6.44 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.83 36.43 8.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.28 -147.74 46.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -87.13 31.6 0.71 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.198 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -115.03 -31.84 5.93 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.236 -0.915 . . . . 0.0 111.032 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -122.81 165.75 15.4 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.162 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.626 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.7 m95 -144.74 169.71 17.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.461 -1.023 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 5.8 t -109.61 113.33 26.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.829 -1.17 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.8 OUTLIER -132.52 160.96 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 109.126 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -50.84 -50.5 56.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.859 -1.151 . . . . 0.0 108.269 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -124.72 -178.98 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.528 0.68 . . . . 0.0 110.492 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 12.4 m -125.05 166.33 16.57 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.975 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -79.7 171.37 15.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.11 -0.994 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -39.41 71.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.207 -0.933 . . . . 0.0 110.17 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -71.21 -2.99 17.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 13.0 mt-10 -126.39 -172.35 2.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 6.2 p90 -144.52 -164.15 1.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' THR . 54.3 t -110.3 89.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.502 -0.749 . . . . 0.0 109.969 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 30.1 t0 -41.86 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.21 -28.67 65.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' OH ' ' HB1' ' A' ' 6' ' ' ALA . 16.4 t80 -68.86 -49.23 60.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 110.526 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 17.7 m-85 -82.91 -8.56 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 t -51.09 -21.71 2.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.987 -1.07 . . . . 0.0 109.115 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -67.49 -68.97 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 110.294 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' HG12 ' A' ' 13' ' ' VAL . 10.8 p -46.35 -30.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 109.35 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.522 ' N ' HG13 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -60.15 -70.93 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 110.415 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.2 -115.5 5.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -61.0 -39.8 91.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -1.165 . . . . 0.0 109.995 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 29.3 m-85 -92.26 -177.69 4.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.877 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -122.3 145.87 47.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 0.0 109.642 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 8.7 t -85.08 99.24 10.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.64 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 18.3 m -78.36 163.89 25.29 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 109.667 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.0 mtp180 -154.09 -175.58 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 110.658 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -111.87 102.08 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.149 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.272 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 t30 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.05 93.77 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.904 1.476 . . . . 0.0 110.367 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.54 139.68 24.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.363 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.492 HG21 ' N ' ' A' ' 5' ' ' PRO . 1.4 mm -57.64 147.23 62.05 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.596 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.7 Cg_endo -76.36 164.34 31.02 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.035 1.545 . . . . 0.0 109.921 178.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -80.62 -20.96 42.01 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.631 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.92 -56.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.9 -179.643 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.596 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.3 m-85 -47.6 -25.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.0 110.004 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 8.3 mt -69.15 125.49 27.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 60.2 31.41 73.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -118.72 -160.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.447 -1.031 . . . . 0.0 110.759 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.605 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 5.8 m -156.26 104.33 2.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG12 ' CG2' ' A' ' 69' ' ' VAL . 3.4 m -99.03 169.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.154 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 -163.89 21.54 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.5 Cg_endo -73.73 -46.1 0.35 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.051 1.553 . . . . 0.0 110.281 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -52.43 56.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.503 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 59.6 t -57.63 -41.36 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.568 ' CD2' ' HD2' ' A' ' 37' ' ' ARG . 43.0 t-105 -54.22 -66.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.14 -0.975 . . . . 0.0 109.633 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.27 -33.97 1.77 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.707 . . . . 0.0 110.334 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 74.2 t80 -65.13 -65.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.117 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 35' ' ' ILE . 1.6 tt -44.7 -35.8 2.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.441 ' HA ' HG21 ' A' ' 30' ' ' VAL . 21.7 t -60.96 -48.24 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.21 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.459 -0.776 . . . . 0.0 109.968 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 tp -60.71 -42.98 98.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.607 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -121.7 -88.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 110.163 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 175.64 165.77 32.16 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.32 -19.25 61.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -1.132 . . . . 0.0 110.486 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -63.11 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.884 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.607 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.4 -19.7 64.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.514 HG13 ' CZ2' ' A' ' 18' ' ' TRP . 38.2 t -75.78 -32.03 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.442 -0.786 . . . . 0.0 109.856 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.2 m -89.37 -23.21 22.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.18 -24.9 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -81.07 8.38 8.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 61.2 t-20 59.21 74.73 0.43 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.562 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 67.9 mt -125.19 128.4 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.437 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mmt180 -109.99 146.32 35.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.568 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 6.6 mtp180 -92.79 148.86 21.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.82 173.69 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.097 -1.002 . . . . 0.0 110.328 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 t -51.29 -37.02 45.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.33 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.497 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.2 m -161.2 -162.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.346 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.2 m-20 -67.47 -18.55 65.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.405 -0.809 . . . . 0.0 110.344 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -91.75 92.19 8.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.273 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.605 ' CE1' ' O ' ' A' ' 12' ' ' THR . 2.7 p80 -127.49 -178.6 4.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.159 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -88.95 117.64 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 46' ' ' ALA . 21.4 p -104.11 -175.47 2.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.439 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 77' ' ' ARG . . . 43.98 39.57 2.8 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.446 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.63 -150.23 50.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 34.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.153 -1.204 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -117.93 -28.63 5.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.319 -0.863 . . . . 0.0 110.924 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -126.53 165.17 19.83 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.165 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 30.2 m95 -138.61 176.16 8.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.044 . . . . 0.0 109.956 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 m -105.66 102.41 11.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 5.3 mtt180 -122.21 137.71 54.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.147 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.559 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -49.25 -41.2 36.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 108.977 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.44 144.13 51.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 4.4 m -103.62 166.8 10.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.038 -1.038 . . . . 0.0 110.048 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -79.9 167.8 20.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.417 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -41.03 90.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.22 -6.18 17.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 15.5 mt-10 -126.18 178.04 6.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 109.887 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.583 ' CE1' ' HB2' ' A' ' 77' ' ' ARG . 12.6 p90 -133.49 -170.32 2.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.277 179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 64' ' ' THR . 41.8 t -107.48 87.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 32.0 t0 -40.49 91.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.617 -0.677 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.2 -27.73 55.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.572 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.449 ' OH ' ' HB1' ' A' ' 6' ' ' ALA . 19.7 t80 -70.43 -50.35 39.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.886 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.631 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 24.0 m-85 -82.7 -8.0 59.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 111.065 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 -21.39 3.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.017 -1.052 . . . . 0.0 109.308 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -69.96 -51.16 34.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.552 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 7.6 p -64.24 -31.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.95 -1.094 . . . . 0.0 110.495 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.509 ' N ' HG12 ' A' ' 69' ' ' VAL . 57.8 m -62.74 -52.3 63.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.944 -1.097 . . . . 0.0 109.466 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 -119.56 5.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.09 -23.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 110.11 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -116.67 178.44 4.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.559 ' CE2' ' O ' ' A' ' 54' ' ' SER . 1.6 m-85 -115.73 147.22 41.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 8.8 t -79.5 95.91 5.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 0.0 109.58 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 77' ' ' ARG . 31.3 m -78.66 160.98 27.24 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.957 -1.09 . . . . 0.0 109.355 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.583 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 43.4 mtp180 -157.83 -172.52 3.97 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.359 -0.838 . . . . 0.0 110.591 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 7.6 t -114.87 96.31 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.611 -0.681 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.481 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.728 0.299 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 1' ' ' ASN . 46.2 Cg_endo -72.89 84.29 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.929 1.489 . . . . 0.0 110.507 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 4' ' ' ILE . 3.1 tm? -96.74 150.98 20.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.09 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 3' ' ' LEU . 3.6 mm -40.91 145.44 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.851 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.6 Cg_endo -71.37 -158.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.125 1.592 . . . . 0.0 109.615 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.425 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.24 -21.49 9.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.781 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.651 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -56.09 -44.9 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.454 -0.778 . . . . 0.0 110.807 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.607 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.3 m-85 -55.86 -24.17 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.987 . . . . 0.0 110.758 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 54.3 mt -61.18 127.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 54.7 32.58 54.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -112.29 -170.83 1.73 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.504 -0.997 . . . . 0.0 110.645 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.587 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.2 m -145.75 90.13 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.546 HG12 ' CG2' ' A' ' 69' ' ' VAL . 3.1 m -82.99 175.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.04 -1.038 . . . . 0.0 109.826 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.83 -166.49 42.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 44.0 Cg_endo -72.21 -46.49 0.51 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.976 1.514 . . . . 0.0 110.185 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -47.57 82.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 57.1 t -59.5 -51.81 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.581 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 36.4 t-105 -44.43 -66.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 109.824 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.71 -39.76 2.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.844 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 38.9 t80 -62.44 -64.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.363 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.523 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.9 OUTLIER -42.74 -52.0 5.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 30' ' ' VAL . 73.2 t -47.65 -50.89 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.78 -46.53 59.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 tp -60.58 -38.87 86.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.844 . . . . 0.0 110.036 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.603 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -126.99 -89.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 173.55 171.25 37.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.38 -19.18 65.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -1.169 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.95 -63.13 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.07 -1.018 . . . . 0.0 109.945 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.603 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -62.84 -21.87 66.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 26' ' ' GLY . 24.6 t -74.0 -33.48 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.726 . . . . 0.0 109.929 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 m -85.31 -27.01 26.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.009 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.02 -25.93 48.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.948 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -81.46 3.25 25.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.025 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.472 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.2 t-20 58.73 77.95 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.59 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.578 HG21 ' CZ3' ' A' ' 18' ' ' TRP . 2.6 mt -121.43 140.76 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.505 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 5.5 mtt180 -117.49 153.82 32.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.567 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.581 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 19.0 mtp-105 -109.04 134.3 51.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -109.44 173.82 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 40' ' ' SER . 77.9 p -49.58 -27.48 4.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.5 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 39.0 m -167.71 -166.08 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -65.83 -10.17 35.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.472 ' OD1' ' CG ' ' A' ' 73' ' ' TYR . 2.8 m-20 -96.31 105.58 17.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.9 p80 -145.71 -179.85 6.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -0.977 . . . . 0.0 110.647 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.625 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -91.64 148.31 22.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.443 -0.786 . . . . 0.0 109.521 179.627 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 9.3 p -141.27 -177.32 5.07 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 110.611 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.3 43.54 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.27 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.69 -161.04 53.92 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -83.82 41.33 0.79 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.031 -1.276 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -119.38 -31.16 4.71 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.64 158.76 14.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.223 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.625 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.1 m95 -140.05 169.05 18.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -1.028 . . . . 0.0 109.189 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 4.6 t -112.45 115.91 29.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.786 -1.197 . . . . 0.0 110.893 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 0.9 OUTLIER -132.44 161.38 33.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.349 -0.844 . . . . 0.0 109.25 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -46.08 66.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.985 -1.072 . . . . 0.0 108.856 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.52 163.19 30.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 10.9 m -103.73 170.22 8.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 110.265 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 21.5 m-85 -87.39 -178.88 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.2 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -75.23 -38.47 60.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.333 -0.854 . . . . 0.0 110.008 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.54 0.74 13.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -132.36 177.9 7.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 9.7 p90 -138.89 -168.83 2.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' THR . 26.2 t -104.07 89.63 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.64 -0.663 . . . . 0.0 109.828 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.489 ' OD2' ' CD ' ' A' ' 77' ' ' ARG . 16.8 t0 -42.64 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.8 p -58.08 -32.74 68.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -44.89 80.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.651 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 37.8 m-85 -89.1 -5.99 57.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.963 -179.347 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 t -50.51 -22.5 1.97 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.013 -1.055 . . . . 0.0 108.766 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . . . -70.61 -67.78 0.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 13' ' ' VAL . 12.9 p -44.71 -28.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.018 -1.051 . . . . 0.0 109.671 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.531 ' N ' HG11 ' A' ' 69' ' ' VAL . 1.1 m -67.08 -62.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.453 -0.78 . . . . 0.0 110.449 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.7 -114.81 4.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -69.04 -34.0 74.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' CG ' ' OD1' ' A' ' 42' ' ' ASN . 61.7 m-85 -87.79 179.72 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 7.0 m-85 -121.89 129.55 52.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -0.853 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.513 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -79.46 99.61 7.3 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.04 -1.038 . . . . 0.0 108.816 179.376 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.9 m -78.38 163.83 25.33 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.903 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 10.1 mtp180 -148.02 176.55 10.09 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 110.31 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 t -103.93 88.5 3.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 6.7 ttm180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.813 0.339 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.2 100.36 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.032 1.543 . . . . 0.0 110.48 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.44 155.02 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.47 HG22 ' HD2' ' A' ' 5' ' ' PRO . 2.4 mm -54.56 144.97 41.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.338 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.6 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.4 Cg_endo -76.89 163.59 30.98 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.063 1.559 . . . . 0.0 109.828 178.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.507 ' HA ' ' CD1' ' A' ' 9' ' ' ILE . . . -80.22 -22.48 41.77 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -51.37 -55.11 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -179.663 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.25 -30.76 5.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 6' ' ' ALA . 65.0 mt -67.99 135.23 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 54.43 33.55 53.69 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.154 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -125.51 -160.28 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.513 -0.992 . . . . 0.0 110.417 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.584 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 3.6 m -155.18 92.57 1.44 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.952 . . . . 0.0 110.451 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.539 ' HA ' HG23 ' A' ' 69' ' ' VAL . 2.9 m -84.21 -147.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 110.28 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -125.58 -161.31 10.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.22 -47.27 0.32 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.992 1.522 . . . . 0.0 110.542 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -55.64 11.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 64.2 t -53.71 -39.74 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.578 ' CD2' ' HD2' ' A' ' 37' ' ' ARG . 25.9 t90 -55.99 -61.87 2.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.76 -38.23 3.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -66.16 -44.2 84.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' VAL . 1.3 tt -65.1 -27.89 69.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 110.27 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.51 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 85.9 t -71.37 -42.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 110.281 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 HD23 HG12 ' A' ' 4' ' ' ILE . 8.7 tp -72.92 -69.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 110.794 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.623 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 14.9 p -88.43 -26.48 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 110.702 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 25' ' ' VAL . . . 119.72 161.37 11.57 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 22' ' ' VAL . . . -63.42 -63.2 1.25 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -1.121 . . . . 0.0 110.318 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.2 -34.25 31.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.992 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.623 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -63.6 -43.67 96.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.483 HG12 HD12 ' A' ' 35' ' ' ILE . 49.8 t -60.84 -39.76 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m -71.47 -23.45 61.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.19 -20.8 31.75 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.391 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.11 9.14 29.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.513 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 1.3 t-20 59.13 68.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.383 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.483 HD12 HG12 ' A' ' 30' ' ' VAL . 3.3 mt -120.13 110.81 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.652 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.1 mtm105 -92.04 160.11 15.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.555 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.578 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 8.4 mtp-105 -110.54 151.52 27.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.83 -172.46 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 4.9 t -71.92 -2.76 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 170.65 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.076 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -71.24 -9.65 58.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.7 t-20 -97.39 100.48 11.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.133 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.584 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.0 p80 -142.22 176.78 8.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.112 -0.993 . . . . 0.0 110.501 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.5 p -78.51 129.74 35.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.16 175.64 6.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 110.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.81 42.74 20.49 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.73 -150.65 49.74 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -86.17 38.57 0.77 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.103 -1.234 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.3 mtm-85 -116.96 -35.35 4.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.171 -0.956 . . . . 0.0 111.013 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.457 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -125.45 165.49 18.58 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.501 -1.333 . . . . 0.0 109.931 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.9 m95 -136.77 175.0 10.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.443 -1.034 . . . . 0.0 109.673 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.453 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 5.6 t -107.97 120.09 41.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.976 -1.078 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -139.02 144.89 39.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.36 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.47 ' CB ' ' HD3' ' A' ' 55' ' ' LYS . 1.4 m -45.78 -38.73 7.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.954 -1.092 . . . . 0.0 108.479 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HD3' ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.8 -162.83 1.27 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.455 ' SG ' HG21 ' A' ' 62' ' ' VAL . 20.7 m -143.4 179.06 7.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.928 -1.108 . . . . 0.0 110.37 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.93 -176.12 5.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.028 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -84.26 -38.46 20.46 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 9.58 7.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 11.1 mt-10 -124.06 -168.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.6 p90 -154.4 -160.09 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.896 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 64' ' ' THR . 66.2 t -122.5 96.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.683 -0.636 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.473 ' OD1' ' HB3' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -52.69 89.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 109.796 -179.63 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -43.08 -24.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.58 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 63' ' ' ASP . 26.6 t80 -67.32 -55.13 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.83 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.3 m-85 -81.95 -9.92 59.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.195 -0.941 . . . . 0.0 110.982 -179.286 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 t -48.25 -23.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.094 -1.004 . . . . 0.0 109.215 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' A' ' 8' ' ' TYR . . . -67.54 -71.5 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.722 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 13' ' ' VAL . 9.3 p -43.33 -29.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 109.668 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.528 ' N ' HG11 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -62.44 -58.67 6.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.471 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.69 -136.91 12.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.47 -27.69 4.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -1.166 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -93.71 179.18 5.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.152 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.525 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 10.9 m-85 -122.68 137.29 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 178.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 t -78.76 103.35 8.65 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.969 -1.082 . . . . 0.0 108.818 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.5 m -79.58 163.06 24.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.523 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 26.3 mtp180 -160.08 -170.24 2.78 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.534 -0.729 . . . . 0.0 110.274 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.69 114.9 21.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.826 . . . . 0.0 110.22 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.174 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.771 0.32 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.3 86.76 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.538 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.38 167.89 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 110.115 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 21' ' ' LEU . 2.1 mm -58.7 145.27 78.36 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.247 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HB2' HG23 ' A' ' 7' ' ' ILE . 46.4 Cg_endo -77.68 164.79 27.71 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.03 1.542 . . . . 0.0 109.88 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.95 -28.44 27.81 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -54.75 -50.47 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 110.366 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.538 ' CD2' HD11 ' A' ' 21' ' ' LEU . 9.9 m-30 -46.97 -27.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 49.1 mt -64.19 118.55 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.562 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 65.06 30.65 78.5 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -178.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -106.52 -161.57 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.51 -0.994 . . . . 0.0 110.809 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.611 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 4.3 m -156.35 92.28 1.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.539 ' HA ' HG23 ' A' ' 69' ' ' VAL . 3.4 m -93.74 169.75 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.288 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.97 -161.68 36.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.6 Cg_endo -74.09 -38.79 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.024 1.539 . . . . 0.0 110.414 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.94 -53.96 22.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 110.142 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.531 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.6 t -58.48 -46.86 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.986 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.44 ' CZ3' HG23 ' A' ' 35' ' ' ILE . 28.3 t-105 -49.06 -65.2 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.646 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.48 -40.91 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 110.263 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 54.0 t80 -59.24 -58.0 10.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.538 HD11 ' CD2' ' A' ' 8' ' ' TYR . 2.8 tt -51.73 -36.2 46.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 40.8 t -58.4 -49.29 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.085 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.16 82.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.178 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 tp -57.14 -44.71 83.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.609 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.39 -88.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.265 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.575 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 176.02 166.93 34.16 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -20.34 63.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -1.192 . . . . 0.0 110.637 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.57 -64.24 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.081 -1.012 . . . . 0.0 109.779 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -60.76 -23.5 65.02 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.024 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.521 ' CG2' HD22 ' A' ' 21' ' ' LEU . 21.9 t -67.43 -37.02 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.443 -0.786 . . . . 0.0 109.533 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.2 m -85.26 -23.85 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.22 -23.05 54.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.6 24.76 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 30.7 t-20 41.23 75.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 30' ' ' VAL . 53.1 mt -117.2 126.47 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.496 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -100.78 146.06 27.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.564 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -91.5 146.91 23.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.83 . . . . 0.0 109.693 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.45 152.91 42.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' ALA . 18.2 t -42.27 -27.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.211 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.436 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m -171.65 -165.03 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -65.23 -12.91 56.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 30.9 t-20 -95.8 103.38 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.575 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.611 ' CE1' ' O ' ' A' ' 12' ' ' THR . 4.5 p80 -145.77 -179.9 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.363 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.578 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.4 p -84.66 133.33 34.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.694 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.0 p -122.06 174.78 6.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 50.0 33.09 6.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.323 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 -144.93 43.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.87 40.65 0.82 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.025 -1.28 . . . . 0.0 109.976 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -113.11 -40.37 3.96 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 110.989 -179.412 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.478 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -131.6 172.37 20.9 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.271 -1.443 . . . . 0.0 110.573 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.578 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.3 m95 -136.22 177.18 8.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.895 . . . . 0.0 109.356 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.48 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -107.62 115.07 29.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' NH1' ' HB2' ' A' ' 51' ' ' TRP . 1.6 mtt180 -132.16 142.95 49.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.729 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 2.1 t -48.1 -43.15 30.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.883 -1.135 . . . . 0.0 108.834 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.11 50.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.506 ' SG ' ' CG2' ' A' ' 62' ' ' VAL . 6.3 m -101.85 162.2 13.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.952 -1.092 . . . . 0.0 110.331 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -79.98 167.34 20.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.887 . . . . 0.0 110.478 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -67.01 -39.55 87.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -63.91 -9.89 17.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.918 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 13.3 mt-10 -126.48 179.15 5.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.212 -0.93 . . . . 0.0 109.817 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 13.4 p90 -130.58 -169.45 2.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -0.96 . . . . 0.0 110.34 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 64' ' ' THR . 41.9 t -111.08 88.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 62' ' ' VAL . 3.7 t70 -38.56 91.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.43 0.633 . . . . 0.0 110.477 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.85 -29.54 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 110.049 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.467 ' O ' HD12 ' A' ' 7' ' ' ILE . 51.2 t80 -68.48 -53.51 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.435 -0.79 . . . . 0.0 110.462 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 46' ' ' ALA . 11.6 m-85 -80.09 -4.26 52.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 111.489 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -16.62 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.944 -1.097 . . . . 0.0 109.626 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -73.19 -45.99 53.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.003 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 13' ' ' VAL . 10.0 p -71.63 -26.28 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.935 -1.103 . . . . 0.0 109.343 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -65.28 -50.91 63.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.77 . . . . 0.0 109.83 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.12 -131.04 10.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -33.67 9.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -1.074 . . . . 0.0 109.798 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 8.9 m-85 -92.83 -177.63 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.857 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 6.8 m-85 -126.69 140.77 52.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 8.6 t -79.48 97.25 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.568 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 14.2 m -79.23 163.26 25.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.981 . . . . 0.0 110.069 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.636 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 6.5 mmm180 -153.59 -172.43 4.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 110.242 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 29.3 p -120.17 81.03 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.489 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.169 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' LEU . 46.5 Cg_endo -73.83 153.12 47.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.544 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -55.39 -162.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.308 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.528 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.3 mm -87.62 143.37 33.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 109.972 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HB2' ' CG2' ' A' ' 7' ' ' ILE . 47.2 Cg_endo -79.29 162.11 25.58 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.151 1.606 . . . . 0.0 110.166 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.49 -20.31 37.05 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.547 -0.72 . . . . 0.0 110.22 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.638 ' CD1' ' CD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -57.73 -39.18 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.879 . . . . 0.0 110.457 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.565 ' CD2' HD13 ' A' ' 21' ' ' LEU . 12.8 m-30 -63.14 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.518 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.8 mt -72.44 126.55 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 109.281 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.79 31.01 79.36 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 7' ' ' ILE . . . -118.54 -163.08 0.93 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.501 -0.999 . . . . 0.0 110.711 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.606 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 1.8 m -154.85 99.54 2.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -0.894 . . . . 0.0 109.835 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.527 HG13 ' CG2' ' A' ' 69' ' ' VAL . 3.1 m -94.72 178.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.991 -1.068 . . . . 0.0 110.445 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.12 -161.74 37.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 45.6 Cg_endo -73.33 -46.52 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.985 1.519 . . . . 0.0 110.509 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -47.78 74.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.317 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.514 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 14.9 t -58.8 -46.05 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.447 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 7.7 t90 -52.66 -55.67 20.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.55 59.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.605 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.19 -59.06 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.92 . . . . 0.0 110.302 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.565 HD13 ' CD2' ' A' ' 8' ' ' TYR . 1.6 tt -52.04 -36.31 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.791 . . . . 0.0 110.366 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 26' ' ' GLY . 46.8 t -62.73 -48.58 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.11 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.85 -34.76 68.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 4' ' ' ILE . 6.4 tp -69.54 -39.15 77.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.376 -0.828 . . . . 0.0 110.371 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.612 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -128.71 -52.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.425 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . 134.85 164.19 10.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -65.2 -7.99 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -1.087 . . . . 0.0 110.884 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.947 -1.096 . . . . 0.0 109.817 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.612 ' CB ' ' CG2' ' A' ' 25' ' ' VAL . . . -64.74 -19.25 65.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.855 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' CG2' HD22 ' A' ' 21' ' ' LEU . 18.2 t -75.21 -32.83 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.9 m -87.26 -27.01 23.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.044 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.94 -19.91 36.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -84.57 9.18 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 110.156 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER 59.05 72.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.345 -0.847 . . . . 0.0 110.624 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 8' ' ' TYR . 38.0 mt -124.96 114.54 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 109.692 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.8 mtt-85 -98.67 152.11 19.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 4.1 mtm180 -93.68 159.59 15.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -134.52 164.02 28.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.18 -25.31 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.459 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -179.54 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.293 -179.865 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 62.1 m-20 -65.97 -10.45 39.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -98.33 100.19 11.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.351 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.606 ' CE1' ' O ' ' A' ' 12' ' ' THR . 3.0 p80 -143.25 175.04 10.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.943 . . . . 0.0 110.451 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.572 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 5.7 p -80.38 125.63 30.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.403 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.97 177.44 4.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.07 44.03 18.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.47 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.42 -152.13 51.49 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -86.75 36.14 0.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.061 -1.258 . . . . 0.0 109.989 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -31.2 5.11 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.225 -0.922 . . . . 0.0 110.859 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.487 ' CA ' ' HG2' ' A' ' 77' ' ' ARG . . . -118.78 163.46 13.17 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.061 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.572 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 8.1 m95 -140.84 165.92 26.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -1.082 . . . . 0.0 109.839 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.5 t -104.37 107.95 19.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 0.0 110.787 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -128.29 149.93 50.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -0.898 . . . . 0.0 109.622 179.351 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 65.8 p -55.99 -49.87 72.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 109.035 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -130.49 173.57 10.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 57.1 m -148.6 172.04 15.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -79.54 -170.29 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.506 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -45.28 10.69 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.338 -0.852 . . . . 0.0 110.332 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.7 -20.31 1.2 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 109.517 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -113.58 170.77 8.0 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.395 -0.816 . . . . 0.0 109.832 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.9 p90 -133.85 -168.33 2.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 0.0 110.145 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 64' ' ' THR . 62.6 t -111.76 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.546 -0.721 . . . . 0.0 110.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.2 t0 -40.21 91.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 110.19 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' VAL . 2.8 p -55.13 -33.98 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 110.505 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.93 -46.79 83.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.78 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.638 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 27.4 m-85 -87.2 -6.48 58.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 0.0 111.021 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -21.96 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.053 . . . . 0.0 108.904 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.416 ' HB2' HG21 ' A' ' 7' ' ' ILE . . . -69.67 -66.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 0.0 110.53 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.538 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 9.7 p -48.54 -26.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.077 . . . . 0.0 109.603 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' N ' HG13 ' A' ' 69' ' ' VAL . 0.6 OUTLIER -65.39 -63.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 110.231 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -114.94 5.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -61.06 -47.98 83.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -1.181 . . . . 0.0 110.027 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.46 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 22.5 m-85 -82.69 -178.45 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 2.0 m-85 -121.23 138.82 54.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.7 t -79.68 98.49 6.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.762 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 96.1 m -79.06 173.16 12.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.955 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.5 mtp180 -160.55 179.88 8.22 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.482 -0.761 . . . . 0.0 110.276 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.68 117.49 34.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.159 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.728 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.1 Cg_endo . . . . . 0 C--O 1.215 -0.648 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.58 -24.78 33.77 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.824 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -53.51 -54.83 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.79 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.58 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 10.0 m-30 -48.48 -26.82 2.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 110.172 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 15.7 mt -71.84 139.15 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.391 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.626 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 49.06 35.93 19.85 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -123.72 -161.84 1.01 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.542 -0.975 . . . . 0.0 110.515 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.787 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.6 m -153.93 93.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.815 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -88.76 -171.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.062 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -100.58 -163.6 28.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.4 Cg_endo -72.83 -48.82 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.963 1.507 . . . . 0.0 110.458 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 t -62.78 -52.09 64.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.575 HG23 ' OD1' ' A' ' 41' ' ' ASP . 79.5 t -58.31 -45.85 89.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 110.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.603 ' CZ3' ' NH2' ' A' ' 37' ' ' ARG . 22.2 t90 -50.35 -63.92 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.917 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.03 -36.14 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 52.1 t80 -62.21 -60.97 2.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.9 HD22 HG22 ' A' ' 30' ' ' VAL . 2.6 tt -49.47 -34.55 17.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' VAL . 64.1 t -60.39 -51.04 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.152 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.88 76.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.433 -0.792 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -0.935 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.037 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -126.34 -88.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.18 166.0 32.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.88 -19.32 60.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -1.147 . . . . 0.0 110.562 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -62.94 1.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.115 -0.991 . . . . 0.0 109.949 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.037 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.54 -21.02 66.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.327 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.9 HG22 HD22 ' A' ' 21' ' ' LEU . 38.0 t -75.86 -32.44 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.49 -0.756 . . . . 0.0 109.755 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 m -93.29 -14.99 26.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.057 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.07 -24.67 21.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.016 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -82.18 9.34 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.626 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 44.3 t30 59.34 72.6 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 110.652 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 21' ' ' LEU . 22.4 mt -119.45 120.38 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.627 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' THR . 10.1 mtm180 -101.19 149.07 24.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.569 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.603 ' NH2' ' CZ3' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -100.22 152.26 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.823 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.82 172.47 9.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.167 -0.958 . . . . 0.0 110.405 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 40' ' ' SER . 1.2 p -50.92 -27.31 7.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.517 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 5.1 m -172.06 -173.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.575 ' OD1' HG23 ' A' ' 17' ' ' VAL . 2.6 m-20 -55.12 -22.83 18.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 17.6 t-20 -87.8 107.73 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.917 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.5 p80 -147.33 -175.98 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -95.2 148.73 22.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 10.4 p -139.9 -176.08 4.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.935 . . . . 0.0 110.458 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' CYS . . . 45.84 43.17 9.75 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.3 -157.66 53.45 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.54 44.44 1.04 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.045 -1.267 . . . . 0.0 109.598 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -117.33 -34.37 4.34 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.292 -0.88 . . . . 0.0 111.342 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.02 165.22 12.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.233 -1.46 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 3.5 m95 -140.32 171.37 14.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.608 -0.937 . . . . 0.0 108.948 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.1 t -113.99 123.4 49.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 111.565 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -135.1 156.65 48.65 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' ARG . 80.0 p -46.58 -41.42 14.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.86 -1.15 . . . . 0.0 109.027 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -142.63 178.27 7.74 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 62' ' ' VAL . 10.8 m -122.15 165.69 15.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.895 -1.128 . . . . 0.0 110.153 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -79.93 175.36 10.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -73.47 -39.45 64.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 0.0 110.646 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -2.74 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.139 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.36 -174.66 3.06 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 5.8 p90 -146.72 -159.7 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.674 HG22 ' SG ' ' A' ' 56' ' ' CYS . 45.1 t -125.44 104.85 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.627 -0.671 . . . . 0.0 109.594 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 75' ' ' CYS . 9.7 p30 -51.69 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -44.07 -25.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.706 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.35 -48.5 41.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 111.085 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.686 ' O ' HG12 ' A' ' 69' ' ' VAL . 60.0 m-85 -89.28 -4.66 58.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 111.408 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -51.08 -23.1 2.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.147 . . . . 0.0 108.693 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -72.01 -66.08 0.69 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.624 -0.672 . . . . 0.0 110.538 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.917 HG22 ' CE1' ' A' ' 43' ' ' HIS . 13.2 p -44.08 -30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.078 -1.013 . . . . 0.0 109.67 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -65.47 -63.76 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.109 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.0 -132.6 11.08 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -51.88 -34.55 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.168 . . . . 0.0 110.06 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.35 -174.01 4.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -130.72 128.57 41.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.848 . . . . 0.0 109.877 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.03 99.38 6.86 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.94 -1.1 . . . . 0.0 108.804 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 5.6 m -79.56 160.99 26.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 1.1 mtp180 -151.0 170.93 18.15 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 110.144 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.38 117.02 33.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.655 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 49.2 Cg_endo . . . . . 0 N--CA 1.485 0.994 0 N-CA-C 110.032 -0.795 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.595 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -116.18 -43.45 2.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.86 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -54.11 -39.43 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 1.034 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 47.3 m-85 -59.93 -31.78 70.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 6' ' ' ALA . 66.1 mt -72.87 143.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.454 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.98 35.26 63.37 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -127.77 -162.57 1.18 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -1.065 . . . . 0.0 110.646 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.827 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.7 m -150.35 89.87 1.61 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -83.19 -163.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.018 -1.051 . . . . 0.0 110.336 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.92 -165.62 21.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -73.16 -44.29 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.313 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -65.01 -49.88 68.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.121 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.567 HG11 ' HB ' ' A' ' 13' ' ' VAL . 44.4 t -60.64 -49.81 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.848 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 46.4 t-105 -46.26 -63.87 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.97 -43.06 6.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -59.62 -66.64 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.895 HD22 HG22 ' A' ' 30' ' ' VAL . 4.8 tt -40.78 -49.17 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.489 -0.757 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.5 t -48.75 -50.96 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.39 64.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.399 -0.813 . . . . 0.0 109.868 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.18 -42.2 94.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 110.016 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.959 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -125.93 -87.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.972 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.82 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.4 163.58 27.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.71 60.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -1.132 . . . . 0.0 110.612 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -62.63 1.32 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.14 -0.975 . . . . 0.0 109.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.959 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.13 -25.33 66.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.895 HG22 HD22 ' A' ' 21' ' ' LEU . 20.1 t -68.64 -34.0 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 m -77.09 -44.27 31.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.82 65.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.62 23.06 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.964 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.451 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 62.7 t-20 39.82 70.78 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.423 -0.798 . . . . 0.0 110.646 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.848 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 14.8 mt -115.16 130.16 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.716 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.486 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 10.2 mtt180 -114.86 148.96 37.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.416 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.574 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 6.6 mtp180 -99.47 149.14 23.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.473 -0.767 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -122.95 159.47 28.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.112 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.445 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.3 m -45.08 -25.09 0.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 39' ' ' SER . 44.6 m -167.47 -171.99 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.113 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.1 m-20 -64.22 -14.85 58.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 11.2 t-20 -93.53 109.72 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.5 p80 -146.55 -175.69 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.586 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 1.9 p -88.66 127.24 35.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.681 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.9 p -117.32 178.1 4.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.575 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.06 33.14 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.357 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.63 -149.37 36.6 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -87.6 29.12 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.129 -1.218 . . . . 0.0 109.963 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -108.4 -32.12 7.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.218 -0.926 . . . . 0.0 110.855 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.519 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.8 164.68 15.68 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -138.46 178.59 7.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.456 -1.026 . . . . 0.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.3 t -115.6 113.43 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.889 -1.132 . . . . 0.0 110.707 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -131.58 157.32 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -56.21 -52.77 63.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.966 -1.083 . . . . 0.0 108.76 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' N ' ' OG ' ' A' ' 54' ' ' SER . 1.1 tttt -138.81 139.58 38.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 2.0 t -103.87 168.33 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.449 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.4 m-85 -79.62 168.09 19.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -38.16 86.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.786 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.86 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.995 -1.066 . . . . 0.0 109.739 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.3 mt-10 -124.05 179.3 4.91 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.358 -0.839 . . . . 0.0 109.998 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.6 p90 -135.29 -166.53 1.85 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.809 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.801 HG13 ' HB3' ' A' ' 74' ' ' PHE . 28.6 t -112.31 88.24 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.461 -0.774 . . . . 0.0 109.933 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' A' ' 77' ' ' ARG . 51.8 t0 -37.14 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.377 0.608 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.75 -28.29 60.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -69.91 -44.11 70.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 22.3 m-85 -92.12 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 111.001 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.86 -20.64 3.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.025 -1.047 . . . . 0.0 108.924 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.034 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -70.03 -71.49 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.575 -0.703 . . . . 0.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.827 HG21 ' H ' ' A' ' 12' ' ' THR . 7.2 p -44.28 -28.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.066 -1.021 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -63.05 -59.39 4.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 110.271 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -134.47 11.76 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -31.85 12.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -1.194 . . . . 0.0 109.859 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.7 m-85 -91.58 -179.63 5.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 110.115 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.801 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.1 m-85 -122.95 140.57 52.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.765 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.1 t -79.53 98.25 6.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.085 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 10.9 t -78.58 163.77 25.23 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.04 . . . . 0.0 110.198 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 44.4 mtp180 -159.12 176.08 12.69 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.406 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -94.84 109.89 21.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.162 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.637 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 47.5 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.484 -1.006 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.23 -44.14 2.91 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.04 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -53.58 -49.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.357 -0.839 . . . . 0.0 110.049 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.695 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 41.7 m-85 -47.13 -33.67 5.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 109.742 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 73.8 mt -72.17 124.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.294 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 72.95 29.94 64.17 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -120.33 -163.12 0.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.476 -1.014 . . . . 0.0 110.766 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.738 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 4.2 m -153.66 99.77 2.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.875 . . . . 0.0 109.84 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.962 HG12 HG23 ' A' ' 69' ' ' VAL . 10.4 m -95.38 168.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.224 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -75.65 -162.62 11.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -75.47 -49.08 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.028 1.541 . . . . 0.0 110.35 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 t -60.46 -54.22 48.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 110.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 76.3 t -58.33 -45.67 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.628 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 27.3 t90 -51.56 -66.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.64 -34.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.735 . . . . 0.0 110.289 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 56.4 t80 -64.05 -62.29 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.975 HD22 HG22 ' A' ' 30' ' ' VAL . 1.4 tt -52.36 -26.22 11.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.56 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.8 t -69.94 -50.55 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.731 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.08 -26.62 50.31 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.219 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 24' ' ' LEU . 9.1 tp -73.91 -50.59 19.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.518 -0.739 . . . . 0.0 110.669 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.915 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.1 m -113.05 -44.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.462 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 129.2 169.0 12.48 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.57 -26.74 66.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.901 -1.353 . . . . 0.0 110.479 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 -54.97 14.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.915 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -64.05 -40.76 97.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.87 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.975 HG22 HD22 ' A' ' 21' ' ' LEU . 54.7 t -68.29 -25.26 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 110.181 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.2 m -86.67 -22.41 26.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.2 -19.59 26.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -86.46 17.11 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.22 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.45 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 60.8 t-20 55.4 67.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 110.603 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.774 HD13 HD13 ' A' ' 21' ' ' LEU . 65.2 mt -120.35 110.06 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -91.77 152.83 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.661 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.628 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 1.4 mtp180 -94.76 157.18 16.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 109.691 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -132.03 163.58 28.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.432 ' C ' ' OG ' ' A' ' 40' ' ' SER . 84.1 p -53.33 -31.91 46.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.44 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.432 ' OG ' ' C ' ' A' ' 39' ' ' SER . 2.1 m -164.74 -179.8 6.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.68 -23.42 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.082 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.9 t30 -87.7 110.42 20.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.738 ' CD2' ' O ' ' A' ' 12' ' ' THR . 5.0 p-80 -150.12 177.85 9.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.584 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 5.2 p -81.49 130.41 35.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.46 -0.775 . . . . 0.0 109.62 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 p -121.97 173.85 7.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 0.0 110.424 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . . . 48.37 40.24 14.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.124 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 -149.25 49.23 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -87.21 23.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.138 -1.213 . . . . 0.0 109.864 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -100.84 -34.62 9.74 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 0.0 111.051 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.494 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.37 166.57 14.92 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.987 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.59 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.4 m95 -140.99 171.07 14.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -1.07 . . . . 0.0 109.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 4.4 t -106.07 108.79 20.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.59 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -130.41 157.45 42.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.211 -0.93 . . . . 0.0 109.938 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -63.93 -52.75 58.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.965 . . . . 0.0 109.021 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.4 tttt -128.75 174.66 9.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.503 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 58.2 m -150.34 170.08 19.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.867 -1.145 . . . . 0.0 110.747 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 15.7 m-85 -81.97 -176.06 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.476 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -80.37 -46.95 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.25 -0.906 . . . . 0.0 110.646 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' ARG . 1.5 t-80 -46.46 -23.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 109.153 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mt-10 -118.67 175.35 5.77 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.456 -0.777 . . . . 0.0 109.445 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.8 p90 -139.94 -167.26 2.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.543 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 74' ' ' PHE . 49.8 t -110.96 89.45 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.636 -0.665 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 16.8 t0 -40.6 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.49 -0.756 . . . . 0.0 110.42 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.25 -24.93 30.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.566 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 7' ' ' ILE . 18.6 t80 -68.74 -51.99 35.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.526 -0.734 . . . . 0.0 110.714 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.645 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 9.1 m-85 -81.58 -4.98 57.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.161 -0.962 . . . . 0.0 111.414 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.7 p -49.6 -21.5 1.02 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.057 -1.027 . . . . 0.0 109.979 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -66.09 -69.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 110.602 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.962 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -49.07 -26.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.056 . . . . 0.0 109.476 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -68.2 -44.29 76.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -124.32 6.5 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.58 74.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -1.209 . . . . 0.0 110.045 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 80.4 m-85 -81.22 -178.99 7.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.1 m-85 -125.36 138.92 54.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.32 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 16.4 t -81.85 101.06 9.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.145 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 76.9 m -79.49 175.0 11.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 9.2 mtp180 -160.52 179.8 8.29 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 110.054 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.2 85.5 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.724 ' HB2' HG22 ' A' ' 7' ' ' ILE . 51.3 Cg_endo . . . . . 0 C--O 1.215 -0.669 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB3' ' OH ' ' A' ' 65' ' ' TYR . . . -88.83 -23.6 22.78 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 110.164 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.914 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -53.41 -57.16 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 110.995 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.641 ' H ' HG23 ' A' ' 7' ' ' ILE . 23.2 m-30 -48.32 -25.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.018 -1.051 . . . . 0.0 110.169 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.0 mt -73.17 128.37 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 58.05 32.79 67.49 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.914 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -117.46 -159.21 0.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.515 -0.991 . . . . 0.0 110.601 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.802 ' H ' HG21 ' A' ' 69' ' ' VAL . 2.8 m -153.13 91.05 1.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 109.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.914 HG12 HG23 ' A' ' 69' ' ' VAL . 5.9 m -90.66 164.62 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 110.506 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -89.69 -158.02 33.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.8 Cg_endo -74.42 -42.78 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.912 1.48 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.486 ' HB2' ' OD1' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -63.81 -57.75 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 110.089 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.9 t -58.51 -49.67 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.73 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.569 ' CH2' HG12 ' A' ' 30' ' ' VAL . 56.4 t-105 -46.52 -66.4 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.705 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.44 -38.11 1.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.485 -0.759 . . . . 0.0 110.33 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 6.4 t80 -63.36 -64.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.754 HD22 HG22 ' A' ' 30' ' ' VAL . 1.8 tt -46.68 -51.28 16.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.325 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 HG21 ' A' ' 30' ' ' VAL . 78.3 t -48.77 -52.87 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.69 44.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.108 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.8 tp -59.76 -41.88 92.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.007 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -126.21 -86.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.834 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.7 170.03 38.06 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.07 66.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 110.607 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.58 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.045 -1.034 . . . . 0.0 109.838 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.95 -22.28 66.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.204 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.754 HG22 HD22 ' A' ' 21' ' ' LEU . 24.1 t -73.54 -35.72 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.466 -0.771 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 m -78.65 -34.27 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.967 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.17 -23.89 59.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.49 4.88 12.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 59.5 t-20 59.05 68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.446 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 30' ' ' VAL . 25.8 mt -117.57 109.95 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.6 mtt180 -83.45 143.71 30.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.55 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.06 150.88 23.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.789 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.73 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -124.85 162.14 24.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.54 -26.33 20.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.311 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 2.5 m -170.44 -170.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 16' ' ' SER . 15.2 m-20 -62.5 -13.9 35.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.902 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.5 m-20 -99.61 102.82 14.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.795 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -141.47 175.38 9.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.414 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.594 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.3 p -79.17 129.59 34.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p -122.32 176.74 5.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.421 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.68 37.83 7.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.3 -148.62 45.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 14.8 p30 -87.84 26.64 1.29 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.168 -1.195 . . . . 0.0 109.912 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -105.63 -29.23 10.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.23 21.1 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.391 -1.385 . . . . 0.0 109.893 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.594 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 6.7 m95 -137.67 170.9 15.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.46 -1.023 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -105.75 115.89 31.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.667 -1.27 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -133.39 155.22 49.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.78 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -55.56 -56.97 14.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.891 -1.131 . . . . 0.0 108.754 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.79 -165.15 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 1.2 m -163.64 173.38 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.728 -1.233 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.51 -179.3 6.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.501 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -40.31 20.31 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.163 -0.961 . . . . 0.0 110.359 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.63 -16.88 4.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.54 178.19 4.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.477 -0.765 . . . . 0.0 109.539 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 4.4 p90 -144.39 -164.66 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.8 t -126.01 98.31 4.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -48.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.47 -26.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.67 . . . . 0.0 110.47 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.501 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 12.2 t80 -68.77 -52.47 30.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -81.21 -10.18 59.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 111.005 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -49.35 -22.85 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.05 -1.031 . . . . 0.0 109.357 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.665 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -66.92 -69.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.914 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -45.7 -30.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 109.624 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.51 -53.99 50.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.09 -139.39 14.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -50.49 -23.17 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -1.108 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.467 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 12.2 m-85 -94.27 -170.54 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 37.0 m-85 -129.32 133.47 47.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 109.732 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 7.5 t -79.98 101.94 8.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 109.212 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.7 m -78.7 167.21 21.54 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.875 -1.141 . . . . 0.0 110.376 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 2.4 mtp180 -160.87 167.44 26.67 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.91 102.46 13.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.204 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.662 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 47.7 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 109.932 -0.834 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -87.18 -44.71 11.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.442 -0.786 . . . . 0.0 110.238 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.774 HD11 ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -51.46 -41.86 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.286 -0.884 . . . . 0.0 110.483 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.951 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 28.3 m-85 -60.57 -33.73 73.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.179 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 6' ' ' ALA . 51.2 mt -71.97 138.5 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.118 -0.989 . . . . 0.0 109.514 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.96 33.95 81.11 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -127.48 -162.25 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.519 -0.989 . . . . 0.0 110.543 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.79 ' H ' HG21 ' A' ' 69' ' ' VAL . 2.3 m -151.15 98.43 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.237 -0.914 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.902 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -93.22 -175.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 13' ' ' VAL . . . -93.12 -164.56 37.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -72.62 -41.9 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.966 1.509 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -67.67 -47.34 69.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 47.6 t -62.64 -37.94 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.561 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 13.3 t90 -57.33 -58.9 6.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -50.45 -39.41 47.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 3.9 t80 -57.72 -65.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.058 HD22 HG22 ' A' ' 30' ' ' VAL . 4.1 tt -41.98 -44.38 3.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.506 -0.747 . . . . 0.0 109.987 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG22 HG21 ' A' ' 30' ' ' VAL . 71.7 t -55.27 -48.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.28 76.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -59.57 -41.12 89.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.94 -88.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.405 -0.81 . . . . 0.0 110.199 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.838 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.76 163.92 29.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.41 -20.59 56.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.603 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.24 1.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.094 -1.004 . . . . 0.0 109.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.03 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.93 -22.0 66.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.058 HG22 HD22 ' A' ' 21' ' ' LEU . 26.0 t -71.39 -33.58 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.8 m -86.25 -26.71 24.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.84 -18.87 49.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.892 . . . . 0.0 109.782 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.65 23.32 2.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 62.5 t-20 43.36 71.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 21' ' ' LEU . 65.2 mt -121.59 112.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -95.71 148.88 22.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.681 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.561 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm-85 -89.69 159.12 17.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 110.005 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -42.82 -26.73 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.908 . . . . 0.0 110.08 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' ALA . 3.2 m -174.43 -171.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 110.073 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 72' ' ' ARG . 70.6 m-20 -57.51 -17.24 12.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 12.9 t30 -91.25 108.64 20.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.327 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.742 ' CD2' ' O ' ' A' ' 12' ' ' THR . 8.5 p-80 -151.65 179.72 8.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.208 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -81.09 148.04 29.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.864 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 7.8 p -141.28 -178.47 5.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.913 ' HB1' ' NH2' ' A' ' 77' ' ' ARG . . . 47.42 42.7 14.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 -154.88 48.54 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.424 -1.87 . . . . 0.0 108.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -84.05 42.91 0.9 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.112 -1.228 . . . . 0.0 109.665 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -119.31 -35.33 3.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.2 -0.938 . . . . 0.0 111.252 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -127.11 171.21 18.72 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.319 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 17.5 m95 -138.63 179.13 6.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.983 . . . . 0.0 109.405 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.447 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.0 t -112.59 118.5 35.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.812 -1.18 . . . . 0.0 110.769 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -130.47 158.3 40.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.663 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -53.39 -47.84 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.049 -1.032 . . . . 0.0 109.146 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 140.93 44.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 62' ' ' VAL . 15.5 m -77.48 159.38 29.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 110.097 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -80.59 -171.43 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.418 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -43.23 39.3 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.12 3.85 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 9.3 mt-10 -129.35 162.74 27.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 0.0 109.958 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 24.3 p90 -129.36 -178.83 4.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.625 HG22 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -91.42 92.84 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.332 0.587 . . . . 0.0 109.474 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 1.5 m-20 -51.52 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.694 . . . . 0.0 109.782 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -51.7 -22.65 3.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 0.0 110.683 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -70.02 -56.93 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 111.043 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.774 ' CD1' HD11 ' A' ' 7' ' ' ILE . 4.0 m-85 -86.06 -3.47 58.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 111.374 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.57 -23.03 1.45 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.951 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.33 -71.97 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.656 -0.653 . . . . 0.0 110.757 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.902 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.24 -27.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 1.0 OUTLIER -63.5 -63.35 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.265 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.15 -112.29 4.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HG3' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mtt180 -62.66 -50.2 72.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -1.162 . . . . 0.0 110.093 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 20.2 m-85 -79.89 -173.05 3.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.951 . . . . 0.0 110.006 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' HG13 ' A' ' 62' ' ' VAL . 29.2 m-85 -126.56 139.23 53.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.799 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 t -79.6 107.3 12.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 0.0 108.735 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 10.3 m -97.45 157.57 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.793 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.913 ' NH2' ' HB1' ' A' ' 46' ' ' ALA . 8.5 mtp180 -142.63 -175.36 4.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.724 -0.61 . . . . 0.0 109.801 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.8 p -110.6 94.88 5.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.26 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 8' ' ' TYR . 45.3 Cg_endo . . . . . 0 C--O 1.215 -0.655 0 N-CA-C 110.027 -0.797 . . . . 0.0 110.027 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.469 ' CB ' ' OH ' ' A' ' 65' ' ' TYR . . . -61.67 -43.34 99.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.016 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.973 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -50.39 -54.24 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.62 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.617 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 8.8 m-30 -51.57 -31.03 23.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.972 . . . . 0.0 110.369 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 58.3 mt -71.95 129.41 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 60.14 31.66 73.79 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.973 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -114.55 -162.47 0.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -1.028 . . . . 0.0 110.668 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.706 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.8 m -154.68 97.89 2.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 109.758 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.098 HG12 HG23 ' A' ' 69' ' ' VAL . 3.5 m -93.77 172.78 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.099 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -85.82 -159.59 32.35 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 48.9 Cg_endo -74.74 -46.58 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.015 1.534 . . . . 0.0 110.5 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -67.65 -50.43 57.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.0 t -57.22 -45.78 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.992 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 11.3 t90 -52.17 -61.45 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.623 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.89 -37.97 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.424 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.4 t80 -60.29 -53.75 53.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.985 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.654 HD22 HG22 ' A' ' 30' ' ' VAL . 1.6 tt -57.63 -55.57 33.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.11 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.4 t -44.01 -61.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.065 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.19 -41.26 17.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.0 tp -59.95 -41.44 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.095 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -126.4 -88.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.839 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.05 166.18 33.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.94 -19.25 60.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.13 . . . . 0.0 110.699 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.17 -64.25 1.01 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.019 -1.051 . . . . 0.0 109.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.095 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.52 -21.74 65.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.214 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.654 HG22 HD22 ' A' ' 21' ' ' LEU . 24.5 t -73.65 -34.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.454 -0.778 . . . . 0.0 109.714 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.0 m -87.8 -19.64 27.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 109.899 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.21 -22.1 28.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.837 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -89.01 23.51 2.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.88 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.442 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 37.8 t-20 42.54 76.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 110.355 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.619 HD13 HD13 ' A' ' 21' ' ' LEU . 19.4 mt -123.6 110.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 109.701 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -93.22 144.44 25.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.907 . . . . 0.0 110.589 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 2.7 mtm180 -82.93 166.0 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 0.0 109.708 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.742 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -139.05 161.87 36.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.01 . . . . 0.0 110.266 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -51.19 -36.48 41.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.296 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 16.5 m -164.72 -179.07 5.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 38.6 m-20 -46.63 -30.89 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 17.2 t-20 -84.96 110.56 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.862 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.7 p80 -147.27 175.91 10.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.073 -1.017 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.594 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 17.9 p -78.23 127.54 32.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.426 -0.797 . . . . 0.0 109.749 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 p -120.49 168.43 11.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.006 -1.059 . . . . 0.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 53.22 50.0 18.66 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.551 -0.718 . . . . 0.0 109.303 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.17 -149.94 25.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -86.18 36.49 0.68 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.171 -1.193 . . . . 0.0 110.065 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HB3' ' NH1' ' A' ' 77' ' ' ARG . 3.5 mtt180 -113.57 -33.13 5.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -127.28 168.03 19.51 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.0 m95 -142.22 170.79 15.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -117.73 113.68 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.777 -1.202 . . . . 0.0 110.684 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -132.7 163.56 28.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.353 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.445 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 24.8 p -50.57 -48.17 57.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.897 -1.127 . . . . 0.0 108.508 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -127.74 179.83 5.33 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.641 0.734 . . . . 0.0 110.562 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.782 ' SG ' HG22 ' A' ' 62' ' ' VAL . 20.9 m -121.63 168.99 11.14 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.037 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -79.82 -173.62 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.5 -36.82 21.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.245 -0.909 . . . . 0.0 110.25 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -78.98 5.22 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 46.6 mt-10 -128.83 -175.68 3.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 7.5 p90 -141.12 -162.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 109.833 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.782 HG22 ' SG ' ' A' ' 56' ' ' CYS . 53.2 t -111.69 89.08 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.122 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 14.2 t0 -41.64 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 0.0 110.213 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -57.84 -27.1 62.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.207 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.469 ' OH ' ' CB ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -68.6 -49.51 58.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 110.605 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.4 m-85 -83.76 -9.28 58.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.945 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -22.57 1.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.039 -1.038 . . . . 0.0 109.537 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.96 -70.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 110.303 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.098 HG23 HG12 ' A' ' 13' ' ' VAL . 10.6 p -45.74 -25.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.998 -1.064 . . . . 0.0 109.341 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -67.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.781 . . . . 0.0 110.048 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.4 -96.13 2.0 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -56.77 7.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.422 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 24.6 m-85 -89.27 -168.99 2.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.091 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.496 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.3 m-85 -123.34 149.64 44.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.84 . . . . 0.0 109.73 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 15.7 t -86.03 100.88 12.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 0.0 109.765 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.2 m -79.34 163.56 24.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 3.4 mtp180 -153.95 176.88 11.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 t -104.67 94.37 5.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.171 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.155 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.8 Cg_endo . . . . . 0 C--O 1.216 -0.61 0 N-CA-C 109.937 -0.832 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -84.68 -16.74 40.82 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.421 -0.799 . . . . 0.0 110.287 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.842 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -55.91 -47.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -0.869 . . . . 0.0 110.737 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.604 ' CZ ' ' HB1' ' A' ' 68' ' ' ALA . 22.8 m-85 -52.37 -24.42 7.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.476 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 70.2 mt -60.37 136.51 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.715 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 46.31 34.92 6.58 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.15 -167.48 1.2 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.509 -0.994 . . . . 0.0 110.671 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.825 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.7 m -150.06 88.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.0 m -83.16 -165.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.35 -163.46 17.8 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -73.11 -45.45 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -67.59 -49.14 64.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.099 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 91.1 t -58.91 -48.0 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.606 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 7.8 t-105 -50.81 -59.35 4.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.732 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.46 -39.67 7.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.095 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 68.1 t80 -63.62 -63.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.335 -0.853 . . . . 0.0 110.145 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -42.37 -54.44 3.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.211 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG22 HG21 ' A' ' 30' ' ' VAL . 75.1 t -48.02 -50.2 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.11 -43.46 61.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 110.161 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -66.14 -36.12 82.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.092 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.04 -88.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.812 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 171.59 167.72 32.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.59 62.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -1.171 . . . . 0.0 110.524 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -63.66 1.1 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.053 -1.03 . . . . 0.0 109.914 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.092 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.19 -22.46 65.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.909 . . . . 0.0 109.297 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 26' ' ' GLY . 34.7 t -73.61 -31.46 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.486 -0.759 . . . . 0.0 109.979 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -87.83 -26.83 22.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.225 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -25.38 43.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -83.64 6.59 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 110.353 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 46.8 t-20 58.32 79.3 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -0.92 . . . . 0.0 110.619 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 40.0 mt -118.84 136.97 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -110.18 151.2 27.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 110.575 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.5 OUTLIER -100.95 143.05 31.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.0 109.887 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.88 152.2 37.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.406 ' C ' ' OG ' ' A' ' 40' ' ' SER . 9.6 m -42.39 -27.08 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -163.4 -176.02 4.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.196 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.5 -12.21 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.34 103.44 15.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.847 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.1 p80 -142.62 -178.56 5.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.615 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -92.92 147.22 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.802 . . . . 0.0 110.002 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.0 p -137.26 178.59 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 110.313 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 46.97 46.55 15.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.884 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.22 -153.11 48.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.66 42.88 0.94 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.054 -1.262 . . . . 0.0 109.604 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.4 mmm180 -109.44 -39.0 5.32 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 111.21 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.21 164.12 18.91 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.761 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.615 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.3 m95 -134.76 167.75 20.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.066 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.71 117.52 34.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.77 -1.206 . . . . 0.0 111.272 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mtt-85 -129.24 153.05 48.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.208 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.16 -48.98 64.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.09 . . . . 0.0 109.257 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.2 tttt -138.44 177.5 7.83 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 16.3 m -149.96 169.98 19.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.823 -1.173 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -80.03 -175.02 4.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.404 -0.81 . . . . 0.0 110.562 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 -43.36 14.64 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.324 -0.86 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.51 -20.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.688 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.88 174.35 5.98 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 9.2 p90 -138.96 -165.1 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.95 -1.094 . . . . 0.0 110.376 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 64' ' ' THR . 16.6 t -124.95 103.63 12.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 75' ' ' CYS . 14.8 p30 -47.91 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.85 -25.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.414 -0.803 . . . . 0.0 110.505 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' ASP . 12.8 t80 -71.34 -48.05 52.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.781 ' CD2' HD11 ' A' ' 7' ' ' ILE . 40.7 m-85 -90.2 -4.1 57.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 111.292 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -22.97 2.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 108.587 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.604 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -71.67 -64.48 0.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.671 -0.643 . . . . 0.0 110.485 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.847 HG22 ' CE1' ' A' ' 43' ' ' HIS . 10.1 p -44.96 -30.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.997 -1.064 . . . . 0.0 109.552 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -66.3 -58.31 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.147 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.98 -121.7 7.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -63.73 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -1.214 . . . . 0.0 110.166 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.7 m-30 -87.73 -174.96 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.884 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 39.8 m-85 -128.31 126.82 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.969 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.71 97.33 6.53 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.881 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 65.2 m -79.71 169.13 18.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 110.959 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -160.41 170.57 20.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.0 109.898 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.6 m -97.93 103.43 15.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 5.5 tpt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.292 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.8 Cg_endo . . . . . 0 C--O 1.215 -0.65 0 N-CA-C 109.834 -0.871 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -81.23 -24.11 37.61 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.842 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -51.33 -59.6 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.655 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.6 m-85 -45.97 -28.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 109.845 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.0 mt -69.55 131.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.482 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.46 32.15 57.68 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.02 -162.93 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.984 . . . . 0.0 110.517 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.812 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.7 m -153.82 99.02 2.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 0.0 110.099 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.719 HG12 HG23 ' A' ' 69' ' ' VAL . 2.8 m -89.96 -175.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.999 -1.063 . . . . 0.0 110.187 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -95.04 -160.94 34.01 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.508 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.1 Cg_endo -73.41 -47.87 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.963 1.507 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -48.0 73.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.53 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 15.9 t -58.98 -47.11 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.981 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.625 ' CE3' ' CD ' ' A' ' 37' ' ' ARG . 6.0 t90 -50.45 -60.76 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.56 -34.87 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.277 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 13.8 t80 -64.49 -66.07 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.899 HD22 HG22 ' A' ' 30' ' ' VAL . 1.1 tt -50.34 -24.97 3.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 26' ' ' GLY . 24.3 t -73.36 -42.36 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.792 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.81 69.88 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -77.93 -47.34 18.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.53 -0.732 . . . . 0.0 110.407 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.957 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.5 m -113.33 -42.78 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 110.448 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.567 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 120.36 170.06 14.15 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.13 69.46 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.915 -1.344 . . . . 0.0 110.427 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.16 -52.07 57.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.211 -0.931 . . . . 0.0 110.05 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.957 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -64.03 -44.6 92.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.899 HG22 HD22 ' A' ' 21' ' ' LEU . 74.2 t -62.66 -26.31 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.792 . . . . 0.0 110.231 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -83.85 -31.59 25.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.01 . . . . 0.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.23 -17.55 49.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.652 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -90.01 8.11 34.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 57.1 t-20 58.78 72.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.253 -0.905 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 33' ' ' ALA . 5.7 mt -126.2 113.78 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.829 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' THR . 25.1 mtm-85 -99.62 156.26 17.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.712 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.625 ' CD ' ' CE3' ' A' ' 18' ' ' TRP . 8.2 mtp180 -100.4 158.37 15.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.94 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -127.83 -174.6 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.317 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -60.67 -23.59 64.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.508 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.9 m -178.09 -169.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.3 m-20 -56.6 -24.08 45.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 110.091 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 31.0 t-20 -89.61 110.68 21.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.882 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.818 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.3 p80 -147.28 -176.03 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.107 -0.996 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.541 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -85.16 126.81 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 109.664 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.4 p -128.87 170.84 12.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 56.55 31.44 19.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.44 44.63 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 34.49 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.085 -1.244 . . . . 0.0 109.848 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.5 mmt85 -113.29 -36.14 5.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.396 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.17 160.08 23.26 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.419 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.541 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 19.5 m95 -131.47 175.29 9.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.598 -0.942 . . . . 0.0 108.646 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -118.9 116.54 26.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.724 -1.235 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -131.62 171.13 13.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.545 -0.722 . . . . 0.0 109.452 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -55.35 -47.62 75.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.054 -1.029 . . . . 0.0 109.228 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 7.4 tttt -135.03 177.05 8.11 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 62' ' ' VAL . 17.6 m -119.21 175.93 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.944 -1.097 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 65.1 m-85 -79.75 -176.42 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 110.239 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -39.79 22.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.131 -0.981 . . . . 0.0 110.5 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.592 ' CD2' ' HG3' ' A' ' 60' ' ' GLU . 31.8 p-80 -79.04 7.16 7.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 7.9 mt-10 -124.42 -170.46 2.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 3.3 p90 -152.43 -161.34 1.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' SG ' ' A' ' 56' ' ' CYS . 47.8 t -123.15 99.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 66' ' ' TYR . 46.0 p30 -52.11 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.892 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.72 -25.6 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -0.764 . . . . 0.0 110.982 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 63' ' ' ASP . 28.4 t80 -66.25 -53.13 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.055 -1.028 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 14.7 m-85 -83.16 -11.67 57.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 110.995 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -46.7 -24.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.686 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.21 -71.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 110.561 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.818 HG22 ' CE1' ' A' ' 43' ' ' HIS . 7.2 p -42.27 -28.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -64.2 -69.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.168 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.08 -119.94 6.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -27.18 68.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -1.169 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.1 m-85 -99.5 177.05 5.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.201 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 16.0 m-85 -121.02 138.01 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.958 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 41.1 t -79.51 100.59 7.8 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 108.837 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 9.4 m -79.35 160.84 26.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.17 . . . . 0.0 110.139 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.584 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -159.98 173.46 15.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.52 -0.737 . . . . 0.0 110.22 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 p -103.41 112.81 25.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 110.217 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.6 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.89 -0.85 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -118.54 -22.07 7.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.88 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.89 ' CD1' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -55.7 -52.05 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 110.397 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.622 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.2 m-85 -46.22 -25.97 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.877 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.5 mt -61.28 126.85 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.186 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 58.0 32.94 67.53 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.18 -162.53 0.81 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.666 -0.902 . . . . 0.0 110.872 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.746 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 3.1 m -157.25 97.04 1.61 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.067 HG12 HG23 ' A' ' 69' ' ' VAL . 3.6 m -95.22 174.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.996 -1.065 . . . . 0.0 110.21 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.88 -163.09 37.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 48.2 Cg_endo -74.14 -51.53 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.046 1.551 . . . . 0.0 110.522 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -49.76 76.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 48.6 t -58.93 -47.6 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.722 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 9.9 t-105 -51.73 -58.13 7.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.802 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.36 -39.85 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.131 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.69 -58.13 9.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.84 HD22 HG22 ' A' ' 30' ' ' VAL . 1.5 tt -51.05 -34.12 28.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.121 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 24.4 t -63.65 -47.97 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.44 -40.71 68.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.753 . . . . 0.0 109.823 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.1 tp -63.3 -39.78 95.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.002 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -132.46 -88.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.002 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.822 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 172.52 166.37 30.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.9 -20.45 65.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 110.446 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -61.54 1.73 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.112 -0.992 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.002 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.05 -28.74 70.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.84 HG22 HD22 ' A' ' 21' ' ' LEU . 37.8 t -70.27 -30.99 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.4 -0.812 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.3 m -76.55 -36.0 57.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.4 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.37 4.63 12.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.288 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 42.2 t-20 57.9 74.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.722 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 49.1 mt -122.26 121.73 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.5 mtt85 -101.11 150.29 23.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.608 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.86 159.61 16.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 110.077 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -133.58 151.13 51.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -42.98 -26.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' ALA . 4.9 m -172.36 -173.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 110.007 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -17.31 15.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.224 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 12.3 t30 -89.25 98.12 11.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.469 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.746 ' CD2' ' O ' ' A' ' 12' ' ' THR . 8.0 p-80 -142.49 176.53 8.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 110.53 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.588 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.6 p -81.82 130.48 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.783 . . . . 0.0 109.847 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.91 174.64 6.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 48.69 46.31 21.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 109.084 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.09 -151.99 41.15 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.4 40.46 0.84 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -1.208 . . . . 0.0 109.752 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 10.4 mtp180 -112.46 -38.64 4.6 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.985 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -126.1 168.98 18.09 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.133 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.588 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -136.13 172.19 13.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -1.028 . . . . 0.0 109.861 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.4 t -104.41 112.37 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.76 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 7.2 mtt-85 -127.96 142.46 51.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.858 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.44 ' N ' ' CD2' ' A' ' 73' ' ' TYR . 2.1 p -51.89 -46.39 64.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.011 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -137.16 175.67 9.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 11.8 m -153.65 170.69 20.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.891 -1.131 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -79.74 177.57 8.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -79.61 -42.68 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -22.19 0.72 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.304 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.77 -175.69 2.73 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.51 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 3.1 p90 -147.38 -164.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 34.6 t -128.54 98.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -50.15 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.826 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.05 -26.7 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.579 -0.7 . . . . 0.0 110.26 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 7' ' ' ILE . 14.8 t80 -65.6 -49.79 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.63 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.4 m-85 -86.56 -3.09 58.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 111.562 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -17.28 6.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.016 -1.053 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.89 ' HB3' ' CD1' ' A' ' 7' ' ' ILE . . . -70.87 -56.67 5.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.95 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.067 HG23 HG12 ' A' ' 13' ' ' VAL . 7.9 p -61.11 -27.79 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.969 -1.082 . . . . 0.0 109.469 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -64.57 -49.05 72.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 -137.2 14.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -48.67 -31.56 6.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 109.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 54' ' ' SER . 8.6 m-85 -87.95 -177.83 5.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.006 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.547 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 46.8 m-85 -125.81 136.6 53.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 10.7 t -79.47 97.72 6.52 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.034 -1.041 . . . . 0.0 108.755 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 74.1 m -79.01 166.43 22.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.03 -1.044 . . . . 0.0 110.501 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.51 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 17.5 mtp180 -161.19 176.16 11.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.323 0.582 . . . . 0.0 109.83 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 78' ' ' SER . 11.5 p -108.08 104.53 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.505 -0.747 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.2 -179.812 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.587 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.0 Cg_endo . . . . . 0 C--O 1.216 -0.609 0 N-CA-C 110.255 -0.71 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.93 -23.27 28.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.443 -0.786 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.848 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -60.01 -38.23 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.687 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.511 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 9.7 m-30 -64.05 -18.79 64.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 9.4 mt -81.05 124.12 38.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.162 -0.961 . . . . 0.0 109.016 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 68.56 31.82 74.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -119.62 -163.08 0.96 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.468 -1.019 . . . . 0.0 110.752 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.728 ' H ' HG21 ' A' ' 69' ' ' VAL . 11.3 m -155.29 95.37 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.005 HG12 HG23 ' A' ' 69' ' ' VAL . 4.3 m -90.18 171.5 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -83.77 -161.18 31.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.7 Cg_endo -74.26 -45.07 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.911 1.479 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.1 m -66.75 -55.49 14.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.537 HG23 ' OD1' ' A' ' 41' ' ' ASP . 84.1 t -56.09 -45.56 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.814 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 22.8 t-105 -51.16 -62.99 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.19 -38.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.143 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.426 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.9 t80 -63.68 -60.21 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.106 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.807 HD13 HD13 ' A' ' 35' ' ' ILE . 1.2 tt -47.89 -55.37 9.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.625 ' HA ' HG21 ' A' ' 30' ' ' VAL . 41.3 t -44.15 -56.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.78 -42.74 47.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.4 tp -53.29 -42.94 67.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 109.988 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.099 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -127.99 -86.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 109.936 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.842 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.33 166.1 33.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -61.22 -19.93 62.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -1.145 . . . . 0.0 110.449 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -63.4 1.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.099 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.8 -20.17 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.649 HG22 HD22 ' A' ' 21' ' ' LEU . 29.6 t -77.85 -33.6 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.477 -0.764 . . . . 0.0 109.892 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -80.89 -33.16 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.52 -23.49 46.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.28 4.88 11.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 59.4 t-20 60.78 63.98 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.654 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.814 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 54.8 mt -113.78 128.39 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.368 -0.832 . . . . 0.0 109.481 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -110.25 145.27 37.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 110.488 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.598 ' HG3' ' CD2' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -90.31 154.38 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 109.761 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -129.54 171.0 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.253 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' HG ' ' A' ' 40' ' ' SER . 1.9 t -58.76 -33.3 70.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.533 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -159.92 178.94 9.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.567 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 41.6 m-20 -52.33 -33.31 42.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 15.2 t-20 -82.71 99.81 9.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.89 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.7 p80 -136.25 177.01 8.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.409 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -75.25 141.66 43.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.977 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 10.9 p -131.79 178.78 6.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 44.16 44.88 6.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.229 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.03 -156.75 51.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' ASN . 22.9 t30 -84.33 41.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.963 -1.316 . . . . 0.0 109.959 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.35 -33.36 3.89 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.149 -0.969 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.533 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -121.19 173.84 15.68 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.831 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 16.5 m95 -150.73 161.35 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.424 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 86.4 m -96.5 104.57 16.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.12 . . . . 0.0 109.971 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 6.0 mtt180 -120.23 151.5 39.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 109.976 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.493 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -57.56 -52.84 63.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 109.122 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.38 172.98 10.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.029 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 94.6 m -149.5 168.09 24.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.785 -1.197 . . . . 0.0 110.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -79.91 176.22 9.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.731 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -75.34 -44.5 44.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -48.01 -21.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -118.3 174.29 6.32 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.417 -0.802 . . . . 0.0 109.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 11.2 p90 -134.4 -167.65 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.975 . . . . 0.0 110.227 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.797 HG13 ' HB3' ' A' ' 74' ' ' PHE . 17.9 t -113.97 89.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.73 . . . . 0.0 109.981 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.1 t0 -39.82 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.363 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -52.91 -23.34 6.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 110.591 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.08 -44.01 55.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.733 ' CD1' HD11 ' A' ' 7' ' ' ILE . 20.3 m-85 -89.83 -9.93 47.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 111.622 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -22.17 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.787 -1.196 . . . . 0.0 109.049 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -68.91 -52.62 27.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.488 -0.757 . . . . 0.0 110.645 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.005 HG23 HG12 ' A' ' 13' ' ' VAL . 9.7 p -60.0 -34.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.887 -1.133 . . . . 0.0 110.32 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 75' ' ' CYS . 61.6 m -60.4 -51.68 68.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.955 -1.091 . . . . 0.0 109.682 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.93 -102.78 2.91 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HD2' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -76.57 -5.27 46.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -1.151 . . . . 0.0 109.881 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.65 178.09 4.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.797 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.1 m-85 -120.5 137.85 54.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 109.755 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 11.3 t -79.69 94.29 5.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.967 -1.083 . . . . 0.0 109.352 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.5 m -77.78 170.75 16.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.003 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.9 mtp180 -160.27 -177.5 6.3 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.244 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 m -110.19 91.15 3.54 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.192 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 10.3 tpt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.642 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 50.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.29 -41.33 3.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.627 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.766 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -57.64 -38.19 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.451 -0.781 . . . . 0.0 110.443 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.925 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 45.2 m-85 -62.71 -25.04 67.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.282 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 61.3 mt -73.4 143.72 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.637 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 49.51 36.58 24.4 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.23 -164.32 1.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.523 -0.986 . . . . 0.0 110.549 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.848 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.2 m -152.1 91.77 1.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.032 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.869 HG12 HG23 ' A' ' 69' ' ' VAL . 2.7 m -89.14 162.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.111 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.65 -166.68 9.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.1 Cg_endo -73.37 -39.41 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.999 1.526 . . . . 0.0 110.448 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -51.25 43.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.38 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 48.0 t -57.62 -46.5 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.742 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 35.2 t-105 -49.8 -61.14 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.45 -44.3 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.283 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -58.12 -66.81 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.849 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.992 HD22 HG22 ' A' ' 30' ' ' VAL . 5.7 tt -40.52 -56.19 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 110.12 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 21' ' ' LEU . 47.2 t -42.44 -55.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.878 . . . . 0.0 110.061 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.18 -44.85 33.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 24' ' ' LEU . 12.9 tp -57.27 -49.94 74.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.15 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.973 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -117.02 -88.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.821 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.82 165.71 32.16 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.73 -20.13 63.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -1.129 . . . . 0.0 110.54 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.13 -63.29 1.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.149 -0.969 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.973 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.91 -19.14 62.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.223 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.992 HG22 HD22 ' A' ' 21' ' ' LEU . 10.9 t -75.09 -39.83 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.48 -0.762 . . . . 0.0 109.743 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.5 m -77.8 -28.8 50.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.4 -24.22 42.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -80.0 5.55 13.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.637 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 42.3 t30 58.79 69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.742 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 11.0 mt -119.3 135.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mtp180 -115.42 149.84 37.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 10.8 mtp85 -98.46 143.96 28.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 109.839 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -115.57 164.11 14.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.8 p -48.35 -27.79 2.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.4 m -165.01 -168.32 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -64.32 -22.14 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.296 -0.877 . . . . 0.0 110.166 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t-20 -88.58 110.54 20.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.737 ' CD2' ' O ' ' A' ' 12' ' ' THR . 8.5 p-80 -148.72 175.92 10.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.4 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.619 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -79.99 139.07 37.15 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -130.47 176.93 7.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 110.439 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.36 39.45 12.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.76 -151.98 46.86 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -87.44 24.17 1.72 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.171 -1.193 . . . . 0.0 109.972 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -105.65 -28.83 10.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 110.797 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.39 164.53 15.39 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.002 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.619 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 9.3 m95 -142.52 174.41 10.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.44 -1.035 . . . . 0.0 109.701 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.615 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.6 t -109.23 113.16 25.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 2.3 mtt180 -133.43 143.99 49.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -46.61 -39.31 10.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.971 -1.081 . . . . 0.0 108.766 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 4.7 tttt -135.86 171.1 14.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.779 ' SG ' HG22 ' A' ' 62' ' ' VAL . 6.3 m -119.73 177.06 5.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.18 -169.16 2.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -84.45 -42.46 15.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.422 -0.799 . . . . 0.0 110.215 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -72.2 -1.2 14.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 17.9 mt-10 -126.65 -179.92 5.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.917 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.55 ' CD1' ' HB2' ' A' ' 79' ' ' ARG . 8.1 p90 -139.74 -162.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.07 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.779 HG22 ' SG ' ' A' ' 56' ' ' CYS . 47.8 t -110.87 88.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.1 t0 -40.71 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.581 -0.699 . . . . 0.0 110.25 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 4.3 p -57.69 -34.64 69.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.378 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -63.54 -46.38 86.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.695 ' CD1' HD11 ' A' ' 7' ' ' ILE . 18.1 m-85 -86.57 -6.88 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 111.059 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -50.33 -22.29 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.951 -1.093 . . . . 0.0 109.064 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -67.59 -71.59 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.549 -0.72 . . . . 0.0 110.579 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.869 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.75 -29.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.01 -65.76 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 110.354 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.96 -115.81 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -61.6 -49.98 74.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -1.203 . . . . 0.0 109.915 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.475 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.6 m-85 -80.0 -177.22 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.668 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.7 m-85 -121.3 142.27 50.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.483 -0.76 . . . . 0.0 109.096 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.5 t -79.59 100.88 8.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.429 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 33.3 m -78.94 165.87 23.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.536 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -157.13 176.67 12.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.85 . . . . 0.0 110.344 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.43 96.59 6.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.204 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.62 ' HB2' HG22 ' A' ' 7' ' ' ILE . 48.6 Cg_endo . . . . . 0 C--O 1.215 -0.672 0 N-CA-C 109.859 -0.862 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.16 -36.75 34.65 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -50.7 -47.88 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 110.717 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.646 ' O ' HD13 ' A' ' 35' ' ' ILE . 7.8 m-30 -50.68 -34.93 28.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 110.301 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 43.4 mt -69.9 115.6 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.88 28.61 58.59 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.923 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -115.94 -162.65 0.85 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.967 . . . . 0.0 110.71 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.752 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.0 m -153.35 93.78 1.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.044 HG12 HG23 ' A' ' 69' ' ' VAL . 3.9 m -93.41 169.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 110.201 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -79.43 -154.95 9.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 49.1 Cg_endo -76.8 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.007 1.53 . . . . 0.0 110.441 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 t -53.21 -50.89 63.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.47 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 21.9 t -59.91 -46.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.118 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.624 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 11.3 t90 -49.47 -65.5 0.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.517 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.02 -41.55 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.395 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 36.6 t80 -59.33 -62.45 1.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.924 . . . . 0.0 109.87 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.958 HD22 HG22 ' A' ' 30' ' ' VAL . 1.7 tt -43.92 -52.73 6.68 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.393 -0.817 . . . . 0.0 109.811 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' HG21 ' A' ' 30' ' ' VAL . 40.5 t -52.4 -42.67 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.786 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 20' ' ' TYR . . . -50.86 -45.11 59.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.342 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.86 -27.38 62.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.488 -0.757 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -124.18 -91.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.682 . . . . 0.0 110.293 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' H ' HG23 ' A' ' 25' ' ' VAL . . . 167.26 -170.57 41.61 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 -52.65 9.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.32 . . . . 0.0 110.306 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.56 74.16 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.943 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . . . -69.45 -49.93 50.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 109.782 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.958 HG22 HD22 ' A' ' 21' ' ' LEU . 25.0 t -62.88 -21.77 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.2 m -79.78 -40.62 28.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.139 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.08 -17.21 60.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.19 25.05 2.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.9 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.448 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 46.0 t-20 41.87 67.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 8' ' ' TYR . 16.2 mm -110.21 112.5 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.659 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 12' ' ' THR . 5.3 mtt180 -97.6 139.47 33.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.893 . . . . 0.0 110.295 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.624 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -89.52 155.69 19.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -133.73 157.98 44.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.04 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -45.1 -33.27 2.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.545 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -166.92 -156.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 110.262 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD2' ' HD3' ' A' ' 72' ' ' ARG . 59.6 m-20 -71.73 -5.86 37.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.507 -0.746 . . . . 0.0 110.044 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 2.3 t30 -102.57 102.57 12.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.749 ' CD2' ' O ' ' A' ' 12' ' ' THR . 5.2 p-80 -146.03 -175.46 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.454 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.1 p -86.95 129.49 34.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.443 -0.785 . . . . 0.0 109.568 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.45 177.63 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.426 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 48.03 45.35 19.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 -156.01 52.79 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 19.7 p30 -86.24 34.94 0.63 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.013 -1.286 . . . . 0.0 110.009 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -115.9 -30.6 6.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.131 -0.98 . . . . 0.0 110.788 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -117.92 163.74 12.82 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.483 -1.342 . . . . 0.0 109.773 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 7.5 m95 -140.23 177.06 8.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.0 109.367 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 6.2 t -114.55 115.07 26.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 110.928 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -131.91 159.28 39.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 55' ' ' LYS . 5.9 p -57.89 -52.67 64.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.988 -1.07 . . . . 0.0 108.965 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' N ' ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -140.69 139.69 34.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -105.05 163.6 12.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.235 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.63 -164.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' HIS . 8.9 ttp180 -80.64 -43.74 19.99 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.445 ' C ' ' HG2' ' A' ' 60' ' ' GLU . 1.3 m-70 -45.78 -24.49 0.38 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.8 mm-40 -125.91 179.56 5.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.385 -0.822 . . . . 0.0 110.023 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.0 p90 -137.86 -163.11 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.594 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' A' ' 74' ' ' PHE . 25.4 t -113.77 87.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 109.927 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.3 t0 -38.26 90.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.694 -0.629 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.98 -25.34 43.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.545 ' O ' HD12 ' A' ' 7' ' ' ILE . 8.4 t80 -70.8 -51.32 27.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.63 ' O ' HG12 ' A' ' 69' ' ' VAL . 10.9 m-85 -81.44 -6.45 58.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 111.23 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -18.93 2.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.042 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.11 -47.02 63.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.9 . . . . 0.0 110.988 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.044 HG23 HG12 ' A' ' 13' ' ' VAL . 7.9 p -71.54 -24.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.501 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -66.99 -57.33 7.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.452 -0.78 . . . . 0.0 110.267 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.31 -125.75 8.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HD3' ' OD2' ' A' ' 41' ' ' ASP . 5.2 mpt_? -52.51 -36.65 55.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.84 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 39.5 m-85 -90.87 -173.42 3.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.727 ' HB3' HG13 ' A' ' 62' ' ' VAL . 3.0 m-85 -129.65 142.34 50.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 10.5 t -79.6 99.32 7.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.556 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 8.0 t -79.05 165.41 23.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.129 -0.982 . . . . 0.0 109.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 5.4 mtp180 -157.5 171.93 19.48 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.784 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 79' ' ' ARG . 1.1 m -107.55 76.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 78' ' ' SER . 6.6 ttt-85 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.152 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.838 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.9 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 110.028 -0.797 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -80.44 -21.97 41.62 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.403 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.838 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -52.57 -54.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.608 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.66 -28.88 3.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 17.3 mt -64.86 123.91 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.75 29.34 74.47 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -116.92 -162.77 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -1.009 . . . . 0.0 110.429 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.844 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.2 m -151.95 95.09 2.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.012 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 69' ' ' VAL . 3.2 m -88.87 179.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 110.118 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -94.52 -161.81 34.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.31 -45.68 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.016 1.535 . . . . 0.0 110.318 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -53.1 50.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG23 ' OD1' ' A' ' 41' ' ' ASP . 10.7 t -58.55 -47.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -0.946 . . . . 0.0 109.856 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.636 ' CH2' HG12 ' A' ' 30' ' ' VAL . 59.6 t-105 -48.09 -66.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.96 -38.35 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.27 -49.66 76.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.823 ' CD1' HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -60.38 -28.13 67.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . 48.5 t -66.79 -48.75 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 110.0 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.98 92.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.838 . . . . 0.0 109.914 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.8 tp -61.45 -41.94 97.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -130.52 -50.87 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.254 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 30' ' ' VAL . . . 137.02 163.99 9.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -66.2 -9.41 31.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -1.182 . . . . 0.0 110.856 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 -67.64 0.66 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.968 -1.083 . . . . 0.0 109.707 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.025 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.77 -20.08 64.63 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 108.668 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.788 HG22 HD22 ' A' ' 21' ' ' LEU . 14.4 t -70.82 -37.23 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.606 -0.684 . . . . 0.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.7 m -85.04 -25.03 27.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.36 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.866 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.05 25.92 2.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.771 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 5.8 t-20 40.21 75.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 0.0 110.6 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.823 HD13 ' CD1' ' A' ' 21' ' ' LEU . 64.3 mt -124.34 118.34 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.768 . . . . 0.0 109.455 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.482 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.3 mtt180 -96.91 156.68 16.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 110.512 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 8.9 mtp180 -107.27 139.47 41.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.554 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -117.73 164.56 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -42.7 -26.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.356 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.503 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -172.34 -162.42 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' OD1' HG23 ' A' ' 17' ' ' VAL . 54.2 m-20 -66.61 -8.44 27.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.882 . . . . 0.0 110.302 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 18.9 t30 -94.7 101.99 13.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.516 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.765 ' CD2' ' O ' ' A' ' 12' ' ' THR . 4.2 p-80 -143.55 -179.78 6.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.548 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -88.1 120.92 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 109.66 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 p -116.51 -178.75 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' CZ ' ' A' ' 77' ' ' ARG . . . 49.13 41.58 19.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.457 -0.777 . . . . 0.0 108.957 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.57 -153.74 51.0 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.96 36.55 0.67 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.057 -1.26 . . . . 0.0 109.771 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -117.77 -30.74 5.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -124.64 160.23 19.25 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.893 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.548 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 25.2 m95 -132.18 174.68 9.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.318 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.7 t -107.44 112.53 25.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.421 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -127.77 143.2 51.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.894 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -49.52 -46.45 48.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 108.624 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -125.67 -175.84 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 86.6 m -150.9 160.32 43.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.992 -1.067 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -80.56 171.53 14.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 110.365 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -38.97 67.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -13.68 11.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.733 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -120.88 169.93 9.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 109.557 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 15.5 p90 -132.09 -178.01 4.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.913 -1.117 . . . . 0.0 111.102 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 75.6 t -99.61 94.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.294 0.568 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -47.96 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -50.46 -25.4 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 111.027 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.03 -48.6 43.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.17 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.706 ' CD2' HD11 ' A' ' 7' ' ' ILE . 32.0 m-85 -89.79 -4.86 57.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.07 -1.019 . . . . 0.0 111.41 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -49.91 -22.89 1.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.942 -1.099 . . . . 0.0 109.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -70.99 -65.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.447 -0.783 . . . . 0.0 110.541 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.844 HG21 ' H ' ' A' ' 12' ' ' THR . 9.3 p -46.69 -26.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.948 -1.095 . . . . 0.0 109.59 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -68.63 -64.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -124.14 8.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -24.36 22.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.147 . . . . 0.0 109.953 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 12.2 m-85 -102.0 -179.41 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 110.143 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 8.9 m-85 -123.57 130.84 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.131 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.526 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 7.5 t -79.81 105.99 11.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.037 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 66.6 m -102.09 170.07 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.666 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 16.7 mtp180 -149.73 -172.8 4.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.348 0.594 . . . . 0.0 109.559 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 79' ' ' ARG . 5.6 p -115.73 80.42 1.44 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.4 Cg_endo . . . . . 0 N--CA 1.481 0.763 0 N-CA-C 110.429 -0.643 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.86 -27.73 20.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.8 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -54.36 -49.65 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 110.442 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.571 ' H ' HG23 ' A' ' 7' ' ' ILE . 8.5 m-30 -46.6 -29.46 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 109.946 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -66.91 113.83 3.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.211 -0.93 . . . . 0.0 109.547 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 73.13 27.81 67.65 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -110.65 -164.77 0.94 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.527 -0.984 . . . . 0.0 110.619 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.745 ' H ' HG21 ' A' ' 69' ' ' VAL . 54.9 m -155.01 100.09 2.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 110.034 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.041 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -97.5 163.85 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.104 -0.998 . . . . 0.0 110.036 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.19 -164.73 11.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.2 Cg_endo -73.69 -47.5 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.4 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.02 51.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 81.6 t -60.59 -50.71 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.593 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 26.8 t-105 -45.17 -66.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.626 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -41.55 -42.33 2.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.6 t80 -60.73 -65.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -41.75 -44.33 3.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 110.356 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' VAL . 84.9 t -54.69 -49.52 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.81 69.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.65 -46.22 91.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.997 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -120.13 -87.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.825 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.16 170.21 39.29 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.8 -22.62 67.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -1.102 . . . . 0.0 110.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -61.94 1.58 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.997 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.17 -26.49 68.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 26' ' ' GLY . 33.9 t -71.42 -34.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.751 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.9 m -85.32 -20.47 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.905 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -20.52 31.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.85 25.01 2.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.831 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.432 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 49.0 t-20 41.5 74.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.815 . . . . 0.0 110.445 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 21' ' ' LEU . 13.5 mt -118.43 120.34 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 7.3 mmt180 -99.09 147.85 24.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 110.474 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.593 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 17.5 mtp180 -101.38 136.58 40.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.409 -0.807 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -110.44 160.06 16.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 110.233 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -48.62 -25.7 1.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.917 . . . . 0.0 110.313 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.413 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -160.07 -176.6 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD1' HG23 ' A' ' 17' ' ' VAL . 56.9 m-20 -62.17 -16.65 54.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 73' ' ' TYR . 19.8 t-20 -90.4 107.62 19.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.737 ' CD2' ' O ' ' A' ' 12' ' ' THR . 4.2 p-80 -143.77 175.54 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 110.561 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.2 p -78.68 130.41 35.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.736 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.57 179.34 4.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 47.7 41.76 14.33 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.159 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.56 -153.22 51.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 1.8 m-20 -84.47 41.33 0.83 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.164 -1.198 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.96 -36.51 3.4 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -122.71 166.3 15.21 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.094 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 11.1 m95 -135.74 172.07 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -1.033 . . . . 0.0 109.649 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.7 t -105.35 111.62 24.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 1.2 mtt180 -129.14 145.14 51.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 73' ' ' TYR . 23.5 m -46.68 -40.44 13.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.033 . . . . 0.0 108.614 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.83 168.52 19.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 62' ' ' VAL . 7.8 m -117.22 173.67 6.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.899 -1.125 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -79.62 -169.85 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.074 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -87.57 -42.47 12.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.09 -1.22 11.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.229 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 9.2 mt-10 -121.65 -170.88 2.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.7 p90 -150.26 -162.94 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.889 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 56' ' ' CYS . 53.9 t -120.35 94.37 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -51.88 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.739 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -42.77 -25.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.691 -0.631 . . . . 0.0 110.598 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.499 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.9 t80 -66.55 -50.07 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 111.287 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.9 m-85 -87.0 -5.76 58.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 111.761 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 t -55.27 -18.27 5.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.854 -1.153 . . . . 0.0 109.663 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.8 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.25 -49.33 51.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 111.044 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.041 HG23 HG12 ' A' ' 13' ' ' VAL . 7.0 p -68.47 -27.93 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.133 . . . . 0.0 109.224 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.97 -53.58 55.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.52 -123.37 6.88 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -42.79 71.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -1.106 . . . . 0.0 109.971 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 22.6 m-30 -85.96 -178.19 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.947 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.633 ' HB3' HG13 ' A' ' 62' ' ' VAL . 10.3 m-85 -121.05 143.23 49.17 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.447 -0.783 . . . . 0.0 109.236 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 t -79.28 99.72 7.21 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.131 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.7 m -79.3 162.87 25.34 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.145 -0.972 . . . . 0.0 110.153 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 1.6 mtp180 -159.2 -176.21 5.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.512 -0.742 . . . . 0.0 110.275 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -118.31 83.59 2.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.756 . . . . 0.0 110.27 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.0 Cg_endo . . . . . 0 C--O 1.215 -0.661 0 N-CA-C 110.041 -0.792 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.16 -27.17 30.27 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.506 -0.746 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.792 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -56.04 -38.03 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.582 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 10.8 m-30 -64.93 -27.29 68.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.281 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.09 129.18 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.255 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 63.16 32.02 82.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -123.06 -162.14 1.01 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 110.555 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.75 ' H ' HG21 ' A' ' 69' ' ' VAL . 8.4 m -153.2 101.05 2.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.038 HG12 HG23 ' A' ' 69' ' ' VAL . 3.2 m -99.84 157.43 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 0.0 110.284 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -71.87 -162.0 5.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.7 Cg_endo -74.57 -40.54 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.018 1.536 . . . . 0.0 110.428 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.3 m -62.81 -58.93 5.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 84.5 t -59.26 -50.53 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.776 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.801 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 23.7 t-105 -45.09 -64.14 0.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 0.0 109.745 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.15 -44.55 5.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.719 . . . . 0.0 110.387 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 62.4 t80 -57.81 -62.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG22 ' A' ' 30' ' ' VAL . 2.0 tt -44.28 -56.16 4.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.813 . . . . 0.0 109.998 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' LEU . 84.7 t -43.07 -44.55 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 20' ' ' TYR . . . -57.78 -56.31 23.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 24' ' ' LEU . 13.5 tp -49.44 -46.45 47.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.945 . . . . 0.0 110.028 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.99 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -116.37 -89.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.797 . . . . 0.0 110.079 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.831 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.28 165.27 29.9 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.79 59.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 110.626 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.05 -62.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.105 -0.997 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.99 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.21 -21.38 66.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.788 HG22 HD22 ' A' ' 21' ' ' LEU . 24.8 t -74.62 -35.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.471 -0.768 . . . . 0.0 109.885 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -83.57 -26.32 30.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.92 -15.75 38.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.01 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.02 25.1 2.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.773 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 50.0 t-20 47.36 68.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.552 -0.718 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.801 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 57.6 mt -122.62 126.15 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.415 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 73.1 mtt180 -109.1 146.75 33.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.493 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CG ' ' CE3' ' A' ' 18' ' ' TRP . 0.9 OUTLIER -93.32 144.37 25.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.513 -0.742 . . . . 0.0 109.647 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -116.39 155.0 29.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.969 . . . . 0.0 110.401 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -45.66 -27.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -0.85 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -165.07 -163.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -70.45 -12.69 61.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.332 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.514 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.4 OUTLIER -94.57 103.75 15.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.744 ' CD2' ' O ' ' A' ' 12' ' ' THR . 6.5 p-80 -143.42 177.0 8.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 110.336 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.598 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 84.9 p -82.37 131.89 35.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.44 -0.788 . . . . 0.0 109.569 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.9 p -124.27 175.68 6.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 110.62 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 51.11 36.51 15.71 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -150.36 51.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.25 42.64 0.89 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.263 . . . . 0.0 109.827 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.2 mtt180 -117.23 -38.31 3.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -0.911 . . . . 0.0 111.084 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -127.44 171.38 18.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.398 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 7.2 m95 -137.33 172.78 12.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.535 -0.979 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.46 110.69 22.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.158 . . . . 0.0 111.024 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -128.46 145.45 51.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.4 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 30.1 t -53.09 -53.16 54.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.884 -1.135 . . . . 0.0 108.316 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -124.87 178.4 5.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.455 0.645 . . . . 0.0 110.047 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' CD ' ' A' ' 53' ' ' ARG . 5.3 m -155.63 171.22 20.34 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.817 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -79.72 178.31 8.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.689 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -47.3 15.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -48.59 -21.04 0.51 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 109.64 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -110.5 178.17 4.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 109.705 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.5 p90 -144.18 -164.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.054 -1.029 . . . . 0.0 110.297 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 64' ' ' THR . 39.3 t -127.82 98.02 4.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -50.03 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.782 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.6 -26.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.674 -0.641 . . . . 0.0 110.458 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.5 t80 -66.79 -49.39 66.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 111.04 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.728 ' CD1' HD11 ' A' ' 7' ' ' ILE . 12.4 m-85 -85.77 -8.15 58.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 111.15 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.7 p -49.08 -22.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.921 -1.112 . . . . 0.0 109.017 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -65.36 -70.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.038 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -47.43 -29.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.907 -1.121 . . . . 0.0 109.845 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -63.95 -46.19 85.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.32 -132.82 11.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.1 mmt85 -57.07 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -1.19 . . . . 0.0 110.132 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 8.8 m-85 -84.26 -173.26 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 15.9 m-85 -128.39 134.49 48.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 110.078 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.0 t -79.73 97.11 6.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 108.635 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 70.9 m -79.21 166.29 22.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 110.581 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 13.6 mtp180 -160.77 177.56 10.31 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.217 0.532 . . . . 0.0 109.666 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 t -106.94 106.58 17.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.72 -35.61 5.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 110.036 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.923 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -53.01 -50.28 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.57 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.587 ' H ' HG23 ' A' ' 7' ' ' ILE . 15.9 m-30 -48.58 -31.76 7.06 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.887 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 41.7 mt -67.31 113.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.75 27.14 61.33 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.11 -164.4 0.92 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.552 -0.969 . . . . 0.0 110.6 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.678 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.0 m -155.89 103.08 2.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.073 HG12 HG23 ' A' ' 69' ' ' VAL . 4.0 m -98.62 -175.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.21 -160.32 32.5 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.84 -43.64 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.01 1.532 . . . . 0.0 110.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.9 p -65.44 -53.75 38.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 ' OD1' ' A' ' 41' ' ' ASP . 60.1 t -59.9 -48.81 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 109.968 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.721 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 14.3 t-105 -48.58 -60.38 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.858 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.07 -42.47 13.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.256 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.4 t80 -59.69 -65.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.836 HD22 HG22 ' A' ' 30' ' ' VAL . 3.9 tt -42.58 -43.94 3.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 18' ' ' TRP . 40.1 t -54.34 -50.08 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.96 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.5 -45.66 66.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.0 tp -58.27 -41.66 84.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.362 -0.836 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.007 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.64 -88.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.975 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.831 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 172.51 163.99 27.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -18.32 53.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.7 1.07 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.05 -1.031 . . . . 0.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.22 -25.64 67.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.12 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.836 HG22 HD22 ' A' ' 21' ' ' LEU . 37.3 t -68.75 -33.27 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.491 -0.756 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -77.5 -46.67 21.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.26 -17.77 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.27 23.31 2.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.439 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 35.5 t-20 40.69 69.84 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.721 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 21.2 mt -118.34 122.04 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.1 mtp180 -104.15 148.79 25.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 110.59 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 5.5 mtt85 -91.93 154.3 18.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.546 -0.721 . . . . 0.0 109.771 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.552 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.34 160.62 36.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -44.42 -35.03 2.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.557 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -164.17 -165.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.404 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' HG23 ' A' ' 17' ' ' VAL . 70.3 m-20 -64.37 -11.38 32.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.165 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 24.2 t-20 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.111 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.887 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -144.16 177.61 8.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.487 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.596 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.5 p -76.32 131.36 39.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -0.778 . . . . 0.0 109.699 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.51 173.96 8.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.985 -1.072 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.54 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 49.83 38.79 16.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.179 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.64 -149.44 51.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -85.14 40.91 0.85 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.098 -1.237 . . . . 0.0 109.706 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.9 mmt180 -113.77 -37.2 4.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.341 -0.849 . . . . 0.0 110.843 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -130.86 173.6 20.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.128 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.596 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -140.17 171.43 14.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.397 -1.061 . . . . 0.0 109.223 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.2 t -106.38 120.5 42.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.791 -1.193 . . . . 0.0 111.287 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 3.4 mtt-85 -132.95 156.21 47.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.464 -0.772 . . . . 0.0 108.922 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -48.53 -50.05 33.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 107.964 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.66 179.86 5.89 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.806 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.1 m -127.64 159.92 33.2 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.789 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -79.97 -177.0 5.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.41 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.48 -39.13 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.898 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -12.87 13.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.554 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 77' ' ' ARG . 5.3 mt-10 -124.56 -164.83 1.3 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.427 -0.796 . . . . 0.0 109.933 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.8 p90 -155.44 -162.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.709 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 ' SG ' ' A' ' 56' ' ' CYS . 78.4 t -119.86 95.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -53.04 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.334 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -44.17 -24.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.672 -0.643 . . . . 0.0 110.627 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.562 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.8 t80 -66.81 -50.85 61.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 111.164 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.611 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 8.0 m-85 -86.69 -5.6 59.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.108 -0.995 . . . . 0.0 111.724 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -54.68 -18.29 4.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.875 -1.141 . . . . 0.0 109.573 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.923 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -69.33 -51.81 33.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.073 HG23 HG12 ' A' ' 13' ' ' VAL . 8.1 p -66.71 -26.84 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 109.414 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -65.26 -44.5 87.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.871 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.08 -128.04 8.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -53.01 -34.02 54.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -1.097 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.555 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.4 m-30 -88.46 -174.62 4.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.001 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HB3' HG13 ' A' ' 62' ' ' VAL . 25.2 m-85 -130.17 135.97 48.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.957 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.3 t -79.36 101.25 8.0 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 108.958 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.0 m -83.09 162.31 21.38 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.054 -1.029 . . . . 0.0 109.817 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.423 ' CG ' ' HA3' ' A' ' 50' ' ' GLY . 10.0 mtp180 -157.14 -175.84 5.64 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.27 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -119.58 81.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 110.142 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 78' ' ' SER . 1.8 mtm-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.914 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.6 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.97 -20.86 32.15 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.914 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -51.84 -57.54 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 111.119 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.681 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.2 m-85 -48.07 -27.28 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.063 -1.023 . . . . 0.0 110.236 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 12.4 mt -69.1 128.72 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.631 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 57.47 32.05 63.96 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.65 -163.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.526 -0.985 . . . . 0.0 110.431 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.818 ' H ' HG21 ' A' ' 69' ' ' VAL . 25.4 m -151.81 94.46 1.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.133 -0.979 . . . . 0.0 110.291 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.656 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.3 m -86.24 -168.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.854 -1.154 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.19 -161.46 24.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.13 -45.63 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.805 1.423 . . . . 0.0 110.142 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 p -65.71 -49.3 68.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.3 t -59.34 -48.63 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.827 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.509 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 52.4 t-105 -48.42 -65.63 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.76 -33.2 4.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.808 . . . . 0.0 110.382 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 47.8 t80 -67.95 -70.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 30' ' ' VAL . 1.5 tt -43.65 -30.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' GLY . 30.6 t -63.29 -57.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.77 -31.56 39.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.963 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.08 -51.74 55.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.308 -0.87 . . . . 0.0 110.43 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.722 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 m -114.99 -49.0 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.766 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 147.1 163.83 10.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.36 -48.3 35.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.239 . . . . 0.0 110.68 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.71 76.24 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -61.36 -52.13 65.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.317 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 21' ' ' LEU . 24.1 t -50.02 -31.55 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.724 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -41.63 71.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.108 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.83 63.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.98 5.0 12.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.631 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 46.2 t30 59.05 69.09 0.75 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.36 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.531 ' CD1' HG13 ' A' ' 30' ' ' VAL . 34.3 mt -119.37 134.56 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.478 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.5 OUTLIER -109.04 146.04 34.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 110.59 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 7.7 mtp180 -95.18 142.34 27.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -118.5 156.58 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.6 t -42.17 -27.08 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 25.4 m -164.83 -170.59 2.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.28 -8.38 24.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.085 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 38.7 t-20 -96.52 104.9 16.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.889 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.6 p80 -143.45 -176.64 5.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -95.94 146.88 24.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 109.567 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.621 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 p -136.36 -177.71 4.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 47.31 37.93 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.089 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.97 -158.77 46.78 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.34 44.21 1.01 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.235 . . . . 0.0 109.709 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -119.14 -34.63 3.82 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.18 -0.95 . . . . 0.0 111.388 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.447 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -116.09 163.99 12.31 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.425 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.7 m95 -137.64 173.57 11.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.439 -1.036 . . . . 0.0 109.505 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.7 t -116.09 118.01 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.923 -1.11 . . . . 0.0 111.366 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -133.81 159.0 41.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.488 -0.758 . . . . 0.0 109.13 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -45.12 43.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.95 -1.094 . . . . 0.0 108.88 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 3.1 tttt -138.12 176.8 8.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.703 ' SG ' HG22 ' A' ' 62' ' ' VAL . 7.1 m -122.4 171.99 8.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.905 -1.122 . . . . 0.0 110.271 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -85.63 -178.6 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -44.0 41.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -67.51 -4.06 10.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 110.21 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -123.37 176.48 6.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 6.2 p90 -139.41 -160.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.24 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.703 HG22 ' SG ' ' A' ' 56' ' ' CYS . 76.4 t -125.26 103.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.559 -0.713 . . . . 0.0 109.899 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 9.5 p30 -53.44 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -45.53 -25.34 0.43 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.439 -0.788 . . . . 0.0 110.742 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 10.7 t80 -73.51 -47.41 41.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.812 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 69' ' ' VAL . 32.2 m-85 -85.18 -7.21 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.905 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -49.66 -23.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 109.156 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.511 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . -70.96 -66.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.516 -0.74 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.889 HG22 ' CE1' ' A' ' 43' ' ' HIS . 13.0 p -44.25 -31.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -63.92 -67.86 0.4 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.186 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.54 -124.08 7.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -57.94 -32.18 67.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -1.191 . . . . 0.0 110.042 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 21.3 m-30 -94.38 175.03 6.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.462 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB3' HG13 ' A' ' 62' ' ' VAL . 22.0 m-85 -115.79 133.25 56.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.737 . . . . 0.0 109.168 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.23 102.55 8.61 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.916 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 7.8 m -79.26 161.87 26.04 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 0.0 109.948 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 24.3 mtp180 -155.78 -169.7 3.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.339 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.23 114.93 29.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 110.298 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.292 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.5 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.369 -0.666 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -88.11 -26.12 22.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.429 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.881 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -51.86 -51.59 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.2 -0.938 . . . . 0.0 110.855 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.473 ' H ' HG23 ' A' ' 7' ' ' ILE . 14.4 m-30 -51.84 -29.21 18.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 21.2 mt -69.1 131.52 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.74 33.17 59.43 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.436 -1.865 . . . . 0.0 108.436 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.881 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -119.31 -163.06 0.95 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.778 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.9 m -152.22 95.86 2.11 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.013 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.958 HG12 HG23 ' A' ' 69' ' ' VAL . 2.6 m -92.3 174.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.274 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.92 38.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.75 -48.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.987 1.519 . . . . 0.0 110.402 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 1.1 p -59.94 -51.09 71.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.48 HG23 ' OD1' ' A' ' 41' ' ' ASP . 96.6 t -61.24 -52.1 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 32.1 t-105 -44.59 -65.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.71 -41.21 3.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 11.4 t80 -61.46 -65.67 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.878 . . . . 0.0 110.241 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.7 tt -42.81 -36.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 64.9 t -60.47 -51.99 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.943 . . . . 0.0 109.819 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.83 51.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 24' ' ' LEU . 9.5 tp -63.73 -38.6 91.71 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.053 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -131.99 -87.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.331 -0.856 . . . . 0.0 109.989 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.825 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.08 169.06 36.49 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 110.63 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.14 1.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.149 -0.969 . . . . 0.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.053 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.01 -21.94 66.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.166 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 26' ' ' GLY . 27.9 t -73.3 -30.99 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.842 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -85.41 -32.05 22.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.07 -24.76 58.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.165 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -79.64 5.98 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 58.3 t-20 58.41 72.77 0.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.611 HD13 HD13 ' A' ' 21' ' ' LEU . 35.5 mt -122.51 129.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.548 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' THR . 13.8 mtt180 -108.97 140.37 42.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm105 -84.2 156.93 21.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -130.92 164.79 24.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -50.85 -27.69 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.509 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 4.4 m -172.38 -170.8 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' HG23 ' A' ' 17' ' ' VAL . 6.8 m-20 -58.37 -15.3 10.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 73' ' ' TYR . 9.9 t-20 -95.13 106.21 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.903 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.7 p80 -147.64 177.01 9.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 110.339 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.622 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -80.14 147.85 31.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.841 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.12 173.89 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.334 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HB1' HH11 ' A' ' 77' ' ' ARG . . . 51.08 36.52 15.63 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.38 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.94 -153.64 48.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -85.65 36.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.066 -1.255 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.23 -30.52 5.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.485 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.52 164.58 15.49 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.484 -1.341 . . . . 0.0 109.767 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.622 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 7.9 m95 -143.47 172.64 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 109.572 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 4.6 t -108.38 112.7 25.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.788 -1.195 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 2.0 mtt-85 -128.4 153.38 47.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -52.35 -46.15 65.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 0.0 109.033 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.06 147.85 49.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.805 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.0 m -97.44 163.25 12.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.69 -179.25 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.244 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -38.26 51.14 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.218 -0.926 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -68.69 -6.48 26.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.264 -0.898 . . . . 0.0 109.77 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' OE2' ' C ' ' A' ' 77' ' ' ARG . 5.9 mt-10 -126.63 -176.6 3.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -140.76 -166.74 2.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.366 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.805 HG22 ' SG ' ' A' ' 56' ' ' CYS . 54.7 t -108.92 90.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.526 -0.734 . . . . 0.0 109.975 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 23.7 t0 -41.49 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.1 p -57.53 -31.02 65.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.833 . . . . 0.0 110.568 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 15.0 t80 -67.29 -48.29 68.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.722 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.637 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 28.3 m-85 -86.28 -6.9 58.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 111.089 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -21.45 4.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.858 -1.151 . . . . 0.0 109.164 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.55 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -69.95 -66.84 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.597 -0.689 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.958 HG23 HG12 ' A' ' 13' ' ' VAL . 14.1 p -46.65 -31.05 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.917 -1.115 . . . . 0.0 109.333 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -59.95 -69.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 0.0 109.949 179.361 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.66 -106.41 2.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -53.31 56.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -1.095 . . . . 0.0 110.06 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 23.7 m-85 -83.94 -169.25 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.687 ' HB3' HG13 ' A' ' 62' ' ' VAL . 7.3 m-85 -126.95 141.95 51.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -0.835 . . . . 0.0 109.476 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.4 t -79.62 97.75 6.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.363 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 16.5 m -78.85 164.14 24.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.663 HH11 ' HB1' ' A' ' 46' ' ' ALA . 9.3 mtp180 -154.35 -177.16 6.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 110.406 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 p -101.37 89.63 3.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.13 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.823 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.6 Cg_endo . . . . . 0 C--O 1.216 -0.605 0 N-CA-C 109.744 -0.906 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.87 -20.94 34.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 110.36 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.823 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -53.7 -53.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 111.042 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.9 m-85 -49.13 -26.27 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -69.65 136.16 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 52.04 33.28 36.75 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.31 -159.56 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.55 -0.971 . . . . 0.0 110.497 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.815 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.2 m -154.19 95.54 1.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 110.307 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.895 HG12 HG23 ' A' ' 69' ' ' VAL . 3.0 m -91.47 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.956 -1.09 . . . . 0.0 110.147 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -162.09 28.39 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -74.08 -51.18 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.944 1.497 . . . . 0.0 110.415 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 2.3 p -60.66 -49.2 78.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.155 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.496 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 26.7 t -59.41 -46.67 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.079 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -50.29 -62.77 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.58 -36.82 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.063 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.7 t80 -60.63 -55.06 37.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.677 HD22 HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -55.23 -36.12 65.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HA ' HG21 ' A' ' 30' ' ' VAL . 25.9 t -60.06 -52.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.2 -40.43 67.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.129 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.2 tp -61.73 -38.82 89.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.92 -88.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.17 164.94 31.69 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -21.81 62.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 110.675 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.79 1.27 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.083 -1.011 . . . . 0.0 110.057 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.995 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.24 -21.81 66.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.389 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 26' ' ' GLY . 44.8 t -74.46 -33.29 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 0.0 110.068 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.7 m -88.8 -21.4 23.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.28 -25.23 31.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.868 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -80.59 7.46 9.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.201 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 52.2 t-20 58.43 74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.27 -0.893 . . . . 0.0 110.534 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.868 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 2.7 mt -124.38 110.41 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.484 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 2.3 mmt85 -87.3 157.24 19.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.402 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.5 mtm180 -102.17 150.7 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 110.018 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.99 154.55 39.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' ALA . 50.9 m -43.82 -26.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.208 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -166.23 -162.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -11.88 60.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.75 106.16 18.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.746 ' CD2' ' O ' ' A' ' 12' ' ' THR . 5.6 p-80 -145.85 175.22 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.177 -0.952 . . . . 0.0 110.454 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.4 p -80.96 124.45 29.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 0.0 109.823 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.0 p -115.3 -177.59 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.115 -0.991 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.543 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.93 39.36 5.47 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.452 -0.78 . . . . 0.0 109.301 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.71 -150.08 48.94 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.581 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -87.29 31.38 0.73 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.095 -1.239 . . . . 0.0 110.012 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.92 -28.96 6.86 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.251 -0.905 . . . . 0.0 110.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.97 162.64 14.03 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.925 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 8.4 m95 -139.55 167.42 22.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.449 -1.03 . . . . 0.0 109.325 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 6.3 t -107.79 108.92 20.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.868 -1.145 . . . . 0.0 111.1 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -130.06 158.96 38.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.836 . . . . 0.0 109.06 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -48.4 51.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.946 -1.097 . . . . 0.0 108.249 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -124.28 -171.24 2.29 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.686 0.755 . . . . 0.0 110.525 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.865 ' SG ' HG22 ' A' ' 62' ' ' VAL . 11.4 m -131.52 164.33 26.03 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.958 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.0 m-85 -79.63 164.76 23.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.153 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -63.56 -44.62 93.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -4.77 13.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.868 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 17.1 mt-10 -123.0 -178.51 3.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.915 . . . . 0.0 110.145 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -139.65 -163.57 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.865 HG22 ' SG ' ' A' ' 56' ' ' CYS . 70.9 t -111.38 89.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 29.9 t0 -40.63 91.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.185 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -57.27 -30.51 64.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.563 -179.477 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.81 -48.61 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 110.818 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 7' ' ' ILE . 22.9 m-85 -83.88 -8.76 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 111.12 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -24.35 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.974 -1.079 . . . . 0.0 109.415 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.591 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.22 -71.36 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.895 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -44.18 -29.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.116 -0.99 . . . . 0.0 109.841 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.41 -64.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.57 -116.07 5.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -60.8 -50.98 71.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 12.4 m-30 -79.91 -175.16 4.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.966 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.66 ' HB3' HG13 ' A' ' 62' ' ' VAL . 5.9 m-85 -122.31 144.83 48.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 t -81.59 97.05 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 109.382 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 21.8 m -79.39 164.09 24.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.194 -0.941 . . . . 0.0 109.753 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.2 mtp180 -151.16 -179.25 7.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 0.0 110.53 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.435 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 54.4 p -116.59 87.35 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.269 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.2 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -113.48 -29.82 7.06 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -51.97 -55.28 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.367 -0.833 . . . . 0.0 110.815 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 21.2 m-85 -48.15 -29.33 3.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 33.1 mt -68.57 129.22 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.422 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.66 32.01 72.74 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.42 -162.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.983 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.778 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.0 m -153.79 100.07 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.939 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -93.73 173.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.115 -0.991 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -161.44 35.11 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 46.8 Cg_endo -74.27 -49.67 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.964 1.507 . . . . 0.0 110.39 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -50.19 74.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.23 -0.919 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.516 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 55.4 t -61.59 -51.0 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.776 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.1 t-105 -44.56 -65.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.703 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.53 -43.27 5.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 67.2 t80 -56.89 -64.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.867 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.813 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.1 tt -44.08 -38.61 3.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 18' ' ' TRP . 15.6 t -54.99 -55.97 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.1 -43.56 64.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.1 tp -55.28 -43.82 75.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.248 -0.908 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.014 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.6 -88.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.238 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.08 166.83 34.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -61.22 -20.88 63.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -1.148 . . . . 0.0 110.588 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -63.62 1.1 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.031 -1.043 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.014 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.45 -18.49 63.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.174 -0.953 . . . . 0.0 109.208 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 21' ' ' LEU . 24.2 t -75.98 -32.02 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.468 -0.77 . . . . 0.0 109.729 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.0 m -93.03 -17.1 24.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.34 -24.0 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -83.18 10.36 8.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.485 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 61.9 t-20 58.81 74.07 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.603 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.643 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 7.0 mt -125.1 125.27 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.858 . . . . 0.0 109.605 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.9 mtt180 -107.2 146.35 31.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 44.0 mtp180 -89.63 154.24 20.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -126.71 161.53 27.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.368 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -51.7 -26.71 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.392 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 39' ' ' SER . 3.7 m -165.32 -177.18 4.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.9 m-20 -56.41 -24.57 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.574 ' OD1' ' CD2' ' A' ' 73' ' ' TYR . 4.0 t30 -86.81 110.94 20.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.881 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.2 p80 -147.85 175.25 11.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.626 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -77.69 138.79 39.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.347 -0.846 . . . . 0.0 109.689 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.3 p -131.37 178.8 6.44 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.83 36.43 8.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.28 -147.74 46.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -87.13 31.6 0.71 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.198 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -115.03 -31.84 5.93 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.236 -0.915 . . . . 0.0 111.032 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.81 165.75 15.4 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.162 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.626 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.7 m95 -144.74 169.71 17.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.461 -1.023 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.8 t -109.61 113.33 26.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.829 -1.17 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.8 OUTLIER -132.52 160.96 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 109.126 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -50.84 -50.5 56.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.859 -1.151 . . . . 0.0 108.269 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -124.72 -178.98 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.528 0.68 . . . . 0.0 110.492 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.842 ' SG ' HG22 ' A' ' 62' ' ' VAL . 12.4 m -125.05 166.33 16.57 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.975 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -79.7 171.37 15.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.11 -0.994 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -39.41 71.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.207 -0.933 . . . . 0.0 110.17 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -71.21 -2.99 17.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 13.0 mt-10 -126.39 -172.35 2.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 6.2 p90 -144.52 -164.15 1.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.842 HG22 ' SG ' ' A' ' 56' ' ' CYS . 54.3 t -110.3 89.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.502 -0.749 . . . . 0.0 109.969 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 30.1 t0 -41.86 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.21 -28.67 65.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -68.86 -49.23 60.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 17.7 m-85 -82.91 -8.56 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 t -51.09 -21.71 2.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.987 -1.07 . . . . 0.0 109.115 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.49 -68.97 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 110.294 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.939 HG23 HG12 ' A' ' 13' ' ' VAL . 10.8 p -46.35 -30.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 109.35 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -60.15 -70.93 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 110.415 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.2 -115.5 5.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -61.0 -39.8 91.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -1.165 . . . . 0.0 109.995 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 29.3 m-85 -92.26 -177.69 4.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.877 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.6 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -122.3 145.87 47.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 0.0 109.642 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 8.7 t -85.08 99.24 10.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.64 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 18.3 m -78.36 163.89 25.29 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 109.667 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.0 mtp180 -154.09 -175.58 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 110.658 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -111.87 102.08 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.149 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.272 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.865 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.7 Cg_endo . . . . . 0 C--O 1.215 -0.66 0 N-CA-C 109.921 -0.838 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.679 ' HB3' ' OH ' ' A' ' 65' ' ' TYR . . . -80.62 -20.96 42.01 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.865 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -53.92 -56.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.9 -179.643 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.624 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.3 m-85 -47.6 -25.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.0 110.004 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 8.3 mt -69.15 125.49 27.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 60.2 31.41 73.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.72 -160.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.447 -1.031 . . . . 0.0 110.759 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.732 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 5.8 m -156.26 104.33 2.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.031 HG12 HG23 ' A' ' 69' ' ' VAL . 3.4 m -99.03 169.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.154 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 -163.89 21.54 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.5 Cg_endo -73.73 -46.1 0.35 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.051 1.553 . . . . 0.0 110.281 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -52.43 56.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 59.6 t -57.63 -41.36 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.727 ' O ' HG23 ' A' ' 22' ' ' VAL . 43.0 t-105 -54.22 -66.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.14 -0.975 . . . . 0.0 109.633 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.27 -33.97 1.77 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.707 . . . . 0.0 110.334 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 74.2 t80 -65.13 -65.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.117 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.6 tt -44.7 -35.8 2.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 18' ' ' TRP . 21.7 t -60.96 -48.24 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.21 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.459 -0.776 . . . . 0.0 109.968 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.8 tp -60.71 -42.98 98.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.017 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -121.7 -88.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 110.163 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.804 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.64 165.77 32.16 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.32 -19.25 61.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -1.132 . . . . 0.0 110.486 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -63.11 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.884 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.017 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.4 -19.7 64.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 26' ' ' GLY . 38.2 t -75.78 -32.03 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.442 -0.786 . . . . 0.0 109.856 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.2 m -89.37 -23.21 22.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.18 -24.9 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -81.07 8.38 8.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 61.2 t-20 59.21 74.73 0.43 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.663 HD13 HD13 ' A' ' 21' ' ' LEU . 67.9 mt -125.19 128.4 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.437 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mmt180 -109.99 146.32 35.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.585 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 6.6 mtp180 -92.79 148.86 21.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.82 173.69 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.097 -1.002 . . . . 0.0 110.328 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 t -51.29 -37.02 45.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.33 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.535 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.2 m -161.2 -162.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.346 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.2 m-20 -67.47 -18.55 65.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.405 -0.809 . . . . 0.0 110.344 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -91.75 92.19 8.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.273 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.744 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 3.9 p-80 -127.49 -178.6 4.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.159 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -88.95 117.64 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.422 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 21.4 p -104.11 -175.47 2.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.439 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HB2' ' HD2' ' A' ' 77' ' ' ARG . . . 43.98 39.57 2.8 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.446 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.63 -150.23 50.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 34.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.153 -1.204 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -117.93 -28.63 5.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.319 -0.863 . . . . 0.0 110.924 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.536 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -126.53 165.17 19.83 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.165 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 30.2 m95 -138.61 176.16 8.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.044 . . . . 0.0 109.956 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 m -105.66 102.41 11.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 5.3 mtt180 -122.21 137.71 54.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.147 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.559 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -49.25 -41.2 36.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 108.977 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.44 144.13 51.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.826 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.4 m -103.62 166.8 10.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.038 -1.038 . . . . 0.0 110.048 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -79.9 167.8 20.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.417 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -41.03 90.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.22 -6.18 17.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 15.5 mt-10 -126.18 178.04 6.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 109.887 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 77' ' ' ARG . 12.6 p90 -133.49 -170.32 2.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.277 179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.826 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -107.48 87.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 32.0 t0 -40.49 91.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.617 -0.677 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.2 -27.73 55.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.572 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.679 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 19.7 t80 -70.43 -50.35 39.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.886 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.654 ' CD2' HD11 ' A' ' 7' ' ' ILE . 24.0 m-85 -82.7 -8.0 59.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 111.065 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 -21.39 3.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.017 -1.052 . . . . 0.0 109.308 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . -69.96 -51.16 34.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.031 HG23 HG12 ' A' ' 13' ' ' VAL . 7.6 p -64.24 -31.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.95 -1.094 . . . . 0.0 110.495 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 75' ' ' CYS . 57.8 m -62.74 -52.3 63.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.944 -1.097 . . . . 0.0 109.466 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 -119.56 5.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.09 -23.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 110.11 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 25.7 m-85 -116.67 178.44 4.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.676 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.6 m-85 -115.73 147.22 41.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 8.8 t -79.5 95.91 5.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 0.0 109.58 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 77' ' ' ARG . 31.3 m -78.66 160.98 27.24 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.957 -1.09 . . . . 0.0 109.355 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.602 ' HD2' ' HB2' ' A' ' 46' ' ' ALA . 43.4 mtp180 -157.83 -172.52 3.97 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.359 -0.838 . . . . 0.0 110.591 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 7.6 t -114.87 96.31 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.611 -0.681 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.49 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.626 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.6 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.24 -21.49 9.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.781 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.731 HD11 ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -56.09 -44.9 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.454 -0.778 . . . . 0.0 110.807 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.3 m-85 -55.86 -24.17 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.987 . . . . 0.0 110.758 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 54.3 mt -61.18 127.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.626 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 54.7 32.58 54.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -112.29 -170.83 1.73 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.504 -0.997 . . . . 0.0 110.645 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.814 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.2 m -145.75 90.13 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.1 m -82.99 175.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.04 -1.038 . . . . 0.0 109.826 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.83 -166.49 42.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 44.0 Cg_endo -72.21 -46.49 0.51 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.976 1.514 . . . . 0.0 110.185 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -47.57 82.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 57.1 t -59.5 -51.81 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.594 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 36.4 t-105 -44.43 -66.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 109.824 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.71 -39.76 2.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.844 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 38.9 t80 -62.44 -64.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.363 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -42.74 -52.0 5.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG22 HG21 ' A' ' 30' ' ' VAL . 73.2 t -47.65 -50.89 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.78 -46.53 59.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.6 tp -60.58 -38.87 86.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.844 . . . . 0.0 110.036 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -126.99 -89.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.805 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.55 171.25 37.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.38 -19.18 65.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -1.169 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.95 -63.13 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.07 -1.018 . . . . 0.0 109.945 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.043 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.84 -21.87 66.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' HD12 ' A' ' 35' ' ' ILE . 24.6 t -74.0 -33.48 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.726 . . . . 0.0 109.929 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 m -85.31 -27.01 26.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.009 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.02 -25.93 48.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.948 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.695 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -81.46 3.25 25.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.025 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.626 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 43.9 t30 58.73 77.95 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.59 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.695 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 2.6 mt -121.43 140.76 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.505 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 5.5 mtt180 -117.49 153.82 32.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.567 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.594 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 19.0 mtp-105 -109.04 134.3 51.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -109.44 173.82 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -49.58 -27.48 4.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.538 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 39.0 m -167.71 -166.08 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' OD1' HG23 ' A' ' 17' ' ' VAL . 97.9 m-20 -65.83 -10.17 35.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 2.8 m-20 -96.31 105.58 17.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.868 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.9 p80 -145.71 -179.85 6.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -0.977 . . . . 0.0 110.647 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.625 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -91.64 148.31 22.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.443 -0.786 . . . . 0.0 109.521 179.627 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.636 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 9.3 p -141.27 -177.32 5.07 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 110.611 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.3 43.54 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.27 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.69 -161.04 53.92 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -83.82 41.33 0.79 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.031 -1.276 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -119.38 -31.16 4.71 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.64 158.76 14.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.223 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.625 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.1 m95 -140.05 169.05 18.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -1.028 . . . . 0.0 109.189 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -112.45 115.91 29.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.786 -1.197 . . . . 0.0 110.893 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 0.9 OUTLIER -132.44 161.38 33.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.349 -0.844 . . . . 0.0 109.25 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -46.08 66.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.985 -1.072 . . . . 0.0 108.856 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.52 163.19 30.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.662 ' SG ' HG22 ' A' ' 62' ' ' VAL . 10.9 m -103.73 170.22 8.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 110.265 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 21.5 m-85 -87.39 -178.88 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.2 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -75.23 -38.47 60.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.333 -0.854 . . . . 0.0 110.008 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.54 0.74 13.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -132.36 177.9 7.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 9.7 p90 -138.89 -168.83 2.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 74' ' ' PHE . 26.2 t -104.07 89.63 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.64 -0.663 . . . . 0.0 109.828 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.489 ' OD2' ' CD ' ' A' ' 77' ' ' ARG . 16.8 t0 -42.64 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.8 p -58.08 -32.74 68.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -44.89 80.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.731 ' CD1' HD11 ' A' ' 7' ' ' ILE . 37.8 m-85 -89.1 -5.99 57.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.963 -179.347 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 t -50.51 -22.5 1.97 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.013 -1.055 . . . . 0.0 108.766 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -70.61 -67.78 0.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.868 HG22 ' CE1' ' A' ' 43' ' ' HIS . 12.9 p -44.71 -28.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.018 -1.051 . . . . 0.0 109.671 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' HA ' ' NE2' ' A' ' 43' ' ' HIS . 1.1 m -67.08 -62.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.453 -0.78 . . . . 0.0 110.449 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.7 -114.81 4.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -69.04 -34.0 74.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' CG ' ' OD1' ' A' ' 42' ' ' ASN . 61.7 m-85 -87.79 179.72 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.663 ' HB3' HG13 ' A' ' 62' ' ' VAL . 7.0 m-85 -121.89 129.55 52.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -0.853 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.46 99.61 7.3 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.04 -1.038 . . . . 0.0 108.816 179.376 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.9 m -78.38 163.83 25.33 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.903 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 10.1 mtp180 -148.02 176.55 10.09 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 110.31 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 t -103.93 88.5 3.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 6.7 ttm180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.876 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.4 Cg_endo . . . . . 0 C--O 1.215 -0.672 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -80.22 -22.48 41.77 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.876 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -51.37 -55.11 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -179.663 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.25 -30.76 5.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 6' ' ' ALA . 65.0 mt -67.99 135.23 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.622 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 54.43 33.55 53.69 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.154 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -125.51 -160.28 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.513 -0.992 . . . . 0.0 110.417 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.821 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.6 m -155.18 92.57 1.44 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.952 . . . . 0.0 110.451 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.737 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -84.21 -147.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 110.28 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -125.58 -161.31 10.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.22 -47.27 0.32 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.992 1.522 . . . . 0.0 110.542 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -55.64 11.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 64.2 t -53.71 -39.74 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.601 ' CD2' ' HD2' ' A' ' 37' ' ' ARG . 25.9 t90 -55.99 -61.87 2.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.76 -38.23 3.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -66.16 -44.2 84.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.915 HD22 HG22 ' A' ' 30' ' ' VAL . 1.3 tt -65.1 -27.89 69.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 110.27 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.628 HG13 ' CA ' ' A' ' 27' ' ' ALA . 85.9 t -71.37 -42.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 110.281 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' LEU . 8.7 tp -72.92 -69.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 110.794 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.005 HG22 ' CB ' ' A' ' 29' ' ' ALA . 14.9 p -88.43 -26.48 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 110.702 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.787 ' O ' HG23 ' A' ' 30' ' ' VAL . . . 119.72 161.37 11.57 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.628 ' CA ' HG13 ' A' ' 22' ' ' VAL . . . -63.42 -63.2 1.25 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -1.121 . . . . 0.0 110.318 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.2 -34.25 31.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.992 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.005 ' CB ' HG22 ' A' ' 25' ' ' VAL . . . -63.6 -43.67 96.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.915 HG22 HD22 ' A' ' 21' ' ' LEU . 49.8 t -60.84 -39.76 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m -71.47 -23.45 61.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.19 -20.8 31.75 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.391 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -90.11 9.14 29.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.513 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.622 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 44.9 t30 59.13 68.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.383 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.766 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 3.3 mt -120.13 110.81 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.652 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.1 mtm105 -92.04 160.11 15.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.555 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.601 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 8.4 mtp-105 -110.54 151.52 27.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.83 -172.46 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 4.9 t -71.92 -2.76 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 170.65 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.076 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -71.24 -9.65 58.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.7 t-20 -97.39 100.48 11.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.133 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.805 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -142.22 176.78 8.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.112 -0.993 . . . . 0.0 110.501 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.584 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.5 p -78.51 129.74 35.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.16 175.64 6.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 110.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.81 42.74 20.49 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.73 -150.65 49.74 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -86.17 38.57 0.77 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.103 -1.234 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.3 mtm-85 -116.96 -35.35 4.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.171 -0.956 . . . . 0.0 111.013 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -125.45 165.49 18.58 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.501 -1.333 . . . . 0.0 109.931 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.584 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.9 m95 -136.77 175.0 10.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.443 -1.034 . . . . 0.0 109.673 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.6 t -107.97 120.09 41.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.976 -1.078 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -139.02 144.89 39.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.36 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 1.4 m -45.78 -38.73 7.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.954 -1.092 . . . . 0.0 108.479 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HD3' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.8 -162.83 1.27 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' HG22 ' A' ' 62' ' ' VAL . 20.7 m -143.4 179.06 7.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.928 -1.108 . . . . 0.0 110.37 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.93 -176.12 5.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.028 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -84.26 -38.46 20.46 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 9.58 7.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 11.1 mt-10 -124.06 -168.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.6 p90 -154.4 -160.09 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.896 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.638 HG13 ' HB3' ' A' ' 74' ' ' PHE . 66.2 t -122.5 96.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.683 -0.636 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -52.69 89.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 109.796 -179.63 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -43.08 -24.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.58 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 63' ' ' ASP . 26.6 t80 -67.32 -55.13 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.83 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.3 m-85 -81.95 -9.92 59.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.195 -0.941 . . . . 0.0 110.982 -179.286 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 t -48.25 -23.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.094 -1.004 . . . . 0.0 109.215 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.675 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.54 -71.5 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.722 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.821 HG21 ' H ' ' A' ' 12' ' ' THR . 9.3 p -43.33 -29.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 109.668 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -62.44 -58.67 6.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.471 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.69 -136.91 12.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.47 -27.69 4.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -1.166 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -93.71 179.18 5.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.152 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.638 ' HB3' HG13 ' A' ' 62' ' ' VAL . 10.9 m-85 -122.68 137.29 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 178.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 t -78.76 103.35 8.65 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.969 -1.082 . . . . 0.0 108.818 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.5 m -79.58 163.06 24.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.524 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 26.3 mtp180 -160.08 -170.24 2.78 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.534 -0.729 . . . . 0.0 110.274 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.69 114.9 21.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.826 . . . . 0.0 110.22 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.174 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.4 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.95 -28.44 27.81 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -54.75 -50.47 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 110.366 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.584 ' H ' HG23 ' A' ' 7' ' ' ILE . 9.9 m-30 -46.97 -27.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 49.1 mt -64.19 118.55 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.562 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 65.06 30.65 78.5 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -178.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -106.52 -161.57 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.51 -0.994 . . . . 0.0 110.809 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.762 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.3 m -156.35 92.28 1.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.037 HG12 HG23 ' A' ' 69' ' ' VAL . 3.4 m -93.74 169.75 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.288 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.97 -161.68 36.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.6 Cg_endo -74.09 -38.79 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.024 1.539 . . . . 0.0 110.414 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.94 -53.96 22.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 110.142 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.6 t -58.48 -46.86 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.986 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' ALA . 28.3 t-105 -49.06 -65.2 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.646 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.48 -40.91 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 110.263 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 54.0 t80 -59.24 -58.0 10.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.969 HD22 HG22 ' A' ' 30' ' ' VAL . 2.8 tt -51.73 -36.2 46.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 40.8 t -58.4 -49.29 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.085 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.16 82.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.178 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.0 tp -57.14 -44.71 83.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.39 -88.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.265 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.841 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.02 166.93 34.16 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -20.34 63.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -1.192 . . . . 0.0 110.637 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.57 -64.24 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.081 -1.012 . . . . 0.0 109.779 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.025 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -60.76 -23.5 65.02 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.024 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.969 HG22 HD22 ' A' ' 21' ' ' LEU . 21.9 t -67.43 -37.02 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.443 -0.786 . . . . 0.0 109.533 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.2 m -85.26 -23.85 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.22 -23.05 54.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.6 24.76 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 30.7 t-20 41.23 75.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.697 HD12 ' O ' ' A' ' 30' ' ' VAL . 53.1 mt -117.2 126.47 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.496 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -100.78 146.06 27.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.564 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -91.5 146.91 23.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.83 . . . . 0.0 109.693 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.662 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -124.45 152.91 42.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' ALA . 18.2 t -42.27 -27.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.211 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m -171.65 -165.03 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -65.23 -12.91 56.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 30.9 t-20 -95.8 103.38 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.575 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.737 ' CD2' ' O ' ' A' ' 12' ' ' THR . 7.8 p-80 -145.77 -179.9 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.363 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.4 p -84.66 133.33 34.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.694 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.0 p -122.06 174.78 6.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 50.0 33.09 6.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.323 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 -144.93 43.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.87 40.65 0.82 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.025 -1.28 . . . . 0.0 109.976 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -113.11 -40.37 3.96 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 110.989 -179.412 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -131.6 172.37 20.9 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.271 -1.443 . . . . 0.0 110.573 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.3 m95 -136.22 177.18 8.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.895 . . . . 0.0 109.356 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -107.62 115.07 29.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.6 mtt180 -132.16 142.95 49.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.729 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 2.1 t -48.1 -43.15 30.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.883 -1.135 . . . . 0.0 108.834 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.11 50.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.881 ' SG ' HG22 ' A' ' 62' ' ' VAL . 6.3 m -101.85 162.2 13.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.952 -1.092 . . . . 0.0 110.331 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -79.98 167.34 20.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.887 . . . . 0.0 110.478 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -67.01 -39.55 87.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -63.91 -9.89 17.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.918 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 13.3 mt-10 -126.48 179.15 5.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.212 -0.93 . . . . 0.0 109.817 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 13.4 p90 -130.58 -169.45 2.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -0.96 . . . . 0.0 110.34 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.881 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.9 t -111.08 88.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 77' ' ' ARG . 3.7 t70 -38.56 91.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.43 0.633 . . . . 0.0 110.477 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.85 -29.54 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 110.049 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.544 ' O ' HD12 ' A' ' 7' ' ' ILE . 51.2 t80 -68.48 -53.51 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.435 -0.79 . . . . 0.0 110.462 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -80.09 -4.26 52.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 111.489 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -16.62 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.944 -1.097 . . . . 0.0 109.626 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.785 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -73.19 -45.99 53.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.003 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.037 HG23 HG12 ' A' ' 13' ' ' VAL . 10.0 p -71.63 -26.28 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.935 -1.103 . . . . 0.0 109.343 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -65.28 -50.91 63.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.77 . . . . 0.0 109.83 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.12 -131.04 10.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -33.67 9.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -1.074 . . . . 0.0 109.798 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 8.9 m-85 -92.83 -177.63 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.857 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.688 ' HB3' HG13 ' A' ' 62' ' ' VAL . 6.8 m-85 -126.69 140.77 52.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 8.6 t -79.48 97.25 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.568 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 14.2 m -79.23 163.26 25.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.981 . . . . 0.0 110.069 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.636 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 6.5 mmm180 -153.59 -172.43 4.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 110.242 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 29.3 p -120.17 81.03 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.491 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.169 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.2 Cg_endo . . . . . 0 C--O 1.214 -0.698 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.49 -20.31 37.05 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.547 -0.72 . . . . 0.0 110.22 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.835 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -57.73 -39.18 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.879 . . . . 0.0 110.457 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 12.8 m-30 -63.14 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.518 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.8 mt -72.44 126.55 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 109.281 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.631 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 63.79 31.01 79.36 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.54 -163.08 0.93 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.501 -0.999 . . . . 0.0 110.711 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.832 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.8 m -154.85 99.54 2.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -0.894 . . . . 0.0 109.835 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.886 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -94.72 178.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.991 -1.068 . . . . 0.0 110.445 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.12 -161.74 37.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.6 Cg_endo -73.33 -46.52 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.985 1.519 . . . . 0.0 110.509 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -47.78 74.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.317 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 14.9 t -58.8 -46.05 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.447 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 7.7 t90 -52.66 -55.67 20.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.55 59.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.605 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.19 -59.06 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.92 . . . . 0.0 110.302 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.844 HD22 HG22 ' A' ' 30' ' ' VAL . 1.6 tt -52.04 -36.31 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.791 . . . . 0.0 110.366 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 26' ' ' GLY . 46.8 t -62.73 -48.58 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.11 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.85 -34.76 68.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.54 -39.15 77.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.376 -0.828 . . . . 0.0 110.371 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.123 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -128.71 -52.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.425 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . 134.85 164.19 10.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -65.2 -7.99 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -1.087 . . . . 0.0 110.884 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.947 -1.096 . . . . 0.0 109.817 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.123 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.74 -19.25 65.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.855 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.844 HG22 HD22 ' A' ' 21' ' ' LEU . 18.2 t -75.21 -32.83 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.9 m -87.26 -27.01 23.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.044 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.94 -19.91 36.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -84.57 9.18 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 110.156 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.631 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 52.3 t-20 59.05 72.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.345 -0.847 . . . . 0.0 110.624 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.617 HD13 HD13 ' A' ' 21' ' ' LEU . 38.0 mt -124.96 114.54 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 109.692 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 12' ' ' THR . 19.8 mtt-85 -98.67 152.11 19.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 4.1 mtm180 -93.68 159.59 15.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -134.52 164.02 28.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.18 -25.31 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -179.54 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.293 -179.865 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 62.1 m-20 -65.97 -10.45 39.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 9.6 t-20 -98.33 100.19 11.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.351 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.745 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 5.2 p-80 -143.25 175.04 10.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.943 . . . . 0.0 110.451 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.569 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 5.7 p -80.38 125.63 30.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.403 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.97 177.44 4.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.07 44.03 18.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.47 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.42 -152.13 51.49 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -86.75 36.14 0.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.061 -1.258 . . . . 0.0 109.989 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -31.2 5.11 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.225 -0.922 . . . . 0.0 110.859 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.521 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -118.78 163.46 13.17 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.061 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 8.1 m95 -140.84 165.92 26.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -1.082 . . . . 0.0 109.839 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.5 t -104.37 107.95 19.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 0.0 110.787 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -128.29 149.93 50.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -0.898 . . . . 0.0 109.622 179.351 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 65.8 p -55.99 -49.87 72.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 109.035 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -130.49 173.57 10.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 57.1 m -148.6 172.04 15.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -79.54 -170.29 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.506 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -45.28 10.69 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.338 -0.852 . . . . 0.0 110.332 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.7 -20.31 1.2 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 109.517 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -113.58 170.77 8.0 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.395 -0.816 . . . . 0.0 109.832 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.9 p90 -133.85 -168.33 2.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 0.0 110.145 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.72 HG13 ' HB3' ' A' ' 74' ' ' PHE . 62.6 t -111.76 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.546 -0.721 . . . . 0.0 110.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.2 t0 -40.21 91.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 110.19 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' VAL . 2.8 p -55.13 -33.98 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 110.505 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.93 -46.79 83.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.78 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CD2' HD11 ' A' ' 7' ' ' ILE . 27.4 m-85 -87.2 -6.48 58.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 0.0 111.021 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -21.96 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.053 . . . . 0.0 108.904 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -69.67 -66.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 0.0 110.53 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.886 HG23 HG12 ' A' ' 13' ' ' VAL . 9.7 p -48.54 -26.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.077 . . . . 0.0 109.603 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -65.39 -63.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 110.231 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -114.94 5.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -61.06 -47.98 83.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -1.181 . . . . 0.0 110.027 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.484 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 22.5 m-85 -82.69 -178.45 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.72 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.0 m-85 -121.23 138.82 54.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.7 t -79.68 98.49 6.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.762 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 96.1 m -79.06 173.16 12.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.955 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.5 mtp180 -160.55 179.88 8.22 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.482 -0.761 . . . . 0.0 110.276 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.68 117.49 34.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.159 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 2.0 m-20 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.671 0.272 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 1' ' ' ASN . 47.2 Cg_endo -74.15 126.42 10.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.867 1.456 . . . . 0.0 110.476 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -166.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.253 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.483 HG23 ' HD2' ' A' ' 5' ' ' PRO . 1.6 mm -52.67 146.46 17.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.728 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.1 Cg_endo -76.09 164.08 31.92 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.093 1.575 . . . . 0.0 110.053 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.58 -24.78 33.77 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.824 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -53.51 -54.83 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.79 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.58 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 10.0 m-30 -48.48 -26.82 2.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 110.172 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 15.7 mt -71.84 139.15 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.391 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.626 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 49.06 35.93 19.85 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -123.72 -161.84 1.01 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.542 -0.975 . . . . 0.0 110.515 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.787 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.6 m -153.93 93.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.815 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -88.76 -171.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.062 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -100.58 -163.6 28.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.4 Cg_endo -72.83 -48.82 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.963 1.507 . . . . 0.0 110.458 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 t -62.78 -52.09 64.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.575 HG23 ' OD1' ' A' ' 41' ' ' ASP . 79.5 t -58.31 -45.85 89.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 110.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.603 ' CZ3' ' NH2' ' A' ' 37' ' ' ARG . 22.2 t90 -50.35 -63.92 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.917 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.03 -36.14 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 52.1 t80 -62.21 -60.97 2.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.9 HD22 HG22 ' A' ' 30' ' ' VAL . 2.6 tt -49.47 -34.55 17.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' VAL . 64.1 t -60.39 -51.04 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.152 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.88 76.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.433 -0.792 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD23 ' CD1' ' A' ' 4' ' ' ILE . 9.9 tp -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -0.935 . . . . 0.0 110.179 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.037 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -126.34 -88.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.18 166.0 32.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.88 -19.32 60.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -1.147 . . . . 0.0 110.562 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -62.94 1.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.115 -0.991 . . . . 0.0 109.949 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.037 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.54 -21.02 66.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.327 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.9 HG22 HD22 ' A' ' 21' ' ' LEU . 38.0 t -75.86 -32.44 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.49 -0.756 . . . . 0.0 109.755 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 m -93.29 -14.99 26.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.057 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.07 -24.67 21.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.016 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -82.18 9.34 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.626 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 44.3 t30 59.34 72.6 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 110.652 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 21' ' ' LEU . 22.4 mt -119.45 120.38 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.627 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' THR . 10.1 mtm180 -101.19 149.07 24.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.569 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.603 ' NH2' ' CZ3' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -100.22 152.26 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.823 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.82 172.47 9.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.167 -0.958 . . . . 0.0 110.405 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 40' ' ' SER . 1.2 p -50.92 -27.31 7.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.517 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 5.1 m -172.06 -173.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.575 ' OD1' HG23 ' A' ' 17' ' ' VAL . 2.6 m-20 -55.12 -22.83 18.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 17.6 t-20 -87.8 107.73 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.917 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.5 p80 -147.33 -175.98 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -95.2 148.73 22.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 10.4 p -139.9 -176.08 4.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.935 . . . . 0.0 110.458 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' CYS . . . 45.84 43.17 9.75 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.3 -157.66 53.45 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.54 44.44 1.04 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.045 -1.267 . . . . 0.0 109.598 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -117.33 -34.37 4.34 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.292 -0.88 . . . . 0.0 111.342 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.02 165.22 12.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.233 -1.46 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 3.5 m95 -140.32 171.37 14.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.608 -0.937 . . . . 0.0 108.948 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.1 t -113.99 123.4 49.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 111.565 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -135.1 156.65 48.65 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' ARG . 80.0 p -46.58 -41.42 14.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.86 -1.15 . . . . 0.0 109.027 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -142.63 178.27 7.74 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 62' ' ' VAL . 10.8 m -122.15 165.69 15.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.895 -1.128 . . . . 0.0 110.153 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -79.93 175.36 10.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -73.47 -39.45 64.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 0.0 110.646 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -2.74 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.139 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.36 -174.66 3.06 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 5.8 p90 -146.72 -159.7 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.674 HG22 ' SG ' ' A' ' 56' ' ' CYS . 45.1 t -125.44 104.85 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.627 -0.671 . . . . 0.0 109.594 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 75' ' ' CYS . 9.7 p30 -51.69 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -44.07 -25.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.706 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.35 -48.5 41.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 111.085 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.686 ' O ' HG12 ' A' ' 69' ' ' VAL . 60.0 m-85 -89.28 -4.66 58.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 111.408 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -51.08 -23.1 2.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.147 . . . . 0.0 108.693 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -72.01 -66.08 0.69 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.624 -0.672 . . . . 0.0 110.538 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.917 HG22 ' CE1' ' A' ' 43' ' ' HIS . 13.2 p -44.08 -30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.078 -1.013 . . . . 0.0 109.67 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -65.47 -63.76 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.109 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.0 -132.6 11.08 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -51.88 -34.55 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.168 . . . . 0.0 110.06 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.35 -174.01 4.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -130.72 128.57 41.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.848 . . . . 0.0 109.877 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.03 99.38 6.86 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.94 -1.1 . . . . 0.0 108.804 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 5.6 m -79.56 160.99 26.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 1.1 mtp180 -151.0 170.93 18.15 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 110.144 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.38 117.02 33.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.716 0.293 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.42 112.04 3.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.115 1.587 . . . . 0.0 110.391 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 4' ' ' ILE . 3.1 tm? -114.23 134.19 55.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.784 ' N ' HD13 ' A' ' 3' ' ' LEU . 5.0 mm -48.79 146.3 5.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.44 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.655 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 49.2 Cg_endo -70.56 -157.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.14 1.6 . . . . 0.0 110.032 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.595 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -116.18 -43.45 2.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.86 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -54.11 -39.43 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 1.034 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 47.3 m-85 -59.93 -31.78 70.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 6' ' ' ALA . 66.1 mt -72.87 143.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.454 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.98 35.26 63.37 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -127.77 -162.57 1.18 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -1.065 . . . . 0.0 110.646 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.827 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.7 m -150.35 89.87 1.61 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -83.19 -163.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.018 -1.051 . . . . 0.0 110.336 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.92 -165.62 21.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -73.16 -44.29 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.313 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -65.01 -49.88 68.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.121 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.567 HG11 ' HB ' ' A' ' 13' ' ' VAL . 44.4 t -60.64 -49.81 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.848 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 46.4 t-105 -46.26 -63.87 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.97 -43.06 6.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -59.62 -66.64 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.895 HD22 HG22 ' A' ' 30' ' ' VAL . 4.8 tt -40.78 -49.17 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.489 -0.757 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.5 t -48.75 -50.96 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.39 64.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.399 -0.813 . . . . 0.0 109.868 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.571 HD23 HD13 ' A' ' 4' ' ' ILE . 7.1 tp -60.18 -42.2 94.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 110.016 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.959 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -125.93 -87.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.972 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.82 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.4 163.58 27.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.71 60.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -1.132 . . . . 0.0 110.612 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -62.63 1.32 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.14 -0.975 . . . . 0.0 109.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.959 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.13 -25.33 66.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.895 HG22 HD22 ' A' ' 21' ' ' LEU . 20.1 t -68.64 -34.0 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 m -77.09 -44.27 31.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.82 65.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.62 23.06 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.964 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.451 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 62.7 t-20 39.82 70.78 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.423 -0.798 . . . . 0.0 110.646 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.848 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 14.8 mt -115.16 130.16 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.716 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.486 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 10.2 mtt180 -114.86 148.96 37.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.416 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.574 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 6.6 mtp180 -99.47 149.14 23.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.473 -0.767 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -122.95 159.47 28.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.112 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.445 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.3 m -45.08 -25.09 0.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 39' ' ' SER . 44.6 m -167.47 -171.99 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.113 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.1 m-20 -64.22 -14.85 58.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 11.2 t-20 -93.53 109.72 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.5 p80 -146.55 -175.69 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.586 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 1.9 p -88.66 127.24 35.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.681 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.9 p -117.32 178.1 4.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.575 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.06 33.14 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.357 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.63 -149.37 36.6 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -87.6 29.12 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.129 -1.218 . . . . 0.0 109.963 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -108.4 -32.12 7.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.218 -0.926 . . . . 0.0 110.855 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.519 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.8 164.68 15.68 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -138.46 178.59 7.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.456 -1.026 . . . . 0.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.3 t -115.6 113.43 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.889 -1.132 . . . . 0.0 110.707 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -131.58 157.32 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -56.21 -52.77 63.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.966 -1.083 . . . . 0.0 108.76 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' N ' ' OG ' ' A' ' 54' ' ' SER . 1.1 tttt -138.81 139.58 38.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 2.0 t -103.87 168.33 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.449 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.4 m-85 -79.62 168.09 19.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -38.16 86.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.786 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.86 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.995 -1.066 . . . . 0.0 109.739 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.3 mt-10 -124.05 179.3 4.91 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.358 -0.839 . . . . 0.0 109.998 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.6 p90 -135.29 -166.53 1.85 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.809 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.801 HG13 ' HB3' ' A' ' 74' ' ' PHE . 28.6 t -112.31 88.24 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.461 -0.774 . . . . 0.0 109.933 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' A' ' 77' ' ' ARG . 51.8 t0 -37.14 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.377 0.608 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.75 -28.29 60.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -69.91 -44.11 70.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 22.3 m-85 -92.12 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 111.001 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.86 -20.64 3.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.025 -1.047 . . . . 0.0 108.924 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.034 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -70.03 -71.49 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.575 -0.703 . . . . 0.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.827 HG21 ' H ' ' A' ' 12' ' ' THR . 7.2 p -44.28 -28.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.066 -1.021 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -63.05 -59.39 4.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 110.271 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -134.47 11.76 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -31.85 12.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -1.194 . . . . 0.0 109.859 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.7 m-85 -91.58 -179.63 5.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 110.115 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.801 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.1 m-85 -122.95 140.57 52.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.765 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.1 t -79.53 98.25 6.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.085 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 10.9 t -78.58 163.77 25.23 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.04 . . . . 0.0 110.198 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 44.4 mtp180 -159.12 176.08 12.69 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.406 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -94.84 109.89 21.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.162 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 118.75 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.998 1.525 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 3' ' ' LEU . 2.4 tt -110.0 46.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.743 HG23 ' HD2' ' A' ' 5' ' ' PRO . 7.5 mm -81.81 148.73 62.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.743 ' HD2' HG23 ' A' ' 4' ' ' ILE . 47.5 Cg_endo -72.03 -158.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.004 1.528 . . . . 0.0 109.484 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.23 -44.14 2.91 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.04 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -53.58 -49.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.357 -0.839 . . . . 0.0 110.049 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.695 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 41.7 m-85 -47.13 -33.67 5.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 109.742 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 73.8 mt -72.17 124.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.294 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 72.95 29.94 64.17 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -120.33 -163.12 0.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.476 -1.014 . . . . 0.0 110.766 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.738 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 4.2 m -153.66 99.77 2.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.875 . . . . 0.0 109.84 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.962 HG12 HG23 ' A' ' 69' ' ' VAL . 10.4 m -95.38 168.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.224 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -75.65 -162.62 11.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -75.47 -49.08 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.028 1.541 . . . . 0.0 110.35 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 t -60.46 -54.22 48.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 110.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 76.3 t -58.33 -45.67 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.628 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 27.3 t90 -51.56 -66.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.64 -34.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.735 . . . . 0.0 110.289 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 56.4 t80 -64.05 -62.29 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.975 HD22 HG22 ' A' ' 30' ' ' VAL . 1.4 tt -52.36 -26.22 11.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.56 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.8 t -69.94 -50.55 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.731 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.08 -26.62 50.31 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.219 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 24' ' ' LEU . 9.1 tp -73.91 -50.59 19.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.518 -0.739 . . . . 0.0 110.669 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.915 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.1 m -113.05 -44.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.462 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 129.2 169.0 12.48 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.57 -26.74 66.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.901 -1.353 . . . . 0.0 110.479 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 -54.97 14.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.915 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -64.05 -40.76 97.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.87 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.975 HG22 HD22 ' A' ' 21' ' ' LEU . 54.7 t -68.29 -25.26 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 110.181 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.2 m -86.67 -22.41 26.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.2 -19.59 26.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -86.46 17.11 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.22 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.45 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 60.8 t-20 55.4 67.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 110.603 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.774 HD13 HD13 ' A' ' 21' ' ' LEU . 65.2 mt -120.35 110.06 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -91.77 152.83 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.661 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.628 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 1.4 mtp180 -94.76 157.18 16.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 109.691 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -132.03 163.58 28.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.432 ' C ' ' OG ' ' A' ' 40' ' ' SER . 84.1 p -53.33 -31.91 46.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.44 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.432 ' OG ' ' C ' ' A' ' 39' ' ' SER . 2.1 m -164.74 -179.8 6.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.68 -23.42 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.082 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.9 t30 -87.7 110.42 20.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.738 ' CD2' ' O ' ' A' ' 12' ' ' THR . 5.0 p-80 -150.12 177.85 9.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.584 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 5.2 p -81.49 130.41 35.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.46 -0.775 . . . . 0.0 109.62 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 p -121.97 173.85 7.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 0.0 110.424 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . . . 48.37 40.24 14.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.124 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 -149.25 49.23 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -87.21 23.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.138 -1.213 . . . . 0.0 109.864 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -100.84 -34.62 9.74 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 0.0 111.051 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.494 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.37 166.57 14.92 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.987 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.59 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.4 m95 -140.99 171.07 14.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -1.07 . . . . 0.0 109.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 4.4 t -106.07 108.79 20.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.59 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -130.41 157.45 42.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.211 -0.93 . . . . 0.0 109.938 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -63.93 -52.75 58.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.965 . . . . 0.0 109.021 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.4 tttt -128.75 174.66 9.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.503 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 58.2 m -150.34 170.08 19.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.867 -1.145 . . . . 0.0 110.747 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 15.7 m-85 -81.97 -176.06 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.476 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -80.37 -46.95 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.25 -0.906 . . . . 0.0 110.646 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' ARG . 1.5 t-80 -46.46 -23.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 109.153 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mt-10 -118.67 175.35 5.77 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.456 -0.777 . . . . 0.0 109.445 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.8 p90 -139.94 -167.26 2.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.543 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 74' ' ' PHE . 49.8 t -110.96 89.45 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.636 -0.665 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 16.8 t0 -40.6 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.49 -0.756 . . . . 0.0 110.42 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.25 -24.93 30.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.566 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 7' ' ' ILE . 18.6 t80 -68.74 -51.99 35.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.526 -0.734 . . . . 0.0 110.714 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.645 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 9.1 m-85 -81.58 -4.98 57.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.161 -0.962 . . . . 0.0 111.414 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.7 p -49.6 -21.5 1.02 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.057 -1.027 . . . . 0.0 109.979 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -66.09 -69.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 110.602 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.962 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -49.07 -26.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.056 . . . . 0.0 109.476 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -68.2 -44.29 76.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -124.32 6.5 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.58 74.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -1.209 . . . . 0.0 110.045 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 80.4 m-85 -81.22 -178.99 7.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.1 m-85 -125.36 138.92 54.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.32 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 16.4 t -81.85 101.06 9.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.145 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 76.9 m -79.49 175.0 11.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 9.2 mtp180 -160.52 179.8 8.29 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 110.054 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.2 85.5 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.782 0.325 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.47 160.46 44.45 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.09 1.574 . . . . 0.0 110.495 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 3' ' ' LEU . 1.1 mt -74.09 -177.39 2.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.175 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.939 HD11 HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -55.08 156.53 7.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 109.974 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.724 ' HB2' HG22 ' A' ' 7' ' ' ILE . 51.3 Cg_endo -77.26 169.64 20.97 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.154 1.607 . . . . 0.0 110.169 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB3' ' OH ' ' A' ' 65' ' ' TYR . . . -88.83 -23.6 22.78 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 110.164 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.914 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -53.41 -57.16 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 110.995 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.641 ' H ' HG23 ' A' ' 7' ' ' ILE . 23.2 m-30 -48.32 -25.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.018 -1.051 . . . . 0.0 110.169 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.0 mt -73.17 128.37 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 58.05 32.79 67.49 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.914 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -117.46 -159.21 0.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.515 -0.991 . . . . 0.0 110.601 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.802 ' H ' HG21 ' A' ' 69' ' ' VAL . 2.8 m -153.13 91.05 1.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 109.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.914 HG12 HG23 ' A' ' 69' ' ' VAL . 5.9 m -90.66 164.62 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 110.506 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -89.69 -158.02 33.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.8 Cg_endo -74.42 -42.78 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.912 1.48 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.486 ' HB2' ' OD1' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -63.81 -57.75 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 110.089 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.9 t -58.51 -49.67 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.73 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.569 ' CH2' HG12 ' A' ' 30' ' ' VAL . 56.4 t-105 -46.52 -66.4 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.705 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.44 -38.11 1.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.485 -0.759 . . . . 0.0 110.33 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 6.4 t80 -63.36 -64.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.939 HD21 HD11 ' A' ' 4' ' ' ILE . 1.8 tt -46.68 -51.28 16.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.325 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 HG21 ' A' ' 30' ' ' VAL . 78.3 t -48.77 -52.87 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.69 44.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.108 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD23 HG13 ' A' ' 4' ' ' ILE . 10.8 tp -59.76 -41.88 92.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.007 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -126.21 -86.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.834 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.7 170.03 38.06 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.07 66.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 110.607 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.58 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.045 -1.034 . . . . 0.0 109.838 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.95 -22.28 66.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.204 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.754 HG22 HD22 ' A' ' 21' ' ' LEU . 24.1 t -73.54 -35.72 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.466 -0.771 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 m -78.65 -34.27 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.967 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.17 -23.89 59.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.49 4.88 12.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 59.5 t-20 59.05 68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.446 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 30' ' ' VAL . 25.8 mt -117.57 109.95 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.6 mtt180 -83.45 143.71 30.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.55 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.06 150.88 23.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.789 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.73 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -124.85 162.14 24.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.54 -26.33 20.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.311 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 2.5 m -170.44 -170.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 16' ' ' SER . 15.2 m-20 -62.5 -13.9 35.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.902 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.5 m-20 -99.61 102.82 14.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.795 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -141.47 175.38 9.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.414 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.594 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.3 p -79.17 129.59 34.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p -122.32 176.74 5.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.421 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.68 37.83 7.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.3 -148.62 45.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 14.8 p30 -87.84 26.64 1.29 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.168 -1.195 . . . . 0.0 109.912 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -105.63 -29.23 10.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.23 21.1 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.391 -1.385 . . . . 0.0 109.893 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.594 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 6.7 m95 -137.67 170.9 15.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.46 -1.023 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -105.75 115.89 31.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.667 -1.27 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -133.39 155.22 49.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.78 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -55.56 -56.97 14.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.891 -1.131 . . . . 0.0 108.754 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.79 -165.15 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 1.2 m -163.64 173.38 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.728 -1.233 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.51 -179.3 6.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.501 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -40.31 20.31 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.163 -0.961 . . . . 0.0 110.359 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.63 -16.88 4.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.54 178.19 4.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.477 -0.765 . . . . 0.0 109.539 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 4.4 p90 -144.39 -164.66 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.8 t -126.01 98.31 4.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -48.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.47 -26.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.67 . . . . 0.0 110.47 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.501 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 12.2 t80 -68.77 -52.47 30.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -81.21 -10.18 59.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 111.005 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -49.35 -22.85 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.05 -1.031 . . . . 0.0 109.357 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.665 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -66.92 -69.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.914 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -45.7 -30.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 109.624 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.51 -53.99 50.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.09 -139.39 14.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -50.49 -23.17 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -1.108 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.467 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 12.2 m-85 -94.27 -170.54 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 37.0 m-85 -129.32 133.47 47.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 109.732 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 7.5 t -79.98 101.94 8.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 109.212 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.7 m -78.7 167.21 21.54 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.875 -1.141 . . . . 0.0 110.376 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 2.4 mtp180 -160.87 167.44 26.67 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.91 102.46 13.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.204 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.66 152.75 48.34 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.106 1.582 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER 56.0 -179.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.561 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -67.25 150.51 97.85 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.662 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 47.7 Cg_endo -73.31 170.02 20.87 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.164 1.613 . . . . 0.0 109.932 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -87.18 -44.71 11.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.442 -0.786 . . . . 0.0 110.238 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.774 HD11 ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -51.46 -41.86 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.286 -0.884 . . . . 0.0 110.483 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.951 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 28.3 m-85 -60.57 -33.73 73.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.179 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 6' ' ' ALA . 51.2 mt -71.97 138.5 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.118 -0.989 . . . . 0.0 109.514 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.96 33.95 81.11 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -127.48 -162.25 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.519 -0.989 . . . . 0.0 110.543 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.79 ' H ' HG21 ' A' ' 69' ' ' VAL . 2.3 m -151.15 98.43 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.237 -0.914 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.902 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -93.22 -175.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 13' ' ' VAL . . . -93.12 -164.56 37.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -72.62 -41.9 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.966 1.509 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -67.67 -47.34 69.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 47.6 t -62.64 -37.94 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.561 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 13.3 t90 -57.33 -58.9 6.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -50.45 -39.41 47.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 3.9 t80 -57.72 -65.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.058 HD22 HG22 ' A' ' 30' ' ' VAL . 4.1 tt -41.98 -44.38 3.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.506 -0.747 . . . . 0.0 109.987 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG22 HG21 ' A' ' 30' ' ' VAL . 71.7 t -55.27 -48.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.28 76.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -59.57 -41.12 89.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.94 -88.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.405 -0.81 . . . . 0.0 110.199 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.838 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.76 163.92 29.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.41 -20.59 56.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.603 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.24 1.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.094 -1.004 . . . . 0.0 109.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.03 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.93 -22.0 66.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.058 HG22 HD22 ' A' ' 21' ' ' LEU . 26.0 t -71.39 -33.58 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.8 m -86.25 -26.71 24.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.84 -18.87 49.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.892 . . . . 0.0 109.782 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.65 23.32 2.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 62.5 t-20 43.36 71.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 21' ' ' LEU . 65.2 mt -121.59 112.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -95.71 148.88 22.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.681 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.561 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm-85 -89.69 159.12 17.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 110.005 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -42.82 -26.73 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.908 . . . . 0.0 110.08 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' ALA . 3.2 m -174.43 -171.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 110.073 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 72' ' ' ARG . 70.6 m-20 -57.51 -17.24 12.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 12.9 t30 -91.25 108.64 20.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.327 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.742 ' CD2' ' O ' ' A' ' 12' ' ' THR . 8.5 p-80 -151.65 179.72 8.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.208 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -81.09 148.04 29.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.864 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 7.8 p -141.28 -178.47 5.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.913 ' HB1' ' NH2' ' A' ' 77' ' ' ARG . . . 47.42 42.7 14.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 -154.88 48.54 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.424 -1.87 . . . . 0.0 108.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -84.05 42.91 0.9 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.112 -1.228 . . . . 0.0 109.665 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -119.31 -35.33 3.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.2 -0.938 . . . . 0.0 111.252 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -127.11 171.21 18.72 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.319 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 17.5 m95 -138.63 179.13 6.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.983 . . . . 0.0 109.405 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.447 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.0 t -112.59 118.5 35.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.812 -1.18 . . . . 0.0 110.769 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -130.47 158.3 40.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.663 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -53.39 -47.84 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.049 -1.032 . . . . 0.0 109.146 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 140.93 44.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 62' ' ' VAL . 15.5 m -77.48 159.38 29.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 110.097 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -80.59 -171.43 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.418 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -43.23 39.3 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.12 3.85 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 9.3 mt-10 -129.35 162.74 27.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 0.0 109.958 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 24.3 p90 -129.36 -178.83 4.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.625 HG22 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -91.42 92.84 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.332 0.587 . . . . 0.0 109.474 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 1.5 m-20 -51.52 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.694 . . . . 0.0 109.782 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -51.7 -22.65 3.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 0.0 110.683 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -70.02 -56.93 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 111.043 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.774 ' CD1' HD11 ' A' ' 7' ' ' ILE . 4.0 m-85 -86.06 -3.47 58.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 111.374 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.57 -23.03 1.45 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.951 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.33 -71.97 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.656 -0.653 . . . . 0.0 110.757 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.902 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.24 -27.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 1.0 OUTLIER -63.5 -63.35 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.265 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.15 -112.29 4.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HG3' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mtt180 -62.66 -50.2 72.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -1.162 . . . . 0.0 110.093 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 20.2 m-85 -79.89 -173.05 3.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.951 . . . . 0.0 110.006 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' HG13 ' A' ' 62' ' ' VAL . 29.2 m-85 -126.56 139.23 53.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.799 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 t -79.6 107.3 12.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 0.0 108.735 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 10.3 m -97.45 157.57 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.793 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.913 ' NH2' ' HB1' ' A' ' 46' ' ' ALA . 8.5 mtp180 -142.63 -175.36 4.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.724 -0.61 . . . . 0.0 109.801 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.8 p -110.6 94.88 5.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.26 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.815 0.341 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.614 ' HG2' HD21 ' A' ' 24' ' ' LEU . 46.5 Cg_endo -73.26 109.38 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.971 1.511 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.865 HD13 ' N ' ' A' ' 4' ' ' ILE . 2.6 tm? -42.83 136.41 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.245 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.865 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -42.67 142.14 1.42 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 0.0 110.116 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 8' ' ' TYR . 45.3 Cg_endo -76.05 162.47 34.37 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.056 1.556 . . . . 0.0 110.027 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.469 ' CB ' ' OH ' ' A' ' 65' ' ' TYR . . . -61.67 -43.34 99.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.016 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.973 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -50.39 -54.24 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.62 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.617 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 8.8 m-30 -51.57 -31.03 23.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.972 . . . . 0.0 110.369 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 58.3 mt -71.95 129.41 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 60.14 31.66 73.79 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.973 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -114.55 -162.47 0.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -1.028 . . . . 0.0 110.668 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.706 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.8 m -154.68 97.89 2.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 109.758 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.098 HG12 HG23 ' A' ' 69' ' ' VAL . 3.5 m -93.77 172.78 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.099 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -85.82 -159.59 32.35 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 48.9 Cg_endo -74.74 -46.58 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.015 1.534 . . . . 0.0 110.5 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -67.65 -50.43 57.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.0 t -57.22 -45.78 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.992 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 11.3 t90 -52.17 -61.45 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.623 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.89 -37.97 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.424 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.4 t80 -60.29 -53.75 53.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.985 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD21 HD11 ' A' ' 4' ' ' ILE . 1.6 tt -57.63 -55.57 33.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.11 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.4 t -44.01 -61.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.065 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.19 -41.26 17.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.614 HD21 ' HG2' ' A' ' 2' ' ' PRO . 11.0 tp -59.95 -41.44 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.095 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -126.4 -88.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.839 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.05 166.18 33.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.94 -19.25 60.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.13 . . . . 0.0 110.699 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.17 -64.25 1.01 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.019 -1.051 . . . . 0.0 109.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.095 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.52 -21.74 65.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.214 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.654 HG22 HD22 ' A' ' 21' ' ' LEU . 24.5 t -73.65 -34.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.454 -0.778 . . . . 0.0 109.714 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.0 m -87.8 -19.64 27.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 109.899 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.21 -22.1 28.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.837 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -89.01 23.51 2.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.88 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.442 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 37.8 t-20 42.54 76.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 110.355 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.619 HD13 HD13 ' A' ' 21' ' ' LEU . 19.4 mt -123.6 110.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 109.701 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -93.22 144.44 25.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.907 . . . . 0.0 110.589 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 2.7 mtm180 -82.93 166.0 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 0.0 109.708 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.742 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -139.05 161.87 36.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.01 . . . . 0.0 110.266 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -51.19 -36.48 41.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.296 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 16.5 m -164.72 -179.07 5.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 38.6 m-20 -46.63 -30.89 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 17.2 t-20 -84.96 110.56 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.862 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.7 p80 -147.27 175.91 10.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.073 -1.017 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.594 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 17.9 p -78.23 127.54 32.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.426 -0.797 . . . . 0.0 109.749 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 p -120.49 168.43 11.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.006 -1.059 . . . . 0.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 53.22 50.0 18.66 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.551 -0.718 . . . . 0.0 109.303 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.17 -149.94 25.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -86.18 36.49 0.68 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.171 -1.193 . . . . 0.0 110.065 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HB3' ' NH1' ' A' ' 77' ' ' ARG . 3.5 mtt180 -113.57 -33.13 5.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -127.28 168.03 19.51 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.0 m95 -142.22 170.79 15.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -117.73 113.68 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.777 -1.202 . . . . 0.0 110.684 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -132.7 163.56 28.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.353 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.445 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 24.8 p -50.57 -48.17 57.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.897 -1.127 . . . . 0.0 108.508 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -127.74 179.83 5.33 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.641 0.734 . . . . 0.0 110.562 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.782 ' SG ' HG22 ' A' ' 62' ' ' VAL . 20.9 m -121.63 168.99 11.14 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.037 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -79.82 -173.62 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.5 -36.82 21.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.245 -0.909 . . . . 0.0 110.25 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -78.98 5.22 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 46.6 mt-10 -128.83 -175.68 3.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 7.5 p90 -141.12 -162.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 109.833 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.782 HG22 ' SG ' ' A' ' 56' ' ' CYS . 53.2 t -111.69 89.08 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.122 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 14.2 t0 -41.64 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 0.0 110.213 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -57.84 -27.1 62.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.207 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.469 ' OH ' ' CB ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -68.6 -49.51 58.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 110.605 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.4 m-85 -83.76 -9.28 58.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.945 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -22.57 1.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.039 -1.038 . . . . 0.0 109.537 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.96 -70.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 110.303 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.098 HG23 HG12 ' A' ' 13' ' ' VAL . 10.6 p -45.74 -25.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.998 -1.064 . . . . 0.0 109.341 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -67.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.781 . . . . 0.0 110.048 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.4 -96.13 2.0 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -56.77 7.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.422 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 24.6 m-85 -89.27 -168.99 2.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.091 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.496 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.3 m-85 -123.34 149.64 44.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.84 . . . . 0.0 109.73 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 15.7 t -86.03 100.88 12.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 0.0 109.765 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.2 m -79.34 163.56 24.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 3.4 mtp180 -153.95 176.88 11.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 t -104.67 94.37 5.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.171 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.155 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 6.9 m120 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.802 0.334 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 1' ' ' ASN . 45.5 Cg_endo -72.6 124.87 10.13 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.016 1.535 . . . . 0.0 110.46 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -134.78 160.79 37.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.605 HG13 HD21 ' A' ' 21' ' ' LEU . 1.2 mm -43.03 148.55 0.58 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.8 Cg_endo -75.09 166.73 28.48 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.01 1.531 . . . . 0.0 109.937 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -84.68 -16.74 40.82 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.421 -0.799 . . . . 0.0 110.287 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.842 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -55.91 -47.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -0.869 . . . . 0.0 110.737 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.604 ' CZ ' ' HB1' ' A' ' 68' ' ' ALA . 22.8 m-85 -52.37 -24.42 7.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.476 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 70.2 mt -60.37 136.51 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.715 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 46.31 34.92 6.58 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.15 -167.48 1.2 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.509 -0.994 . . . . 0.0 110.671 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.825 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.7 m -150.06 88.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.0 m -83.16 -165.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.35 -163.46 17.8 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -73.11 -45.45 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -67.59 -49.14 64.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.099 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 91.1 t -58.91 -48.0 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.606 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 7.8 t-105 -50.81 -59.35 4.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.732 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.46 -39.67 7.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.095 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 68.1 t80 -63.62 -63.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.335 -0.853 . . . . 0.0 110.145 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 HG13 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -42.37 -54.44 3.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.211 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG22 HG21 ' A' ' 30' ' ' VAL . 75.1 t -48.02 -50.2 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.11 -43.46 61.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 110.161 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 4' ' ' ILE . 6.3 tp -66.14 -36.12 82.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.092 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.04 -88.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.812 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 171.59 167.72 32.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.59 62.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -1.171 . . . . 0.0 110.524 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -63.66 1.1 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.053 -1.03 . . . . 0.0 109.914 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.092 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.19 -22.46 65.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.909 . . . . 0.0 109.297 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 26' ' ' GLY . 34.7 t -73.61 -31.46 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.486 -0.759 . . . . 0.0 109.979 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -87.83 -26.83 22.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.225 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -25.38 43.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -83.64 6.59 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 110.353 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 46.8 t-20 58.32 79.3 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -0.92 . . . . 0.0 110.619 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 40.0 mt -118.84 136.97 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -110.18 151.2 27.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 110.575 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.5 OUTLIER -100.95 143.05 31.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.0 109.887 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.88 152.2 37.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.406 ' C ' ' OG ' ' A' ' 40' ' ' SER . 9.6 m -42.39 -27.08 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -163.4 -176.02 4.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.196 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.5 -12.21 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.34 103.44 15.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.847 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.1 p80 -142.62 -178.56 5.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.615 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -92.92 147.22 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.802 . . . . 0.0 110.002 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.0 p -137.26 178.59 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 110.313 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 46.97 46.55 15.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.884 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.22 -153.11 48.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.66 42.88 0.94 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.054 -1.262 . . . . 0.0 109.604 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.4 mmm180 -109.44 -39.0 5.32 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 111.21 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.21 164.12 18.91 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.761 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.615 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.3 m95 -134.76 167.75 20.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.066 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.71 117.52 34.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.77 -1.206 . . . . 0.0 111.272 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mtt-85 -129.24 153.05 48.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.208 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.16 -48.98 64.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.09 . . . . 0.0 109.257 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.2 tttt -138.44 177.5 7.83 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 16.3 m -149.96 169.98 19.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.823 -1.173 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -80.03 -175.02 4.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.404 -0.81 . . . . 0.0 110.562 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 -43.36 14.64 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.324 -0.86 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.51 -20.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.688 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.88 174.35 5.98 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 9.2 p90 -138.96 -165.1 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.95 -1.094 . . . . 0.0 110.376 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 64' ' ' THR . 16.6 t -124.95 103.63 12.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 75' ' ' CYS . 14.8 p30 -47.91 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.85 -25.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.414 -0.803 . . . . 0.0 110.505 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' ASP . 12.8 t80 -71.34 -48.05 52.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.781 ' CD2' HD11 ' A' ' 7' ' ' ILE . 40.7 m-85 -90.2 -4.1 57.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 111.292 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -22.97 2.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 108.587 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.604 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -71.67 -64.48 0.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.671 -0.643 . . . . 0.0 110.485 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.847 HG22 ' CE1' ' A' ' 43' ' ' HIS . 10.1 p -44.96 -30.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.997 -1.064 . . . . 0.0 109.552 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -66.3 -58.31 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.147 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.98 -121.7 7.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -63.73 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -1.214 . . . . 0.0 110.166 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.7 m-30 -87.73 -174.96 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.884 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 39.8 m-85 -128.31 126.82 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.969 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.71 97.33 6.53 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.881 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 65.2 m -79.71 169.13 18.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 110.959 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -160.41 170.57 20.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.0 109.898 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.6 m -97.93 103.43 15.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 5.5 tpt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.292 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.52 138.06 26.32 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.853 1.449 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 -163.08 0.94 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.535 HG13 HG11 ' A' ' 25' ' ' VAL . 1.5 mm -55.11 147.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.8 Cg_endo -75.66 164.46 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.077 1.567 . . . . 0.0 109.834 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -81.23 -24.11 37.61 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.842 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -51.33 -59.6 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.655 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.6 m-85 -45.97 -28.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 109.845 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.0 mt -69.55 131.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.482 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.46 32.15 57.68 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.02 -162.93 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.984 . . . . 0.0 110.517 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.812 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.7 m -153.82 99.02 2.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 0.0 110.099 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.719 HG12 HG23 ' A' ' 69' ' ' VAL . 2.8 m -89.96 -175.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.999 -1.063 . . . . 0.0 110.187 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -95.04 -160.94 34.01 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.1 Cg_endo -73.41 -47.87 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.963 1.507 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -48.0 73.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.53 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 15.9 t -58.98 -47.11 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.981 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.625 ' CE3' ' CD ' ' A' ' 37' ' ' ARG . 6.0 t90 -50.45 -60.76 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.56 -34.87 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.277 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 13.8 t80 -64.49 -66.07 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.899 HD22 HG22 ' A' ' 30' ' ' VAL . 1.1 tt -50.34 -24.97 3.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 26' ' ' GLY . 24.3 t -73.36 -42.36 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.792 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.81 69.88 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -77.93 -47.34 18.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.53 -0.732 . . . . 0.0 110.407 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.957 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.5 m -113.33 -42.78 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 110.448 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.567 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 120.36 170.06 14.15 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.13 69.46 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.915 -1.344 . . . . 0.0 110.427 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.16 -52.07 57.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.211 -0.931 . . . . 0.0 110.05 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.957 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -64.03 -44.6 92.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.899 HG22 HD22 ' A' ' 21' ' ' LEU . 74.2 t -62.66 -26.31 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.792 . . . . 0.0 110.231 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -83.85 -31.59 25.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.01 . . . . 0.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.23 -17.55 49.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.652 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -90.01 8.11 34.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 57.1 t-20 58.78 72.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.253 -0.905 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 33' ' ' ALA . 5.7 mt -126.2 113.78 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.829 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' THR . 25.1 mtm-85 -99.62 156.26 17.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.712 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.625 ' CD ' ' CE3' ' A' ' 18' ' ' TRP . 8.2 mtp180 -100.4 158.37 15.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.94 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -127.83 -174.6 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.317 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -60.67 -23.59 64.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.508 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.9 m -178.09 -169.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.3 m-20 -56.6 -24.08 45.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 110.091 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 31.0 t-20 -89.61 110.68 21.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.882 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.818 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.3 p80 -147.28 -176.03 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.107 -0.996 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.541 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -85.16 126.81 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 109.664 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.4 p -128.87 170.84 12.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 56.55 31.44 19.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.44 44.63 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 34.49 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.085 -1.244 . . . . 0.0 109.848 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.5 mmt85 -113.29 -36.14 5.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.396 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.17 160.08 23.26 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.419 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.541 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 19.5 m95 -131.47 175.29 9.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.598 -0.942 . . . . 0.0 108.646 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -118.9 116.54 26.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.724 -1.235 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -131.62 171.13 13.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.545 -0.722 . . . . 0.0 109.452 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -55.35 -47.62 75.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.054 -1.029 . . . . 0.0 109.228 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 7.4 tttt -135.03 177.05 8.11 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 62' ' ' VAL . 17.6 m -119.21 175.93 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.944 -1.097 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 65.1 m-85 -79.75 -176.42 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 110.239 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -39.79 22.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.131 -0.981 . . . . 0.0 110.5 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.592 ' CD2' ' HG3' ' A' ' 60' ' ' GLU . 31.8 p-80 -79.04 7.16 7.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 7.9 mt-10 -124.42 -170.46 2.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 3.3 p90 -152.43 -161.34 1.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' SG ' ' A' ' 56' ' ' CYS . 47.8 t -123.15 99.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 66' ' ' TYR . 46.0 p30 -52.11 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.892 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.72 -25.6 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -0.764 . . . . 0.0 110.982 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 63' ' ' ASP . 28.4 t80 -66.25 -53.13 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.055 -1.028 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 14.7 m-85 -83.16 -11.67 57.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 110.995 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -46.7 -24.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.21 -71.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 110.561 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.818 HG22 ' CE1' ' A' ' 43' ' ' HIS . 7.2 p -42.27 -28.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -64.2 -69.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.168 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.08 -119.94 6.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -27.18 68.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -1.169 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.1 m-85 -99.5 177.05 5.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.201 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 16.0 m-85 -121.02 138.01 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.958 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 41.1 t -79.51 100.59 7.8 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 108.837 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 9.4 m -79.35 160.84 26.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.17 . . . . 0.0 110.139 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.584 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -159.98 173.46 15.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.52 -0.737 . . . . 0.0 110.22 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 p -103.41 112.81 25.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 110.217 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.802 0.334 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.61 135.02 21.25 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.07 1.563 . . . . 0.0 110.521 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.99 -170.26 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.119 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.526 HD11 ' CD2' ' A' ' 21' ' ' LEU . 2.6 mm -45.23 145.54 1.8 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.6 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 Cg_endo -73.11 -159.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.17 1.616 . . . . 0.0 109.89 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -118.54 -22.07 7.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.88 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.89 ' CD1' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -55.7 -52.05 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 110.397 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.622 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.2 m-85 -46.22 -25.97 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.877 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.5 mt -61.28 126.85 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.186 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 58.0 32.94 67.53 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.18 -162.53 0.81 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.666 -0.902 . . . . 0.0 110.872 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.746 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 3.1 m -157.25 97.04 1.61 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.067 HG12 HG23 ' A' ' 69' ' ' VAL . 3.6 m -95.22 174.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.996 -1.065 . . . . 0.0 110.21 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.88 -163.09 37.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 48.2 Cg_endo -74.14 -51.53 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.046 1.551 . . . . 0.0 110.522 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -49.76 76.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 48.6 t -58.93 -47.6 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.722 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 9.9 t-105 -51.73 -58.13 7.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.802 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.36 -39.85 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.131 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.69 -58.13 9.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.84 HD22 HG22 ' A' ' 30' ' ' VAL . 1.5 tt -51.05 -34.12 28.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.121 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 24.4 t -63.65 -47.97 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.44 -40.71 68.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.753 . . . . 0.0 109.823 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.1 tp -63.3 -39.78 95.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.002 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -132.46 -88.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.002 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.822 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 172.52 166.37 30.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.9 -20.45 65.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 110.446 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -61.54 1.73 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.112 -0.992 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.002 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.05 -28.74 70.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.84 HG22 HD22 ' A' ' 21' ' ' LEU . 37.8 t -70.27 -30.99 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.4 -0.812 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.3 m -76.55 -36.0 57.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.4 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.37 4.63 12.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.288 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 42.2 t-20 57.9 74.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.722 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 49.1 mt -122.26 121.73 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.5 mtt85 -101.11 150.29 23.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.608 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.86 159.61 16.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 110.077 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -133.58 151.13 51.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -42.98 -26.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' ALA . 4.9 m -172.36 -173.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 110.007 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -17.31 15.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.224 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 12.3 t30 -89.25 98.12 11.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.469 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.746 ' CD2' ' O ' ' A' ' 12' ' ' THR . 8.0 p-80 -142.49 176.53 8.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 110.53 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.588 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.6 p -81.82 130.48 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.783 . . . . 0.0 109.847 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.91 174.64 6.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 48.69 46.31 21.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 109.084 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.09 -151.99 41.15 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.4 40.46 0.84 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -1.208 . . . . 0.0 109.752 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 10.4 mtp180 -112.46 -38.64 4.6 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.985 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -126.1 168.98 18.09 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.133 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.588 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -136.13 172.19 13.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -1.028 . . . . 0.0 109.861 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.4 t -104.41 112.37 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.76 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 7.2 mtt-85 -127.96 142.46 51.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.858 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.44 ' N ' ' CD2' ' A' ' 73' ' ' TYR . 2.1 p -51.89 -46.39 64.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.011 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -137.16 175.67 9.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 11.8 m -153.65 170.69 20.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.891 -1.131 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -79.74 177.57 8.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -79.61 -42.68 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -22.19 0.72 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.304 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.77 -175.69 2.73 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.51 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 3.1 p90 -147.38 -164.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 34.6 t -128.54 98.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -50.15 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.826 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.05 -26.7 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.579 -0.7 . . . . 0.0 110.26 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 7' ' ' ILE . 14.8 t80 -65.6 -49.79 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.63 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.4 m-85 -86.56 -3.09 58.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 111.562 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -17.28 6.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.016 -1.053 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.89 ' HB3' ' CD1' ' A' ' 7' ' ' ILE . . . -70.87 -56.67 5.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.95 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.067 HG23 HG12 ' A' ' 13' ' ' VAL . 7.9 p -61.11 -27.79 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.969 -1.082 . . . . 0.0 109.469 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -64.57 -49.05 72.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 -137.2 14.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -48.67 -31.56 6.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 109.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 54' ' ' SER . 8.6 m-85 -87.95 -177.83 5.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.006 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.547 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 46.8 m-85 -125.81 136.6 53.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 10.7 t -79.47 97.72 6.52 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.034 -1.041 . . . . 0.0 108.755 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 74.1 m -79.01 166.43 22.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.03 -1.044 . . . . 0.0 110.501 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.51 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 17.5 mtp180 -161.19 176.16 11.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.323 0.582 . . . . 0.0 109.83 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 78' ' ' SER . 11.5 p -108.08 104.53 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.505 -0.747 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.2 -179.812 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.35 161.07 45.41 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.51 . . . . 0.0 110.419 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -164.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.665 HG12 HD23 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -65.8 151.6 94.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.136 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.587 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.0 Cg_endo -74.86 164.73 32.92 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.144 1.602 . . . . 0.0 110.255 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.93 -23.27 28.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.443 -0.786 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.848 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -60.01 -38.23 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.687 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.511 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 9.7 m-30 -64.05 -18.79 64.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 9.4 mt -81.05 124.12 38.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.162 -0.961 . . . . 0.0 109.016 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 68.56 31.82 74.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -119.62 -163.08 0.96 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.468 -1.019 . . . . 0.0 110.752 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.728 ' H ' HG21 ' A' ' 69' ' ' VAL . 11.3 m -155.29 95.37 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.005 HG12 HG23 ' A' ' 69' ' ' VAL . 4.3 m -90.18 171.5 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -83.77 -161.18 31.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.7 Cg_endo -74.26 -45.07 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.911 1.479 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.1 m -66.75 -55.49 14.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.537 HG23 ' OD1' ' A' ' 41' ' ' ASP . 84.1 t -56.09 -45.56 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.814 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 22.8 t-105 -51.16 -62.99 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.19 -38.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.143 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.426 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.9 t80 -63.68 -60.21 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.106 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.807 HD13 HD13 ' A' ' 35' ' ' ILE . 1.2 tt -47.89 -55.37 9.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.625 ' HA ' HG21 ' A' ' 30' ' ' VAL . 41.3 t -44.15 -56.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.78 -42.74 47.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.665 HD23 HG12 ' A' ' 4' ' ' ILE . 11.4 tp -53.29 -42.94 67.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 109.988 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.099 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -127.99 -86.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 109.936 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.842 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.33 166.1 33.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -61.22 -19.93 62.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -1.145 . . . . 0.0 110.449 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -63.4 1.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.099 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.8 -20.17 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.649 HG22 HD22 ' A' ' 21' ' ' LEU . 29.6 t -77.85 -33.6 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.477 -0.764 . . . . 0.0 109.892 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -80.89 -33.16 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.52 -23.49 46.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.28 4.88 11.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 59.4 t-20 60.78 63.98 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.654 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.814 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 54.8 mt -113.78 128.39 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.368 -0.832 . . . . 0.0 109.481 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -110.25 145.27 37.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 110.488 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.598 ' HG3' ' CD2' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -90.31 154.38 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 109.761 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -129.54 171.0 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.253 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' HG ' ' A' ' 40' ' ' SER . 1.9 t -58.76 -33.3 70.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.533 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -159.92 178.94 9.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.567 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 41.6 m-20 -52.33 -33.31 42.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 15.2 t-20 -82.71 99.81 9.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.89 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.7 p80 -136.25 177.01 8.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.409 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -75.25 141.66 43.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.977 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 10.9 p -131.79 178.78 6.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 44.16 44.88 6.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.229 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.03 -156.75 51.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' ASN . 22.9 t30 -84.33 41.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.963 -1.316 . . . . 0.0 109.959 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.35 -33.36 3.89 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.149 -0.969 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.533 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -121.19 173.84 15.68 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.831 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 16.5 m95 -150.73 161.35 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.424 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 86.4 m -96.5 104.57 16.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.12 . . . . 0.0 109.971 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 6.0 mtt180 -120.23 151.5 39.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 109.976 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.493 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -57.56 -52.84 63.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 109.122 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.38 172.98 10.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.029 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 94.6 m -149.5 168.09 24.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.785 -1.197 . . . . 0.0 110.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -79.91 176.22 9.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.731 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -75.34 -44.5 44.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -48.01 -21.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -118.3 174.29 6.32 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.417 -0.802 . . . . 0.0 109.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 11.2 p90 -134.4 -167.65 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.975 . . . . 0.0 110.227 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.797 HG13 ' HB3' ' A' ' 74' ' ' PHE . 17.9 t -113.97 89.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.73 . . . . 0.0 109.981 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.1 t0 -39.82 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.363 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -52.91 -23.34 6.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 110.591 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.08 -44.01 55.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.733 ' CD1' HD11 ' A' ' 7' ' ' ILE . 20.3 m-85 -89.83 -9.93 47.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 111.622 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -22.17 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.787 -1.196 . . . . 0.0 109.049 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -68.91 -52.62 27.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.488 -0.757 . . . . 0.0 110.645 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.005 HG23 HG12 ' A' ' 13' ' ' VAL . 9.7 p -60.0 -34.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.887 -1.133 . . . . 0.0 110.32 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 75' ' ' CYS . 61.6 m -60.4 -51.68 68.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.955 -1.091 . . . . 0.0 109.682 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.93 -102.78 2.91 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HD2' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -76.57 -5.27 46.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -1.151 . . . . 0.0 109.881 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.65 178.09 4.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.797 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.1 m-85 -120.5 137.85 54.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 109.755 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 11.3 t -79.69 94.29 5.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.967 -1.083 . . . . 0.0 109.352 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.5 m -77.78 170.75 16.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.003 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.9 mtp180 -160.27 -177.5 6.3 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.244 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 m -110.19 91.15 3.54 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.192 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 10.3 tpt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.532 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 5.0 m-20 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 1' ' ' ASN . 46.2 Cg_endo -72.17 160.33 47.57 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.858 1.452 . . . . 0.0 110.466 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER 55.89 160.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 110.364 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 21' ' ' LEU . 2.6 mm -56.81 144.12 67.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.642 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 50.4 Cg_endo -72.86 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.243 1.654 . . . . 0.0 109.835 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.29 -41.33 3.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.627 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.766 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -57.64 -38.19 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.451 -0.781 . . . . 0.0 110.443 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.925 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 45.2 m-85 -62.71 -25.04 67.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.282 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 61.3 mt -73.4 143.72 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.637 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 49.51 36.58 24.4 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.23 -164.32 1.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.523 -0.986 . . . . 0.0 110.549 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.848 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.2 m -152.1 91.77 1.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.032 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.869 HG12 HG23 ' A' ' 69' ' ' VAL . 2.7 m -89.14 162.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.111 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.65 -166.68 9.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.1 Cg_endo -73.37 -39.41 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.999 1.526 . . . . 0.0 110.448 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -51.25 43.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.38 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 48.0 t -57.62 -46.5 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.742 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 35.2 t-105 -49.8 -61.14 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.45 -44.3 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.283 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -58.12 -66.81 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.849 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.992 HD22 HG22 ' A' ' 30' ' ' VAL . 5.7 tt -40.52 -56.19 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 110.12 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 21' ' ' LEU . 47.2 t -42.44 -55.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.878 . . . . 0.0 110.061 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.18 -44.85 33.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 24' ' ' LEU . 12.9 tp -57.27 -49.94 74.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.15 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.973 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -117.02 -88.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.821 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.82 165.71 32.16 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.73 -20.13 63.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -1.129 . . . . 0.0 110.54 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.13 -63.29 1.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.149 -0.969 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.973 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.91 -19.14 62.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.223 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.992 HG22 HD22 ' A' ' 21' ' ' LEU . 10.9 t -75.09 -39.83 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.48 -0.762 . . . . 0.0 109.743 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.5 m -77.8 -28.8 50.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.4 -24.22 42.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -80.0 5.55 13.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.637 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 42.3 t30 58.79 69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.742 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 11.0 mt -119.3 135.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mtp180 -115.42 149.84 37.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 10.8 mtp85 -98.46 143.96 28.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 109.839 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -115.57 164.11 14.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.8 p -48.35 -27.79 2.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.4 m -165.01 -168.32 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -64.32 -22.14 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.296 -0.877 . . . . 0.0 110.166 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t-20 -88.58 110.54 20.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.737 ' CD2' ' O ' ' A' ' 12' ' ' THR . 8.5 p-80 -148.72 175.92 10.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.4 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.619 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -79.99 139.07 37.15 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -130.47 176.93 7.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 110.439 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.36 39.45 12.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.76 -151.98 46.86 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -87.44 24.17 1.72 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.171 -1.193 . . . . 0.0 109.972 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -105.65 -28.83 10.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 110.797 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.39 164.53 15.39 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.002 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.619 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 9.3 m95 -142.52 174.41 10.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.44 -1.035 . . . . 0.0 109.701 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.615 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.6 t -109.23 113.16 25.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 2.3 mtt180 -133.43 143.99 49.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -46.61 -39.31 10.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.971 -1.081 . . . . 0.0 108.766 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 4.7 tttt -135.86 171.1 14.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.779 ' SG ' HG22 ' A' ' 62' ' ' VAL . 6.3 m -119.73 177.06 5.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.18 -169.16 2.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -84.45 -42.46 15.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.422 -0.799 . . . . 0.0 110.215 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -72.2 -1.2 14.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 17.9 mt-10 -126.65 -179.92 5.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.917 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.55 ' CD1' ' HB2' ' A' ' 79' ' ' ARG . 8.1 p90 -139.74 -162.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.07 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.779 HG22 ' SG ' ' A' ' 56' ' ' CYS . 47.8 t -110.87 88.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.1 t0 -40.71 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.581 -0.699 . . . . 0.0 110.25 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 4.3 p -57.69 -34.64 69.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.378 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -63.54 -46.38 86.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.695 ' CD1' HD11 ' A' ' 7' ' ' ILE . 18.1 m-85 -86.57 -6.88 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 111.059 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -50.33 -22.29 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.951 -1.093 . . . . 0.0 109.064 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -67.59 -71.59 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.549 -0.72 . . . . 0.0 110.579 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.869 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.75 -29.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.01 -65.76 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 110.354 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.96 -115.81 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -61.6 -49.98 74.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -1.203 . . . . 0.0 109.915 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.475 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.6 m-85 -80.0 -177.22 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.668 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.7 m-85 -121.3 142.27 50.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.483 -0.76 . . . . 0.0 109.096 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.5 t -79.59 100.88 8.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.429 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 33.3 m -78.94 165.87 23.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.536 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -157.13 176.67 12.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.85 . . . . 0.0 110.344 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.43 96.59 6.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.204 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.775 0.322 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.25 118.42 5.52 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.998 1.525 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -175.96 2.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 110.148 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CD1' HD21 ' A' ' 21' ' ' LEU . 1.9 mt -74.89 144.47 79.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.62 ' HB2' HG22 ' A' ' 7' ' ' ILE . 48.6 Cg_endo -79.5 165.44 22.97 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.142 1.601 . . . . 0.0 109.859 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.16 -36.75 34.65 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -50.7 -47.88 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 110.717 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.646 ' O ' HD13 ' A' ' 35' ' ' ILE . 7.8 m-30 -50.68 -34.93 28.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 110.301 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 43.4 mt -69.9 115.6 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.88 28.61 58.59 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.923 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -115.94 -162.65 0.85 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.967 . . . . 0.0 110.71 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.752 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.0 m -153.35 93.78 1.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.044 HG12 HG23 ' A' ' 69' ' ' VAL . 3.9 m -93.41 169.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 110.201 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -79.43 -154.95 9.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 49.1 Cg_endo -76.8 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.007 1.53 . . . . 0.0 110.441 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 t -53.21 -50.89 63.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.47 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 21.9 t -59.91 -46.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.118 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.624 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 11.3 t90 -49.47 -65.5 0.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.517 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.02 -41.55 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.395 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 36.6 t80 -59.33 -62.45 1.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.924 . . . . 0.0 109.87 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.958 HD22 HG22 ' A' ' 30' ' ' VAL . 1.7 tt -43.92 -52.73 6.68 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.393 -0.817 . . . . 0.0 109.811 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' HG21 ' A' ' 30' ' ' VAL . 40.5 t -52.4 -42.67 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.786 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 20' ' ' TYR . . . -50.86 -45.11 59.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.342 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD23 HG13 ' A' ' 4' ' ' ILE . 4.6 tp -71.86 -27.38 62.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.488 -0.757 . . . . 0.0 109.673 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -124.18 -91.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.682 . . . . 0.0 110.293 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' H ' HG23 ' A' ' 25' ' ' VAL . . . 167.26 -170.57 41.61 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 -52.65 9.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.32 . . . . 0.0 110.306 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.56 74.16 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.943 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . . . -69.45 -49.93 50.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 109.782 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.958 HG22 HD22 ' A' ' 21' ' ' LEU . 25.0 t -62.88 -21.77 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.2 m -79.78 -40.62 28.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.139 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.08 -17.21 60.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.19 25.05 2.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.9 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.448 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 46.0 t-20 41.87 67.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 8' ' ' TYR . 16.2 mm -110.21 112.5 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.659 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 12' ' ' THR . 5.3 mtt180 -97.6 139.47 33.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.893 . . . . 0.0 110.295 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.624 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -89.52 155.69 19.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -133.73 157.98 44.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.04 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -45.1 -33.27 2.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.545 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -166.92 -156.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 110.262 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD2' ' HD3' ' A' ' 72' ' ' ARG . 59.6 m-20 -71.73 -5.86 37.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.507 -0.746 . . . . 0.0 110.044 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 2.3 t30 -102.57 102.57 12.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.749 ' CD2' ' O ' ' A' ' 12' ' ' THR . 5.2 p-80 -146.03 -175.46 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.454 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.1 p -86.95 129.49 34.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.443 -0.785 . . . . 0.0 109.568 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.45 177.63 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.426 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 48.03 45.35 19.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 -156.01 52.79 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 19.7 p30 -86.24 34.94 0.63 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.013 -1.286 . . . . 0.0 110.009 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -115.9 -30.6 6.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.131 -0.98 . . . . 0.0 110.788 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -117.92 163.74 12.82 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.483 -1.342 . . . . 0.0 109.773 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 7.5 m95 -140.23 177.06 8.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.0 109.367 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 6.2 t -114.55 115.07 26.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 110.928 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -131.91 159.28 39.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 55' ' ' LYS . 5.9 p -57.89 -52.67 64.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.988 -1.07 . . . . 0.0 108.965 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' N ' ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -140.69 139.69 34.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -105.05 163.6 12.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.235 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.63 -164.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' HIS . 8.9 ttp180 -80.64 -43.74 19.99 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.445 ' C ' ' HG2' ' A' ' 60' ' ' GLU . 1.3 m-70 -45.78 -24.49 0.38 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.8 mm-40 -125.91 179.56 5.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.385 -0.822 . . . . 0.0 110.023 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.0 p90 -137.86 -163.11 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.594 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' A' ' 74' ' ' PHE . 25.4 t -113.77 87.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 109.927 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.3 t0 -38.26 90.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.694 -0.629 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.98 -25.34 43.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.545 ' O ' HD12 ' A' ' 7' ' ' ILE . 8.4 t80 -70.8 -51.32 27.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.63 ' O ' HG12 ' A' ' 69' ' ' VAL . 10.9 m-85 -81.44 -6.45 58.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 111.23 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -18.93 2.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.042 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.11 -47.02 63.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.9 . . . . 0.0 110.988 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.044 HG23 HG12 ' A' ' 13' ' ' VAL . 7.9 p -71.54 -24.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.501 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -66.99 -57.33 7.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.452 -0.78 . . . . 0.0 110.267 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.31 -125.75 8.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HD3' ' OD2' ' A' ' 41' ' ' ASP . 5.2 mpt_? -52.51 -36.65 55.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.84 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 39.5 m-85 -90.87 -173.42 3.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.727 ' HB3' HG13 ' A' ' 62' ' ' VAL . 3.0 m-85 -129.65 142.34 50.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 10.5 t -79.6 99.32 7.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.556 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 8.0 t -79.05 165.41 23.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.129 -0.982 . . . . 0.0 109.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 5.4 mtp180 -157.5 171.93 19.48 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.784 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 79' ' ' ARG . 1.1 m -107.55 76.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 78' ' ' SER . 6.6 ttt-85 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.152 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.522 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.9 t30 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 1' ' ' ASN . 48.0 Cg_endo -75.91 -176.59 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.872 1.459 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.56 HD23 ' H ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER 52.12 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -0.849 . . . . 0.0 110.279 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.724 ' CD1' HD23 ' A' ' 24' ' ' LEU . 2.1 mm -89.87 144.71 31.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.838 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.9 Cg_endo -78.05 162.78 28.73 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.098 1.578 . . . . 0.0 110.028 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -80.44 -21.97 41.62 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.403 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.838 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -52.57 -54.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.608 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.66 -28.88 3.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 17.3 mt -64.86 123.91 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.75 29.34 74.47 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -116.92 -162.77 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -1.009 . . . . 0.0 110.429 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.844 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.2 m -151.95 95.09 2.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.012 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 69' ' ' VAL . 3.2 m -88.87 179.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 110.118 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -94.52 -161.81 34.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.31 -45.68 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.016 1.535 . . . . 0.0 110.318 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -53.1 50.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG23 ' OD1' ' A' ' 41' ' ' ASP . 10.7 t -58.55 -47.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -0.946 . . . . 0.0 109.856 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.636 ' CH2' HG12 ' A' ' 30' ' ' VAL . 59.6 t-105 -48.09 -66.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.96 -38.35 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.27 -49.66 76.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.823 ' CD1' HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -60.38 -28.13 67.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . 48.5 t -66.79 -48.75 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 110.0 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.98 92.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.838 . . . . 0.0 109.914 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.724 HD23 ' CD1' ' A' ' 4' ' ' ILE . 10.8 tp -61.45 -41.94 97.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -130.52 -50.87 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.254 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 30' ' ' VAL . . . 137.02 163.99 9.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -66.2 -9.41 31.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -1.182 . . . . 0.0 110.856 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 -67.64 0.66 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.968 -1.083 . . . . 0.0 109.707 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.025 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.77 -20.08 64.63 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 108.668 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.788 HG22 HD22 ' A' ' 21' ' ' LEU . 14.4 t -70.82 -37.23 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.606 -0.684 . . . . 0.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.7 m -85.04 -25.03 27.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.36 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.866 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.05 25.92 2.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.771 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 5.8 t-20 40.21 75.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 0.0 110.6 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.823 HD13 ' CD1' ' A' ' 21' ' ' LEU . 64.3 mt -124.34 118.34 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.768 . . . . 0.0 109.455 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.482 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.3 mtt180 -96.91 156.68 16.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 110.512 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 8.9 mtp180 -107.27 139.47 41.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.554 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -117.73 164.56 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -42.7 -26.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.356 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.503 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -172.34 -162.42 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' OD1' HG23 ' A' ' 17' ' ' VAL . 54.2 m-20 -66.61 -8.44 27.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.882 . . . . 0.0 110.302 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 18.9 t30 -94.7 101.99 13.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.516 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.765 ' CD2' ' O ' ' A' ' 12' ' ' THR . 4.2 p-80 -143.55 -179.78 6.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.548 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -88.1 120.92 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 109.66 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 p -116.51 -178.75 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' CZ ' ' A' ' 77' ' ' ARG . . . 49.13 41.58 19.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.457 -0.777 . . . . 0.0 108.957 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.57 -153.74 51.0 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.96 36.55 0.67 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.057 -1.26 . . . . 0.0 109.771 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -117.77 -30.74 5.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -124.64 160.23 19.25 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.893 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.548 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 25.2 m95 -132.18 174.68 9.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.318 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.7 t -107.44 112.53 25.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.421 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -127.77 143.2 51.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.894 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -49.52 -46.45 48.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 108.624 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -125.67 -175.84 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 86.6 m -150.9 160.32 43.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.992 -1.067 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -80.56 171.53 14.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 110.365 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -38.97 67.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -13.68 11.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.733 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -120.88 169.93 9.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 109.557 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 15.5 p90 -132.09 -178.01 4.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.913 -1.117 . . . . 0.0 111.102 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 75.6 t -99.61 94.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.294 0.568 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -47.96 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -50.46 -25.4 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 111.027 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.03 -48.6 43.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.17 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.706 ' CD2' HD11 ' A' ' 7' ' ' ILE . 32.0 m-85 -89.79 -4.86 57.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.07 -1.019 . . . . 0.0 111.41 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -49.91 -22.89 1.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.942 -1.099 . . . . 0.0 109.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -70.99 -65.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.447 -0.783 . . . . 0.0 110.541 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.844 HG21 ' H ' ' A' ' 12' ' ' THR . 9.3 p -46.69 -26.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.948 -1.095 . . . . 0.0 109.59 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -68.63 -64.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -124.14 8.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -24.36 22.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.147 . . . . 0.0 109.953 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 12.2 m-85 -102.0 -179.41 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 110.143 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 8.9 m-85 -123.57 130.84 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.131 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.526 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 7.5 t -79.81 105.99 11.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.037 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 66.6 m -102.09 170.07 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.666 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 16.7 mtp180 -149.73 -172.8 4.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.348 0.594 . . . . 0.0 109.559 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 79' ' ' ARG . 5.6 p -115.73 80.42 1.44 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.79 0.328 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.07 135.47 21.02 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.021 1.537 . . . . 0.0 110.493 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -172.18 3.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.998 HD11 HD21 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -54.9 160.15 3.18 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.94 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.4 Cg_endo -75.35 166.57 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.86 -27.73 20.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.8 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -54.36 -49.65 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 110.442 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.571 ' H ' HG23 ' A' ' 7' ' ' ILE . 8.5 m-30 -46.6 -29.46 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 109.946 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -66.91 113.83 3.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.211 -0.93 . . . . 0.0 109.547 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 73.13 27.81 67.65 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -110.65 -164.77 0.94 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.527 -0.984 . . . . 0.0 110.619 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.745 ' H ' HG21 ' A' ' 69' ' ' VAL . 54.9 m -155.01 100.09 2.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 110.034 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.041 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -97.5 163.85 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.104 -0.998 . . . . 0.0 110.036 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.19 -164.73 11.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.2 Cg_endo -73.69 -47.5 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.4 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.02 51.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 81.6 t -60.59 -50.71 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.593 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 26.8 t-105 -45.17 -66.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.626 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -41.55 -42.33 2.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.6 t80 -60.73 -65.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.998 HD21 HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -41.75 -44.33 3.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 110.356 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' VAL . 84.9 t -54.69 -49.52 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.81 69.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.606 HD23 HG13 ' A' ' 4' ' ' ILE . 6.7 tp -60.65 -46.22 91.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.997 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -120.13 -87.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.825 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.16 170.21 39.29 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.8 -22.62 67.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -1.102 . . . . 0.0 110.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -61.94 1.58 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.997 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.17 -26.49 68.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 26' ' ' GLY . 33.9 t -71.42 -34.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.751 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.9 m -85.32 -20.47 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.905 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -20.52 31.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.85 25.01 2.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.831 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 49.0 t-20 41.5 74.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.815 . . . . 0.0 110.445 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 21' ' ' LEU . 13.5 mt -118.43 120.34 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 7.3 mmt180 -99.09 147.85 24.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 110.474 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.593 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 17.5 mtp180 -101.38 136.58 40.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.409 -0.807 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -110.44 160.06 16.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 110.233 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -48.62 -25.7 1.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.917 . . . . 0.0 110.313 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.413 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -160.07 -176.6 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD1' HG23 ' A' ' 17' ' ' VAL . 56.9 m-20 -62.17 -16.65 54.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 73' ' ' TYR . 19.8 t-20 -90.4 107.62 19.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.737 ' CD2' ' O ' ' A' ' 12' ' ' THR . 4.2 p-80 -143.77 175.54 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 110.561 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.2 p -78.68 130.41 35.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.736 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.57 179.34 4.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 47.7 41.76 14.33 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.159 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.56 -153.22 51.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 1.8 m-20 -84.47 41.33 0.83 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.164 -1.198 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.96 -36.51 3.4 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -122.71 166.3 15.21 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.094 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 11.1 m95 -135.74 172.07 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -1.033 . . . . 0.0 109.649 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.7 t -105.35 111.62 24.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 1.2 mtt180 -129.14 145.14 51.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 73' ' ' TYR . 23.5 m -46.68 -40.44 13.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.033 . . . . 0.0 108.614 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.83 168.52 19.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 62' ' ' VAL . 7.8 m -117.22 173.67 6.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.899 -1.125 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -79.62 -169.85 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.074 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -87.57 -42.47 12.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.09 -1.22 11.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.229 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 9.2 mt-10 -121.65 -170.88 2.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.7 p90 -150.26 -162.94 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.889 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 56' ' ' CYS . 53.9 t -120.35 94.37 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -51.88 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.739 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -42.77 -25.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.691 -0.631 . . . . 0.0 110.598 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.499 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.9 t80 -66.55 -50.07 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 111.287 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.9 m-85 -87.0 -5.76 58.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 111.761 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 t -55.27 -18.27 5.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.854 -1.153 . . . . 0.0 109.663 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.8 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.25 -49.33 51.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 111.044 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.041 HG23 HG12 ' A' ' 13' ' ' VAL . 7.0 p -68.47 -27.93 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.133 . . . . 0.0 109.224 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.97 -53.58 55.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.52 -123.37 6.88 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -42.79 71.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -1.106 . . . . 0.0 109.971 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 22.6 m-30 -85.96 -178.19 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.947 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.633 ' HB3' HG13 ' A' ' 62' ' ' VAL . 10.3 m-85 -121.05 143.23 49.17 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.447 -0.783 . . . . 0.0 109.236 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 t -79.28 99.72 7.21 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.131 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.7 m -79.3 162.87 25.34 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.145 -0.972 . . . . 0.0 110.153 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 1.6 mtp180 -159.2 -176.21 5.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.512 -0.742 . . . . 0.0 110.275 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -118.31 83.59 2.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.756 . . . . 0.0 110.27 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.39 -160.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.927 1.488 . . . . 0.0 110.495 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.906 ' CD2' HD21 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -159.57 41.93 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.538 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.482 ' CD1' HD23 ' A' ' 24' ' ' LEU . 1.7 mm -51.72 145.87 15.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.0 Cg_endo -77.04 163.87 30.29 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.066 1.561 . . . . 0.0 110.041 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.16 -27.17 30.27 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.506 -0.746 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.792 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -56.04 -38.03 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.582 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 10.8 m-30 -64.93 -27.29 68.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.281 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.09 129.18 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.255 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 63.16 32.02 82.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -123.06 -162.14 1.01 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 110.555 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.75 ' H ' HG21 ' A' ' 69' ' ' VAL . 8.4 m -153.2 101.05 2.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.038 HG12 HG23 ' A' ' 69' ' ' VAL . 3.2 m -99.84 157.43 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 0.0 110.284 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -71.87 -162.0 5.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.7 Cg_endo -74.57 -40.54 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.018 1.536 . . . . 0.0 110.428 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.3 m -62.81 -58.93 5.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 84.5 t -59.26 -50.53 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.776 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.801 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 23.7 t-105 -45.09 -64.14 0.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 0.0 109.745 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.15 -44.55 5.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.719 . . . . 0.0 110.387 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 62.4 t80 -57.81 -62.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG22 ' A' ' 30' ' ' VAL . 2.0 tt -44.28 -56.16 4.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.813 . . . . 0.0 109.998 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' LEU . 84.7 t -43.07 -44.55 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 20' ' ' TYR . . . -57.78 -56.31 23.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.906 HD21 ' CD2' ' A' ' 3' ' ' LEU . 13.5 tp -49.44 -46.45 47.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.945 . . . . 0.0 110.028 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.99 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -116.37 -89.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.797 . . . . 0.0 110.079 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.831 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.28 165.27 29.9 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.79 59.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 110.626 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.05 -62.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.105 -0.997 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.99 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.21 -21.38 66.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.788 HG22 HD22 ' A' ' 21' ' ' LEU . 24.8 t -74.62 -35.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.471 -0.768 . . . . 0.0 109.885 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -83.57 -26.32 30.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.92 -15.75 38.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.01 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.02 25.1 2.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.773 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 50.0 t-20 47.36 68.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.552 -0.718 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.801 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 57.6 mt -122.62 126.15 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.415 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 73.1 mtt180 -109.1 146.75 33.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.493 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CG ' ' CE3' ' A' ' 18' ' ' TRP . 0.9 OUTLIER -93.32 144.37 25.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.513 -0.742 . . . . 0.0 109.647 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -116.39 155.0 29.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.969 . . . . 0.0 110.401 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -45.66 -27.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -0.85 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -165.07 -163.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -70.45 -12.69 61.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.332 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.514 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.4 OUTLIER -94.57 103.75 15.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.744 ' CD2' ' O ' ' A' ' 12' ' ' THR . 6.5 p-80 -143.42 177.0 8.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 110.336 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.598 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 84.9 p -82.37 131.89 35.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.44 -0.788 . . . . 0.0 109.569 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.9 p -124.27 175.68 6.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 110.62 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 51.11 36.51 15.71 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -150.36 51.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.25 42.64 0.89 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.263 . . . . 0.0 109.827 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.2 mtt180 -117.23 -38.31 3.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -0.911 . . . . 0.0 111.084 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -127.44 171.38 18.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.398 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 7.2 m95 -137.33 172.78 12.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.535 -0.979 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.46 110.69 22.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.158 . . . . 0.0 111.024 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -128.46 145.45 51.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.4 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 30.1 t -53.09 -53.16 54.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.884 -1.135 . . . . 0.0 108.316 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -124.87 178.4 5.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.455 0.645 . . . . 0.0 110.047 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' CD ' ' A' ' 53' ' ' ARG . 5.3 m -155.63 171.22 20.34 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.817 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -79.72 178.31 8.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.689 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -47.3 15.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -48.59 -21.04 0.51 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 109.64 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -110.5 178.17 4.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 109.705 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.5 p90 -144.18 -164.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.054 -1.029 . . . . 0.0 110.297 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 64' ' ' THR . 39.3 t -127.82 98.02 4.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -50.03 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.782 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.6 -26.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.674 -0.641 . . . . 0.0 110.458 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.5 t80 -66.79 -49.39 66.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 111.04 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.728 ' CD1' HD11 ' A' ' 7' ' ' ILE . 12.4 m-85 -85.77 -8.15 58.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 111.15 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.7 p -49.08 -22.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.921 -1.112 . . . . 0.0 109.017 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -65.36 -70.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.038 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -47.43 -29.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.907 -1.121 . . . . 0.0 109.845 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -63.95 -46.19 85.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.32 -132.82 11.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.1 mmt85 -57.07 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -1.19 . . . . 0.0 110.132 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 8.8 m-85 -84.26 -173.26 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 15.9 m-85 -128.39 134.49 48.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 110.078 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.0 t -79.73 97.11 6.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 108.635 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 70.9 m -79.21 166.29 22.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 110.581 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 13.6 mtp180 -160.77 177.56 10.31 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.217 0.532 . . . . 0.0 109.666 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 t -106.94 106.58 17.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.783 0.325 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.19 124.69 9.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.973 1.512 . . . . 0.0 110.395 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -164.78 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.852 HD11 ' CD2' ' A' ' 21' ' ' LEU . 4.2 mm -79.84 144.41 59.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.965 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 4' ' ' ILE . 45.6 Cg_endo -72.27 -159.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.072 1.564 . . . . 0.0 109.805 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.72 -35.61 5.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 110.036 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.923 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -53.01 -50.28 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.57 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.587 ' H ' HG23 ' A' ' 7' ' ' ILE . 15.9 m-30 -48.58 -31.76 7.06 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.887 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 41.7 mt -67.31 113.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.75 27.14 61.33 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.11 -164.4 0.92 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.552 -0.969 . . . . 0.0 110.6 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.678 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.0 m -155.89 103.08 2.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.073 HG12 HG23 ' A' ' 69' ' ' VAL . 4.0 m -98.62 -175.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.21 -160.32 32.5 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.84 -43.64 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.01 1.532 . . . . 0.0 110.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.9 p -65.44 -53.75 38.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 ' OD1' ' A' ' 41' ' ' ASP . 60.1 t -59.9 -48.81 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 109.968 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.721 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 14.3 t-105 -48.58 -60.38 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.858 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.07 -42.47 13.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.256 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.4 t80 -59.69 -65.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.852 ' CD2' HD11 ' A' ' 4' ' ' ILE . 3.9 tt -42.58 -43.94 3.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 18' ' ' TRP . 40.1 t -54.34 -50.08 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.96 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.5 -45.66 66.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.0 tp -58.27 -41.66 84.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.362 -0.836 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.007 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.64 -88.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.975 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.831 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 172.51 163.99 27.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -18.32 53.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.7 1.07 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.05 -1.031 . . . . 0.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.22 -25.64 67.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.12 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.836 HG22 HD22 ' A' ' 21' ' ' LEU . 37.3 t -68.75 -33.27 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.491 -0.756 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -77.5 -46.67 21.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.26 -17.77 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.27 23.31 2.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 35.5 t-20 40.69 69.84 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.721 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 21.2 mt -118.34 122.04 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.1 mtp180 -104.15 148.79 25.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 110.59 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 5.5 mtt85 -91.93 154.3 18.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.546 -0.721 . . . . 0.0 109.771 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.552 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.34 160.62 36.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -44.42 -35.03 2.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.557 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -164.17 -165.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.404 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' HG23 ' A' ' 17' ' ' VAL . 70.3 m-20 -64.37 -11.38 32.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.165 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 24.2 t-20 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.111 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.887 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -144.16 177.61 8.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.487 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.596 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.5 p -76.32 131.36 39.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -0.778 . . . . 0.0 109.699 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.51 173.96 8.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.985 -1.072 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.54 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 49.83 38.79 16.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.179 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.64 -149.44 51.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -85.14 40.91 0.85 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.098 -1.237 . . . . 0.0 109.706 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.9 mmt180 -113.77 -37.2 4.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.341 -0.849 . . . . 0.0 110.843 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -130.86 173.6 20.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.128 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.596 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -140.17 171.43 14.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.397 -1.061 . . . . 0.0 109.223 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.2 t -106.38 120.5 42.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.791 -1.193 . . . . 0.0 111.287 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 3.4 mtt-85 -132.95 156.21 47.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.464 -0.772 . . . . 0.0 108.922 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -48.53 -50.05 33.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 107.964 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.66 179.86 5.89 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.806 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.1 m -127.64 159.92 33.2 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.789 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -79.97 -177.0 5.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.41 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.48 -39.13 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.898 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -12.87 13.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.554 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 77' ' ' ARG . 5.3 mt-10 -124.56 -164.83 1.3 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.427 -0.796 . . . . 0.0 109.933 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.8 p90 -155.44 -162.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.709 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 ' SG ' ' A' ' 56' ' ' CYS . 78.4 t -119.86 95.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -53.04 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.334 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -44.17 -24.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.672 -0.643 . . . . 0.0 110.627 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.562 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.8 t80 -66.81 -50.85 61.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 111.164 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.611 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 8.0 m-85 -86.69 -5.6 59.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.108 -0.995 . . . . 0.0 111.724 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -54.68 -18.29 4.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.875 -1.141 . . . . 0.0 109.573 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.923 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -69.33 -51.81 33.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.073 HG23 HG12 ' A' ' 13' ' ' VAL . 8.1 p -66.71 -26.84 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 109.414 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -65.26 -44.5 87.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.871 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.08 -128.04 8.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -53.01 -34.02 54.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -1.097 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.555 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.4 m-30 -88.46 -174.62 4.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.001 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HB3' HG13 ' A' ' 62' ' ' VAL . 25.2 m-85 -130.17 135.97 48.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.957 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.3 t -79.36 101.25 8.0 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 108.958 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.0 m -83.09 162.31 21.38 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.054 -1.029 . . . . 0.0 109.817 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.423 ' CG ' ' HA3' ' A' ' 50' ' ' GLY . 10.0 mtp180 -157.14 -175.84 5.64 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.27 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -119.58 81.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 110.142 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 78' ' ' SER . 1.8 mtm-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.775 0.321 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.41 -174.46 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.13 1.595 . . . . 0.0 110.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.16 -166.36 1.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.544 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mm -72.3 145.19 87.84 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.914 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.6 Cg_endo -78.54 163.57 26.77 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.18 1.621 . . . . 0.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.97 -20.86 32.15 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.914 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -51.84 -57.54 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 111.119 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.681 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.2 m-85 -48.07 -27.28 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.063 -1.023 . . . . 0.0 110.236 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 12.4 mt -69.1 128.72 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.631 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 57.47 32.05 63.96 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.65 -163.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.526 -0.985 . . . . 0.0 110.431 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.818 ' H ' HG21 ' A' ' 69' ' ' VAL . 25.4 m -151.81 94.46 1.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.133 -0.979 . . . . 0.0 110.291 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.656 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.3 m -86.24 -168.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.854 -1.154 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.19 -161.46 24.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.13 -45.63 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.805 1.423 . . . . 0.0 110.142 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 p -65.71 -49.3 68.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.3 t -59.34 -48.63 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.827 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.509 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 52.4 t-105 -48.42 -65.63 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.76 -33.2 4.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.808 . . . . 0.0 110.382 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 47.8 t80 -67.95 -70.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 30' ' ' VAL . 1.5 tt -43.65 -30.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' GLY . 30.6 t -63.29 -57.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.77 -31.56 39.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.963 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 4' ' ' ILE . 10.1 tp -66.08 -51.74 55.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.308 -0.87 . . . . 0.0 110.43 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.722 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 m -114.99 -49.0 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.766 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 147.1 163.83 10.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.36 -48.3 35.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.239 . . . . 0.0 110.68 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.71 76.24 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -61.36 -52.13 65.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.317 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 21' ' ' LEU . 24.1 t -50.02 -31.55 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.724 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -41.63 71.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.108 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.83 63.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.98 5.0 12.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.631 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 46.2 t30 59.05 69.09 0.75 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.36 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.531 ' CD1' HG13 ' A' ' 30' ' ' VAL . 34.3 mt -119.37 134.56 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.478 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.5 OUTLIER -109.04 146.04 34.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 110.59 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 7.7 mtp180 -95.18 142.34 27.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -118.5 156.58 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.6 t -42.17 -27.08 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 25.4 m -164.83 -170.59 2.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.28 -8.38 24.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.085 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 38.7 t-20 -96.52 104.9 16.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.889 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.6 p80 -143.45 -176.64 5.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -95.94 146.88 24.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 109.567 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.621 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 p -136.36 -177.71 4.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 47.31 37.93 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.089 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.97 -158.77 46.78 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.34 44.21 1.01 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.235 . . . . 0.0 109.709 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -119.14 -34.63 3.82 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.18 -0.95 . . . . 0.0 111.388 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -116.09 163.99 12.31 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.425 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.7 m95 -137.64 173.57 11.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.439 -1.036 . . . . 0.0 109.505 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.7 t -116.09 118.01 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.923 -1.11 . . . . 0.0 111.366 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -133.81 159.0 41.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.488 -0.758 . . . . 0.0 109.13 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -45.12 43.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.95 -1.094 . . . . 0.0 108.88 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 3.1 tttt -138.12 176.8 8.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.703 ' SG ' HG22 ' A' ' 62' ' ' VAL . 7.1 m -122.4 171.99 8.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.905 -1.122 . . . . 0.0 110.271 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -85.63 -178.6 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -44.0 41.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -67.51 -4.06 10.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 110.21 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -123.37 176.48 6.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 6.2 p90 -139.41 -160.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.24 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.703 HG22 ' SG ' ' A' ' 56' ' ' CYS . 76.4 t -125.26 103.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.559 -0.713 . . . . 0.0 109.899 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 9.5 p30 -53.44 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -45.53 -25.34 0.43 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.439 -0.788 . . . . 0.0 110.742 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 10.7 t80 -73.51 -47.41 41.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.812 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 69' ' ' VAL . 32.2 m-85 -85.18 -7.21 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.905 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -49.66 -23.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 109.156 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.511 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . -70.96 -66.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.516 -0.74 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.889 HG22 ' CE1' ' A' ' 43' ' ' HIS . 13.0 p -44.25 -31.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -63.92 -67.86 0.4 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.186 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.54 -124.08 7.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -57.94 -32.18 67.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -1.191 . . . . 0.0 110.042 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 21.3 m-30 -94.38 175.03 6.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.462 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB3' HG13 ' A' ' 62' ' ' VAL . 22.0 m-85 -115.79 133.25 56.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.737 . . . . 0.0 109.168 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.23 102.55 8.61 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.916 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 7.8 m -79.26 161.87 26.04 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 0.0 109.948 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 24.3 mtp180 -155.78 -169.7 3.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.339 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.23 114.93 29.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 110.298 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.292 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.769 0.319 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.58 161.72 43.29 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.977 1.514 . . . . 0.0 110.597 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.03 -169.86 1.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.018 HD11 HD21 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.18 158.9 43.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.409 -179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.5 Cg_endo -75.76 167.97 25.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.172 1.617 . . . . 0.0 110.369 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -88.11 -26.12 22.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.429 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.881 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -51.86 -51.59 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.2 -0.938 . . . . 0.0 110.855 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.473 ' H ' HG23 ' A' ' 7' ' ' ILE . 14.4 m-30 -51.84 -29.21 18.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 21.2 mt -69.1 131.52 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.74 33.17 59.43 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.436 -1.865 . . . . 0.0 108.436 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.881 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -119.31 -163.06 0.95 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.778 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.9 m -152.22 95.86 2.11 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.013 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.958 HG12 HG23 ' A' ' 69' ' ' VAL . 2.6 m -92.3 174.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.274 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.92 38.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.75 -48.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.987 1.519 . . . . 0.0 110.402 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 1.1 p -59.94 -51.09 71.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.48 HG23 ' OD1' ' A' ' 41' ' ' ASP . 96.6 t -61.24 -52.1 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 32.1 t-105 -44.59 -65.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.71 -41.21 3.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 11.4 t80 -61.46 -65.67 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.878 . . . . 0.0 110.241 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.018 HD21 HD11 ' A' ' 4' ' ' ILE . 1.7 tt -42.81 -36.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 64.9 t -60.47 -51.99 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.943 . . . . 0.0 109.819 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.83 51.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 24' ' ' LEU . 9.5 tp -63.73 -38.6 91.71 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.053 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -131.99 -87.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.331 -0.856 . . . . 0.0 109.989 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.825 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.08 169.06 36.49 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 110.63 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.14 1.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.149 -0.969 . . . . 0.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.053 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.01 -21.94 66.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.166 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 26' ' ' GLY . 27.9 t -73.3 -30.99 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.842 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -85.41 -32.05 22.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.07 -24.76 58.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.165 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -79.64 5.98 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 58.3 t-20 58.41 72.77 0.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.611 HD13 HD13 ' A' ' 21' ' ' LEU . 35.5 mt -122.51 129.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.548 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' THR . 13.8 mtt180 -108.97 140.37 42.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm105 -84.2 156.93 21.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -130.92 164.79 24.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -50.85 -27.69 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.509 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 4.4 m -172.38 -170.8 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' HG23 ' A' ' 17' ' ' VAL . 6.8 m-20 -58.37 -15.3 10.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 73' ' ' TYR . 9.9 t-20 -95.13 106.21 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.903 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.7 p80 -147.64 177.01 9.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 110.339 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.622 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -80.14 147.85 31.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.841 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.12 173.89 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.334 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HB1' HH11 ' A' ' 77' ' ' ARG . . . 51.08 36.52 15.63 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.38 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.94 -153.64 48.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -85.65 36.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.066 -1.255 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.23 -30.52 5.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.485 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.52 164.58 15.49 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.484 -1.341 . . . . 0.0 109.767 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.622 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 7.9 m95 -143.47 172.64 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 109.572 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 4.6 t -108.38 112.7 25.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.788 -1.195 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 2.0 mtt-85 -128.4 153.38 47.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -52.35 -46.15 65.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 0.0 109.033 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.06 147.85 49.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.805 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.0 m -97.44 163.25 12.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.69 -179.25 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.244 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -38.26 51.14 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.218 -0.926 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -68.69 -6.48 26.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.264 -0.898 . . . . 0.0 109.77 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' OE2' ' C ' ' A' ' 77' ' ' ARG . 5.9 mt-10 -126.63 -176.6 3.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -140.76 -166.74 2.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.366 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.805 HG22 ' SG ' ' A' ' 56' ' ' CYS . 54.7 t -108.92 90.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.526 -0.734 . . . . 0.0 109.975 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 23.7 t0 -41.49 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.1 p -57.53 -31.02 65.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.833 . . . . 0.0 110.568 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 15.0 t80 -67.29 -48.29 68.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.722 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.637 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 28.3 m-85 -86.28 -6.9 58.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 111.089 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -21.45 4.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.858 -1.151 . . . . 0.0 109.164 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.55 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -69.95 -66.84 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.597 -0.689 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.958 HG23 HG12 ' A' ' 13' ' ' VAL . 14.1 p -46.65 -31.05 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.917 -1.115 . . . . 0.0 109.333 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -59.95 -69.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 0.0 109.949 179.361 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.66 -106.41 2.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -53.31 56.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -1.095 . . . . 0.0 110.06 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 23.7 m-85 -83.94 -169.25 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.687 ' HB3' HG13 ' A' ' 62' ' ' VAL . 7.3 m-85 -126.95 141.95 51.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -0.835 . . . . 0.0 109.476 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.4 t -79.62 97.75 6.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.363 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 16.5 m -78.85 164.14 24.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.663 HH11 ' HB1' ' A' ' 46' ' ' ALA . 9.3 mtp180 -154.35 -177.16 6.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 110.406 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 p -101.37 89.63 3.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.13 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 24.3 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.797 0.332 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 46.8 Cg_endo -72.78 172.12 15.94 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.054 1.555 . . . . 0.0 110.415 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -174.68 42.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.794 HG12 HD23 ' A' ' 24' ' ' LEU . 1.9 mm -64.04 145.84 97.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.823 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.6 Cg_endo -76.73 166.47 27.05 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.118 1.589 . . . . 0.0 109.744 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.87 -20.94 34.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 110.36 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.823 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -53.7 -53.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 111.042 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.9 m-85 -49.13 -26.27 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -69.65 136.16 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 52.04 33.28 36.75 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.31 -159.56 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.55 -0.971 . . . . 0.0 110.497 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.815 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.2 m -154.19 95.54 1.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 110.307 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.895 HG12 HG23 ' A' ' 69' ' ' VAL . 3.0 m -91.47 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.956 -1.09 . . . . 0.0 110.147 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -162.09 28.39 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -74.08 -51.18 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.944 1.497 . . . . 0.0 110.415 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 2.3 p -60.66 -49.2 78.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.155 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.496 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 26.7 t -59.41 -46.67 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.079 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -50.29 -62.77 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.58 -36.82 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.063 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.7 t80 -60.63 -55.06 37.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.677 HD22 HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -55.23 -36.12 65.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HA ' HG21 ' A' ' 30' ' ' VAL . 25.9 t -60.06 -52.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.2 -40.43 67.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.129 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.794 HD23 HG12 ' A' ' 4' ' ' ILE . 10.2 tp -61.73 -38.82 89.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.92 -88.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.17 164.94 31.69 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -21.81 62.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 110.675 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.79 1.27 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.083 -1.011 . . . . 0.0 110.057 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.995 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.24 -21.81 66.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.389 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 26' ' ' GLY . 44.8 t -74.46 -33.29 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 0.0 110.068 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.7 m -88.8 -21.4 23.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.28 -25.23 31.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.868 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -80.59 7.46 9.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.201 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 52.2 t-20 58.43 74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.27 -0.893 . . . . 0.0 110.534 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.868 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 2.7 mt -124.38 110.41 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.484 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 2.3 mmt85 -87.3 157.24 19.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.402 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.5 mtm180 -102.17 150.7 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 110.018 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.99 154.55 39.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' ALA . 50.9 m -43.82 -26.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.208 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -166.23 -162.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.28 -11.88 60.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.75 106.16 18.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.746 ' CD2' ' O ' ' A' ' 12' ' ' THR . 5.6 p-80 -145.85 175.22 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.177 -0.952 . . . . 0.0 110.454 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.4 p -80.96 124.45 29.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 0.0 109.823 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.0 p -115.3 -177.59 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.115 -0.991 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.543 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.93 39.36 5.47 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.452 -0.78 . . . . 0.0 109.301 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.71 -150.08 48.94 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.581 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -87.29 31.38 0.73 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.095 -1.239 . . . . 0.0 110.012 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.92 -28.96 6.86 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.251 -0.905 . . . . 0.0 110.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.97 162.64 14.03 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.925 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 8.4 m95 -139.55 167.42 22.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.449 -1.03 . . . . 0.0 109.325 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 6.3 t -107.79 108.92 20.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.868 -1.145 . . . . 0.0 111.1 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -130.06 158.96 38.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.836 . . . . 0.0 109.06 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -48.4 51.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.946 -1.097 . . . . 0.0 108.249 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -124.28 -171.24 2.29 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.686 0.755 . . . . 0.0 110.525 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.865 ' SG ' HG22 ' A' ' 62' ' ' VAL . 11.4 m -131.52 164.33 26.03 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.958 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.0 m-85 -79.63 164.76 23.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.153 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -63.56 -44.62 93.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -4.77 13.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.868 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 17.1 mt-10 -123.0 -178.51 3.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.915 . . . . 0.0 110.145 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -139.65 -163.57 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.865 HG22 ' SG ' ' A' ' 56' ' ' CYS . 70.9 t -111.38 89.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 29.9 t0 -40.63 91.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.185 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -57.27 -30.51 64.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.563 -179.477 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.81 -48.61 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 110.818 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 7' ' ' ILE . 22.9 m-85 -83.88 -8.76 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 111.12 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -24.35 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.974 -1.079 . . . . 0.0 109.415 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.591 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.22 -71.36 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.895 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -44.18 -29.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.116 -0.99 . . . . 0.0 109.841 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.41 -64.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.57 -116.07 5.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -60.8 -50.98 71.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 12.4 m-30 -79.91 -175.16 4.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.966 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.66 ' HB3' HG13 ' A' ' 62' ' ' VAL . 5.9 m-85 -122.31 144.83 48.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 t -81.59 97.05 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 109.382 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 21.8 m -79.39 164.09 24.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.194 -0.941 . . . . 0.0 109.753 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.2 mtp180 -151.16 -179.25 7.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 0.0 110.53 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.435 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 54.4 p -116.59 87.35 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.269 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.509 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.4 t-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 1' ' ' ASN . 48.3 Cg_endo -75.34 141.09 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.901 1.474 . . . . 0.0 110.473 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -129.51 -169.26 2.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm -62.42 144.32 95.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.2 Cg_endo -72.4 -158.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.183 1.622 . . . . 0.0 109.701 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -113.48 -29.82 7.06 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -51.97 -55.28 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.367 -0.833 . . . . 0.0 110.815 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 21.2 m-85 -48.15 -29.33 3.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 33.1 mt -68.57 129.22 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.422 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.66 32.01 72.74 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.42 -162.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.983 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.778 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.0 m -153.79 100.07 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.939 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -93.73 173.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.115 -0.991 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -161.44 35.11 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 46.8 Cg_endo -74.27 -49.67 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.964 1.507 . . . . 0.0 110.39 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -50.19 74.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.23 -0.919 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.516 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 55.4 t -61.59 -51.0 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.776 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.1 t-105 -44.56 -65.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.703 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.53 -43.27 5.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 67.2 t80 -56.89 -64.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.867 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.813 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.1 tt -44.08 -38.61 3.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 18' ' ' TRP . 15.6 t -54.99 -55.97 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.1 -43.56 64.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD23 ' CD1' ' A' ' 4' ' ' ILE . 12.1 tp -55.28 -43.82 75.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.248 -0.908 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.014 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.6 -88.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.238 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.08 166.83 34.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -61.22 -20.88 63.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -1.148 . . . . 0.0 110.588 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -63.62 1.1 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.031 -1.043 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.014 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.45 -18.49 63.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.174 -0.953 . . . . 0.0 109.208 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 21' ' ' LEU . 24.2 t -75.98 -32.02 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.468 -0.77 . . . . 0.0 109.729 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.0 m -93.03 -17.1 24.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.34 -24.0 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -83.18 10.36 8.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.485 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 61.9 t-20 58.81 74.07 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.603 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.643 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 7.0 mt -125.1 125.27 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.858 . . . . 0.0 109.605 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.9 mtt180 -107.2 146.35 31.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 44.0 mtp180 -89.63 154.24 20.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -126.71 161.53 27.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.368 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -51.7 -26.71 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.392 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 39' ' ' SER . 3.7 m -165.32 -177.18 4.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.9 m-20 -56.41 -24.57 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.574 ' OD1' ' CD2' ' A' ' 73' ' ' TYR . 4.0 t30 -86.81 110.94 20.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.881 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.2 p80 -147.85 175.25 11.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.626 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -77.69 138.79 39.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.347 -0.846 . . . . 0.0 109.689 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.3 p -131.37 178.8 6.44 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.83 36.43 8.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.28 -147.74 46.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -87.13 31.6 0.71 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.198 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -115.03 -31.84 5.93 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.236 -0.915 . . . . 0.0 111.032 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.81 165.75 15.4 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.162 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.626 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.7 m95 -144.74 169.71 17.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.461 -1.023 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.8 t -109.61 113.33 26.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.829 -1.17 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.8 OUTLIER -132.52 160.96 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 109.126 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -50.84 -50.5 56.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.859 -1.151 . . . . 0.0 108.269 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -124.72 -178.98 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.528 0.68 . . . . 0.0 110.492 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.842 ' SG ' HG22 ' A' ' 62' ' ' VAL . 12.4 m -125.05 166.33 16.57 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.975 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -79.7 171.37 15.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.11 -0.994 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -39.41 71.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.207 -0.933 . . . . 0.0 110.17 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -71.21 -2.99 17.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 13.0 mt-10 -126.39 -172.35 2.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 6.2 p90 -144.52 -164.15 1.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.842 HG22 ' SG ' ' A' ' 56' ' ' CYS . 54.3 t -110.3 89.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.502 -0.749 . . . . 0.0 109.969 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 30.1 t0 -41.86 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.21 -28.67 65.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -68.86 -49.23 60.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 17.7 m-85 -82.91 -8.56 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 t -51.09 -21.71 2.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.987 -1.07 . . . . 0.0 109.115 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.49 -68.97 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 110.294 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.939 HG23 HG12 ' A' ' 13' ' ' VAL . 10.8 p -46.35 -30.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 109.35 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -60.15 -70.93 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 110.415 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.2 -115.5 5.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -61.0 -39.8 91.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -1.165 . . . . 0.0 109.995 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 29.3 m-85 -92.26 -177.69 4.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.877 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.6 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -122.3 145.87 47.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 0.0 109.642 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 8.7 t -85.08 99.24 10.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.64 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 18.3 m -78.36 163.89 25.29 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 109.667 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.0 mtp180 -154.09 -175.58 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 110.658 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -111.87 102.08 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.149 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.272 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 t30 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' HG2' HD11 ' A' ' 24' ' ' LEU . 46.2 Cg_endo -73.05 93.77 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.904 1.476 . . . . 0.0 110.367 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -52.54 139.68 24.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.363 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.494 HG23 ' HD2' ' A' ' 5' ' ' PRO . 1.4 mm -57.64 147.23 62.05 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.865 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.7 Cg_endo -76.36 164.34 31.02 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.035 1.545 . . . . 0.0 109.921 178.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.679 ' HB3' ' OH ' ' A' ' 65' ' ' TYR . . . -80.62 -20.96 42.01 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.865 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -53.92 -56.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.9 -179.643 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.624 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.3 m-85 -47.6 -25.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.0 110.004 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 8.3 mt -69.15 125.49 27.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 60.2 31.41 73.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.72 -160.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.447 -1.031 . . . . 0.0 110.759 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.732 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 5.8 m -156.26 104.33 2.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.031 HG12 HG23 ' A' ' 69' ' ' VAL . 3.4 m -99.03 169.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.154 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 -163.89 21.54 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.5 Cg_endo -73.73 -46.1 0.35 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.051 1.553 . . . . 0.0 110.281 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -52.43 56.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 59.6 t -57.63 -41.36 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.727 ' O ' HG23 ' A' ' 22' ' ' VAL . 43.0 t-105 -54.22 -66.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.14 -0.975 . . . . 0.0 109.633 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.27 -33.97 1.77 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.707 . . . . 0.0 110.334 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 74.2 t80 -65.13 -65.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.117 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.6 tt -44.7 -35.8 2.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 18' ' ' TRP . 21.7 t -60.96 -48.24 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.21 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.459 -0.776 . . . . 0.0 109.968 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.8 tp -60.71 -42.98 98.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.017 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -121.7 -88.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 110.163 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.804 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.64 165.77 32.16 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.32 -19.25 61.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -1.132 . . . . 0.0 110.486 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -63.11 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.884 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.017 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.4 -19.7 64.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 26' ' ' GLY . 38.2 t -75.78 -32.03 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.442 -0.786 . . . . 0.0 109.856 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.2 m -89.37 -23.21 22.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.18 -24.9 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -81.07 8.38 8.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 61.2 t-20 59.21 74.73 0.43 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.663 HD13 HD13 ' A' ' 21' ' ' LEU . 67.9 mt -125.19 128.4 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.437 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mmt180 -109.99 146.32 35.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.585 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 6.6 mtp180 -92.79 148.86 21.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.82 173.69 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.097 -1.002 . . . . 0.0 110.328 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 t -51.29 -37.02 45.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.33 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.535 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.2 m -161.2 -162.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.346 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.2 m-20 -67.47 -18.55 65.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.405 -0.809 . . . . 0.0 110.344 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -91.75 92.19 8.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.273 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.744 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 3.9 p-80 -127.49 -178.6 4.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.159 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -88.95 117.64 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.422 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 21.4 p -104.11 -175.47 2.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.439 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HB2' ' HD2' ' A' ' 77' ' ' ARG . . . 43.98 39.57 2.8 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.446 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.63 -150.23 50.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 34.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.153 -1.204 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -117.93 -28.63 5.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.319 -0.863 . . . . 0.0 110.924 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.536 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -126.53 165.17 19.83 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.165 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 30.2 m95 -138.61 176.16 8.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.044 . . . . 0.0 109.956 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 m -105.66 102.41 11.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 5.3 mtt180 -122.21 137.71 54.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.147 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.559 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -49.25 -41.2 36.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 108.977 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.44 144.13 51.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.826 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.4 m -103.62 166.8 10.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.038 -1.038 . . . . 0.0 110.048 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -79.9 167.8 20.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.417 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -41.03 90.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.22 -6.18 17.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 15.5 mt-10 -126.18 178.04 6.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 109.887 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 77' ' ' ARG . 12.6 p90 -133.49 -170.32 2.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.277 179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.826 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -107.48 87.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 32.0 t0 -40.49 91.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.617 -0.677 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.2 -27.73 55.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.572 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.679 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 19.7 t80 -70.43 -50.35 39.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.886 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.654 ' CD2' HD11 ' A' ' 7' ' ' ILE . 24.0 m-85 -82.7 -8.0 59.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 111.065 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 -21.39 3.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.017 -1.052 . . . . 0.0 109.308 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . -69.96 -51.16 34.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.031 HG23 HG12 ' A' ' 13' ' ' VAL . 7.6 p -64.24 -31.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.95 -1.094 . . . . 0.0 110.495 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 75' ' ' CYS . 57.8 m -62.74 -52.3 63.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.944 -1.097 . . . . 0.0 109.466 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 -119.56 5.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.09 -23.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 110.11 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 25.7 m-85 -116.67 178.44 4.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.676 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.6 m-85 -115.73 147.22 41.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 8.8 t -79.5 95.91 5.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 0.0 109.58 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 77' ' ' ARG . 31.3 m -78.66 160.98 27.24 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.957 -1.09 . . . . 0.0 109.355 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.602 ' HD2' ' HB2' ' A' ' 46' ' ' ALA . 43.4 mtp180 -157.83 -172.52 3.97 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.359 -0.838 . . . . 0.0 110.591 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 7.6 t -114.87 96.31 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.611 -0.681 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.49 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.728 0.299 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 1' ' ' ASN . 46.2 Cg_endo -72.89 84.29 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.929 1.489 . . . . 0.0 110.507 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.09 HD13 ' N ' ' A' ' 4' ' ' ILE . 3.1 tm? -96.74 150.98 20.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.09 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.09 ' N ' HD13 ' A' ' 3' ' ' LEU . 3.6 mm -40.91 145.44 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.851 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.626 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.6 Cg_endo -71.37 -158.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.125 1.592 . . . . 0.0 109.615 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.24 -21.49 9.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.781 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.731 HD11 ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -56.09 -44.9 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.454 -0.778 . . . . 0.0 110.807 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.3 m-85 -55.86 -24.17 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.987 . . . . 0.0 110.758 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 54.3 mt -61.18 127.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.626 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 54.7 32.58 54.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -112.29 -170.83 1.73 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.504 -0.997 . . . . 0.0 110.645 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.814 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.2 m -145.75 90.13 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.1 m -82.99 175.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.04 -1.038 . . . . 0.0 109.826 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.83 -166.49 42.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 44.0 Cg_endo -72.21 -46.49 0.51 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.976 1.514 . . . . 0.0 110.185 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -47.57 82.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 57.1 t -59.5 -51.81 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.594 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 36.4 t-105 -44.43 -66.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 109.824 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.71 -39.76 2.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.844 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 38.9 t80 -62.44 -64.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.363 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.763 ' CD2' HD11 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -42.74 -52.0 5.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG22 HG21 ' A' ' 30' ' ' VAL . 73.2 t -47.65 -50.89 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.78 -46.53 59.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.6 tp -60.58 -38.87 86.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.844 . . . . 0.0 110.036 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -126.99 -89.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.805 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.55 171.25 37.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.38 -19.18 65.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -1.169 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.95 -63.13 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.07 -1.018 . . . . 0.0 109.945 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.043 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.84 -21.87 66.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' HD12 ' A' ' 35' ' ' ILE . 24.6 t -74.0 -33.48 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.726 . . . . 0.0 109.929 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 m -85.31 -27.01 26.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.009 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.02 -25.93 48.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.948 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.695 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -81.46 3.25 25.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.025 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.626 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 43.9 t30 58.73 77.95 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.59 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.695 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 2.6 mt -121.43 140.76 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.505 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 5.5 mtt180 -117.49 153.82 32.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.567 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.594 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 19.0 mtp-105 -109.04 134.3 51.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -109.44 173.82 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -49.58 -27.48 4.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.538 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 39.0 m -167.71 -166.08 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' OD1' HG23 ' A' ' 17' ' ' VAL . 97.9 m-20 -65.83 -10.17 35.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 2.8 m-20 -96.31 105.58 17.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.868 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.9 p80 -145.71 -179.85 6.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -0.977 . . . . 0.0 110.647 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.625 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -91.64 148.31 22.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.443 -0.786 . . . . 0.0 109.521 179.627 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.636 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 9.3 p -141.27 -177.32 5.07 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 110.611 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.3 43.54 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.27 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.69 -161.04 53.92 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -83.82 41.33 0.79 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.031 -1.276 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -119.38 -31.16 4.71 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.64 158.76 14.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.223 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.625 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.1 m95 -140.05 169.05 18.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -1.028 . . . . 0.0 109.189 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -112.45 115.91 29.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.786 -1.197 . . . . 0.0 110.893 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 0.9 OUTLIER -132.44 161.38 33.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.349 -0.844 . . . . 0.0 109.25 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -46.08 66.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.985 -1.072 . . . . 0.0 108.856 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.52 163.19 30.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.662 ' SG ' HG22 ' A' ' 62' ' ' VAL . 10.9 m -103.73 170.22 8.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 110.265 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 21.5 m-85 -87.39 -178.88 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.2 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -75.23 -38.47 60.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.333 -0.854 . . . . 0.0 110.008 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.54 0.74 13.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -132.36 177.9 7.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 9.7 p90 -138.89 -168.83 2.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 74' ' ' PHE . 26.2 t -104.07 89.63 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.64 -0.663 . . . . 0.0 109.828 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.489 ' OD2' ' CD ' ' A' ' 77' ' ' ARG . 16.8 t0 -42.64 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.8 p -58.08 -32.74 68.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -44.89 80.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.731 ' CD1' HD11 ' A' ' 7' ' ' ILE . 37.8 m-85 -89.1 -5.99 57.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.963 -179.347 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 t -50.51 -22.5 1.97 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.013 -1.055 . . . . 0.0 108.766 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -70.61 -67.78 0.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.868 HG22 ' CE1' ' A' ' 43' ' ' HIS . 12.9 p -44.71 -28.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.018 -1.051 . . . . 0.0 109.671 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' HA ' ' NE2' ' A' ' 43' ' ' HIS . 1.1 m -67.08 -62.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.453 -0.78 . . . . 0.0 110.449 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.7 -114.81 4.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -69.04 -34.0 74.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' CG ' ' OD1' ' A' ' 42' ' ' ASN . 61.7 m-85 -87.79 179.72 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.663 ' HB3' HG13 ' A' ' 62' ' ' VAL . 7.0 m-85 -121.89 129.55 52.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -0.853 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.46 99.61 7.3 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.04 -1.038 . . . . 0.0 108.816 179.376 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.9 m -78.38 163.83 25.33 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.903 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 10.1 mtp180 -148.02 176.55 10.09 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 110.31 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 t -103.93 88.5 3.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 6.7 ttm180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.813 0.339 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.2 100.36 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.032 1.543 . . . . 0.0 110.48 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -93.44 155.02 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.616 ' CD1' HD23 ' A' ' 24' ' ' LEU . 2.4 mm -54.56 144.97 41.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.338 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.876 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.4 Cg_endo -76.89 163.59 30.98 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.063 1.559 . . . . 0.0 109.828 178.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -80.22 -22.48 41.77 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.876 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -51.37 -55.11 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -179.663 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.25 -30.76 5.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 6' ' ' ALA . 65.0 mt -67.99 135.23 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.622 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 54.43 33.55 53.69 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.154 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -125.51 -160.28 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.513 -0.992 . . . . 0.0 110.417 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.821 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.6 m -155.18 92.57 1.44 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.952 . . . . 0.0 110.451 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.737 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -84.21 -147.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 110.28 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -125.58 -161.31 10.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.22 -47.27 0.32 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.992 1.522 . . . . 0.0 110.542 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -55.64 11.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 64.2 t -53.71 -39.74 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.601 ' CD2' ' HD2' ' A' ' 37' ' ' ARG . 25.9 t90 -55.99 -61.87 2.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.76 -38.23 3.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -66.16 -44.2 84.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.915 HD22 HG22 ' A' ' 30' ' ' VAL . 1.3 tt -65.1 -27.89 69.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 110.27 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.628 HG13 ' CA ' ' A' ' 27' ' ' ALA . 85.9 t -71.37 -42.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 110.281 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.616 HD23 ' CD1' ' A' ' 4' ' ' ILE . 8.7 tp -72.92 -69.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 110.794 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.005 HG22 ' CB ' ' A' ' 29' ' ' ALA . 14.9 p -88.43 -26.48 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 110.702 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.787 ' O ' HG23 ' A' ' 30' ' ' VAL . . . 119.72 161.37 11.57 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.628 ' CA ' HG13 ' A' ' 22' ' ' VAL . . . -63.42 -63.2 1.25 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -1.121 . . . . 0.0 110.318 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.2 -34.25 31.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.992 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.005 ' CB ' HG22 ' A' ' 25' ' ' VAL . . . -63.6 -43.67 96.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.915 HG22 HD22 ' A' ' 21' ' ' LEU . 49.8 t -60.84 -39.76 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m -71.47 -23.45 61.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.19 -20.8 31.75 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.391 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -90.11 9.14 29.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.513 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.622 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 44.9 t30 59.13 68.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.383 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.766 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 3.3 mt -120.13 110.81 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.652 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.1 mtm105 -92.04 160.11 15.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.555 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.601 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 8.4 mtp-105 -110.54 151.52 27.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.83 -172.46 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 4.9 t -71.92 -2.76 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 170.65 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.076 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -71.24 -9.65 58.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.7 t-20 -97.39 100.48 11.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.133 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.805 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -142.22 176.78 8.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.112 -0.993 . . . . 0.0 110.501 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.584 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.5 p -78.51 129.74 35.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.16 175.64 6.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 110.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.81 42.74 20.49 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.73 -150.65 49.74 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -86.17 38.57 0.77 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.103 -1.234 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.3 mtm-85 -116.96 -35.35 4.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.171 -0.956 . . . . 0.0 111.013 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -125.45 165.49 18.58 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.501 -1.333 . . . . 0.0 109.931 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.584 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.9 m95 -136.77 175.0 10.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.443 -1.034 . . . . 0.0 109.673 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.6 t -107.97 120.09 41.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.976 -1.078 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -139.02 144.89 39.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.36 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 1.4 m -45.78 -38.73 7.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.954 -1.092 . . . . 0.0 108.479 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HD3' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.8 -162.83 1.27 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' HG22 ' A' ' 62' ' ' VAL . 20.7 m -143.4 179.06 7.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.928 -1.108 . . . . 0.0 110.37 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.93 -176.12 5.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.028 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -84.26 -38.46 20.46 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 9.58 7.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 11.1 mt-10 -124.06 -168.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.6 p90 -154.4 -160.09 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.896 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.638 HG13 ' HB3' ' A' ' 74' ' ' PHE . 66.2 t -122.5 96.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.683 -0.636 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -52.69 89.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 109.796 -179.63 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -43.08 -24.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.58 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 63' ' ' ASP . 26.6 t80 -67.32 -55.13 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.83 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.3 m-85 -81.95 -9.92 59.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.195 -0.941 . . . . 0.0 110.982 -179.286 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 t -48.25 -23.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.094 -1.004 . . . . 0.0 109.215 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.675 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.54 -71.5 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.722 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.821 HG21 ' H ' ' A' ' 12' ' ' THR . 9.3 p -43.33 -29.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 109.668 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -62.44 -58.67 6.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.471 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.69 -136.91 12.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.47 -27.69 4.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -1.166 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -93.71 179.18 5.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.152 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.638 ' HB3' HG13 ' A' ' 62' ' ' VAL . 10.9 m-85 -122.68 137.29 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 178.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 t -78.76 103.35 8.65 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.969 -1.082 . . . . 0.0 108.818 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.5 m -79.58 163.06 24.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.524 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 26.3 mtp180 -160.08 -170.24 2.78 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.534 -0.729 . . . . 0.0 110.274 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.69 114.9 21.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.826 . . . . 0.0 110.22 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.174 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.771 0.32 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.3 86.76 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.538 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -153.38 167.89 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 110.115 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.828 HD11 ' CD2' ' A' ' 21' ' ' LEU . 2.1 mm -58.7 145.27 78.36 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.247 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.4 Cg_endo -77.68 164.79 27.71 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.03 1.542 . . . . 0.0 109.88 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.95 -28.44 27.81 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -54.75 -50.47 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 110.366 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.584 ' H ' HG23 ' A' ' 7' ' ' ILE . 9.9 m-30 -46.97 -27.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 49.1 mt -64.19 118.55 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.562 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 65.06 30.65 78.5 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -178.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -106.52 -161.57 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.51 -0.994 . . . . 0.0 110.809 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.762 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.3 m -156.35 92.28 1.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.037 HG12 HG23 ' A' ' 69' ' ' VAL . 3.4 m -93.74 169.75 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.288 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.97 -161.68 36.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.6 Cg_endo -74.09 -38.79 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.024 1.539 . . . . 0.0 110.414 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.94 -53.96 22.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 110.142 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.6 t -58.48 -46.86 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.986 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' ALA . 28.3 t-105 -49.06 -65.2 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.646 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.48 -40.91 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 110.263 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 54.0 t80 -59.24 -58.0 10.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.969 HD22 HG22 ' A' ' 30' ' ' VAL . 2.8 tt -51.73 -36.2 46.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 40.8 t -58.4 -49.29 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.085 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.16 82.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.178 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.0 tp -57.14 -44.71 83.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.39 -88.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.265 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.841 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.02 166.93 34.16 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -20.34 63.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -1.192 . . . . 0.0 110.637 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.57 -64.24 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.081 -1.012 . . . . 0.0 109.779 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.025 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -60.76 -23.5 65.02 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.024 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.969 HG22 HD22 ' A' ' 21' ' ' LEU . 21.9 t -67.43 -37.02 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.443 -0.786 . . . . 0.0 109.533 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.2 m -85.26 -23.85 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.22 -23.05 54.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.6 24.76 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 30.7 t-20 41.23 75.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.697 HD12 ' O ' ' A' ' 30' ' ' VAL . 53.1 mt -117.2 126.47 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.496 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -100.78 146.06 27.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.564 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -91.5 146.91 23.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.83 . . . . 0.0 109.693 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.662 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -124.45 152.91 42.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' ALA . 18.2 t -42.27 -27.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.211 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m -171.65 -165.03 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -65.23 -12.91 56.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 30.9 t-20 -95.8 103.38 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.575 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.737 ' CD2' ' O ' ' A' ' 12' ' ' THR . 7.8 p-80 -145.77 -179.9 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.363 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.4 p -84.66 133.33 34.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.694 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.0 p -122.06 174.78 6.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 50.0 33.09 6.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.323 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 -144.93 43.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.87 40.65 0.82 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.025 -1.28 . . . . 0.0 109.976 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -113.11 -40.37 3.96 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 110.989 -179.412 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -131.6 172.37 20.9 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.271 -1.443 . . . . 0.0 110.573 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.3 m95 -136.22 177.18 8.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.895 . . . . 0.0 109.356 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -107.62 115.07 29.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.6 mtt180 -132.16 142.95 49.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.729 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 2.1 t -48.1 -43.15 30.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.883 -1.135 . . . . 0.0 108.834 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.11 50.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.881 ' SG ' HG22 ' A' ' 62' ' ' VAL . 6.3 m -101.85 162.2 13.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.952 -1.092 . . . . 0.0 110.331 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -79.98 167.34 20.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.887 . . . . 0.0 110.478 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -67.01 -39.55 87.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -63.91 -9.89 17.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.918 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 13.3 mt-10 -126.48 179.15 5.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.212 -0.93 . . . . 0.0 109.817 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 13.4 p90 -130.58 -169.45 2.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -0.96 . . . . 0.0 110.34 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.881 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.9 t -111.08 88.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 77' ' ' ARG . 3.7 t70 -38.56 91.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.43 0.633 . . . . 0.0 110.477 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.85 -29.54 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 110.049 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.544 ' O ' HD12 ' A' ' 7' ' ' ILE . 51.2 t80 -68.48 -53.51 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.435 -0.79 . . . . 0.0 110.462 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -80.09 -4.26 52.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 111.489 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -16.62 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.944 -1.097 . . . . 0.0 109.626 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.785 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -73.19 -45.99 53.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.003 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.037 HG23 HG12 ' A' ' 13' ' ' VAL . 10.0 p -71.63 -26.28 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.935 -1.103 . . . . 0.0 109.343 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -65.28 -50.91 63.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.77 . . . . 0.0 109.83 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.12 -131.04 10.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -33.67 9.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -1.074 . . . . 0.0 109.798 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 8.9 m-85 -92.83 -177.63 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.857 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.688 ' HB3' HG13 ' A' ' 62' ' ' VAL . 6.8 m-85 -126.69 140.77 52.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 8.6 t -79.48 97.25 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.568 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 14.2 m -79.23 163.26 25.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.981 . . . . 0.0 110.069 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.636 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 6.5 mmm180 -153.59 -172.43 4.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 110.242 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 29.3 p -120.17 81.03 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.491 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.169 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' LEU . 46.5 Cg_endo -73.83 153.12 47.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.73 HD23 ' C ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -55.39 -162.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.308 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.539 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.3 mm -87.62 143.37 33.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 109.972 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.2 Cg_endo -79.29 162.11 25.58 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.151 1.606 . . . . 0.0 110.166 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.49 -20.31 37.05 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.547 -0.72 . . . . 0.0 110.22 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.835 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -57.73 -39.18 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.879 . . . . 0.0 110.457 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 12.8 m-30 -63.14 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.518 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.8 mt -72.44 126.55 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 109.281 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.631 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 63.79 31.01 79.36 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.54 -163.08 0.93 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.501 -0.999 . . . . 0.0 110.711 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.832 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.8 m -154.85 99.54 2.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -0.894 . . . . 0.0 109.835 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.886 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -94.72 178.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.991 -1.068 . . . . 0.0 110.445 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.12 -161.74 37.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.6 Cg_endo -73.33 -46.52 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.985 1.519 . . . . 0.0 110.509 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -47.78 74.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.317 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 14.9 t -58.8 -46.05 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.447 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 7.7 t90 -52.66 -55.67 20.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.55 59.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.605 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.19 -59.06 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.92 . . . . 0.0 110.302 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.844 HD22 HG22 ' A' ' 30' ' ' VAL . 1.6 tt -52.04 -36.31 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.791 . . . . 0.0 110.366 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 26' ' ' GLY . 46.8 t -62.73 -48.58 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.11 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.85 -34.76 68.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.482 HD23 ' CD1' ' A' ' 4' ' ' ILE . 6.4 tp -69.54 -39.15 77.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.376 -0.828 . . . . 0.0 110.371 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.123 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -128.71 -52.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.425 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . 134.85 164.19 10.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -65.2 -7.99 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -1.087 . . . . 0.0 110.884 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.947 -1.096 . . . . 0.0 109.817 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.123 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.74 -19.25 65.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.855 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.844 HG22 HD22 ' A' ' 21' ' ' LEU . 18.2 t -75.21 -32.83 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.9 m -87.26 -27.01 23.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.044 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.94 -19.91 36.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -84.57 9.18 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 110.156 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.631 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 52.3 t-20 59.05 72.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.345 -0.847 . . . . 0.0 110.624 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.617 HD13 HD13 ' A' ' 21' ' ' LEU . 38.0 mt -124.96 114.54 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 109.692 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 12' ' ' THR . 19.8 mtt-85 -98.67 152.11 19.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 4.1 mtm180 -93.68 159.59 15.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -134.52 164.02 28.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.18 -25.31 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -179.54 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.293 -179.865 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 62.1 m-20 -65.97 -10.45 39.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 9.6 t-20 -98.33 100.19 11.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.351 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.745 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 5.2 p-80 -143.25 175.04 10.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.943 . . . . 0.0 110.451 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.569 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 5.7 p -80.38 125.63 30.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.403 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.97 177.44 4.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.07 44.03 18.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.47 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.42 -152.13 51.49 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -86.75 36.14 0.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.061 -1.258 . . . . 0.0 109.989 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -31.2 5.11 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.225 -0.922 . . . . 0.0 110.859 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.521 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -118.78 163.46 13.17 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.061 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 8.1 m95 -140.84 165.92 26.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -1.082 . . . . 0.0 109.839 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.5 t -104.37 107.95 19.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 0.0 110.787 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -128.29 149.93 50.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -0.898 . . . . 0.0 109.622 179.351 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 65.8 p -55.99 -49.87 72.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 109.035 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -130.49 173.57 10.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 57.1 m -148.6 172.04 15.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -79.54 -170.29 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.506 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -45.28 10.69 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.338 -0.852 . . . . 0.0 110.332 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.7 -20.31 1.2 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 109.517 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -113.58 170.77 8.0 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.395 -0.816 . . . . 0.0 109.832 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.9 p90 -133.85 -168.33 2.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 0.0 110.145 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.72 HG13 ' HB3' ' A' ' 74' ' ' PHE . 62.6 t -111.76 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.546 -0.721 . . . . 0.0 110.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.2 t0 -40.21 91.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 110.19 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' VAL . 2.8 p -55.13 -33.98 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 110.505 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.93 -46.79 83.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.78 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CD2' HD11 ' A' ' 7' ' ' ILE . 27.4 m-85 -87.2 -6.48 58.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 0.0 111.021 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -21.96 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.053 . . . . 0.0 108.904 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -69.67 -66.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 0.0 110.53 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.886 HG23 HG12 ' A' ' 13' ' ' VAL . 9.7 p -48.54 -26.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.077 . . . . 0.0 109.603 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -65.39 -63.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 110.231 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -114.94 5.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -61.06 -47.98 83.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -1.181 . . . . 0.0 110.027 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.484 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 22.5 m-85 -82.69 -178.45 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.72 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.0 m-85 -121.23 138.82 54.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.7 t -79.68 98.49 6.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.762 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 96.1 m -79.06 173.16 12.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.955 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.5 mtp180 -160.55 179.88 8.22 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.482 -0.761 . . . . 0.0 110.276 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.68 117.49 34.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.159 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.728 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.1 Cg_endo . . . . . 0 C--O 1.215 -0.648 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.58 -24.78 33.77 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.824 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -53.51 -54.83 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.79 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.58 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 10.0 m-30 -48.48 -26.82 2.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 110.172 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 15.7 mt -71.84 139.15 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.391 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 49.06 35.93 19.85 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -123.72 -161.84 1.01 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.542 -0.975 . . . . 0.0 110.515 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.787 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.6 m -153.93 93.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.815 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -88.76 -171.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.062 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -100.58 -163.6 28.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.4 Cg_endo -72.83 -48.82 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.963 1.507 . . . . 0.0 110.458 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 t -62.78 -52.09 64.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.575 HG23 ' OD1' ' A' ' 41' ' ' ASP . 79.5 t -58.31 -45.85 89.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 110.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.603 ' CZ3' ' NH2' ' A' ' 37' ' ' ARG . 22.2 t90 -50.35 -63.92 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.917 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.03 -36.14 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 52.1 t80 -62.21 -60.97 2.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.9 HD22 HG22 ' A' ' 30' ' ' VAL . 2.6 tt -49.47 -34.55 17.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' VAL . 64.1 t -60.39 -51.04 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.152 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.88 76.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.433 -0.792 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.9 tp -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -0.935 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.037 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -126.34 -88.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.18 166.0 32.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.88 -19.32 60.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -1.147 . . . . 0.0 110.562 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -62.94 1.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.115 -0.991 . . . . 0.0 109.949 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.037 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.54 -21.02 66.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.327 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.9 HG22 HD22 ' A' ' 21' ' ' LEU . 38.0 t -75.86 -32.44 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.49 -0.756 . . . . 0.0 109.755 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 m -93.29 -14.99 26.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.057 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.07 -24.67 21.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.016 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -82.18 9.34 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.2 t-20 59.34 72.6 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 110.652 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 21' ' ' LEU . 22.4 mt -119.45 120.38 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.627 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' THR . 10.1 mtm180 -101.19 149.07 24.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.569 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.603 ' NH2' ' CZ3' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -100.22 152.26 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.823 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.82 172.47 9.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.167 -0.958 . . . . 0.0 110.405 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 40' ' ' SER . 1.2 p -50.92 -27.31 7.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.517 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 5.1 m -172.06 -173.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.575 ' OD1' HG23 ' A' ' 17' ' ' VAL . 2.6 m-20 -55.12 -22.83 18.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 17.6 t-20 -87.8 107.73 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.917 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.5 p80 -147.33 -175.98 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -95.2 148.73 22.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 10.4 p -139.9 -176.08 4.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.935 . . . . 0.0 110.458 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' CYS . . . 45.84 43.17 9.75 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.3 -157.66 53.45 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.54 44.44 1.04 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.045 -1.267 . . . . 0.0 109.598 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -117.33 -34.37 4.34 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.292 -0.88 . . . . 0.0 111.342 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.02 165.22 12.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.233 -1.46 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 3.5 m95 -140.32 171.37 14.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.608 -0.937 . . . . 0.0 108.948 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.1 t -113.99 123.4 49.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 111.565 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -135.1 156.65 48.65 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' ARG . 80.0 p -46.58 -41.42 14.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.86 -1.15 . . . . 0.0 109.027 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -142.63 178.27 7.74 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 62' ' ' VAL . 10.8 m -122.15 165.69 15.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.895 -1.128 . . . . 0.0 110.153 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -79.93 175.36 10.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -73.47 -39.45 64.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 0.0 110.646 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -2.74 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.139 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.36 -174.66 3.06 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 5.8 p90 -146.72 -159.7 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.674 HG22 ' SG ' ' A' ' 56' ' ' CYS . 45.1 t -125.44 104.85 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.627 -0.671 . . . . 0.0 109.594 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 75' ' ' CYS . 9.7 p30 -51.69 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -44.07 -25.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.706 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.35 -48.5 41.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 111.085 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.686 ' O ' HG12 ' A' ' 69' ' ' VAL . 60.0 m-85 -89.28 -4.66 58.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 111.408 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -51.08 -23.1 2.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.147 . . . . 0.0 108.693 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -72.01 -66.08 0.69 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.624 -0.672 . . . . 0.0 110.538 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.917 HG22 ' CE1' ' A' ' 43' ' ' HIS . 13.2 p -44.08 -30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.078 -1.013 . . . . 0.0 109.67 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -65.47 -63.76 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.109 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.0 -132.6 11.08 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -51.88 -34.55 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.168 . . . . 0.0 110.06 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.35 -174.01 4.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -130.72 128.57 41.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.848 . . . . 0.0 109.877 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.03 99.38 6.86 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.94 -1.1 . . . . 0.0 108.804 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 5.6 m -79.56 160.99 26.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 1.1 mtp180 -151.0 170.93 18.15 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 110.144 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.38 117.02 33.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.655 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 49.2 Cg_endo . . . . . 0 N--CA 1.485 0.994 0 N-CA-C 110.032 -0.795 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.595 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -116.18 -43.45 2.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.86 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -54.11 -39.43 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 1.034 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 47.3 m-85 -59.93 -31.78 70.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 6' ' ' ALA . 66.1 mt -72.87 143.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.454 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.98 35.26 63.37 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -127.77 -162.57 1.18 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -1.065 . . . . 0.0 110.646 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.827 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.7 m -150.35 89.87 1.61 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -83.19 -163.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.018 -1.051 . . . . 0.0 110.336 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.92 -165.62 21.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -73.16 -44.29 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.313 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -65.01 -49.88 68.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.121 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.567 HG11 ' HB ' ' A' ' 13' ' ' VAL . 44.4 t -60.64 -49.81 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.848 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 46.4 t-105 -46.26 -63.87 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.97 -43.06 6.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -59.62 -66.64 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.895 HD22 HG22 ' A' ' 30' ' ' VAL . 4.8 tt -40.78 -49.17 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.489 -0.757 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.5 t -48.75 -50.96 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.39 64.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.399 -0.813 . . . . 0.0 109.868 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 tp -60.18 -42.2 94.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 110.016 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.959 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -125.93 -87.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.972 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.82 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.4 163.58 27.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.71 60.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -1.132 . . . . 0.0 110.612 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -62.63 1.32 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.14 -0.975 . . . . 0.0 109.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.959 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.13 -25.33 66.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.895 HG22 HD22 ' A' ' 21' ' ' LEU . 20.1 t -68.64 -34.0 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 m -77.09 -44.27 31.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.82 65.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.62 23.06 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.964 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.451 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 62.7 t-20 39.82 70.78 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.423 -0.798 . . . . 0.0 110.646 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.848 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 14.8 mt -115.16 130.16 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.716 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.486 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 10.2 mtt180 -114.86 148.96 37.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.416 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.574 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 6.6 mtp180 -99.47 149.14 23.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.473 -0.767 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -122.95 159.47 28.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.112 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.445 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.3 m -45.08 -25.09 0.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 39' ' ' SER . 44.6 m -167.47 -171.99 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.113 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.1 m-20 -64.22 -14.85 58.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 11.2 t-20 -93.53 109.72 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.5 p80 -146.55 -175.69 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.586 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 1.9 p -88.66 127.24 35.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.681 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.9 p -117.32 178.1 4.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.575 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.06 33.14 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.357 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.63 -149.37 36.6 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -87.6 29.12 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.129 -1.218 . . . . 0.0 109.963 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -108.4 -32.12 7.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.218 -0.926 . . . . 0.0 110.855 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.519 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.8 164.68 15.68 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -138.46 178.59 7.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.456 -1.026 . . . . 0.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.3 t -115.6 113.43 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.889 -1.132 . . . . 0.0 110.707 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -131.58 157.32 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -56.21 -52.77 63.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.966 -1.083 . . . . 0.0 108.76 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' N ' ' OG ' ' A' ' 54' ' ' SER . 1.1 tttt -138.81 139.58 38.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 2.0 t -103.87 168.33 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.449 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.4 m-85 -79.62 168.09 19.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -38.16 86.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.786 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.86 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.995 -1.066 . . . . 0.0 109.739 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.3 mt-10 -124.05 179.3 4.91 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.358 -0.839 . . . . 0.0 109.998 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.6 p90 -135.29 -166.53 1.85 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.809 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.801 HG13 ' HB3' ' A' ' 74' ' ' PHE . 28.6 t -112.31 88.24 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.461 -0.774 . . . . 0.0 109.933 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' A' ' 77' ' ' ARG . 51.8 t0 -37.14 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.377 0.608 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.75 -28.29 60.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -69.91 -44.11 70.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 22.3 m-85 -92.12 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 111.001 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.86 -20.64 3.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.025 -1.047 . . . . 0.0 108.924 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.034 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -70.03 -71.49 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.575 -0.703 . . . . 0.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.827 HG21 ' H ' ' A' ' 12' ' ' THR . 7.2 p -44.28 -28.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.066 -1.021 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -63.05 -59.39 4.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 110.271 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -134.47 11.76 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -31.85 12.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -1.194 . . . . 0.0 109.859 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.7 m-85 -91.58 -179.63 5.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 110.115 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.801 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.1 m-85 -122.95 140.57 52.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.765 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.1 t -79.53 98.25 6.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.085 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 10.9 t -78.58 163.77 25.23 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.04 . . . . 0.0 110.198 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 44.4 mtp180 -159.12 176.08 12.69 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.406 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -94.84 109.89 21.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.162 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.637 ' CG ' ' CD1' ' A' ' 8' ' ' TYR . 47.5 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.484 -1.006 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.23 -44.14 2.91 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.04 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -53.58 -49.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.357 -0.839 . . . . 0.0 110.049 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.695 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 41.7 m-85 -47.13 -33.67 5.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 109.742 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 73.8 mt -72.17 124.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.294 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 72.95 29.94 64.17 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -120.33 -163.12 0.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.476 -1.014 . . . . 0.0 110.766 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.727 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.2 m -153.66 99.77 2.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.875 . . . . 0.0 109.84 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.962 HG12 HG23 ' A' ' 69' ' ' VAL . 10.4 m -95.38 168.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.224 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -75.65 -162.62 11.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -75.47 -49.08 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.028 1.541 . . . . 0.0 110.35 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 t -60.46 -54.22 48.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 110.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 76.3 t -58.33 -45.67 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.628 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 27.3 t90 -51.56 -66.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.64 -34.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.735 . . . . 0.0 110.289 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 56.4 t80 -64.05 -62.29 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.975 HD22 HG22 ' A' ' 30' ' ' VAL . 1.4 tt -52.36 -26.22 11.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.56 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.8 t -69.94 -50.55 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.731 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.08 -26.62 50.31 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.219 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 24' ' ' LEU . 9.1 tp -73.91 -50.59 19.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.518 -0.739 . . . . 0.0 110.669 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.915 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.1 m -113.05 -44.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.462 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 129.2 169.0 12.48 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.57 -26.74 66.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.901 -1.353 . . . . 0.0 110.479 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 -54.97 14.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.915 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -64.05 -40.76 97.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.87 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.975 HG22 HD22 ' A' ' 21' ' ' LEU . 54.7 t -68.29 -25.26 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 110.181 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.2 m -86.67 -22.41 26.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.2 -19.59 26.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -86.46 17.11 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.22 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.45 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 60.8 t-20 55.4 67.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 110.603 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.774 HD13 HD13 ' A' ' 21' ' ' LEU . 65.2 mt -120.35 110.06 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -91.77 152.83 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.661 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.628 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 1.4 mtp180 -94.76 157.18 16.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 109.691 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -132.03 163.58 28.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.432 ' C ' ' OG ' ' A' ' 40' ' ' SER . 84.1 p -53.33 -31.91 46.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.44 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.432 ' OG ' ' C ' ' A' ' 39' ' ' SER . 2.1 m -164.74 -179.8 6.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -49.68 -23.42 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.082 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.9 t30 -87.7 110.42 20.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.844 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.1 p80 -150.12 177.85 9.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.584 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 5.2 p -81.49 130.41 35.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.46 -0.775 . . . . 0.0 109.62 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 p -121.97 173.85 7.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 0.0 110.424 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . . . 48.37 40.24 14.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.124 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 -149.25 49.23 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -87.21 23.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.138 -1.213 . . . . 0.0 109.864 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -100.84 -34.62 9.74 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 0.0 111.051 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.494 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.37 166.57 14.92 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.987 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.59 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.4 m95 -140.99 171.07 14.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -1.07 . . . . 0.0 109.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 4.4 t -106.07 108.79 20.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.59 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -130.41 157.45 42.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.211 -0.93 . . . . 0.0 109.938 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -63.93 -52.75 58.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.965 . . . . 0.0 109.021 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.4 tttt -128.75 174.66 9.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.503 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 58.2 m -150.34 170.08 19.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.867 -1.145 . . . . 0.0 110.747 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 15.7 m-85 -81.97 -176.06 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.476 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -80.37 -46.95 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.25 -0.906 . . . . 0.0 110.646 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' ARG . 1.5 t-80 -46.46 -23.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 109.153 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mt-10 -118.67 175.35 5.77 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.456 -0.777 . . . . 0.0 109.445 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.8 p90 -139.94 -167.26 2.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.543 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 74' ' ' PHE . 49.8 t -110.96 89.45 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.636 -0.665 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 16.8 t0 -40.6 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.49 -0.756 . . . . 0.0 110.42 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.25 -24.93 30.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.566 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 7' ' ' ILE . 18.6 t80 -68.74 -51.99 35.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.526 -0.734 . . . . 0.0 110.714 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.645 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 9.1 m-85 -81.58 -4.98 57.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.161 -0.962 . . . . 0.0 111.414 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.7 p -49.6 -21.5 1.02 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.057 -1.027 . . . . 0.0 109.979 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -66.09 -69.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 110.602 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.962 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -49.07 -26.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.056 . . . . 0.0 109.476 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -68.2 -44.29 76.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -124.32 6.5 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.58 74.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -1.209 . . . . 0.0 110.045 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 80.4 m-85 -81.22 -178.99 7.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.1 m-85 -125.36 138.92 54.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.32 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 16.4 t -81.85 101.06 9.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.145 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 76.9 m -79.49 175.0 11.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 9.2 mtp180 -160.52 179.8 8.29 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 110.054 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.2 85.5 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.724 ' HB2' HG22 ' A' ' 7' ' ' ILE . 51.3 Cg_endo . . . . . 0 C--O 1.215 -0.669 0 N-CA-C 110.169 -0.743 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB3' ' OH ' ' A' ' 65' ' ' TYR . . . -88.83 -23.6 22.78 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 110.164 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.914 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -53.41 -57.16 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 110.995 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.641 ' H ' HG23 ' A' ' 7' ' ' ILE . 23.2 m-30 -48.32 -25.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.018 -1.051 . . . . 0.0 110.169 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.0 mt -73.17 128.37 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 58.05 32.79 67.49 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.914 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -117.46 -159.21 0.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.515 -0.991 . . . . 0.0 110.601 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.802 ' H ' HG21 ' A' ' 69' ' ' VAL . 2.8 m -153.13 91.05 1.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 109.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.914 HG12 HG23 ' A' ' 69' ' ' VAL . 5.9 m -90.66 164.62 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 110.506 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -89.69 -158.02 33.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.8 Cg_endo -74.42 -42.78 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.912 1.48 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.486 ' HB2' ' OD1' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -63.81 -57.75 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 110.089 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.9 t -58.51 -49.67 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.73 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.569 ' CH2' HG12 ' A' ' 30' ' ' VAL . 56.4 t-105 -46.52 -66.4 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.705 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.44 -38.11 1.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.485 -0.759 . . . . 0.0 110.33 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 6.4 t80 -63.36 -64.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.754 HD22 HG22 ' A' ' 30' ' ' VAL . 1.8 tt -46.68 -51.28 16.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.325 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 HG21 ' A' ' 30' ' ' VAL . 78.3 t -48.77 -52.87 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.69 44.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.108 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.8 tp -59.76 -41.88 92.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.007 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -126.21 -86.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.834 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.7 170.03 38.06 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.07 66.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 110.607 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.58 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.045 -1.034 . . . . 0.0 109.838 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.95 -22.28 66.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.204 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.754 HG22 HD22 ' A' ' 21' ' ' LEU . 24.1 t -73.54 -35.72 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.466 -0.771 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 m -78.65 -34.27 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.967 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.17 -23.89 59.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.49 4.88 12.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 59.5 t-20 59.05 68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.446 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 30' ' ' VAL . 25.8 mt -117.57 109.95 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.6 mtt180 -83.45 143.71 30.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.55 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.06 150.88 23.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.789 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.73 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -124.85 162.14 24.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.54 -26.33 20.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.311 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 2.5 m -170.44 -170.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 16' ' ' SER . 15.2 m-20 -62.5 -13.9 35.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.902 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.5 m-20 -99.61 102.82 14.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.795 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -141.47 175.38 9.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.414 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.594 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.3 p -79.17 129.59 34.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p -122.32 176.74 5.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.421 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.68 37.83 7.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.3 -148.62 45.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 14.8 p30 -87.84 26.64 1.29 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.168 -1.195 . . . . 0.0 109.912 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -105.63 -29.23 10.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.23 21.1 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.391 -1.385 . . . . 0.0 109.893 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.594 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 6.7 m95 -137.67 170.9 15.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.46 -1.023 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -105.75 115.89 31.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.667 -1.27 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -133.39 155.22 49.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.78 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -55.56 -56.97 14.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.891 -1.131 . . . . 0.0 108.754 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.79 -165.15 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 1.2 m -163.64 173.38 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.728 -1.233 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.51 -179.3 6.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.501 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -40.31 20.31 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.163 -0.961 . . . . 0.0 110.359 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.63 -16.88 4.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.54 178.19 4.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.477 -0.765 . . . . 0.0 109.539 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 4.4 p90 -144.39 -164.66 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.8 t -126.01 98.31 4.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -48.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.47 -26.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.67 . . . . 0.0 110.47 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.501 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 12.2 t80 -68.77 -52.47 30.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -81.21 -10.18 59.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 111.005 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -49.35 -22.85 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.05 -1.031 . . . . 0.0 109.357 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.665 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -66.92 -69.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.914 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -45.7 -30.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 109.624 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.51 -53.99 50.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.09 -139.39 14.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -50.49 -23.17 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -1.108 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.467 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 12.2 m-85 -94.27 -170.54 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 37.0 m-85 -129.32 133.47 47.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 109.732 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 7.5 t -79.98 101.94 8.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 109.212 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.7 m -78.7 167.21 21.54 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.875 -1.141 . . . . 0.0 110.376 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 2.4 mtp180 -160.87 167.44 26.67 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.91 102.46 13.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.204 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.662 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 47.7 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 109.932 -0.834 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -87.18 -44.71 11.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.442 -0.786 . . . . 0.0 110.238 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.774 HD11 ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -51.46 -41.86 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.286 -0.884 . . . . 0.0 110.483 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.951 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 28.3 m-85 -60.57 -33.73 73.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.179 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 6' ' ' ALA . 51.2 mt -71.97 138.5 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.118 -0.989 . . . . 0.0 109.514 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.96 33.95 81.11 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -127.48 -162.25 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.519 -0.989 . . . . 0.0 110.543 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.79 ' H ' HG21 ' A' ' 69' ' ' VAL . 2.3 m -151.15 98.43 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.237 -0.914 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.902 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -93.22 -175.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 13' ' ' VAL . . . -93.12 -164.56 37.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -72.62 -41.9 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.966 1.509 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -67.67 -47.34 69.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 47.6 t -62.64 -37.94 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.561 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 13.3 t90 -57.33 -58.9 6.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -50.45 -39.41 47.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 3.9 t80 -57.72 -65.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.058 HD22 HG22 ' A' ' 30' ' ' VAL . 4.1 tt -41.98 -44.38 3.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.506 -0.747 . . . . 0.0 109.987 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG22 HG21 ' A' ' 30' ' ' VAL . 71.7 t -55.27 -48.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.28 76.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -59.57 -41.12 89.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.94 -88.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.405 -0.81 . . . . 0.0 110.199 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.838 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.76 163.92 29.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.41 -20.59 56.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.603 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.24 1.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.094 -1.004 . . . . 0.0 109.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.03 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.93 -22.0 66.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.058 HG22 HD22 ' A' ' 21' ' ' LEU . 26.0 t -71.39 -33.58 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.8 m -86.25 -26.71 24.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.84 -18.87 49.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.892 . . . . 0.0 109.782 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.65 23.32 2.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 62.5 t-20 43.36 71.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 21' ' ' LEU . 65.2 mt -121.59 112.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -95.71 148.88 22.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.681 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.561 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm-85 -89.69 159.12 17.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 110.005 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -42.82 -26.73 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.908 . . . . 0.0 110.08 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' ALA . 3.2 m -174.43 -171.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 110.073 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 72' ' ' ARG . 70.6 m-20 -57.51 -17.24 12.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 t-20 -91.25 108.64 20.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.327 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.4 p80 -151.65 179.72 8.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.208 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -81.09 148.04 29.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.864 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 7.8 p -141.28 -178.47 5.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.913 ' HB1' ' NH2' ' A' ' 77' ' ' ARG . . . 47.42 42.7 14.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 -154.88 48.54 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.424 -1.87 . . . . 0.0 108.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -84.05 42.91 0.9 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.112 -1.228 . . . . 0.0 109.665 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -119.31 -35.33 3.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.2 -0.938 . . . . 0.0 111.252 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -127.11 171.21 18.72 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.319 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 17.5 m95 -138.63 179.13 6.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.983 . . . . 0.0 109.405 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.447 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.0 t -112.59 118.5 35.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.812 -1.18 . . . . 0.0 110.769 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -130.47 158.3 40.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.663 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -53.39 -47.84 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.049 -1.032 . . . . 0.0 109.146 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 140.93 44.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 62' ' ' VAL . 15.5 m -77.48 159.38 29.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 110.097 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -80.59 -171.43 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.418 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -43.23 39.3 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.12 3.85 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 9.3 mt-10 -129.35 162.74 27.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 0.0 109.958 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 24.3 p90 -129.36 -178.83 4.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.625 HG22 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -91.42 92.84 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.332 0.587 . . . . 0.0 109.474 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 1.5 m-20 -51.52 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.694 . . . . 0.0 109.782 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -51.7 -22.65 3.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 0.0 110.683 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -70.02 -56.93 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 111.043 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.774 ' CD1' HD11 ' A' ' 7' ' ' ILE . 4.0 m-85 -86.06 -3.47 58.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 111.374 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.57 -23.03 1.45 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.951 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.33 -71.97 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.656 -0.653 . . . . 0.0 110.757 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.902 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.24 -27.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 1.0 OUTLIER -63.5 -63.35 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.265 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.15 -112.29 4.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HG3' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mtt180 -62.66 -50.2 72.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -1.162 . . . . 0.0 110.093 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 20.2 m-85 -79.89 -173.05 3.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.951 . . . . 0.0 110.006 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' HG13 ' A' ' 62' ' ' VAL . 29.2 m-85 -126.56 139.23 53.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.799 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 t -79.6 107.3 12.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 0.0 108.735 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 10.3 m -97.45 157.57 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.793 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.913 ' NH2' ' HB1' ' A' ' 46' ' ' ALA . 8.5 mtp180 -142.63 -175.36 4.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.724 -0.61 . . . . 0.0 109.801 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.8 p -110.6 94.88 5.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.26 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 8' ' ' TYR . 45.3 Cg_endo . . . . . 0 C--O 1.215 -0.655 0 N-CA-C 110.027 -0.797 . . . . 0.0 110.027 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.469 ' CB ' ' OH ' ' A' ' 65' ' ' TYR . . . -61.67 -43.34 99.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.016 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.973 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -50.39 -54.24 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.62 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.617 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 8.8 m-30 -51.57 -31.03 23.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.972 . . . . 0.0 110.369 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 58.3 mt -71.95 129.41 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 60.14 31.66 73.79 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.973 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -114.55 -162.47 0.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -1.028 . . . . 0.0 110.668 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.706 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.8 m -154.68 97.89 2.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 109.758 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.098 HG12 HG23 ' A' ' 69' ' ' VAL . 3.5 m -93.77 172.78 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.099 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -85.82 -159.59 32.35 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 48.9 Cg_endo -74.74 -46.58 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.015 1.534 . . . . 0.0 110.5 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -67.65 -50.43 57.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.0 t -57.22 -45.78 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.992 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 11.3 t90 -52.17 -61.45 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.623 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.89 -37.97 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.424 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.4 t80 -60.29 -53.75 53.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.985 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.654 HD22 HG22 ' A' ' 30' ' ' VAL . 1.6 tt -57.63 -55.57 33.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.11 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.4 t -44.01 -61.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.065 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.19 -41.26 17.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.0 tp -59.95 -41.44 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.095 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -126.4 -88.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.839 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.05 166.18 33.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.94 -19.25 60.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.13 . . . . 0.0 110.699 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.17 -64.25 1.01 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.019 -1.051 . . . . 0.0 109.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.095 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.52 -21.74 65.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.214 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.654 HG22 HD22 ' A' ' 21' ' ' LEU . 24.5 t -73.65 -34.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.454 -0.778 . . . . 0.0 109.714 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.0 m -87.8 -19.64 27.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 109.899 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.21 -22.1 28.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.837 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -89.01 23.51 2.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.88 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.442 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 37.8 t-20 42.54 76.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 110.355 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.619 HD13 HD13 ' A' ' 21' ' ' LEU . 19.4 mt -123.6 110.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 109.701 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -93.22 144.44 25.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.907 . . . . 0.0 110.589 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 2.7 mtm180 -82.93 166.0 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 0.0 109.708 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.742 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -139.05 161.87 36.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.01 . . . . 0.0 110.266 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -51.19 -36.48 41.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.296 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 16.5 m -164.72 -179.07 5.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 38.6 m-20 -46.63 -30.89 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 17.2 t-20 -84.96 110.56 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.862 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.7 p80 -147.27 175.91 10.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.073 -1.017 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.594 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 17.9 p -78.23 127.54 32.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.426 -0.797 . . . . 0.0 109.749 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 p -120.49 168.43 11.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.006 -1.059 . . . . 0.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 53.22 50.0 18.66 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.551 -0.718 . . . . 0.0 109.303 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.17 -149.94 25.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -86.18 36.49 0.68 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.171 -1.193 . . . . 0.0 110.065 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HB3' ' NH1' ' A' ' 77' ' ' ARG . 3.5 mtt180 -113.57 -33.13 5.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -127.28 168.03 19.51 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.0 m95 -142.22 170.79 15.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -117.73 113.68 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.777 -1.202 . . . . 0.0 110.684 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -132.7 163.56 28.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.353 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.445 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 24.8 p -50.57 -48.17 57.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.897 -1.127 . . . . 0.0 108.508 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -127.74 179.83 5.33 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.641 0.734 . . . . 0.0 110.562 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.782 ' SG ' HG22 ' A' ' 62' ' ' VAL . 20.9 m -121.63 168.99 11.14 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.037 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -79.82 -173.62 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.5 -36.82 21.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.245 -0.909 . . . . 0.0 110.25 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -78.98 5.22 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 46.6 mt-10 -128.83 -175.68 3.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 7.5 p90 -141.12 -162.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 109.833 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.782 HG22 ' SG ' ' A' ' 56' ' ' CYS . 53.2 t -111.69 89.08 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.122 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 14.2 t0 -41.64 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 0.0 110.213 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -57.84 -27.1 62.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.207 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.469 ' OH ' ' CB ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -68.6 -49.51 58.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 110.605 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.4 m-85 -83.76 -9.28 58.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.945 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -22.57 1.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.039 -1.038 . . . . 0.0 109.537 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.96 -70.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 110.303 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.098 HG23 HG12 ' A' ' 13' ' ' VAL . 10.6 p -45.74 -25.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.998 -1.064 . . . . 0.0 109.341 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -67.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.781 . . . . 0.0 110.048 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.4 -96.13 2.0 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -56.77 7.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.422 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 24.6 m-85 -89.27 -168.99 2.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.091 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.496 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.3 m-85 -123.34 149.64 44.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.84 . . . . 0.0 109.73 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 15.7 t -86.03 100.88 12.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 0.0 109.765 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.2 m -79.34 163.56 24.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 3.4 mtp180 -153.95 176.88 11.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 t -104.67 94.37 5.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.171 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.155 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.8 Cg_endo . . . . . 0 C--O 1.216 -0.61 0 N-CA-C 109.937 -0.832 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -84.68 -16.74 40.82 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.421 -0.799 . . . . 0.0 110.287 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.842 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -55.91 -47.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -0.869 . . . . 0.0 110.737 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.604 ' CZ ' ' HB1' ' A' ' 68' ' ' ALA . 22.8 m-85 -52.37 -24.42 7.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.476 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 70.2 mt -60.37 136.51 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.715 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 46.31 34.92 6.58 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.15 -167.48 1.2 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.509 -0.994 . . . . 0.0 110.671 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.825 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.7 m -150.06 88.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.0 m -83.16 -165.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.35 -163.46 17.8 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -73.11 -45.45 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -67.59 -49.14 64.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.099 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 91.1 t -58.91 -48.0 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.606 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 7.8 t-105 -50.81 -59.35 4.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.732 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.46 -39.67 7.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.095 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 68.1 t80 -63.62 -63.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.335 -0.853 . . . . 0.0 110.145 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -42.37 -54.44 3.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.211 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG22 HG21 ' A' ' 30' ' ' VAL . 75.1 t -48.02 -50.2 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.11 -43.46 61.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 110.161 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -66.14 -36.12 82.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.092 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.04 -88.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.812 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 171.59 167.72 32.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.59 62.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -1.171 . . . . 0.0 110.524 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -63.66 1.1 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.053 -1.03 . . . . 0.0 109.914 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.092 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.19 -22.46 65.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.909 . . . . 0.0 109.297 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 26' ' ' GLY . 34.7 t -73.61 -31.46 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.486 -0.759 . . . . 0.0 109.979 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -87.83 -26.83 22.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.225 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -25.38 43.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -83.64 6.59 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 110.353 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 46.8 t-20 58.32 79.3 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -0.92 . . . . 0.0 110.619 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 40.0 mt -118.84 136.97 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -110.18 151.2 27.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 110.575 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.5 OUTLIER -100.95 143.05 31.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.0 109.887 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.88 152.2 37.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.406 ' C ' ' OG ' ' A' ' 40' ' ' SER . 9.6 m -42.39 -27.08 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -163.4 -176.02 4.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.196 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.5 -12.21 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.34 103.44 15.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.847 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.1 p80 -142.62 -178.56 5.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.615 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -92.92 147.22 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.802 . . . . 0.0 110.002 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.0 p -137.26 178.59 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 110.313 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 46.97 46.55 15.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.884 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.22 -153.11 48.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.66 42.88 0.94 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.054 -1.262 . . . . 0.0 109.604 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.4 mmm180 -109.44 -39.0 5.32 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 111.21 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.21 164.12 18.91 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.761 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.615 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.3 m95 -134.76 167.75 20.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.066 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.71 117.52 34.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.77 -1.206 . . . . 0.0 111.272 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mtt-85 -129.24 153.05 48.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.208 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.16 -48.98 64.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.09 . . . . 0.0 109.257 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.2 tttt -138.44 177.5 7.83 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 16.3 m -149.96 169.98 19.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.823 -1.173 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -80.03 -175.02 4.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.404 -0.81 . . . . 0.0 110.562 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 -43.36 14.64 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.324 -0.86 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.51 -20.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.688 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.88 174.35 5.98 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 9.2 p90 -138.96 -165.1 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.95 -1.094 . . . . 0.0 110.376 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 64' ' ' THR . 16.6 t -124.95 103.63 12.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 75' ' ' CYS . 14.8 p30 -47.91 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.85 -25.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.414 -0.803 . . . . 0.0 110.505 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' ASP . 12.8 t80 -71.34 -48.05 52.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.781 ' CD2' HD11 ' A' ' 7' ' ' ILE . 40.7 m-85 -90.2 -4.1 57.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 111.292 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -22.97 2.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 108.587 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.604 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -71.67 -64.48 0.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.671 -0.643 . . . . 0.0 110.485 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.847 HG22 ' CE1' ' A' ' 43' ' ' HIS . 10.1 p -44.96 -30.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.997 -1.064 . . . . 0.0 109.552 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -66.3 -58.31 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.147 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.98 -121.7 7.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -63.73 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -1.214 . . . . 0.0 110.166 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.7 m-30 -87.73 -174.96 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.884 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 39.8 m-85 -128.31 126.82 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.969 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.71 97.33 6.53 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.881 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 65.2 m -79.71 169.13 18.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 110.959 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -160.41 170.57 20.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.0 109.898 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.6 m -97.93 103.43 15.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 5.5 tpt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.292 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.8 Cg_endo . . . . . 0 C--O 1.215 -0.65 0 N-CA-C 109.834 -0.871 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -81.23 -24.11 37.61 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.842 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -51.33 -59.6 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.655 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.6 m-85 -45.97 -28.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 109.845 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.0 mt -69.55 131.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.482 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.46 32.15 57.68 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.02 -162.93 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.984 . . . . 0.0 110.517 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.812 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.7 m -153.82 99.02 2.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 0.0 110.099 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.719 HG12 HG23 ' A' ' 69' ' ' VAL . 2.8 m -89.96 -175.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.999 -1.063 . . . . 0.0 110.187 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -95.04 -160.94 34.01 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.508 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.1 Cg_endo -73.41 -47.87 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.963 1.507 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -48.0 73.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.53 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 15.9 t -58.98 -47.11 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.981 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.625 ' CE3' ' CD ' ' A' ' 37' ' ' ARG . 6.0 t90 -50.45 -60.76 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.56 -34.87 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.277 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 13.8 t80 -64.49 -66.07 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.899 HD22 HG22 ' A' ' 30' ' ' VAL . 1.1 tt -50.34 -24.97 3.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 26' ' ' GLY . 24.3 t -73.36 -42.36 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.792 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.81 69.88 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -77.93 -47.34 18.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.53 -0.732 . . . . 0.0 110.407 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.957 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.5 m -113.33 -42.78 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 110.448 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.567 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 120.36 170.06 14.15 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.13 69.46 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.915 -1.344 . . . . 0.0 110.427 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.16 -52.07 57.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.211 -0.931 . . . . 0.0 110.05 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.957 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -64.03 -44.6 92.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.899 HG22 HD22 ' A' ' 21' ' ' LEU . 74.2 t -62.66 -26.31 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.792 . . . . 0.0 110.231 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -83.85 -31.59 25.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.01 . . . . 0.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.23 -17.55 49.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.652 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -90.01 8.11 34.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 57.1 t-20 58.78 72.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.253 -0.905 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 33' ' ' ALA . 5.7 mt -126.2 113.78 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.829 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' THR . 25.1 mtm-85 -99.62 156.26 17.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.712 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.625 ' CD ' ' CE3' ' A' ' 18' ' ' TRP . 8.2 mtp180 -100.4 158.37 15.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.94 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -127.83 -174.6 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.317 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -60.67 -23.59 64.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.508 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.9 m -178.09 -169.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.3 m-20 -56.6 -24.08 45.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 110.091 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 31.0 t-20 -89.61 110.68 21.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.882 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.818 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.3 p80 -147.28 -176.03 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.107 -0.996 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.541 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -85.16 126.81 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 109.664 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.4 p -128.87 170.84 12.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 56.55 31.44 19.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.44 44.63 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 34.49 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.085 -1.244 . . . . 0.0 109.848 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.5 mmt85 -113.29 -36.14 5.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.396 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.17 160.08 23.26 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.419 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.541 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 19.5 m95 -131.47 175.29 9.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.598 -0.942 . . . . 0.0 108.646 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -118.9 116.54 26.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.724 -1.235 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -131.62 171.13 13.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.545 -0.722 . . . . 0.0 109.452 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -55.35 -47.62 75.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.054 -1.029 . . . . 0.0 109.228 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 7.4 tttt -135.03 177.05 8.11 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 62' ' ' VAL . 17.6 m -119.21 175.93 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.944 -1.097 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 65.1 m-85 -79.75 -176.42 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 110.239 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -39.79 22.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.131 -0.981 . . . . 0.0 110.5 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.592 ' CD2' ' HG3' ' A' ' 60' ' ' GLU . 31.8 p-80 -79.04 7.16 7.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 7.9 mt-10 -124.42 -170.46 2.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 3.3 p90 -152.43 -161.34 1.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' SG ' ' A' ' 56' ' ' CYS . 47.8 t -123.15 99.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 66' ' ' TYR . 46.0 p30 -52.11 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.892 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.72 -25.6 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -0.764 . . . . 0.0 110.982 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 63' ' ' ASP . 28.4 t80 -66.25 -53.13 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.055 -1.028 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 14.7 m-85 -83.16 -11.67 57.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 110.995 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -46.7 -24.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.686 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.21 -71.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 110.561 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.818 HG22 ' CE1' ' A' ' 43' ' ' HIS . 7.2 p -42.27 -28.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -64.2 -69.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.168 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.08 -119.94 6.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -27.18 68.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -1.169 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.1 m-85 -99.5 177.05 5.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.201 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 16.0 m-85 -121.02 138.01 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.958 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 41.1 t -79.51 100.59 7.8 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 108.837 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 9.4 m -79.35 160.84 26.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.17 . . . . 0.0 110.139 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.584 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -159.98 173.46 15.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.52 -0.737 . . . . 0.0 110.22 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 p -103.41 112.81 25.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 110.217 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.6 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.89 -0.85 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -118.54 -22.07 7.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.88 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.89 ' CD1' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -55.7 -52.05 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 110.397 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.622 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.2 m-85 -46.22 -25.97 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.877 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.5 mt -61.28 126.85 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.186 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 58.0 32.94 67.53 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.18 -162.53 0.81 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.666 -0.902 . . . . 0.0 110.872 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.739 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.1 m -157.25 97.04 1.61 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.067 HG12 HG23 ' A' ' 69' ' ' VAL . 3.6 m -95.22 174.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.996 -1.065 . . . . 0.0 110.21 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.88 -163.09 37.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 48.2 Cg_endo -74.14 -51.53 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.046 1.551 . . . . 0.0 110.522 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -49.76 76.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 48.6 t -58.93 -47.6 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.722 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 9.9 t-105 -51.73 -58.13 7.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.802 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.36 -39.85 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.131 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.69 -58.13 9.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.84 HD22 HG22 ' A' ' 30' ' ' VAL . 1.5 tt -51.05 -34.12 28.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.121 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 24.4 t -63.65 -47.97 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.44 -40.71 68.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.753 . . . . 0.0 109.823 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.1 tp -63.3 -39.78 95.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.002 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -132.46 -88.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.002 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.822 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 172.52 166.37 30.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.9 -20.45 65.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 110.446 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -61.54 1.73 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.112 -0.992 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.002 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.05 -28.74 70.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.84 HG22 HD22 ' A' ' 21' ' ' LEU . 37.8 t -70.27 -30.99 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.4 -0.812 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.3 m -76.55 -36.0 57.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.4 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.37 4.63 12.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.288 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 42.2 t-20 57.9 74.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.722 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 49.1 mt -122.26 121.73 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.5 mtt85 -101.11 150.29 23.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.608 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.86 159.61 16.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 110.077 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -133.58 151.13 51.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -42.98 -26.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' ALA . 4.9 m -172.36 -173.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 110.007 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -57.85 -17.31 15.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.224 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.1 t-20 -89.25 98.12 11.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.469 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.784 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.8 p80 -142.49 176.53 8.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 110.53 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.588 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.6 p -81.82 130.48 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.783 . . . . 0.0 109.847 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.91 174.64 6.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 48.69 46.31 21.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 109.084 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.09 -151.99 41.15 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.4 40.46 0.84 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -1.208 . . . . 0.0 109.752 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 10.4 mtp180 -112.46 -38.64 4.6 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.985 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -126.1 168.98 18.09 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.133 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.588 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -136.13 172.19 13.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -1.028 . . . . 0.0 109.861 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.4 t -104.41 112.37 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.76 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 7.2 mtt-85 -127.96 142.46 51.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.858 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.44 ' N ' ' CD2' ' A' ' 73' ' ' TYR . 2.1 p -51.89 -46.39 64.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.011 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -137.16 175.67 9.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 11.8 m -153.65 170.69 20.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.891 -1.131 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -79.74 177.57 8.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -79.61 -42.68 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -22.19 0.72 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.304 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.77 -175.69 2.73 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.51 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 3.1 p90 -147.38 -164.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 34.6 t -128.54 98.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -50.15 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.826 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.05 -26.7 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.579 -0.7 . . . . 0.0 110.26 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 7' ' ' ILE . 14.8 t80 -65.6 -49.79 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.63 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.4 m-85 -86.56 -3.09 58.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 111.562 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -17.28 6.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.016 -1.053 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.89 ' HB3' ' CD1' ' A' ' 7' ' ' ILE . . . -70.87 -56.67 5.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.95 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.067 HG23 HG12 ' A' ' 13' ' ' VAL . 7.9 p -61.11 -27.79 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.969 -1.082 . . . . 0.0 109.469 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -64.57 -49.05 72.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 -137.2 14.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -48.67 -31.56 6.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 109.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 54' ' ' SER . 8.6 m-85 -87.95 -177.83 5.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.006 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.547 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 46.8 m-85 -125.81 136.6 53.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 10.7 t -79.47 97.72 6.52 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.034 -1.041 . . . . 0.0 108.755 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 74.1 m -79.01 166.43 22.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.03 -1.044 . . . . 0.0 110.501 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.51 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 17.5 mtp180 -161.19 176.16 11.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.323 0.582 . . . . 0.0 109.83 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 78' ' ' SER . 11.5 p -108.08 104.53 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.505 -0.747 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.2 -179.812 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.587 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.0 Cg_endo . . . . . 0 C--O 1.216 -0.609 0 N-CA-C 110.255 -0.71 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.93 -23.27 28.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.443 -0.786 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.848 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -60.01 -38.23 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.687 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.511 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 9.7 m-30 -64.05 -18.79 64.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 9.4 mt -81.05 124.12 38.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.162 -0.961 . . . . 0.0 109.016 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 68.56 31.82 74.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -119.62 -163.08 0.96 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.468 -1.019 . . . . 0.0 110.752 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.728 ' H ' HG21 ' A' ' 69' ' ' VAL . 11.3 m -155.29 95.37 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.005 HG12 HG23 ' A' ' 69' ' ' VAL . 4.3 m -90.18 171.5 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -83.77 -161.18 31.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.7 Cg_endo -74.26 -45.07 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.911 1.479 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.1 m -66.75 -55.49 14.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.537 HG23 ' OD1' ' A' ' 41' ' ' ASP . 84.1 t -56.09 -45.56 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.814 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 22.8 t-105 -51.16 -62.99 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.19 -38.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.143 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.426 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.9 t80 -63.68 -60.21 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.106 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.807 HD13 HD13 ' A' ' 35' ' ' ILE . 1.2 tt -47.89 -55.37 9.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.625 ' HA ' HG21 ' A' ' 30' ' ' VAL . 41.3 t -44.15 -56.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.78 -42.74 47.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.4 tp -53.29 -42.94 67.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 109.988 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.099 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -127.99 -86.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 109.936 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.842 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.33 166.1 33.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -61.22 -19.93 62.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -1.145 . . . . 0.0 110.449 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -63.4 1.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.099 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.8 -20.17 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.649 HG22 HD22 ' A' ' 21' ' ' LEU . 29.6 t -77.85 -33.6 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.477 -0.764 . . . . 0.0 109.892 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -80.89 -33.16 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.52 -23.49 46.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.28 4.88 11.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 59.4 t-20 60.78 63.98 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.654 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.814 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 54.8 mt -113.78 128.39 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.368 -0.832 . . . . 0.0 109.481 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -110.25 145.27 37.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 110.488 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.598 ' HG3' ' CD2' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -90.31 154.38 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 109.761 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -129.54 171.0 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.253 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' HG ' ' A' ' 40' ' ' SER . 1.9 t -58.76 -33.3 70.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.533 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -159.92 178.94 9.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.567 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 41.6 m-20 -52.33 -33.31 42.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 15.2 t-20 -82.71 99.81 9.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.89 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.7 p80 -136.25 177.01 8.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.409 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -75.25 141.66 43.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.977 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 10.9 p -131.79 178.78 6.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 44.16 44.88 6.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.229 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.03 -156.75 51.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' ASN . 22.9 t30 -84.33 41.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.963 -1.316 . . . . 0.0 109.959 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.35 -33.36 3.89 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.149 -0.969 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.533 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -121.19 173.84 15.68 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.831 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 16.5 m95 -150.73 161.35 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.424 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 86.4 m -96.5 104.57 16.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.12 . . . . 0.0 109.971 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 6.0 mtt180 -120.23 151.5 39.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 109.976 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.493 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -57.56 -52.84 63.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 109.122 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.38 172.98 10.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 94.6 m -149.5 168.09 24.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.785 -1.197 . . . . 0.0 110.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -79.91 176.22 9.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.731 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -75.34 -44.5 44.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -48.01 -21.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -118.3 174.29 6.32 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.417 -0.802 . . . . 0.0 109.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 11.2 p90 -134.4 -167.65 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.975 . . . . 0.0 110.227 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.797 HG13 ' HB3' ' A' ' 74' ' ' PHE . 17.9 t -113.97 89.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.73 . . . . 0.0 109.981 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.1 t0 -39.82 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.363 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -52.91 -23.34 6.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 110.591 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.08 -44.01 55.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.733 ' CD1' HD11 ' A' ' 7' ' ' ILE . 20.3 m-85 -89.83 -9.93 47.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 111.622 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -22.17 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.787 -1.196 . . . . 0.0 109.049 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -68.91 -52.62 27.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.488 -0.757 . . . . 0.0 110.645 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.005 HG23 HG12 ' A' ' 13' ' ' VAL . 9.7 p -60.0 -34.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.887 -1.133 . . . . 0.0 110.32 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 75' ' ' CYS . 61.6 m -60.4 -51.68 68.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.955 -1.091 . . . . 0.0 109.682 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.93 -102.78 2.91 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HD2' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -76.57 -5.27 46.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -1.151 . . . . 0.0 109.881 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.65 178.09 4.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.797 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.1 m-85 -120.5 137.85 54.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 109.755 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 11.3 t -79.69 94.29 5.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.967 -1.083 . . . . 0.0 109.352 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.5 m -77.78 170.75 16.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.003 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.9 mtp180 -160.27 -177.5 6.3 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.244 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 m -110.19 91.15 3.54 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.192 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 10.3 tpt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.642 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 50.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.29 -41.33 3.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.627 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.766 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -57.64 -38.19 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.451 -0.781 . . . . 0.0 110.443 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.925 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 45.2 m-85 -62.71 -25.04 67.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.282 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 61.3 mt -73.4 143.72 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 49.51 36.58 24.4 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.23 -164.32 1.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.523 -0.986 . . . . 0.0 110.549 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.848 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.2 m -152.1 91.77 1.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.032 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.869 HG12 HG23 ' A' ' 69' ' ' VAL . 2.7 m -89.14 162.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.111 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.65 -166.68 9.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.1 Cg_endo -73.37 -39.41 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.999 1.526 . . . . 0.0 110.448 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -51.25 43.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.38 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 48.0 t -57.62 -46.5 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.742 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 35.2 t-105 -49.8 -61.14 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.45 -44.3 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.283 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -58.12 -66.81 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.849 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.992 HD22 HG22 ' A' ' 30' ' ' VAL . 5.7 tt -40.52 -56.19 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 110.12 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 21' ' ' LEU . 47.2 t -42.44 -55.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.878 . . . . 0.0 110.061 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.18 -44.85 33.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 24' ' ' LEU . 12.9 tp -57.27 -49.94 74.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.15 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.973 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -117.02 -88.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.821 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.82 165.71 32.16 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.73 -20.13 63.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -1.129 . . . . 0.0 110.54 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.13 -63.29 1.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.149 -0.969 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.973 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.91 -19.14 62.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.223 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.992 HG22 HD22 ' A' ' 21' ' ' LEU . 10.9 t -75.09 -39.83 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.48 -0.762 . . . . 0.0 109.743 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.5 m -77.8 -28.8 50.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.4 -24.22 42.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -80.0 5.55 13.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.487 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.1 t-20 58.79 69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.742 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 11.0 mt -119.3 135.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mtp180 -115.42 149.84 37.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 10.8 mtp85 -98.46 143.96 28.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 109.839 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -115.57 164.11 14.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.8 p -48.35 -27.79 2.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.4 m -165.01 -168.32 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 78.9 m-20 -64.32 -22.14 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.296 -0.877 . . . . 0.0 110.166 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.6 t30 -88.58 110.54 20.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.777 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.0 p80 -148.72 175.92 10.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.4 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.619 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -79.99 139.07 37.15 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -130.47 176.93 7.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 110.439 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.36 39.45 12.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.76 -151.98 46.86 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -87.44 24.17 1.72 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.171 -1.193 . . . . 0.0 109.972 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -105.65 -28.83 10.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 110.797 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.39 164.53 15.39 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.002 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.619 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 9.3 m95 -142.52 174.41 10.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.44 -1.035 . . . . 0.0 109.701 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.6 t -109.23 113.16 25.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 2.3 mtt180 -133.43 143.99 49.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -46.61 -39.31 10.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.971 -1.081 . . . . 0.0 108.766 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 4.7 tttt -135.86 171.1 14.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.779 ' SG ' HG22 ' A' ' 62' ' ' VAL . 6.3 m -119.73 177.06 5.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.18 -169.16 2.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -84.45 -42.46 15.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.422 -0.799 . . . . 0.0 110.215 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -72.2 -1.2 14.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 17.9 mt-10 -126.65 -179.92 5.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.917 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.55 ' CD1' ' HB2' ' A' ' 79' ' ' ARG . 8.1 p90 -139.74 -162.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.07 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.779 HG22 ' SG ' ' A' ' 56' ' ' CYS . 47.8 t -110.87 88.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.1 t0 -40.71 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.581 -0.699 . . . . 0.0 110.25 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 4.3 p -57.69 -34.64 69.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.378 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -63.54 -46.38 86.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.695 ' CD1' HD11 ' A' ' 7' ' ' ILE . 18.1 m-85 -86.57 -6.88 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 111.059 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -50.33 -22.29 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.951 -1.093 . . . . 0.0 109.064 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -67.59 -71.59 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.549 -0.72 . . . . 0.0 110.579 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.869 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.75 -29.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.01 -65.76 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 110.354 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.96 -115.81 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -61.6 -49.98 74.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -1.203 . . . . 0.0 109.915 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.475 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.6 m-85 -80.0 -177.22 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.668 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.7 m-85 -121.3 142.27 50.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.483 -0.76 . . . . 0.0 109.096 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.5 t -79.59 100.88 8.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.429 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 33.3 m -78.94 165.87 23.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.536 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -157.13 176.67 12.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.85 . . . . 0.0 110.344 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.43 96.59 6.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.204 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.62 ' HB2' HG22 ' A' ' 7' ' ' ILE . 48.6 Cg_endo . . . . . 0 C--O 1.215 -0.672 0 N-CA-C 109.859 -0.862 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.16 -36.75 34.65 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -50.7 -47.88 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 110.717 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.646 ' O ' HD13 ' A' ' 35' ' ' ILE . 7.8 m-30 -50.68 -34.93 28.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 110.301 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 43.4 mt -69.9 115.6 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.88 28.61 58.59 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.923 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -115.94 -162.65 0.85 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.967 . . . . 0.0 110.71 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.752 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.0 m -153.35 93.78 1.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.044 HG12 HG23 ' A' ' 69' ' ' VAL . 3.9 m -93.41 169.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 110.201 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -79.43 -154.95 9.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 49.1 Cg_endo -76.8 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.007 1.53 . . . . 0.0 110.441 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 t -53.21 -50.89 63.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.47 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 21.9 t -59.91 -46.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.118 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.624 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 11.3 t90 -49.47 -65.5 0.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.517 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.02 -41.55 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.395 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 36.6 t80 -59.33 -62.45 1.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.924 . . . . 0.0 109.87 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.958 HD22 HG22 ' A' ' 30' ' ' VAL . 1.7 tt -43.92 -52.73 6.68 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.393 -0.817 . . . . 0.0 109.811 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' HG21 ' A' ' 30' ' ' VAL . 40.5 t -52.4 -42.67 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.786 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 20' ' ' TYR . . . -50.86 -45.11 59.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.342 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.86 -27.38 62.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.488 -0.757 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -124.18 -91.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.682 . . . . 0.0 110.293 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' H ' HG23 ' A' ' 25' ' ' VAL . . . 167.26 -170.57 41.61 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 -52.65 9.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.32 . . . . 0.0 110.306 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.56 74.16 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.943 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . . . -69.45 -49.93 50.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 109.782 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.958 HG22 HD22 ' A' ' 21' ' ' LEU . 25.0 t -62.88 -21.77 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.2 m -79.78 -40.62 28.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.139 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.08 -17.21 60.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.19 25.05 2.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.9 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.448 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 46.0 t-20 41.87 67.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 8' ' ' TYR . 16.2 mm -110.21 112.5 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.659 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 12' ' ' THR . 5.3 mtt180 -97.6 139.47 33.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.893 . . . . 0.0 110.295 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.624 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -89.52 155.69 19.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -133.73 157.98 44.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.04 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -45.1 -33.27 2.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.545 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -166.92 -156.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 110.262 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD2' ' HD3' ' A' ' 72' ' ' ARG . 59.6 m-20 -71.73 -5.86 37.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.507 -0.746 . . . . 0.0 110.044 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 2.3 t30 -102.57 102.57 12.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.777 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.2 p80 -146.03 -175.46 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.454 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.1 p -86.95 129.49 34.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.443 -0.785 . . . . 0.0 109.568 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.45 177.63 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.426 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 48.03 45.35 19.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 -156.01 52.79 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 19.7 p30 -86.24 34.94 0.63 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.013 -1.286 . . . . 0.0 110.009 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -115.9 -30.6 6.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.131 -0.98 . . . . 0.0 110.788 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -117.92 163.74 12.82 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.483 -1.342 . . . . 0.0 109.773 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 7.5 m95 -140.23 177.06 8.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.0 109.367 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 6.2 t -114.55 115.07 26.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 110.928 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -131.91 159.28 39.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 55' ' ' LYS . 5.9 p -57.89 -52.67 64.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.988 -1.07 . . . . 0.0 108.965 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' N ' ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -140.69 139.69 34.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -105.05 163.6 12.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.235 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.63 -164.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' HIS . 8.9 ttp180 -80.64 -43.74 19.99 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.445 ' C ' ' HG2' ' A' ' 60' ' ' GLU . 1.3 m-70 -45.78 -24.49 0.38 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.8 mm-40 -125.91 179.56 5.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.385 -0.822 . . . . 0.0 110.023 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.0 p90 -137.86 -163.11 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.594 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' A' ' 74' ' ' PHE . 25.4 t -113.77 87.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 109.927 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.3 t0 -38.26 90.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.694 -0.629 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.98 -25.34 43.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.545 ' O ' HD12 ' A' ' 7' ' ' ILE . 8.4 t80 -70.8 -51.32 27.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.63 ' O ' HG12 ' A' ' 69' ' ' VAL . 10.9 m-85 -81.44 -6.45 58.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 111.23 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -18.93 2.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.042 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.11 -47.02 63.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.9 . . . . 0.0 110.988 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.044 HG23 HG12 ' A' ' 13' ' ' VAL . 7.9 p -71.54 -24.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.501 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -66.99 -57.33 7.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.452 -0.78 . . . . 0.0 110.267 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.31 -125.75 8.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HD3' ' OD2' ' A' ' 41' ' ' ASP . 5.2 mpt_? -52.51 -36.65 55.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.84 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 39.5 m-85 -90.87 -173.42 3.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.727 ' HB3' HG13 ' A' ' 62' ' ' VAL . 3.0 m-85 -129.65 142.34 50.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 10.5 t -79.6 99.32 7.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.556 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 8.0 t -79.05 165.41 23.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.129 -0.982 . . . . 0.0 109.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 5.4 mtp180 -157.5 171.93 19.48 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.784 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 79' ' ' ARG . 1.1 m -107.55 76.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 78' ' ' SER . 6.6 ttt-85 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.152 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.838 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.9 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 110.028 -0.797 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -80.44 -21.97 41.62 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.403 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.838 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -52.57 -54.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.608 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.66 -28.88 3.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 17.3 mt -64.86 123.91 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.75 29.34 74.47 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -116.92 -162.77 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -1.009 . . . . 0.0 110.429 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.844 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.2 m -151.95 95.09 2.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.012 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 69' ' ' VAL . 3.2 m -88.87 179.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 110.118 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -94.52 -161.81 34.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.31 -45.68 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.016 1.535 . . . . 0.0 110.318 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -53.1 50.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG23 ' OD1' ' A' ' 41' ' ' ASP . 10.7 t -58.55 -47.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -0.946 . . . . 0.0 109.856 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.636 ' CH2' HG12 ' A' ' 30' ' ' VAL . 59.6 t-105 -48.09 -66.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.96 -38.35 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.27 -49.66 76.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.823 ' CD1' HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -60.38 -28.13 67.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . 48.5 t -66.79 -48.75 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 110.0 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.98 92.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.838 . . . . 0.0 109.914 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.8 tp -61.45 -41.94 97.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -130.52 -50.87 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.254 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 30' ' ' VAL . . . 137.02 163.99 9.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -66.2 -9.41 31.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -1.182 . . . . 0.0 110.856 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 -67.64 0.66 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.968 -1.083 . . . . 0.0 109.707 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.025 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.77 -20.08 64.63 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 108.668 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.788 HG22 HD22 ' A' ' 21' ' ' LEU . 14.4 t -70.82 -37.23 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.606 -0.684 . . . . 0.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.7 m -85.04 -25.03 27.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.36 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.866 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.05 25.92 2.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.771 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 5.8 t-20 40.21 75.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 0.0 110.6 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.823 HD13 ' CD1' ' A' ' 21' ' ' LEU . 64.3 mt -124.34 118.34 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.768 . . . . 0.0 109.455 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.482 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.3 mtt180 -96.91 156.68 16.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 110.512 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 8.9 mtp180 -107.27 139.47 41.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.554 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -117.73 164.56 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -42.7 -26.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.356 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.503 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -172.34 -162.42 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' OD1' HG23 ' A' ' 17' ' ' VAL . 54.2 m-20 -66.61 -8.44 27.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.882 . . . . 0.0 110.302 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.2 t-20 -94.7 101.99 13.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.516 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.802 ' CE1' HG22 ' A' ' 69' ' ' VAL . 2.6 p80 -143.55 -179.78 6.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.548 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -88.1 120.92 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 109.66 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 p -116.51 -178.75 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' CZ ' ' A' ' 77' ' ' ARG . . . 49.13 41.58 19.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.457 -0.777 . . . . 0.0 108.957 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.57 -153.74 51.0 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.96 36.55 0.67 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.057 -1.26 . . . . 0.0 109.771 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -117.77 -30.74 5.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -124.64 160.23 19.25 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.893 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.548 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 25.2 m95 -132.18 174.68 9.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.318 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.7 t -107.44 112.53 25.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.421 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -127.77 143.2 51.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.894 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -49.52 -46.45 48.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 108.624 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -125.67 -175.84 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 86.6 m -150.9 160.32 43.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.992 -1.067 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -80.56 171.53 14.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 110.365 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -38.97 67.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -13.68 11.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.733 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -120.88 169.93 9.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 109.557 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 15.5 p90 -132.09 -178.01 4.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.913 -1.117 . . . . 0.0 111.102 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 75.6 t -99.61 94.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.294 0.568 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -47.96 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -50.46 -25.4 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 111.027 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.03 -48.6 43.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.17 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.706 ' CD2' HD11 ' A' ' 7' ' ' ILE . 32.0 m-85 -89.79 -4.86 57.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.07 -1.019 . . . . 0.0 111.41 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -49.91 -22.89 1.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.942 -1.099 . . . . 0.0 109.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -70.99 -65.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.447 -0.783 . . . . 0.0 110.541 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.844 HG21 ' H ' ' A' ' 12' ' ' THR . 9.3 p -46.69 -26.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.948 -1.095 . . . . 0.0 109.59 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -68.63 -64.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -124.14 8.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -24.36 22.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.147 . . . . 0.0 109.953 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 12.2 m-85 -102.0 -179.41 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 110.143 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 8.9 m-85 -123.57 130.84 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.131 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.526 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 7.5 t -79.81 105.99 11.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.037 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 66.6 m -102.09 170.07 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.666 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 16.7 mtp180 -149.73 -172.8 4.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.348 0.594 . . . . 0.0 109.559 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 79' ' ' ARG . 5.6 p -115.73 80.42 1.44 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.4 Cg_endo . . . . . 0 N--CA 1.481 0.763 0 N-CA-C 110.429 -0.643 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.86 -27.73 20.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.8 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -54.36 -49.65 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 110.442 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.571 ' H ' HG23 ' A' ' 7' ' ' ILE . 8.5 m-30 -46.6 -29.46 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 109.946 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -66.91 113.83 3.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.211 -0.93 . . . . 0.0 109.547 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 73.13 27.81 67.65 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -110.65 -164.77 0.94 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.527 -0.984 . . . . 0.0 110.619 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.745 ' H ' HG21 ' A' ' 69' ' ' VAL . 54.9 m -155.01 100.09 2.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 110.034 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.041 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -97.5 163.85 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.104 -0.998 . . . . 0.0 110.036 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.19 -164.73 11.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.2 Cg_endo -73.69 -47.5 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.4 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.02 51.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 81.6 t -60.59 -50.71 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.593 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 26.8 t-105 -45.17 -66.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.626 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -41.55 -42.33 2.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.6 t80 -60.73 -65.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -41.75 -44.33 3.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 110.356 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' VAL . 84.9 t -54.69 -49.52 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.81 69.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.65 -46.22 91.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.997 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -120.13 -87.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.825 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.16 170.21 39.29 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.8 -22.62 67.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -1.102 . . . . 0.0 110.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -61.94 1.58 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.997 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.17 -26.49 68.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 26' ' ' GLY . 33.9 t -71.42 -34.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.751 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.9 m -85.32 -20.47 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.905 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -20.52 31.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.85 25.01 2.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.831 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.432 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 49.0 t-20 41.5 74.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.815 . . . . 0.0 110.445 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 21' ' ' LEU . 13.5 mt -118.43 120.34 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 7.3 mmt180 -99.09 147.85 24.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 110.474 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.593 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 17.5 mtp180 -101.38 136.58 40.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.409 -0.807 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -110.44 160.06 16.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 110.233 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -48.62 -25.7 1.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.917 . . . . 0.0 110.313 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.413 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -160.07 -176.6 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD1' HG23 ' A' ' 17' ' ' VAL . 56.9 m-20 -62.17 -16.65 54.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 73' ' ' TYR . 19.8 t-20 -90.4 107.62 19.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.891 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.6 p80 -143.77 175.54 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 110.561 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.2 p -78.68 130.41 35.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.736 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.57 179.34 4.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 47.7 41.76 14.33 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.159 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.56 -153.22 51.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 1.8 m-20 -84.47 41.33 0.83 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.164 -1.198 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.96 -36.51 3.4 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -122.71 166.3 15.21 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.094 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 11.1 m95 -135.74 172.07 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -1.033 . . . . 0.0 109.649 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.7 t -105.35 111.62 24.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 1.2 mtt180 -129.14 145.14 51.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 73' ' ' TYR . 23.5 m -46.68 -40.44 13.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.033 . . . . 0.0 108.614 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.83 168.52 19.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 62' ' ' VAL . 7.8 m -117.22 173.67 6.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.899 -1.125 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -79.62 -169.85 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.074 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -87.57 -42.47 12.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.09 -1.22 11.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.229 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 9.2 mt-10 -121.65 -170.88 2.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.7 p90 -150.26 -162.94 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.889 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 56' ' ' CYS . 53.9 t -120.35 94.37 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -51.88 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.739 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -42.77 -25.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.691 -0.631 . . . . 0.0 110.598 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.499 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.9 t80 -66.55 -50.07 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 111.287 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.9 m-85 -87.0 -5.76 58.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 111.761 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 t -55.27 -18.27 5.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.854 -1.153 . . . . 0.0 109.663 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.8 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.25 -49.33 51.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 111.044 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.041 HG23 HG12 ' A' ' 13' ' ' VAL . 7.0 p -68.47 -27.93 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.133 . . . . 0.0 109.224 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.97 -53.58 55.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.52 -123.37 6.88 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -42.79 71.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -1.106 . . . . 0.0 109.971 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 22.6 m-30 -85.96 -178.19 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.947 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.633 ' HB3' HG13 ' A' ' 62' ' ' VAL . 10.3 m-85 -121.05 143.23 49.17 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.447 -0.783 . . . . 0.0 109.236 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 t -79.28 99.72 7.21 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.131 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.7 m -79.3 162.87 25.34 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.145 -0.972 . . . . 0.0 110.153 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 1.6 mtp180 -159.2 -176.21 5.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.512 -0.742 . . . . 0.0 110.275 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -118.31 83.59 2.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.756 . . . . 0.0 110.27 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.0 Cg_endo . . . . . 0 C--O 1.215 -0.661 0 N-CA-C 110.041 -0.792 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.16 -27.17 30.27 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.506 -0.746 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.792 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -56.04 -38.03 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.582 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 10.8 m-30 -64.93 -27.29 68.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.281 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.09 129.18 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.255 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 63.16 32.02 82.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -123.06 -162.14 1.01 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 110.555 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.75 ' H ' HG21 ' A' ' 69' ' ' VAL . 8.4 m -153.2 101.05 2.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.038 HG12 HG23 ' A' ' 69' ' ' VAL . 3.2 m -99.84 157.43 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 0.0 110.284 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -71.87 -162.0 5.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.7 Cg_endo -74.57 -40.54 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.018 1.536 . . . . 0.0 110.428 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.3 m -62.81 -58.93 5.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 84.5 t -59.26 -50.53 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.776 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.801 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 23.7 t-105 -45.09 -64.14 0.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 0.0 109.745 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.15 -44.55 5.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.719 . . . . 0.0 110.387 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 62.4 t80 -57.81 -62.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG22 ' A' ' 30' ' ' VAL . 2.0 tt -44.28 -56.16 4.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.813 . . . . 0.0 109.998 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' LEU . 84.7 t -43.07 -44.55 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 20' ' ' TYR . . . -57.78 -56.31 23.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 24' ' ' LEU . 13.5 tp -49.44 -46.45 47.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.945 . . . . 0.0 110.028 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.99 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -116.37 -89.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.797 . . . . 0.0 110.079 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.831 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.28 165.27 29.9 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.79 59.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 110.626 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.05 -62.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.105 -0.997 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.99 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.21 -21.38 66.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.788 HG22 HD22 ' A' ' 21' ' ' LEU . 24.8 t -74.62 -35.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.471 -0.768 . . . . 0.0 109.885 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -83.57 -26.32 30.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.92 -15.75 38.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.01 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.02 25.1 2.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.773 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 50.0 t-20 47.36 68.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.552 -0.718 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.801 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 57.6 mt -122.62 126.15 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.415 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 73.1 mtt180 -109.1 146.75 33.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.493 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CG ' ' CE3' ' A' ' 18' ' ' TRP . 0.9 OUTLIER -93.32 144.37 25.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.513 -0.742 . . . . 0.0 109.647 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -116.39 155.0 29.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.969 . . . . 0.0 110.401 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -45.66 -27.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -0.85 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -165.07 -163.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -70.45 -12.69 61.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.332 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.514 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.4 OUTLIER -94.57 103.75 15.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.816 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.7 p80 -143.42 177.0 8.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 110.336 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.598 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 84.9 p -82.37 131.89 35.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.44 -0.788 . . . . 0.0 109.569 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.9 p -124.27 175.68 6.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 110.62 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 51.11 36.51 15.71 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -150.36 51.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.25 42.64 0.89 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.263 . . . . 0.0 109.827 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.2 mtt180 -117.23 -38.31 3.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -0.911 . . . . 0.0 111.084 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -127.44 171.38 18.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.398 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 7.2 m95 -137.33 172.78 12.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.535 -0.979 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.46 110.69 22.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.158 . . . . 0.0 111.024 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -128.46 145.45 51.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.4 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 30.1 t -53.09 -53.16 54.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.884 -1.135 . . . . 0.0 108.316 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -124.87 178.4 5.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.455 0.645 . . . . 0.0 110.047 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' CD ' ' A' ' 53' ' ' ARG . 5.3 m -155.63 171.22 20.34 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.817 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -79.72 178.31 8.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.689 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -47.3 15.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -48.59 -21.04 0.51 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 109.64 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -110.5 178.17 4.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 109.705 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.5 p90 -144.18 -164.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.054 -1.029 . . . . 0.0 110.297 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 64' ' ' THR . 39.3 t -127.82 98.02 4.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -50.03 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.782 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.6 -26.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.674 -0.641 . . . . 0.0 110.458 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.5 t80 -66.79 -49.39 66.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 111.04 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.728 ' CD1' HD11 ' A' ' 7' ' ' ILE . 12.4 m-85 -85.77 -8.15 58.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 111.15 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.7 p -49.08 -22.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.921 -1.112 . . . . 0.0 109.017 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -65.36 -70.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.038 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -47.43 -29.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.907 -1.121 . . . . 0.0 109.845 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -63.95 -46.19 85.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.32 -132.82 11.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.1 mmt85 -57.07 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -1.19 . . . . 0.0 110.132 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 8.8 m-85 -84.26 -173.26 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 15.9 m-85 -128.39 134.49 48.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 110.078 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.0 t -79.73 97.11 6.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 108.635 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 70.9 m -79.21 166.29 22.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 110.581 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 13.6 mtp180 -160.77 177.56 10.31 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.217 0.532 . . . . 0.0 109.666 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 t -106.94 106.58 17.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.72 -35.61 5.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 110.036 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.923 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -53.01 -50.28 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.57 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.587 ' H ' HG23 ' A' ' 7' ' ' ILE . 15.9 m-30 -48.58 -31.76 7.06 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.887 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 41.7 mt -67.31 113.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.75 27.14 61.33 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.11 -164.4 0.92 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.552 -0.969 . . . . 0.0 110.6 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.678 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.0 m -155.89 103.08 2.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.073 HG12 HG23 ' A' ' 69' ' ' VAL . 4.0 m -98.62 -175.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.21 -160.32 32.5 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.84 -43.64 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.01 1.532 . . . . 0.0 110.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.9 p -65.44 -53.75 38.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 ' OD1' ' A' ' 41' ' ' ASP . 60.1 t -59.9 -48.81 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 109.968 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.721 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 14.3 t-105 -48.58 -60.38 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.858 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.07 -42.47 13.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.256 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.4 t80 -59.69 -65.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.836 HD22 HG22 ' A' ' 30' ' ' VAL . 3.9 tt -42.58 -43.94 3.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 18' ' ' TRP . 40.1 t -54.34 -50.08 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.96 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.5 -45.66 66.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.0 tp -58.27 -41.66 84.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.362 -0.836 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.007 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.64 -88.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.975 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.831 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 172.51 163.99 27.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -18.32 53.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.7 1.07 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.05 -1.031 . . . . 0.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.22 -25.64 67.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.12 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.836 HG22 HD22 ' A' ' 21' ' ' LEU . 37.3 t -68.75 -33.27 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.491 -0.756 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -77.5 -46.67 21.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.26 -17.77 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.27 23.31 2.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.439 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 35.5 t-20 40.69 69.84 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.721 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 21.2 mt -118.34 122.04 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.1 mtp180 -104.15 148.79 25.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 110.59 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 5.5 mtt85 -91.93 154.3 18.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.546 -0.721 . . . . 0.0 109.771 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.552 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.34 160.62 36.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -44.42 -35.03 2.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.557 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -164.17 -165.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.404 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' HG23 ' A' ' 17' ' ' VAL . 70.3 m-20 -64.37 -11.38 32.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.165 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 24.2 t-20 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.111 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.887 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -144.16 177.61 8.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.487 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.596 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.5 p -76.32 131.36 39.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -0.778 . . . . 0.0 109.699 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.51 173.96 8.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.985 -1.072 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.54 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 49.83 38.79 16.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.179 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.64 -149.44 51.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -85.14 40.91 0.85 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.098 -1.237 . . . . 0.0 109.706 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.9 mmt180 -113.77 -37.2 4.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.341 -0.849 . . . . 0.0 110.843 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -130.86 173.6 20.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.128 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.596 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -140.17 171.43 14.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.397 -1.061 . . . . 0.0 109.223 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.2 t -106.38 120.5 42.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.791 -1.193 . . . . 0.0 111.287 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 3.4 mtt-85 -132.95 156.21 47.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.464 -0.772 . . . . 0.0 108.922 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -48.53 -50.05 33.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 107.964 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.66 179.86 5.89 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.806 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.1 m -127.64 159.92 33.2 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.789 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -79.97 -177.0 5.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.41 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.48 -39.13 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.898 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -12.87 13.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.554 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 77' ' ' ARG . 5.3 mt-10 -124.56 -164.83 1.3 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.427 -0.796 . . . . 0.0 109.933 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.8 p90 -155.44 -162.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.709 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 ' SG ' ' A' ' 56' ' ' CYS . 78.4 t -119.86 95.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -53.04 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.334 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -44.17 -24.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.672 -0.643 . . . . 0.0 110.627 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.562 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.8 t80 -66.81 -50.85 61.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 111.164 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.611 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 8.0 m-85 -86.69 -5.6 59.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.108 -0.995 . . . . 0.0 111.724 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -54.68 -18.29 4.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.875 -1.141 . . . . 0.0 109.573 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.923 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -69.33 -51.81 33.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.073 HG23 HG12 ' A' ' 13' ' ' VAL . 8.1 p -66.71 -26.84 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 109.414 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -65.26 -44.5 87.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.871 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.08 -128.04 8.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -53.01 -34.02 54.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -1.097 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.555 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.4 m-30 -88.46 -174.62 4.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.001 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HB3' HG13 ' A' ' 62' ' ' VAL . 25.2 m-85 -130.17 135.97 48.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.957 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.3 t -79.36 101.25 8.0 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 108.958 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.0 m -83.09 162.31 21.38 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.054 -1.029 . . . . 0.0 109.817 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.423 ' CG ' ' HA3' ' A' ' 50' ' ' GLY . 10.0 mtp180 -157.14 -175.84 5.64 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.27 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -119.58 81.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 110.142 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 78' ' ' SER . 1.8 mtm-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.914 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.6 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 109.888 -0.851 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.97 -20.86 32.15 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.914 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -51.84 -57.54 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 111.119 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.681 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.2 m-85 -48.07 -27.28 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.063 -1.023 . . . . 0.0 110.236 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 12.4 mt -69.1 128.72 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 57.47 32.05 63.96 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.65 -163.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.526 -0.985 . . . . 0.0 110.431 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.818 ' H ' HG21 ' A' ' 69' ' ' VAL . 25.4 m -151.81 94.46 1.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.133 -0.979 . . . . 0.0 110.291 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.656 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.3 m -86.24 -168.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.854 -1.154 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.19 -161.46 24.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.13 -45.63 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.805 1.423 . . . . 0.0 110.142 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 p -65.71 -49.3 68.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.3 t -59.34 -48.63 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.827 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.509 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 52.4 t-105 -48.42 -65.63 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.76 -33.2 4.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.808 . . . . 0.0 110.382 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 47.8 t80 -67.95 -70.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 30' ' ' VAL . 1.5 tt -43.65 -30.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' GLY . 30.6 t -63.29 -57.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.77 -31.56 39.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.963 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.08 -51.74 55.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.308 -0.87 . . . . 0.0 110.43 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.722 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 m -114.99 -49.0 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.766 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 147.1 163.83 10.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.36 -48.3 35.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.239 . . . . 0.0 110.68 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.71 76.24 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -61.36 -52.13 65.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.317 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 21' ' ' LEU . 24.1 t -50.02 -31.55 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.724 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -41.63 71.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.108 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.83 63.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.98 5.0 12.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.487 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.0 OUTLIER 59.05 69.09 0.75 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.36 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.531 ' CD1' HG13 ' A' ' 30' ' ' VAL . 34.3 mt -119.37 134.56 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.478 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.5 OUTLIER -109.04 146.04 34.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 110.59 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 7.7 mtp180 -95.18 142.34 27.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -118.5 156.58 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.6 t -42.17 -27.08 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 25.4 m -164.83 -170.59 2.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.28 -8.38 24.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.085 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 38.7 t-20 -96.52 104.9 16.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.889 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.6 p80 -143.45 -176.64 5.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -95.94 146.88 24.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 109.567 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.621 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 p -136.36 -177.71 4.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 47.31 37.93 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.089 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.97 -158.77 46.78 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.34 44.21 1.01 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.235 . . . . 0.0 109.709 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -119.14 -34.63 3.82 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.18 -0.95 . . . . 0.0 111.388 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.447 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -116.09 163.99 12.31 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.425 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.7 m95 -137.64 173.57 11.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.439 -1.036 . . . . 0.0 109.505 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.7 t -116.09 118.01 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.923 -1.11 . . . . 0.0 111.366 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -133.81 159.0 41.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.488 -0.758 . . . . 0.0 109.13 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -45.12 43.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.95 -1.094 . . . . 0.0 108.88 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 3.1 tttt -138.12 176.8 8.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.703 ' SG ' HG22 ' A' ' 62' ' ' VAL . 7.1 m -122.4 171.99 8.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.905 -1.122 . . . . 0.0 110.271 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -85.63 -178.6 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -44.0 41.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -67.51 -4.06 10.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 110.21 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -123.37 176.48 6.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 6.2 p90 -139.41 -160.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.24 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.703 HG22 ' SG ' ' A' ' 56' ' ' CYS . 76.4 t -125.26 103.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.559 -0.713 . . . . 0.0 109.899 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 9.5 p30 -53.44 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -45.53 -25.34 0.43 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.439 -0.788 . . . . 0.0 110.742 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 10.7 t80 -73.51 -47.41 41.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.812 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 69' ' ' VAL . 32.2 m-85 -85.18 -7.21 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.905 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -49.66 -23.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 109.156 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.511 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . -70.96 -66.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.516 -0.74 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.889 HG22 ' CE1' ' A' ' 43' ' ' HIS . 13.0 p -44.25 -31.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -63.92 -67.86 0.4 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.186 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.54 -124.08 7.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -57.94 -32.18 67.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -1.191 . . . . 0.0 110.042 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 21.3 m-30 -94.38 175.03 6.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.462 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB3' HG13 ' A' ' 62' ' ' VAL . 22.0 m-85 -115.79 133.25 56.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.737 . . . . 0.0 109.168 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.23 102.55 8.61 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.916 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 7.8 m -79.26 161.87 26.04 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 0.0 109.948 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 24.3 mtp180 -155.78 -169.7 3.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.339 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.23 114.93 29.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 110.298 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.292 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.5 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.369 -0.666 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -88.11 -26.12 22.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.429 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.881 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -51.86 -51.59 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.2 -0.938 . . . . 0.0 110.855 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.473 ' H ' HG23 ' A' ' 7' ' ' ILE . 14.4 m-30 -51.84 -29.21 18.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 21.2 mt -69.1 131.52 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.74 33.17 59.43 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.436 -1.865 . . . . 0.0 108.436 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.881 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -119.31 -163.06 0.95 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.778 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.9 m -152.22 95.86 2.11 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.013 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.958 HG12 HG23 ' A' ' 69' ' ' VAL . 2.6 m -92.3 174.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.274 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.92 38.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.75 -48.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.987 1.519 . . . . 0.0 110.402 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 1.1 p -59.94 -51.09 71.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.48 HG23 ' OD1' ' A' ' 41' ' ' ASP . 96.6 t -61.24 -52.1 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 32.1 t-105 -44.59 -65.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.71 -41.21 3.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 11.4 t80 -61.46 -65.67 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.878 . . . . 0.0 110.241 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.796 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.7 tt -42.81 -36.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 64.9 t -60.47 -51.99 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.943 . . . . 0.0 109.819 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.83 51.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 24' ' ' LEU . 9.5 tp -63.73 -38.6 91.71 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.053 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -131.99 -87.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.331 -0.856 . . . . 0.0 109.989 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.825 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.08 169.06 36.49 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 110.63 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.14 1.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.149 -0.969 . . . . 0.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.053 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.01 -21.94 66.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.166 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 26' ' ' GLY . 27.9 t -73.3 -30.99 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.842 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -85.41 -32.05 22.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.07 -24.76 58.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.165 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -79.64 5.98 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 58.3 t-20 58.41 72.77 0.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.611 HD13 HD13 ' A' ' 21' ' ' LEU . 35.5 mt -122.51 129.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.548 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' THR . 13.8 mtt180 -108.97 140.37 42.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm105 -84.2 156.93 21.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -130.92 164.79 24.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -50.85 -27.69 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.509 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 4.4 m -172.38 -170.8 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' HG23 ' A' ' 17' ' ' VAL . 6.8 m-20 -58.37 -15.3 10.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -95.13 106.21 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.903 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.7 p80 -147.64 177.01 9.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 110.339 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.622 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -80.14 147.85 31.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.841 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.12 173.89 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.334 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HB1' HH11 ' A' ' 77' ' ' ARG . . . 51.08 36.52 15.63 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.38 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.94 -153.64 48.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -85.65 36.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.066 -1.255 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.23 -30.52 5.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.485 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.52 164.58 15.49 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.484 -1.341 . . . . 0.0 109.767 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.622 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 7.9 m95 -143.47 172.64 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 109.572 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 4.6 t -108.38 112.7 25.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.788 -1.195 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 2.0 mtt-85 -128.4 153.38 47.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -52.35 -46.15 65.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 0.0 109.033 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.06 147.85 49.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.805 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.0 m -97.44 163.25 12.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.69 -179.25 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.244 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -38.26 51.14 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.218 -0.926 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -68.69 -6.48 26.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.264 -0.898 . . . . 0.0 109.77 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' OE2' ' C ' ' A' ' 77' ' ' ARG . 5.9 mt-10 -126.63 -176.6 3.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -140.76 -166.74 2.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.366 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.805 HG22 ' SG ' ' A' ' 56' ' ' CYS . 54.7 t -108.92 90.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.526 -0.734 . . . . 0.0 109.975 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 23.7 t0 -41.49 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.1 p -57.53 -31.02 65.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.833 . . . . 0.0 110.568 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 15.0 t80 -67.29 -48.29 68.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.722 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.637 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 28.3 m-85 -86.28 -6.9 58.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 111.089 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -21.45 4.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.858 -1.151 . . . . 0.0 109.164 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.55 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -69.95 -66.84 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.597 -0.689 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.958 HG23 HG12 ' A' ' 13' ' ' VAL . 14.1 p -46.65 -31.05 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.917 -1.115 . . . . 0.0 109.333 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -59.95 -69.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 0.0 109.949 179.361 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.66 -106.41 2.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -53.31 56.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -1.095 . . . . 0.0 110.06 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 23.7 m-85 -83.94 -169.25 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.687 ' HB3' HG13 ' A' ' 62' ' ' VAL . 7.3 m-85 -126.95 141.95 51.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -0.835 . . . . 0.0 109.476 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.4 t -79.62 97.75 6.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.363 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 16.5 m -78.85 164.14 24.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.663 HH11 ' HB1' ' A' ' 46' ' ' ALA . 9.3 mtp180 -154.35 -177.16 6.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 110.406 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 p -101.37 89.63 3.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.13 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.823 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.6 Cg_endo . . . . . 0 C--O 1.216 -0.605 0 N-CA-C 109.744 -0.906 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.87 -20.94 34.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 110.36 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.823 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -53.7 -53.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 111.042 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.9 m-85 -49.13 -26.27 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -69.65 136.16 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 52.04 33.28 36.75 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.31 -159.56 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.55 -0.971 . . . . 0.0 110.497 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.815 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.2 m -154.19 95.54 1.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 110.307 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.895 HG12 HG23 ' A' ' 69' ' ' VAL . 3.0 m -91.47 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.956 -1.09 . . . . 0.0 110.147 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -162.09 28.39 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -74.08 -51.18 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.944 1.497 . . . . 0.0 110.415 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 2.3 p -60.66 -49.2 78.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.155 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.496 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 26.7 t -59.41 -46.67 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.079 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -50.29 -62.77 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.58 -36.82 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.063 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.7 t80 -60.63 -55.06 37.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.677 HD22 HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -55.23 -36.12 65.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HA ' HG21 ' A' ' 30' ' ' VAL . 25.9 t -60.06 -52.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.2 -40.43 67.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.129 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.2 tp -61.73 -38.82 89.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.92 -88.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.17 164.94 31.69 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -21.81 62.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 110.675 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.79 1.27 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.083 -1.011 . . . . 0.0 110.057 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.995 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.24 -21.81 66.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.389 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 26' ' ' GLY . 44.8 t -74.46 -33.29 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 0.0 110.068 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.7 m -88.8 -21.4 23.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.28 -25.23 31.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.868 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -80.59 7.46 9.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.201 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 52.2 t-20 58.43 74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.27 -0.893 . . . . 0.0 110.534 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.868 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 2.7 mt -124.38 110.41 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.484 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 2.3 mmt85 -87.3 157.24 19.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.402 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.5 mtm180 -102.17 150.7 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 110.018 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.99 154.55 39.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' ALA . 50.9 m -43.82 -26.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.208 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -166.23 -162.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -72.28 -11.88 60.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.75 106.16 18.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.821 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.2 p80 -145.85 175.22 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.177 -0.952 . . . . 0.0 110.454 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.4 p -80.96 124.45 29.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 0.0 109.823 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.0 p -115.3 -177.59 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.115 -0.991 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.543 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.93 39.36 5.47 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.452 -0.78 . . . . 0.0 109.301 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.71 -150.08 48.94 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 14.4 p30 -87.29 31.38 0.73 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.095 -1.239 . . . . 0.0 110.012 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.92 -28.96 6.86 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.251 -0.905 . . . . 0.0 110.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.97 162.64 14.03 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.925 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 8.4 m95 -139.55 167.42 22.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.449 -1.03 . . . . 0.0 109.325 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 6.3 t -107.79 108.92 20.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.868 -1.145 . . . . 0.0 111.1 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -130.06 158.96 38.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.836 . . . . 0.0 109.06 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -48.4 51.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.946 -1.097 . . . . 0.0 108.249 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -124.28 -171.24 2.29 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.686 0.755 . . . . 0.0 110.525 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.865 ' SG ' HG22 ' A' ' 62' ' ' VAL . 11.4 m -131.52 164.33 26.03 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.958 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.0 m-85 -79.63 164.76 23.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.153 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -63.56 -44.62 93.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -4.77 13.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.868 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 17.1 mt-10 -123.0 -178.51 3.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.915 . . . . 0.0 110.145 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -139.65 -163.57 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.865 HG22 ' SG ' ' A' ' 56' ' ' CYS . 70.9 t -111.38 89.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 29.9 t0 -40.63 91.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.185 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -57.27 -30.51 64.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.563 -179.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.81 -48.61 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 110.818 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 7' ' ' ILE . 22.9 m-85 -83.88 -8.76 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 111.12 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -24.35 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.974 -1.079 . . . . 0.0 109.415 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.591 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.22 -71.36 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.895 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -44.18 -29.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.116 -0.99 . . . . 0.0 109.841 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.41 -64.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.57 -116.07 5.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -60.8 -50.98 71.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 12.4 m-30 -79.91 -175.16 4.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.966 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.66 ' HB3' HG13 ' A' ' 62' ' ' VAL . 5.9 m-85 -122.31 144.83 48.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 t -81.59 97.05 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 109.382 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 21.8 m -79.39 164.09 24.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.194 -0.941 . . . . 0.0 109.753 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.2 mtp180 -151.16 -179.25 7.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 0.0 110.53 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.435 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 54.4 p -116.59 87.35 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.269 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.2 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 109.701 -0.923 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -113.48 -29.82 7.06 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -51.97 -55.28 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.367 -0.833 . . . . 0.0 110.815 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 21.2 m-85 -48.15 -29.33 3.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 33.1 mt -68.57 129.22 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.422 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.66 32.01 72.74 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.42 -162.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.983 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.778 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.0 m -153.79 100.07 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.939 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -93.73 173.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.115 -0.991 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -161.44 35.11 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 46.8 Cg_endo -74.27 -49.67 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.964 1.507 . . . . 0.0 110.39 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -50.19 74.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.23 -0.919 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.516 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 55.4 t -61.59 -51.0 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.776 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.1 t-105 -44.56 -65.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.703 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.53 -43.27 5.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 67.2 t80 -56.89 -64.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.867 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.813 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.1 tt -44.08 -38.61 3.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 18' ' ' TRP . 15.6 t -54.99 -55.97 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.1 -43.56 64.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.1 tp -55.28 -43.82 75.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.248 -0.908 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.014 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.6 -88.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.238 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.08 166.83 34.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -61.22 -20.88 63.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -1.148 . . . . 0.0 110.588 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -63.62 1.1 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.031 -1.043 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.014 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.45 -18.49 63.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.174 -0.953 . . . . 0.0 109.208 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 21' ' ' LEU . 24.2 t -75.98 -32.02 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.468 -0.77 . . . . 0.0 109.729 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.0 m -93.03 -17.1 24.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.34 -24.0 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -83.18 10.36 8.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.485 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 61.9 t-20 58.81 74.07 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.603 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.643 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 7.0 mt -125.1 125.27 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.858 . . . . 0.0 109.605 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.9 mtt180 -107.2 146.35 31.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 44.0 mtp180 -89.63 154.24 20.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -126.71 161.53 27.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.368 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -51.7 -26.71 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.392 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 39' ' ' SER . 3.7 m -165.32 -177.18 4.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.9 m-20 -56.41 -24.57 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.574 ' OD1' ' CD2' ' A' ' 73' ' ' TYR . 4.0 t30 -86.81 110.94 20.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.881 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.2 p80 -147.85 175.25 11.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.626 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -77.69 138.79 39.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.347 -0.846 . . . . 0.0 109.689 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.3 p -131.37 178.8 6.44 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.83 36.43 8.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.28 -147.74 46.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -87.13 31.6 0.71 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.198 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -115.03 -31.84 5.93 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.236 -0.915 . . . . 0.0 111.032 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.81 165.75 15.4 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.162 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.626 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.7 m95 -144.74 169.71 17.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.461 -1.023 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.8 t -109.61 113.33 26.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.829 -1.17 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.8 OUTLIER -132.52 160.96 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 109.126 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -50.84 -50.5 56.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.859 -1.151 . . . . 0.0 108.269 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -124.72 -178.98 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.528 0.68 . . . . 0.0 110.492 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.842 ' SG ' HG22 ' A' ' 62' ' ' VAL . 12.4 m -125.05 166.33 16.57 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.975 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -79.7 171.37 15.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.11 -0.994 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -39.41 71.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.207 -0.933 . . . . 0.0 110.17 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -71.21 -2.99 17.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 13.0 mt-10 -126.39 -172.35 2.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 6.2 p90 -144.52 -164.15 1.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.842 HG22 ' SG ' ' A' ' 56' ' ' CYS . 54.3 t -110.3 89.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.502 -0.749 . . . . 0.0 109.969 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 30.1 t0 -41.86 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.21 -28.67 65.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -68.86 -49.23 60.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 17.7 m-85 -82.91 -8.56 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 t -51.09 -21.71 2.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.987 -1.07 . . . . 0.0 109.115 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.49 -68.97 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 110.294 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.939 HG23 HG12 ' A' ' 13' ' ' VAL . 10.8 p -46.35 -30.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 109.35 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -60.15 -70.93 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 110.415 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.2 -115.5 5.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -61.0 -39.8 91.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -1.165 . . . . 0.0 109.995 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 29.3 m-85 -92.26 -177.69 4.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.877 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.6 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -122.3 145.87 47.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 0.0 109.642 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 8.7 t -85.08 99.24 10.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.64 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 18.3 m -78.36 163.89 25.29 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 109.667 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.0 mtp180 -154.09 -175.58 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 110.658 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -111.87 102.08 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.149 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.272 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.865 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.7 Cg_endo . . . . . 0 C--O 1.215 -0.66 0 N-CA-C 109.921 -0.838 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.679 ' HB3' ' OH ' ' A' ' 65' ' ' TYR . . . -80.62 -20.96 42.01 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.865 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -53.92 -56.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.9 -179.643 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.624 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.3 m-85 -47.6 -25.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.0 110.004 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 8.3 mt -69.15 125.49 27.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 60.2 31.41 73.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.72 -160.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.447 -1.031 . . . . 0.0 110.759 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.731 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.8 m -156.26 104.33 2.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.031 HG12 HG23 ' A' ' 69' ' ' VAL . 3.4 m -99.03 169.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.154 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 -163.89 21.54 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.5 Cg_endo -73.73 -46.1 0.35 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.051 1.553 . . . . 0.0 110.281 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -52.43 56.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 59.6 t -57.63 -41.36 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.727 ' O ' HG23 ' A' ' 22' ' ' VAL . 43.0 t-105 -54.22 -66.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.14 -0.975 . . . . 0.0 109.633 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.27 -33.97 1.77 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.707 . . . . 0.0 110.334 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 74.2 t80 -65.13 -65.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.117 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.6 tt -44.7 -35.8 2.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 18' ' ' TRP . 21.7 t -60.96 -48.24 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.21 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.459 -0.776 . . . . 0.0 109.968 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.8 tp -60.71 -42.98 98.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.017 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -121.7 -88.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 110.163 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.804 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.64 165.77 32.16 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.32 -19.25 61.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -1.132 . . . . 0.0 110.486 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -63.11 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.884 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.017 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.4 -19.7 64.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 26' ' ' GLY . 38.2 t -75.78 -32.03 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.442 -0.786 . . . . 0.0 109.856 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.2 m -89.37 -23.21 22.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.18 -24.9 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -81.07 8.38 8.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 61.2 t-20 59.21 74.73 0.43 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.663 HD13 HD13 ' A' ' 21' ' ' LEU . 67.9 mt -125.19 128.4 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.437 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mmt180 -109.99 146.32 35.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.585 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 6.6 mtp180 -92.79 148.86 21.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.82 173.69 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.097 -1.002 . . . . 0.0 110.328 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 t -51.29 -37.02 45.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.33 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.535 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.2 m -161.2 -162.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.346 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.2 m-20 -67.47 -18.55 65.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.405 -0.809 . . . . 0.0 110.344 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -91.75 92.19 8.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.273 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.886 ' CE1' HG22 ' A' ' 69' ' ' VAL . 2.7 p80 -127.49 -178.6 4.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.159 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -88.95 117.64 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.422 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 21.4 p -104.11 -175.47 2.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.439 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HB2' ' HD2' ' A' ' 77' ' ' ARG . . . 43.98 39.57 2.8 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.446 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.63 -150.23 50.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 34.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.153 -1.204 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -117.93 -28.63 5.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.319 -0.863 . . . . 0.0 110.924 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.536 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -126.53 165.17 19.83 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.165 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 30.2 m95 -138.61 176.16 8.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.044 . . . . 0.0 109.956 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 m -105.66 102.41 11.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 5.3 mtt180 -122.21 137.71 54.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.147 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.559 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -49.25 -41.2 36.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 108.977 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.44 144.13 51.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.826 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.4 m -103.62 166.8 10.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.038 -1.038 . . . . 0.0 110.048 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -79.9 167.8 20.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.417 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -41.03 90.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.22 -6.18 17.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 15.5 mt-10 -126.18 178.04 6.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 109.887 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 77' ' ' ARG . 12.6 p90 -133.49 -170.32 2.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.277 179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.826 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -107.48 87.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 32.0 t0 -40.49 91.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.617 -0.677 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.2 -27.73 55.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.572 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.679 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 19.7 t80 -70.43 -50.35 39.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.886 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.654 ' CD2' HD11 ' A' ' 7' ' ' ILE . 24.0 m-85 -82.7 -8.0 59.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 111.065 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 -21.39 3.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.017 -1.052 . . . . 0.0 109.308 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . -69.96 -51.16 34.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.031 HG23 HG12 ' A' ' 13' ' ' VAL . 7.6 p -64.24 -31.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.95 -1.094 . . . . 0.0 110.495 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 75' ' ' CYS . 57.8 m -62.74 -52.3 63.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.944 -1.097 . . . . 0.0 109.466 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 -119.56 5.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.09 -23.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 110.11 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 25.7 m-85 -116.67 178.44 4.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.676 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.6 m-85 -115.73 147.22 41.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 8.8 t -79.5 95.91 5.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 0.0 109.58 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 77' ' ' ARG . 31.3 m -78.66 160.98 27.24 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.957 -1.09 . . . . 0.0 109.355 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.602 ' HD2' ' HB2' ' A' ' 46' ' ' ALA . 43.4 mtp180 -157.83 -172.52 3.97 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.359 -0.838 . . . . 0.0 110.591 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 7.6 t -114.87 96.31 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.611 -0.681 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.49 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.626 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.6 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.24 -21.49 9.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.781 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.731 HD11 ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -56.09 -44.9 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.454 -0.778 . . . . 0.0 110.807 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.3 m-85 -55.86 -24.17 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.987 . . . . 0.0 110.758 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 54.3 mt -61.18 127.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 54.7 32.58 54.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -112.29 -170.83 1.73 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.504 -0.997 . . . . 0.0 110.645 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.814 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.2 m -145.75 90.13 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.1 m -82.99 175.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.04 -1.038 . . . . 0.0 109.826 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.83 -166.49 42.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 44.0 Cg_endo -72.21 -46.49 0.51 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.976 1.514 . . . . 0.0 110.185 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -47.57 82.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 57.1 t -59.5 -51.81 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.594 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 36.4 t-105 -44.43 -66.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 109.824 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.71 -39.76 2.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.844 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 38.9 t80 -62.44 -64.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.363 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -42.74 -52.0 5.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG22 HG21 ' A' ' 30' ' ' VAL . 73.2 t -47.65 -50.89 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.78 -46.53 59.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.6 tp -60.58 -38.87 86.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.844 . . . . 0.0 110.036 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -126.99 -89.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.805 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.55 171.25 37.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.38 -19.18 65.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -1.169 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.95 -63.13 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.07 -1.018 . . . . 0.0 109.945 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.043 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.84 -21.87 66.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' HD12 ' A' ' 35' ' ' ILE . 24.6 t -74.0 -33.48 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.726 . . . . 0.0 109.929 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 m -85.31 -27.01 26.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.009 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.02 -25.93 48.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.948 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.695 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -81.46 3.25 25.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.025 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.2 t-20 58.73 77.95 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.59 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.695 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 2.6 mt -121.43 140.76 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.505 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 5.5 mtt180 -117.49 153.82 32.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.567 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.594 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 19.0 mtp-105 -109.04 134.3 51.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -109.44 173.82 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -49.58 -27.48 4.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.538 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 39.0 m -167.71 -166.08 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' OD1' HG23 ' A' ' 17' ' ' VAL . 97.9 m-20 -65.83 -10.17 35.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 2.8 m-20 -96.31 105.58 17.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.868 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.9 p80 -145.71 -179.85 6.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -0.977 . . . . 0.0 110.647 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.625 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -91.64 148.31 22.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.443 -0.786 . . . . 0.0 109.521 179.627 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.636 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 9.3 p -141.27 -177.32 5.07 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 110.611 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.3 43.54 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.27 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.69 -161.04 53.92 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -83.82 41.33 0.79 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.031 -1.276 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -119.38 -31.16 4.71 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.64 158.76 14.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.223 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.625 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.1 m95 -140.05 169.05 18.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -1.028 . . . . 0.0 109.189 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -112.45 115.91 29.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.786 -1.197 . . . . 0.0 110.893 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 0.9 OUTLIER -132.44 161.38 33.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.349 -0.844 . . . . 0.0 109.25 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -46.08 66.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.985 -1.072 . . . . 0.0 108.856 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.52 163.19 30.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.662 ' SG ' HG22 ' A' ' 62' ' ' VAL . 10.9 m -103.73 170.22 8.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 110.265 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 21.5 m-85 -87.39 -178.88 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.2 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -75.23 -38.47 60.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.333 -0.854 . . . . 0.0 110.008 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.54 0.74 13.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -132.36 177.9 7.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 9.7 p90 -138.89 -168.83 2.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 74' ' ' PHE . 26.2 t -104.07 89.63 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.64 -0.663 . . . . 0.0 109.828 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.489 ' OD2' ' CD ' ' A' ' 77' ' ' ARG . 16.8 t0 -42.64 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.8 p -58.08 -32.74 68.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -44.89 80.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.731 ' CD1' HD11 ' A' ' 7' ' ' ILE . 37.8 m-85 -89.1 -5.99 57.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.963 -179.347 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 t -50.51 -22.5 1.97 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.013 -1.055 . . . . 0.0 108.766 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -70.61 -67.78 0.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.868 HG22 ' CE1' ' A' ' 43' ' ' HIS . 12.9 p -44.71 -28.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.018 -1.051 . . . . 0.0 109.671 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' HA ' ' NE2' ' A' ' 43' ' ' HIS . 1.1 m -67.08 -62.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.453 -0.78 . . . . 0.0 110.449 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.7 -114.81 4.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -69.04 -34.0 74.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' CG ' ' OD1' ' A' ' 42' ' ' ASN . 61.7 m-85 -87.79 179.72 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.663 ' HB3' HG13 ' A' ' 62' ' ' VAL . 7.0 m-85 -121.89 129.55 52.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -0.853 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.46 99.61 7.3 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.04 -1.038 . . . . 0.0 108.816 179.376 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.9 m -78.38 163.83 25.33 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.903 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 10.1 mtp180 -148.02 176.55 10.09 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 110.31 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 t -103.93 88.5 3.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 6.7 ttm180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.876 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.4 Cg_endo . . . . . 0 C--O 1.215 -0.672 0 N-CA-C 109.828 -0.874 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -80.22 -22.48 41.77 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.876 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -51.37 -55.11 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -179.663 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.25 -30.76 5.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 6' ' ' ALA . 65.0 mt -67.99 135.23 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.478 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 54.43 33.55 53.69 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -125.51 -160.28 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.513 -0.992 . . . . 0.0 110.417 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.821 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.6 m -155.18 92.57 1.44 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.952 . . . . 0.0 110.451 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.737 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -84.21 -147.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 110.28 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -125.58 -161.31 10.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.22 -47.27 0.32 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.992 1.522 . . . . 0.0 110.542 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -55.64 11.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 64.2 t -53.71 -39.74 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.601 ' CD2' ' HD2' ' A' ' 37' ' ' ARG . 25.9 t90 -55.99 -61.87 2.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.76 -38.23 3.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -66.16 -44.2 84.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.915 HD22 HG22 ' A' ' 30' ' ' VAL . 1.3 tt -65.1 -27.89 69.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 110.27 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.628 HG13 ' CA ' ' A' ' 27' ' ' ALA . 85.9 t -71.37 -42.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 110.281 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' LEU . 8.7 tp -72.92 -69.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 110.794 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.005 HG22 ' CB ' ' A' ' 29' ' ' ALA . 14.9 p -88.43 -26.48 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 110.702 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.787 ' O ' HG23 ' A' ' 30' ' ' VAL . . . 119.72 161.37 11.57 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.628 ' CA ' HG13 ' A' ' 22' ' ' VAL . . . -63.42 -63.2 1.25 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -1.121 . . . . 0.0 110.318 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.2 -34.25 31.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.992 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.005 ' CB ' HG22 ' A' ' 25' ' ' VAL . . . -63.6 -43.67 96.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.915 HG22 HD22 ' A' ' 21' ' ' LEU . 49.8 t -60.84 -39.76 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m -71.47 -23.45 61.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.19 -20.8 31.75 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.391 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -90.11 9.14 29.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.513 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.478 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.3 t-20 59.13 68.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.383 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.766 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 3.3 mt -120.13 110.81 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.652 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.1 mtm105 -92.04 160.11 15.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.555 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.601 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 8.4 mtp-105 -110.54 151.52 27.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.83 -172.46 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 4.9 t -71.92 -2.76 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 170.65 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.076 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -71.24 -9.65 58.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.7 t-20 -97.39 100.48 11.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.133 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.805 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -142.22 176.78 8.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.112 -0.993 . . . . 0.0 110.501 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.584 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.5 p -78.51 129.74 35.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.16 175.64 6.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 110.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.81 42.74 20.49 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.73 -150.65 49.74 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -86.17 38.57 0.77 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.103 -1.234 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.3 mtm-85 -116.96 -35.35 4.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.171 -0.956 . . . . 0.0 111.013 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -125.45 165.49 18.58 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.501 -1.333 . . . . 0.0 109.931 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.584 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.9 m95 -136.77 175.0 10.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.443 -1.034 . . . . 0.0 109.673 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.6 t -107.97 120.09 41.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.976 -1.078 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -139.02 144.89 39.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.36 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 1.4 m -45.78 -38.73 7.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.954 -1.092 . . . . 0.0 108.479 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HD3' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.8 -162.83 1.27 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' HG22 ' A' ' 62' ' ' VAL . 20.7 m -143.4 179.06 7.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.928 -1.108 . . . . 0.0 110.37 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.93 -176.12 5.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.028 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -84.26 -38.46 20.46 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 9.58 7.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 11.1 mt-10 -124.06 -168.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.6 p90 -154.4 -160.09 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.896 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.638 HG13 ' HB3' ' A' ' 74' ' ' PHE . 66.2 t -122.5 96.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.683 -0.636 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -52.69 89.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 109.796 -179.63 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -43.08 -24.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.58 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 63' ' ' ASP . 26.6 t80 -67.32 -55.13 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.83 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.3 m-85 -81.95 -9.92 59.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.195 -0.941 . . . . 0.0 110.982 -179.286 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 t -48.25 -23.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.094 -1.004 . . . . 0.0 109.215 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.675 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.54 -71.5 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.722 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.821 HG21 ' H ' ' A' ' 12' ' ' THR . 9.3 p -43.33 -29.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 109.668 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -62.44 -58.67 6.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.471 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.69 -136.91 12.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.47 -27.69 4.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -1.166 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -93.71 179.18 5.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.152 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.638 ' HB3' HG13 ' A' ' 62' ' ' VAL . 10.9 m-85 -122.68 137.29 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 178.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 t -78.76 103.35 8.65 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.969 -1.082 . . . . 0.0 108.818 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.5 m -79.58 163.06 24.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.524 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 26.3 mtp180 -160.08 -170.24 2.78 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.534 -0.729 . . . . 0.0 110.274 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.69 114.9 21.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.826 . . . . 0.0 110.22 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.174 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.4 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.95 -28.44 27.81 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -54.75 -50.47 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 110.366 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.584 ' H ' HG23 ' A' ' 7' ' ' ILE . 9.9 m-30 -46.97 -27.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 49.1 mt -64.19 118.55 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.562 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 65.06 30.65 78.5 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -178.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -106.52 -161.57 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.51 -0.994 . . . . 0.0 110.809 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.762 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.3 m -156.35 92.28 1.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.037 HG12 HG23 ' A' ' 69' ' ' VAL . 3.4 m -93.74 169.75 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.288 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.97 -161.68 36.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.6 Cg_endo -74.09 -38.79 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.024 1.539 . . . . 0.0 110.414 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.94 -53.96 22.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 110.142 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.6 t -58.48 -46.86 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.986 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' ALA . 28.3 t-105 -49.06 -65.2 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.646 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.48 -40.91 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 110.263 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 54.0 t80 -59.24 -58.0 10.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.969 HD22 HG22 ' A' ' 30' ' ' VAL . 2.8 tt -51.73 -36.2 46.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 40.8 t -58.4 -49.29 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.085 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.16 82.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.178 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.0 tp -57.14 -44.71 83.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.39 -88.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.265 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.841 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.02 166.93 34.16 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -20.34 63.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -1.192 . . . . 0.0 110.637 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.57 -64.24 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.081 -1.012 . . . . 0.0 109.779 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.025 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -60.76 -23.5 65.02 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.024 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.969 HG22 HD22 ' A' ' 21' ' ' LEU . 21.9 t -67.43 -37.02 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.443 -0.786 . . . . 0.0 109.533 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.2 m -85.26 -23.85 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.22 -23.05 54.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.6 24.76 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 30.7 t-20 41.23 75.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.697 HD12 ' O ' ' A' ' 30' ' ' VAL . 53.1 mt -117.2 126.47 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.496 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -100.78 146.06 27.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.564 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -91.5 146.91 23.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.83 . . . . 0.0 109.693 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.662 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -124.45 152.91 42.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' ALA . 18.2 t -42.27 -27.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.211 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m -171.65 -165.03 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -65.23 -12.91 56.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 30.9 t-20 -95.8 103.38 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.575 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.758 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.5 p80 -145.77 -179.9 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.363 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.4 p -84.66 133.33 34.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.694 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.0 p -122.06 174.78 6.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 50.0 33.09 6.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.323 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 -144.93 43.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.87 40.65 0.82 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.025 -1.28 . . . . 0.0 109.976 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -113.11 -40.37 3.96 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 110.989 -179.412 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -131.6 172.37 20.9 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.271 -1.443 . . . . 0.0 110.573 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.3 m95 -136.22 177.18 8.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.895 . . . . 0.0 109.356 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -107.62 115.07 29.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.6 mtt180 -132.16 142.95 49.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.729 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 2.1 t -48.1 -43.15 30.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.883 -1.135 . . . . 0.0 108.834 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.11 50.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.881 ' SG ' HG22 ' A' ' 62' ' ' VAL . 6.3 m -101.85 162.2 13.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.952 -1.092 . . . . 0.0 110.331 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -79.98 167.34 20.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.887 . . . . 0.0 110.478 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -67.01 -39.55 87.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -63.91 -9.89 17.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.918 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 13.3 mt-10 -126.48 179.15 5.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.212 -0.93 . . . . 0.0 109.817 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 13.4 p90 -130.58 -169.45 2.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -0.96 . . . . 0.0 110.34 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.881 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.9 t -111.08 88.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 77' ' ' ARG . 3.7 t70 -38.56 91.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.43 0.633 . . . . 0.0 110.477 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.85 -29.54 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 110.049 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.544 ' O ' HD12 ' A' ' 7' ' ' ILE . 51.2 t80 -68.48 -53.51 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.435 -0.79 . . . . 0.0 110.462 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -80.09 -4.26 52.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 111.489 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -16.62 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.944 -1.097 . . . . 0.0 109.626 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.785 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -73.19 -45.99 53.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.003 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.037 HG23 HG12 ' A' ' 13' ' ' VAL . 10.0 p -71.63 -26.28 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.935 -1.103 . . . . 0.0 109.343 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -65.28 -50.91 63.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.77 . . . . 0.0 109.83 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.12 -131.04 10.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -33.67 9.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -1.074 . . . . 0.0 109.798 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 8.9 m-85 -92.83 -177.63 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.857 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.688 ' HB3' HG13 ' A' ' 62' ' ' VAL . 6.8 m-85 -126.69 140.77 52.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 8.6 t -79.48 97.25 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.568 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 14.2 m -79.23 163.26 25.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.981 . . . . 0.0 110.069 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.636 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 6.5 mmm180 -153.59 -172.43 4.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 110.242 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 29.3 p -120.17 81.03 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.491 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.169 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.2 Cg_endo . . . . . 0 C--O 1.214 -0.698 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.49 -20.31 37.05 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.547 -0.72 . . . . 0.0 110.22 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.835 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -57.73 -39.18 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.879 . . . . 0.0 110.457 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 12.8 m-30 -63.14 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.518 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.8 mt -72.44 126.55 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 109.281 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.79 31.01 79.36 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.54 -163.08 0.93 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.501 -0.999 . . . . 0.0 110.711 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.832 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.8 m -154.85 99.54 2.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -0.894 . . . . 0.0 109.835 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.886 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -94.72 178.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.991 -1.068 . . . . 0.0 110.445 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.12 -161.74 37.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.6 Cg_endo -73.33 -46.52 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.985 1.519 . . . . 0.0 110.509 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -47.78 74.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.317 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 14.9 t -58.8 -46.05 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.447 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 7.7 t90 -52.66 -55.67 20.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.55 59.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.605 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.19 -59.06 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.92 . . . . 0.0 110.302 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.844 HD22 HG22 ' A' ' 30' ' ' VAL . 1.6 tt -52.04 -36.31 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.791 . . . . 0.0 110.366 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 26' ' ' GLY . 46.8 t -62.73 -48.58 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.11 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.85 -34.76 68.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.54 -39.15 77.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.376 -0.828 . . . . 0.0 110.371 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.123 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -128.71 -52.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.425 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . 134.85 164.19 10.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -65.2 -7.99 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -1.087 . . . . 0.0 110.884 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.947 -1.096 . . . . 0.0 109.817 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.123 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.74 -19.25 65.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.855 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.844 HG22 HD22 ' A' ' 21' ' ' LEU . 18.2 t -75.21 -32.83 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.9 m -87.26 -27.01 23.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.044 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.94 -19.91 36.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -84.57 9.18 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 110.156 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.473 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 0.7 OUTLIER 59.05 72.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.345 -0.847 . . . . 0.0 110.624 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.617 HD13 HD13 ' A' ' 21' ' ' LEU . 38.0 mt -124.96 114.54 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 109.692 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 12' ' ' THR . 19.8 mtt-85 -98.67 152.11 19.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 4.1 mtm180 -93.68 159.59 15.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -134.52 164.02 28.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.18 -25.31 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -179.54 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.293 -179.865 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 62.1 m-20 -65.97 -10.45 39.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -98.33 100.19 11.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.351 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.764 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.0 p80 -143.25 175.04 10.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.943 . . . . 0.0 110.451 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.569 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 5.7 p -80.38 125.63 30.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.403 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.97 177.44 4.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.07 44.03 18.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.47 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.42 -152.13 51.49 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -86.75 36.14 0.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.061 -1.258 . . . . 0.0 109.989 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -31.2 5.11 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.225 -0.922 . . . . 0.0 110.859 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.521 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -118.78 163.46 13.17 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.061 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 8.1 m95 -140.84 165.92 26.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -1.082 . . . . 0.0 109.839 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.5 t -104.37 107.95 19.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 0.0 110.787 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -128.29 149.93 50.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -0.898 . . . . 0.0 109.622 179.351 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 65.8 p -55.99 -49.87 72.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 109.035 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -130.49 173.57 10.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 57.1 m -148.6 172.04 15.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -79.54 -170.29 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.506 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -45.28 10.69 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.338 -0.852 . . . . 0.0 110.332 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.7 -20.31 1.2 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 109.517 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -113.58 170.77 8.0 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.395 -0.816 . . . . 0.0 109.832 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.9 p90 -133.85 -168.33 2.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 0.0 110.145 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.72 HG13 ' HB3' ' A' ' 74' ' ' PHE . 62.6 t -111.76 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.546 -0.721 . . . . 0.0 110.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.2 t0 -40.21 91.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 110.19 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' VAL . 2.8 p -55.13 -33.98 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 110.505 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.93 -46.79 83.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.78 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CD2' HD11 ' A' ' 7' ' ' ILE . 27.4 m-85 -87.2 -6.48 58.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 0.0 111.021 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -21.96 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.053 . . . . 0.0 108.904 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -69.67 -66.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 0.0 110.53 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.886 HG23 HG12 ' A' ' 13' ' ' VAL . 9.7 p -48.54 -26.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.077 . . . . 0.0 109.603 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -65.39 -63.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 110.231 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -114.94 5.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -61.06 -47.98 83.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -1.181 . . . . 0.0 110.027 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.484 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 22.5 m-85 -82.69 -178.45 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.72 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.0 m-85 -121.23 138.82 54.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.7 t -79.68 98.49 6.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.762 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 96.1 m -79.06 173.16 12.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.955 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.5 mtp180 -160.55 179.88 8.22 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.482 -0.761 . . . . 0.0 110.276 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.68 117.49 34.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.159 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 2.0 m-20 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.671 0.272 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 1' ' ' ASN . 47.2 Cg_endo -74.15 126.42 10.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.867 1.456 . . . . 0.0 110.476 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -166.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.253 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.483 HG23 ' HD2' ' A' ' 5' ' ' PRO . 1.6 mm -52.67 146.46 17.87 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.728 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.1 Cg_endo -76.09 164.08 31.92 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.093 1.575 . . . . 0.0 110.053 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.58 -24.78 33.77 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.393 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.824 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -53.51 -54.83 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.79 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.58 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 10.0 m-30 -48.48 -26.82 2.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.083 -1.011 . . . . 0.0 110.172 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 15.7 mt -71.84 139.15 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.391 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 49.06 35.93 19.85 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -123.72 -161.84 1.01 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.542 -0.975 . . . . 0.0 110.515 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.787 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.6 m -153.93 93.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.374 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.815 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -88.76 -171.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.0 -1.062 . . . . 0.0 110.243 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -100.58 -163.6 28.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.4 Cg_endo -72.83 -48.82 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.963 1.507 . . . . 0.0 110.458 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.6 t -62.78 -52.09 64.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 110.173 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.575 HG23 ' OD1' ' A' ' 41' ' ' ASP . 79.5 t -58.31 -45.85 89.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 110.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.603 ' CZ3' ' NH2' ' A' ' 37' ' ' ARG . 22.2 t90 -50.35 -63.92 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.158 -0.964 . . . . 0.0 109.917 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.03 -36.14 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.857 . . . . 0.0 110.212 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 52.1 t80 -62.21 -60.97 2.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.9 HD22 HG22 ' A' ' 30' ' ' VAL . 2.6 tt -49.47 -34.55 17.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' VAL . 64.1 t -60.39 -51.04 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.152 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.88 76.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.433 -0.792 . . . . 0.0 110.277 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD23 ' CD1' ' A' ' 4' ' ' ILE . 9.9 tp -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -0.935 . . . . 0.0 110.179 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.037 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -126.34 -88.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.18 166.0 32.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.88 -19.32 60.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.25 -1.147 . . . . 0.0 110.562 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.68 -62.94 1.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.115 -0.991 . . . . 0.0 109.949 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.037 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.54 -21.02 66.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.327 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.9 HG22 HD22 ' A' ' 21' ' ' LEU . 38.0 t -75.86 -32.44 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.49 -0.756 . . . . 0.0 109.755 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.8 m -93.29 -14.99 26.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 110.057 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.07 -24.67 21.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.016 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -82.18 9.34 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.2 t-20 59.34 72.6 0.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 110.652 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 21' ' ' LEU . 22.4 mt -119.45 120.38 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.627 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 12' ' ' THR . 10.1 mtm180 -101.19 149.07 24.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.569 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.603 ' NH2' ' CZ3' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -100.22 152.26 20.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.239 -0.913 . . . . 0.0 109.823 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -124.82 172.47 9.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.167 -0.958 . . . . 0.0 110.405 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 40' ' ' SER . 1.2 p -50.92 -27.31 7.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.517 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 5.1 m -172.06 -173.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 110.37 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.575 ' OD1' HG23 ' A' ' 17' ' ' VAL . 2.6 m-20 -55.12 -22.83 18.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 17.6 t-20 -87.8 107.73 18.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.917 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.5 p80 -147.33 -175.98 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -95.2 148.73 22.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 10.4 p -139.9 -176.08 4.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.935 . . . . 0.0 110.458 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' CYS . . . 45.84 43.17 9.75 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.3 -157.66 53.45 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.54 44.44 1.04 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.045 -1.267 . . . . 0.0 109.598 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -117.33 -34.37 4.34 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.292 -0.88 . . . . 0.0 111.342 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.02 165.22 12.71 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.233 -1.46 . . . . 0.0 110.59 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 3.5 m95 -140.32 171.37 14.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.608 -0.937 . . . . 0.0 108.948 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.1 t -113.99 123.4 49.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 0.0 111.565 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -135.1 156.65 48.65 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 53' ' ' ARG . 80.0 p -46.58 -41.42 14.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.86 -1.15 . . . . 0.0 109.027 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -142.63 178.27 7.74 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 62' ' ' VAL . 10.8 m -122.15 165.69 15.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.895 -1.128 . . . . 0.0 110.153 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -79.93 175.36 10.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 110.256 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -73.47 -39.45 64.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 0.0 110.646 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -2.74 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 110.139 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -124.36 -174.66 3.06 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.945 . . . . 0.0 110.22 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 5.8 p90 -146.72 -159.7 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.674 HG22 ' SG ' ' A' ' 56' ' ' CYS . 45.1 t -125.44 104.85 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.627 -0.671 . . . . 0.0 109.594 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 75' ' ' CYS . 9.7 p30 -51.69 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -44.07 -25.0 0.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.706 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.35 -48.5 41.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 111.085 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.686 ' O ' HG12 ' A' ' 69' ' ' VAL . 60.0 m-85 -89.28 -4.66 58.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 111.408 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -51.08 -23.1 2.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.147 . . . . 0.0 108.693 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -72.01 -66.08 0.69 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.624 -0.672 . . . . 0.0 110.538 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.917 HG22 ' CE1' ' A' ' 43' ' ' HIS . 13.2 p -44.08 -30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.078 -1.013 . . . . 0.0 109.67 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -65.47 -63.76 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.396 -0.815 . . . . 0.0 110.109 179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.0 -132.6 11.08 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -51.88 -34.55 41.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -1.168 . . . . 0.0 110.06 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.35 -174.01 4.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -130.72 128.57 41.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.848 . . . . 0.0 109.877 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.03 99.38 6.86 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.94 -1.1 . . . . 0.0 108.804 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 5.6 m -79.56 160.99 26.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.499 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 1.1 mtp180 -151.0 170.93 18.15 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.33 -0.856 . . . . 0.0 110.144 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.38 117.02 33.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.165 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.716 0.293 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.42 112.04 3.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.115 1.587 . . . . 0.0 110.391 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 4' ' ' ILE . 3.1 tm? -114.23 134.19 55.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.784 ' N ' HD13 ' A' ' 3' ' ' LEU . 5.0 mm -48.79 146.3 5.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.259 -0.901 . . . . 0.0 110.44 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.655 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 49.2 Cg_endo -70.56 -157.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.14 1.6 . . . . 0.0 110.032 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.595 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -116.18 -43.45 2.96 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.86 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -54.11 -39.43 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 1.034 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 47.3 m-85 -59.93 -31.78 70.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 6' ' ' ALA . 66.1 mt -72.87 143.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.454 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.98 35.26 63.37 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -127.77 -162.57 1.18 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.39 -1.065 . . . . 0.0 110.646 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.827 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.7 m -150.35 89.87 1.61 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.309 -0.87 . . . . 0.0 110.191 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -83.19 -163.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.018 -1.051 . . . . 0.0 110.336 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -107.92 -165.62 21.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.8 Cg_endo -73.16 -44.29 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.313 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.4 m -65.01 -49.88 68.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.121 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.567 HG11 ' HB ' ' A' ' 13' ' ' VAL . 44.4 t -60.64 -49.81 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.848 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 46.4 t-105 -46.26 -63.87 0.89 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.711 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.97 -43.06 6.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -59.62 -66.64 0.48 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.895 HD22 HG22 ' A' ' 30' ' ' VAL . 4.8 tt -40.78 -49.17 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.489 -0.757 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.5 t -48.75 -50.96 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.82 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.34 -43.39 64.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.399 -0.813 . . . . 0.0 109.868 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.571 HD23 HD13 ' A' ' 4' ' ' ILE . 7.1 tp -60.18 -42.2 94.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 110.016 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.959 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -125.93 -87.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.972 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.82 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.4 163.58 27.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.71 60.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -1.132 . . . . 0.0 110.612 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -62.63 1.32 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.14 -0.975 . . . . 0.0 109.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.959 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.13 -25.33 66.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.895 HG22 HD22 ' A' ' 21' ' ' LEU . 20.1 t -68.64 -34.0 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 m -77.09 -44.27 31.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.67 -18.82 65.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.62 23.06 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.964 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.451 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 62.7 t-20 39.82 70.78 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.423 -0.798 . . . . 0.0 110.646 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.848 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 14.8 mt -115.16 130.16 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.716 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.486 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 10.2 mtt180 -114.86 148.96 37.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 110.416 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.574 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 6.6 mtp180 -99.47 149.14 23.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.473 -0.767 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -122.95 159.47 28.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.112 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.445 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.3 m -45.08 -25.09 0.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 39' ' ' SER . 44.6 m -167.47 -171.99 1.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.113 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.1 m-20 -64.22 -14.85 58.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.121 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 11.2 t-20 -93.53 109.72 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.5 p80 -146.55 -175.69 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.586 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 1.9 p -88.66 127.24 35.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.681 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.9 p -117.32 178.1 4.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.575 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.06 33.14 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.357 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.63 -149.37 36.6 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -87.6 29.12 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.129 -1.218 . . . . 0.0 109.963 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -108.4 -32.12 7.56 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.218 -0.926 . . . . 0.0 110.855 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.519 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.8 164.68 15.68 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.586 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -138.46 178.59 7.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.456 -1.026 . . . . 0.0 109.485 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 5.3 t -115.6 113.43 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.889 -1.132 . . . . 0.0 110.707 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -131.58 157.32 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.601 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -56.21 -52.77 63.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.966 -1.083 . . . . 0.0 108.76 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' N ' ' OG ' ' A' ' 54' ' ' SER . 1.1 tttt -138.81 139.58 38.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 2.0 t -103.87 168.33 9.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.961 -1.087 . . . . 0.0 110.449 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.4 m-85 -79.62 168.09 19.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -38.16 86.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.786 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.86 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.995 -1.066 . . . . 0.0 109.739 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.3 mt-10 -124.05 179.3 4.91 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.358 -0.839 . . . . 0.0 109.998 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.6 p90 -135.29 -166.53 1.85 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.809 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.801 HG13 ' HB3' ' A' ' 74' ' ' PHE . 28.6 t -112.31 88.24 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.461 -0.774 . . . . 0.0 109.933 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' A' ' 77' ' ' ARG . 51.8 t0 -37.14 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.377 0.608 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.546 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.75 -28.29 60.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -69.91 -44.11 70.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.343 -0.848 . . . . 0.0 110.569 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 22.3 m-85 -92.12 -3.74 55.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 111.001 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.86 -20.64 3.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.025 -1.047 . . . . 0.0 108.924 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.034 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -70.03 -71.49 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.575 -0.703 . . . . 0.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.827 HG21 ' H ' ' A' ' 12' ' ' THR . 7.2 p -44.28 -28.89 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.066 -1.021 . . . . 0.0 109.411 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -63.05 -59.39 4.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.801 . . . . 0.0 110.271 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -134.47 11.76 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -31.85 12.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -1.194 . . . . 0.0 109.859 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.7 m-85 -91.58 -179.63 5.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 110.115 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.801 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.1 m-85 -122.95 140.57 52.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.765 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.1 t -79.53 98.25 6.78 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.085 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 10.9 t -78.58 163.77 25.23 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.04 . . . . 0.0 110.198 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 44.4 mtp180 -159.12 176.08 12.69 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.406 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -94.84 109.89 21.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.183 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.162 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.747 0.308 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.74 118.75 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.998 1.525 . . . . 0.0 110.414 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 3' ' ' LEU . 2.4 tt -110.0 46.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.743 HG23 ' HD2' ' A' ' 5' ' ' PRO . 7.5 mm -81.81 148.73 62.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.743 ' HD2' HG23 ' A' ' 4' ' ' ILE . 47.5 Cg_endo -72.03 -158.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.004 1.528 . . . . 0.0 109.484 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.23 -44.14 2.91 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.699 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.04 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -53.58 -49.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.357 -0.839 . . . . 0.0 110.049 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.695 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 41.7 m-85 -47.13 -33.67 5.36 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.454 -0.779 . . . . 0.0 109.742 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 73.8 mt -72.17 124.13 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.294 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 72.95 29.94 64.17 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -120.33 -163.12 0.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.476 -1.014 . . . . 0.0 110.766 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.727 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.2 m -153.66 99.77 2.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.875 . . . . 0.0 109.84 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.962 HG12 HG23 ' A' ' 69' ' ' VAL . 10.4 m -95.38 168.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.224 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -75.65 -162.62 11.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -75.47 -49.08 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.028 1.541 . . . . 0.0 110.35 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 t -60.46 -54.22 48.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -0.879 . . . . 0.0 110.338 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 76.3 t -58.33 -45.67 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.151 -0.968 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.628 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 27.3 t90 -51.56 -66.52 0.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.786 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.64 -34.53 1.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.735 . . . . 0.0 110.289 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 56.4 t80 -64.05 -62.29 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.975 HD22 HG22 ' A' ' 30' ' ' VAL . 1.4 tt -52.36 -26.22 11.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.56 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.8 t -69.94 -50.55 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.731 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.08 -26.62 50.31 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.219 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 24' ' ' LEU . 9.1 tp -73.91 -50.59 19.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.518 -0.739 . . . . 0.0 110.669 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.915 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.1 m -113.05 -44.06 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.462 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 129.2 169.0 12.48 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.57 -26.74 66.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.901 -1.353 . . . . 0.0 110.479 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.03 -54.97 14.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.181 -0.949 . . . . 0.0 110.05 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.915 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -64.05 -40.76 97.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.87 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.975 HG22 HD22 ' A' ' 21' ' ' LEU . 54.7 t -68.29 -25.26 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 110.181 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.2 m -86.67 -22.41 26.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.158 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.2 -19.59 26.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -86.46 17.11 3.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.22 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.45 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 60.8 t-20 55.4 67.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 110.603 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.774 HD13 HD13 ' A' ' 21' ' ' LEU . 65.2 mt -120.35 110.06 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 0.0 109.59 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -91.77 152.83 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.661 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.628 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 1.4 mtp180 -94.76 157.18 16.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 109.691 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -132.03 163.58 28.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.432 ' C ' ' OG ' ' A' ' 40' ' ' SER . 84.1 p -53.33 -31.91 46.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.44 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.432 ' OG ' ' C ' ' A' ' 39' ' ' SER . 2.1 m -164.74 -179.8 6.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -49.68 -23.42 1.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 110.082 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.9 t30 -87.7 110.42 20.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.844 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.1 p80 -150.12 177.85 9.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.584 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 5.2 p -81.49 130.41 35.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.46 -0.775 . . . . 0.0 109.62 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 p -121.97 173.85 7.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 0.0 110.424 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . . . 48.37 40.24 14.18 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.401 -0.812 . . . . 0.0 109.124 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 -149.25 49.23 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -87.21 23.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.138 -1.213 . . . . 0.0 109.864 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -100.84 -34.62 9.74 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 0.0 111.051 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.494 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.37 166.57 14.92 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.987 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.59 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.4 m95 -140.99 171.07 14.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -1.07 . . . . 0.0 109.854 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 4.4 t -106.07 108.79 20.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.59 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -130.41 157.45 42.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.211 -0.93 . . . . 0.0 109.938 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -63.93 -52.75 58.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -0.965 . . . . 0.0 109.021 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.4 tttt -128.75 174.66 9.25 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.503 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 58.2 m -150.34 170.08 19.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.867 -1.145 . . . . 0.0 110.747 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 15.7 m-85 -81.97 -176.06 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.372 -0.83 . . . . 0.0 110.476 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -80.37 -46.95 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.25 -0.906 . . . . 0.0 110.646 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' ARG . 1.5 t-80 -46.46 -23.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.144 -0.973 . . . . 0.0 109.153 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mt-10 -118.67 175.35 5.77 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.456 -0.777 . . . . 0.0 109.445 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.8 p90 -139.94 -167.26 2.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.543 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 74' ' ' PHE . 49.8 t -110.96 89.45 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.636 -0.665 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 16.8 t0 -40.6 90.46 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.49 -0.756 . . . . 0.0 110.42 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.25 -24.93 30.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.566 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 7' ' ' ILE . 18.6 t80 -68.74 -51.99 35.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.526 -0.734 . . . . 0.0 110.714 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.645 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 9.1 m-85 -81.58 -4.98 57.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.161 -0.962 . . . . 0.0 111.414 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.7 p -49.6 -21.5 1.02 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.057 -1.027 . . . . 0.0 109.979 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -66.09 -69.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 110.602 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.962 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -49.07 -26.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.011 -1.056 . . . . 0.0 109.476 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -68.2 -44.29 76.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 110.263 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -124.32 6.5 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.58 74.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.145 -1.209 . . . . 0.0 110.045 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 80.4 m-85 -81.22 -178.99 7.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.1 m-85 -125.36 138.92 54.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.868 . . . . 0.0 109.32 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 16.4 t -81.85 101.06 9.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.145 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 76.9 m -79.49 175.0 11.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 9.2 mtp180 -160.52 179.8 8.29 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.534 -0.729 . . . . 0.0 110.054 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.2 85.5 2.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.782 0.325 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.47 160.46 44.45 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.09 1.574 . . . . 0.0 110.495 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 3' ' ' LEU . 1.1 mt -74.09 -177.39 2.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 110.175 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.939 HD11 HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -55.08 156.53 7.11 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 109.974 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.724 ' HB2' HG22 ' A' ' 7' ' ' ILE . 51.3 Cg_endo -77.26 169.64 20.97 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.154 1.607 . . . . 0.0 110.169 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB3' ' OH ' ' A' ' 65' ' ' TYR . . . -88.83 -23.6 22.78 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.296 -0.877 . . . . 0.0 110.164 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.914 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -53.41 -57.16 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 110.995 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.641 ' H ' HG23 ' A' ' 7' ' ' ILE . 23.2 m-30 -48.32 -25.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.018 -1.051 . . . . 0.0 110.169 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.0 mt -73.17 128.37 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.565 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 58.05 32.79 67.49 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.914 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -117.46 -159.21 0.73 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.515 -0.991 . . . . 0.0 110.601 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.802 ' H ' HG21 ' A' ' 69' ' ' VAL . 2.8 m -153.13 91.05 1.49 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 109.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.914 HG12 HG23 ' A' ' 69' ' ' VAL . 5.9 m -90.66 164.62 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 110.506 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -89.69 -158.02 33.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 46.8 Cg_endo -74.42 -42.78 0.59 Allowed 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.912 1.48 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.486 ' HB2' ' OD1' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -63.81 -57.75 8.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 110.089 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.9 t -58.51 -49.67 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.73 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.569 ' CH2' HG12 ' A' ' 30' ' ' VAL . 56.4 t-105 -46.52 -66.4 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.705 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.44 -38.11 1.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.485 -0.759 . . . . 0.0 110.33 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 6.4 t80 -63.36 -64.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.354 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.939 HD21 HD11 ' A' ' 4' ' ' ILE . 1.8 tt -46.68 -51.28 16.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 110.325 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 HG21 ' A' ' 30' ' ' VAL . 78.3 t -48.77 -52.87 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.69 44.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 110.108 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD23 HG13 ' A' ' 4' ' ' ILE . 10.8 tp -59.76 -41.88 92.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.007 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -126.21 -86.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.834 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.7 170.03 38.06 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.07 66.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -1.148 . . . . 0.0 110.607 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.58 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.045 -1.034 . . . . 0.0 109.838 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.95 -22.28 66.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.204 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.754 HG22 HD22 ' A' ' 21' ' ' LEU . 24.1 t -73.54 -35.72 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.466 -0.771 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 m -78.65 -34.27 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.967 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.17 -23.89 59.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.49 4.88 12.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 59.5 t-20 59.05 68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.446 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 30' ' ' VAL . 25.8 mt -117.57 109.95 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.724 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.6 mtt180 -83.45 143.71 30.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.55 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.06 150.88 23.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.789 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.73 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -124.85 162.14 24.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.54 -26.33 20.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.311 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.563 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 2.5 m -170.44 -170.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.186 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 16' ' ' SER . 15.2 m-20 -62.5 -13.9 35.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.902 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.5 m-20 -99.61 102.82 14.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.795 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -141.47 175.38 9.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.414 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.594 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.3 p -79.17 129.59 34.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.787 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 p -122.32 176.74 5.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.421 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.68 37.83 7.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.44 -0.787 . . . . 0.0 109.223 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.3 -148.62 45.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 14.8 p30 -87.84 26.64 1.29 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.168 -1.195 . . . . 0.0 109.912 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -105.63 -29.23 10.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.23 21.1 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.391 -1.385 . . . . 0.0 109.893 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.594 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 6.7 m95 -137.67 170.9 15.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.46 -1.023 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -105.75 115.89 31.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.667 -1.27 . . . . 0.0 110.787 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' HG3' ' C ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -133.39 155.22 49.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.78 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -55.56 -56.97 14.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.891 -1.131 . . . . 0.0 108.754 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.79 -165.15 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 1.2 m -163.64 173.38 13.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.728 -1.233 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.51 -179.3 6.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.501 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.92 -40.31 20.31 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.163 -0.961 . . . . 0.0 110.359 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.63 -16.88 4.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.54 178.19 4.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.477 -0.765 . . . . 0.0 109.539 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 4.4 p90 -144.39 -164.66 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 110.238 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 64' ' ' THR . 24.8 t -126.01 98.31 4.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -48.74 89.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 0.0 110.029 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.47 -26.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.627 -0.67 . . . . 0.0 110.47 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.501 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 12.2 t80 -68.77 -52.47 30.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -81.21 -10.18 59.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 111.005 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -49.35 -22.85 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.05 -1.031 . . . . 0.0 109.357 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.665 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -66.92 -69.92 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.914 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -45.7 -30.94 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 109.624 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.51 -53.99 50.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.09 -139.39 14.47 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -50.49 -23.17 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -1.108 . . . . 0.0 110.277 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.467 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 12.2 m-85 -94.27 -170.54 2.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.552 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 37.0 m-85 -129.32 133.47 47.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 109.732 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 7.5 t -79.98 101.94 8.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.052 -1.03 . . . . 0.0 109.212 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.7 m -78.7 167.21 21.54 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.875 -1.141 . . . . 0.0 110.376 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 2.4 mtp180 -160.87 167.44 26.67 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.232 0.539 . . . . 0.0 109.627 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.91 102.46 13.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 110.206 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.204 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.66 152.75 48.34 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.106 1.582 . . . . 0.0 110.492 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER 56.0 -179.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.561 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -67.25 150.51 97.85 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.662 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 47.7 Cg_endo -73.31 170.02 20.87 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.164 1.613 . . . . 0.0 109.932 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -87.18 -44.71 11.28 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.442 -0.786 . . . . 0.0 110.238 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.774 HD11 ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -51.46 -41.86 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.286 -0.884 . . . . 0.0 110.483 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.951 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 28.3 m-85 -60.57 -33.73 73.13 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.179 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 6' ' ' ALA . 51.2 mt -71.97 138.5 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.118 -0.989 . . . . 0.0 109.514 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.96 33.95 81.11 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -127.48 -162.25 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.519 -0.989 . . . . 0.0 110.543 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.79 ' H ' HG21 ' A' ' 69' ' ' VAL . 2.3 m -151.15 98.43 2.56 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.237 -0.914 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.902 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -93.22 -175.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 13' ' ' VAL . . . -93.12 -164.56 37.61 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -72.62 -41.9 1.43 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.966 1.509 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -67.67 -47.34 69.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 47.6 t -62.64 -37.94 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.561 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 13.3 t90 -57.33 -58.9 6.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -50.45 -39.41 47.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 110.057 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 3.9 t80 -57.72 -65.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.058 HD22 HG22 ' A' ' 30' ' ' VAL . 4.1 tt -41.98 -44.38 3.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.506 -0.747 . . . . 0.0 109.987 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG22 HG21 ' A' ' 30' ' ' VAL . 71.7 t -55.27 -48.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.28 76.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.388 -0.82 . . . . 0.0 110.046 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tp -59.57 -41.12 89.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 110.064 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.94 -88.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.405 -0.81 . . . . 0.0 110.199 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.838 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.76 163.92 29.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.41 -20.59 56.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.202 -1.175 . . . . 0.0 110.603 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.24 1.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.094 -1.004 . . . . 0.0 109.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.03 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.93 -22.0 66.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.058 HG22 HD22 ' A' ' 21' ' ' LEU . 26.0 t -71.39 -33.58 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.476 -0.765 . . . . 0.0 109.638 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.8 m -86.25 -26.71 24.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.84 -18.87 49.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.892 . . . . 0.0 109.782 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.65 23.32 2.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.838 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 62.5 t-20 43.36 71.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 21' ' ' LEU . 65.2 mt -121.59 112.4 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -95.71 148.88 22.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.681 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.561 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm-85 -89.69 159.12 17.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -132.13 154.45 49.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 110.005 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -42.82 -26.73 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.908 . . . . 0.0 110.08 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' ALA . 3.2 m -174.43 -171.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.875 . . . . 0.0 110.073 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 72' ' ' ARG . 70.6 m-20 -57.51 -17.24 12.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 1.1 t-20 -91.25 108.64 20.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.327 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.4 p80 -151.65 179.72 8.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.208 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -81.09 148.04 29.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.864 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 7.8 p -141.28 -178.47 5.62 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.913 ' HB1' ' NH2' ' A' ' 77' ' ' ARG . . . 47.42 42.7 14.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.72 -154.88 48.54 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.424 -1.87 . . . . 0.0 108.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -84.05 42.91 0.9 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.112 -1.228 . . . . 0.0 109.665 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -119.31 -35.33 3.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.2 -0.938 . . . . 0.0 111.252 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -127.11 171.21 18.72 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.319 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 17.5 m95 -138.63 179.13 6.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.983 . . . . 0.0 109.405 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.447 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.0 t -112.59 118.5 35.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.812 -1.18 . . . . 0.0 110.769 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -130.47 158.3 40.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.663 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -53.39 -47.84 69.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.049 -1.032 . . . . 0.0 109.146 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 140.93 44.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 62' ' ' VAL . 15.5 m -77.48 159.38 29.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 110.097 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -80.59 -171.43 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.418 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -43.23 39.3 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.12 3.85 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.721 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 9.3 mt-10 -129.35 162.74 27.29 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 0.0 109.958 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 24.3 p90 -129.36 -178.83 4.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.625 HG22 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -91.42 92.84 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.332 0.587 . . . . 0.0 109.474 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 1.5 m-20 -51.52 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.694 . . . . 0.0 109.782 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -51.7 -22.65 3.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 0.0 110.683 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -70.02 -56.93 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 0.0 111.043 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.774 ' CD1' HD11 ' A' ' 7' ' ' ILE . 4.0 m-85 -86.06 -3.47 58.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 111.374 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.57 -23.03 1.45 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.831 -1.168 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.951 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.33 -71.97 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.656 -0.653 . . . . 0.0 110.757 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.902 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.24 -27.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.028 -1.045 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 1.0 OUTLIER -63.5 -63.35 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.265 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.15 -112.29 4.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HG3' ' OD2' ' A' ' 41' ' ' ASP . 39.1 mtt180 -62.66 -50.2 72.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -1.162 . . . . 0.0 110.093 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 20.2 m-85 -79.89 -173.05 3.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.179 -0.951 . . . . 0.0 110.006 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.523 ' HB3' HG13 ' A' ' 62' ' ' VAL . 29.2 m-85 -126.56 139.23 53.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.799 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 t -79.6 107.3 12.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 0.0 108.735 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 10.3 m -97.45 157.57 15.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 110.793 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.913 ' NH2' ' HB1' ' A' ' 46' ' ' ALA . 8.5 mtp180 -142.63 -175.36 4.44 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.724 -0.61 . . . . 0.0 109.801 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.8 p -110.6 94.88 5.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.26 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.815 0.341 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.614 ' HG2' HD21 ' A' ' 24' ' ' LEU . 46.5 Cg_endo -73.26 109.38 2.82 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.971 1.511 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.865 HD13 ' N ' ' A' ' 4' ' ' ILE . 2.6 tm? -42.83 136.41 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.245 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.865 ' N ' HD13 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -42.67 142.14 1.42 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 0.0 110.116 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 8' ' ' TYR . 45.3 Cg_endo -76.05 162.47 34.37 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.056 1.556 . . . . 0.0 110.027 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.469 ' CB ' ' OH ' ' A' ' 65' ' ' TYR . . . -61.67 -43.34 99.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.016 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.973 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -50.39 -54.24 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.62 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.617 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 8.8 m-30 -51.57 -31.03 23.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.972 . . . . 0.0 110.369 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 58.3 mt -71.95 129.41 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 60.14 31.66 73.79 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.973 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -114.55 -162.47 0.82 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.452 -1.028 . . . . 0.0 110.668 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.706 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.8 m -154.68 97.89 2.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 109.758 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.098 HG12 HG23 ' A' ' 69' ' ' VAL . 3.5 m -93.77 172.78 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.941 -1.099 . . . . 0.0 110.187 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -85.82 -159.59 32.35 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 48.9 Cg_endo -74.74 -46.58 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.015 1.534 . . . . 0.0 110.5 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 t -67.65 -50.43 57.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.237 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.0 t -57.22 -45.78 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.992 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 37' ' ' ARG . 11.3 t90 -52.17 -61.45 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.623 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.89 -37.97 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.424 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.4 t80 -60.29 -53.75 53.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.985 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD21 HD11 ' A' ' 4' ' ' ILE . 1.6 tt -57.63 -55.57 33.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.11 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' HG21 ' A' ' 30' ' ' VAL . 72.4 t -44.01 -61.17 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.065 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.19 -41.26 17.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.798 . . . . 0.0 109.968 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.614 HD21 ' HG2' ' A' ' 2' ' ' PRO . 11.0 tp -59.95 -41.44 91.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.095 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -126.4 -88.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.839 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.05 166.18 33.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.94 -19.25 60.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -1.13 . . . . 0.0 110.699 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.17 -64.25 1.01 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.019 -1.051 . . . . 0.0 109.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.095 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.52 -21.74 65.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 109.214 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.654 HG22 HD22 ' A' ' 21' ' ' LEU . 24.5 t -73.65 -34.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.454 -0.778 . . . . 0.0 109.714 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.0 m -87.8 -19.64 27.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 109.899 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.21 -22.1 28.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.837 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -89.01 23.51 2.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.88 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.442 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 37.8 t-20 42.54 76.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.381 -0.824 . . . . 0.0 110.355 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.619 HD13 HD13 ' A' ' 21' ' ' LEU . 19.4 mt -123.6 110.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 109.701 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' THR . 0.8 OUTLIER -93.22 144.44 25.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.907 . . . . 0.0 110.589 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 18' ' ' TRP . 2.7 mtm180 -82.93 166.0 19.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 0.0 109.708 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.742 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -139.05 161.87 36.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.083 -1.01 . . . . 0.0 110.266 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -51.19 -36.48 41.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.296 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 16.5 m -164.72 -179.07 5.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 38.6 m-20 -46.63 -30.89 2.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 17.2 t-20 -84.96 110.56 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.012 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.862 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.7 p80 -147.27 175.91 10.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.073 -1.017 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.594 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 17.9 p -78.23 127.54 32.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.426 -0.797 . . . . 0.0 109.749 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 p -120.49 168.43 11.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.006 -1.059 . . . . 0.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 53.22 50.0 18.66 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.551 -0.718 . . . . 0.0 109.303 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.17 -149.94 25.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -86.18 36.49 0.68 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.171 -1.193 . . . . 0.0 110.065 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HB3' ' NH1' ' A' ' 77' ' ' ARG . 3.5 mtt180 -113.57 -33.13 5.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 110.834 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -127.28 168.03 19.51 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 53' ' ' ARG . 7.0 m95 -142.22 170.79 15.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.46 -1.023 . . . . 0.0 109.263 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 0.6 OUTLIER -117.73 113.68 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.777 -1.202 . . . . 0.0 110.684 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -132.7 163.56 28.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.518 -0.739 . . . . 0.0 109.353 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.445 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 24.8 p -50.57 -48.17 57.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.897 -1.127 . . . . 0.0 108.508 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -127.74 179.83 5.33 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.641 0.734 . . . . 0.0 110.562 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.782 ' SG ' HG22 ' A' ' 62' ' ' VAL . 20.9 m -121.63 168.99 11.14 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.037 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -79.82 -173.62 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.116 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.5 -36.82 21.96 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.245 -0.909 . . . . 0.0 110.25 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -78.98 5.22 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.282 -0.886 . . . . 0.0 110.039 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 46.6 mt-10 -128.83 -175.68 3.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.291 -0.881 . . . . 0.0 110.347 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 7.5 p90 -141.12 -162.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.404 -0.81 . . . . 0.0 109.833 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.782 HG22 ' SG ' ' A' ' 56' ' ' CYS . 53.2 t -111.69 89.08 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.122 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 14.2 t0 -41.64 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 0.0 110.213 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -57.84 -27.1 62.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.207 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.469 ' OH ' ' CB ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -68.6 -49.51 58.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 110.605 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.4 m-85 -83.76 -9.28 58.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.945 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -22.57 1.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.039 -1.038 . . . . 0.0 109.537 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -66.96 -70.36 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 110.303 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.098 HG23 HG12 ' A' ' 13' ' ' VAL . 10.6 p -45.74 -25.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.998 -1.064 . . . . 0.0 109.341 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -67.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.781 . . . . 0.0 110.048 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.4 -96.13 2.0 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -56.77 7.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -1.15 . . . . 0.0 110.422 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.594 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 24.6 m-85 -89.27 -168.99 2.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.091 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.496 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.3 m-85 -123.34 149.64 44.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.84 . . . . 0.0 109.73 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 15.7 t -86.03 100.88 12.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 0.0 109.765 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.2 m -79.34 163.56 24.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -0.978 . . . . 0.0 109.802 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 3.4 mtp180 -153.95 176.88 11.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 t -104.67 94.37 5.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.171 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.155 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 6.9 m120 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.802 0.334 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 1' ' ' ASN . 45.5 Cg_endo -72.6 124.87 10.13 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.016 1.535 . . . . 0.0 110.46 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER -134.78 160.79 37.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 0.0 110.219 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.605 HG13 HD21 ' A' ' 21' ' ' LEU . 1.2 mm -43.03 148.55 0.58 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.8 Cg_endo -75.09 166.73 28.48 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.01 1.531 . . . . 0.0 109.937 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -84.68 -16.74 40.82 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.421 -0.799 . . . . 0.0 110.287 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.842 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -55.91 -47.76 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -0.869 . . . . 0.0 110.737 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.604 ' CZ ' ' HB1' ' A' ' 68' ' ' ALA . 22.8 m-85 -52.37 -24.42 7.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.476 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 70.2 mt -60.37 136.51 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.715 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 46.31 34.92 6.58 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.15 -167.48 1.2 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.509 -0.994 . . . . 0.0 110.671 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.825 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.7 m -150.06 88.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.332 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.665 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.0 m -83.16 -165.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.036 -1.04 . . . . 0.0 110.129 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.35 -163.46 17.8 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 45.7 Cg_endo -73.11 -45.45 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -67.59 -49.14 64.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.099 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 91.1 t -58.91 -48.0 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 109.839 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.606 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 7.8 t-105 -50.81 -59.35 4.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.732 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.46 -39.67 7.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.095 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 68.1 t80 -63.62 -63.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.335 -0.853 . . . . 0.0 110.145 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 HG13 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -42.37 -54.44 3.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.466 -0.771 . . . . 0.0 110.211 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG22 HG21 ' A' ' 30' ' ' VAL . 75.1 t -48.02 -50.2 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.11 -43.46 61.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 110.161 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 4' ' ' ILE . 6.3 tp -66.14 -36.12 82.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.092 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.04 -88.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.812 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 171.59 167.72 32.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.59 62.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -1.171 . . . . 0.0 110.524 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -63.66 1.1 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.053 -1.03 . . . . 0.0 109.914 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.092 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.19 -22.46 65.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.909 . . . . 0.0 109.297 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 26' ' ' GLY . 34.7 t -73.61 -31.46 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.486 -0.759 . . . . 0.0 109.979 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -87.83 -26.83 22.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 110.225 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -25.38 43.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -83.64 6.59 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 0.0 110.353 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 46.8 t-20 58.32 79.3 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -0.92 . . . . 0.0 110.619 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 21' ' ' LEU . 40.0 mt -118.84 136.97 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -110.18 151.2 27.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 110.575 -179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.5 OUTLIER -100.95 143.05 31.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.0 109.887 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.88 152.2 37.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.406 ' C ' ' OG ' ' A' ' 40' ' ' SER . 9.6 m -42.39 -27.08 0.13 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' ALA . 1.8 m -163.4 -176.02 4.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.196 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.5 -12.21 20.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.34 103.44 15.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.847 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.1 p80 -142.62 -178.56 5.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 110.578 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.615 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -92.92 147.22 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.802 . . . . 0.0 110.002 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.0 p -137.26 178.59 6.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 110.313 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 46.97 46.55 15.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.728 -0.789 . . . . 0.0 108.884 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.22 -153.11 48.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -84.66 42.88 0.94 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.054 -1.262 . . . . 0.0 109.604 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.4 mmm180 -109.44 -39.0 5.32 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 111.21 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.21 164.12 18.91 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.761 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.615 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.3 m95 -134.76 167.75 20.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.066 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.71 117.52 34.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.77 -1.206 . . . . 0.0 111.272 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mtt-85 -129.24 153.05 48.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.577 -0.702 . . . . 0.0 109.208 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.16 -48.98 64.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.09 . . . . 0.0 109.257 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 2.2 tttt -138.44 177.5 7.83 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 16.3 m -149.96 169.98 19.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.823 -1.173 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -80.03 -175.02 4.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.404 -0.81 . . . . 0.0 110.562 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.5 -43.36 14.64 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.324 -0.86 . . . . 0.0 110.443 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -49.51 -20.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.688 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.88 174.35 5.98 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.334 -0.854 . . . . 0.0 109.692 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 9.2 p90 -138.96 -165.1 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.95 -1.094 . . . . 0.0 110.376 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 64' ' ' THR . 16.6 t -124.95 103.63 12.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 75' ' ' CYS . 14.8 p30 -47.91 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.394 -0.816 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.85 -25.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.414 -0.803 . . . . 0.0 110.505 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' ASP . 12.8 t80 -71.34 -48.05 52.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.781 ' CD2' HD11 ' A' ' 7' ' ' ILE . 40.7 m-85 -90.2 -4.1 57.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.134 -0.979 . . . . 0.0 111.292 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -22.97 2.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 108.587 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.604 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -71.67 -64.48 0.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.671 -0.643 . . . . 0.0 110.485 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.847 HG22 ' CE1' ' A' ' 43' ' ' HIS . 10.1 p -44.96 -30.62 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.997 -1.064 . . . . 0.0 109.552 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -66.3 -58.31 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.361 -0.837 . . . . 0.0 110.147 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.98 -121.7 7.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -63.73 -31.11 72.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -1.214 . . . . 0.0 110.166 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.7 m-30 -87.73 -174.96 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.884 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 39.8 m-85 -128.31 126.82 41.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.363 -0.836 . . . . 0.0 109.969 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.71 97.33 6.53 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.159 -1.016 . . . . 0.0 108.881 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 65.2 m -79.71 169.13 18.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 110.959 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -160.41 170.57 20.72 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.701 -0.624 . . . . 0.0 109.898 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.6 m -97.93 103.43 15.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.436 -0.79 . . . . 0.0 110.162 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 5.5 tpt180 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.292 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.52 138.06 26.32 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.853 1.449 . . . . 0.0 110.43 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 -163.08 0.94 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.535 HG13 HG11 ' A' ' 25' ' ' VAL . 1.5 mm -55.11 147.1 36.39 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.198 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.8 Cg_endo -75.66 164.46 32.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.077 1.567 . . . . 0.0 109.834 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -81.23 -24.11 37.61 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.842 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -51.33 -59.6 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.948 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.655 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.6 m-85 -45.97 -28.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.048 -1.033 . . . . 0.0 109.845 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.0 mt -69.55 131.86 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.482 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.46 32.15 57.68 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.02 -162.93 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.527 -0.984 . . . . 0.0 110.517 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.812 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.7 m -153.82 99.02 2.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.182 -0.949 . . . . 0.0 110.099 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.719 HG12 HG23 ' A' ' 69' ' ' VAL . 2.8 m -89.96 -175.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.999 -1.063 . . . . 0.0 110.187 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -95.04 -160.94 34.01 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.1 Cg_endo -73.41 -47.87 0.28 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.963 1.507 . . . . 0.0 110.314 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -48.0 73.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.53 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 15.9 t -58.98 -47.11 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.981 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.625 ' CE3' ' CD ' ' A' ' 37' ' ' ARG . 6.0 t90 -50.45 -60.76 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.56 -34.87 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.277 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 13.8 t80 -64.49 -66.07 0.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.899 HD22 HG22 ' A' ' 30' ' ' VAL . 1.1 tt -50.34 -24.97 3.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.656 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 26' ' ' GLY . 24.3 t -73.36 -42.36 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.792 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.81 69.88 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tp -77.93 -47.34 18.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.53 -0.732 . . . . 0.0 110.407 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.957 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.5 m -113.33 -42.78 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.227 -0.921 . . . . 0.0 110.448 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.567 ' N ' ' CG2' ' A' ' 25' ' ' VAL . . . 120.36 170.06 14.15 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.99 -29.13 69.46 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.915 -1.344 . . . . 0.0 110.427 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.16 -52.07 57.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.211 -0.931 . . . . 0.0 110.05 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.957 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -64.03 -44.6 92.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.899 HG22 HD22 ' A' ' 21' ' ' LEU . 74.2 t -62.66 -26.31 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.792 . . . . 0.0 110.231 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -83.85 -31.59 25.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.01 . . . . 0.0 110.311 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.23 -17.55 49.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.652 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -90.01 8.11 34.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 110.182 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 57.1 t-20 58.78 72.88 0.5 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.253 -0.905 . . . . 0.0 110.478 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 33' ' ' ALA . 5.7 mt -126.2 113.78 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.829 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 12' ' ' THR . 25.1 mtm-85 -99.62 156.26 17.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 110.712 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.625 ' CD ' ' CE3' ' A' ' 18' ' ' TRP . 8.2 mtp180 -100.4 158.37 15.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.94 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -127.83 -174.6 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.317 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -60.67 -23.59 64.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.355 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.508 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.9 m -178.09 -169.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.3 m-20 -56.6 -24.08 45.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 110.091 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 31.0 t-20 -89.61 110.68 21.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.882 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.818 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.3 p80 -147.28 -176.03 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.107 -0.996 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.541 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -85.16 126.81 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 109.664 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.4 p -128.87 170.84 12.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 56.55 31.44 19.03 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.359 -0.838 . . . . 0.0 108.996 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.44 44.63 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 34.49 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.085 -1.244 . . . . 0.0 109.848 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.5 mmt85 -113.29 -36.14 5.1 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 111.396 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.17 160.08 23.26 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.419 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.541 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 19.5 m95 -131.47 175.29 9.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.598 -0.942 . . . . 0.0 108.646 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.455 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -118.9 116.54 26.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.724 -1.235 . . . . 0.0 111.249 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -131.62 171.13 13.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.545 -0.722 . . . . 0.0 109.452 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 p -55.35 -47.62 75.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.054 -1.029 . . . . 0.0 109.228 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 7.4 tttt -135.03 177.05 8.11 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 62' ' ' VAL . 17.6 m -119.21 175.93 5.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.944 -1.097 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 65.1 m-85 -79.75 -176.42 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 110.239 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -39.79 22.41 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.131 -0.981 . . . . 0.0 110.5 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.592 ' CD2' ' HG3' ' A' ' 60' ' ' GLU . 31.8 p-80 -79.04 7.16 7.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 110.207 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 7.9 mt-10 -124.42 -170.46 2.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 77' ' ' ARG . 3.3 p90 -152.43 -161.34 1.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' SG ' ' A' ' 56' ' ' CYS . 47.8 t -123.15 99.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 66' ' ' TYR . 46.0 p30 -52.11 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.892 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.72 -25.6 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -0.764 . . . . 0.0 110.982 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 63' ' ' ASP . 28.4 t80 -66.25 -53.13 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.055 -1.028 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 14.7 m-85 -83.16 -11.67 57.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 110.995 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -46.7 -24.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.21 -71.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 110.561 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.818 HG22 ' CE1' ' A' ' 43' ' ' HIS . 7.2 p -42.27 -28.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 109.486 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -64.2 -69.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.168 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.08 -119.94 6.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -27.18 68.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -1.169 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 12.1 m-85 -99.5 177.05 5.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.201 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 16.0 m-85 -121.02 138.01 54.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.958 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 41.1 t -79.51 100.59 7.8 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 108.837 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 9.4 m -79.35 160.84 26.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.829 -1.17 . . . . 0.0 110.139 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.584 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -159.98 173.46 15.86 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.52 -0.737 . . . . 0.0 110.22 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 p -103.41 112.81 25.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 110.217 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.225 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.802 0.334 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.61 135.02 21.25 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.07 1.563 . . . . 0.0 110.521 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.99 -170.26 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -0.9 . . . . 0.0 110.119 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.526 HD11 ' CD2' ' A' ' 21' ' ' LEU . 2.6 mm -45.23 145.54 1.8 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.6 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 47.4 Cg_endo -73.11 -159.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.17 1.616 . . . . 0.0 109.89 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -118.54 -22.07 7.69 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.349 -0.844 . . . . 0.0 109.88 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.89 ' CD1' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -55.7 -52.05 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 110.397 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.622 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.2 m-85 -46.22 -25.97 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.877 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 38.5 mt -61.28 126.85 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.186 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 58.0 32.94 67.53 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.18 -162.53 0.81 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.666 -0.902 . . . . 0.0 110.872 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.739 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.1 m -157.25 97.04 1.61 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.067 HG12 HG23 ' A' ' 69' ' ' VAL . 3.6 m -95.22 174.7 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.996 -1.065 . . . . 0.0 110.21 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.88 -163.09 37.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 48.2 Cg_endo -74.14 -51.53 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.046 1.551 . . . . 0.0 110.522 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -49.76 76.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 48.6 t -58.93 -47.6 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.722 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 9.9 t-105 -51.73 -58.13 7.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 109.802 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -46.36 -39.85 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.131 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -60.69 -58.13 9.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.84 HD22 HG22 ' A' ' 30' ' ' VAL . 1.5 tt -51.05 -34.12 28.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 110.121 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 24.4 t -63.65 -47.97 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.44 -40.71 68.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.753 . . . . 0.0 109.823 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.1 tp -63.3 -39.78 95.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.002 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -132.46 -88.05 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.335 -0.853 . . . . 0.0 110.002 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.822 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 172.52 166.37 30.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.9 -20.45 65.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -1.157 . . . . 0.0 110.446 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -61.54 1.73 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.112 -0.992 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.002 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.05 -28.74 70.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.84 HG22 HD22 ' A' ' 21' ' ' LEU . 37.8 t -70.27 -30.99 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.4 -0.812 . . . . 0.0 109.831 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.3 m -76.55 -36.0 57.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.41 -27.4 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.37 4.63 12.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.288 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 42.2 t-20 57.9 74.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.722 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 49.1 mt -122.26 121.73 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.58 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.5 mtt85 -101.11 150.29 23.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.608 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.86 159.61 16.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 110.077 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -133.58 151.13 51.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -42.98 -26.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -0.884 . . . . 0.0 110.145 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' ALA . 4.9 m -172.36 -173.83 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.304 -0.872 . . . . 0.0 110.007 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -57.85 -17.31 15.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.224 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.1 t-20 -89.25 98.12 11.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.469 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.784 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.8 p80 -142.49 176.53 8.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 110.53 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.588 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.6 p -81.82 130.48 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.448 -0.783 . . . . 0.0 109.847 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.8 p -121.91 174.64 6.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.616 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 49' ' ' ARG . . . 48.69 46.31 21.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 109.084 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.09 -151.99 41.15 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -85.4 40.46 0.84 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -1.208 . . . . 0.0 109.752 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 10.4 mtp180 -112.46 -38.64 4.6 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.249 -0.907 . . . . 0.0 110.985 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -126.1 168.98 18.09 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.133 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.588 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -136.13 172.19 13.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.452 -1.028 . . . . 0.0 109.861 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.4 t -104.41 112.37 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.985 -1.072 . . . . 0.0 110.76 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' A' ' 56' ' ' CYS . 7.2 mtt-85 -127.96 142.46 51.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.858 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.44 ' N ' ' CD2' ' A' ' 73' ' ' TYR . 2.1 p -51.89 -46.39 64.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.011 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -137.16 175.67 9.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 11.8 m -153.65 170.69 20.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.891 -1.131 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -79.74 177.57 8.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 110.709 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.9 ttp-105 -79.61 -42.68 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -48.62 -22.19 0.72 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.304 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.77 -175.69 2.73 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.51 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 3.1 p90 -147.38 -164.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 110.409 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 34.6 t -128.54 98.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -50.15 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 109.826 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -42.05 -26.7 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.579 -0.7 . . . . 0.0 110.26 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 7' ' ' ILE . 14.8 t80 -65.6 -49.79 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.834 . . . . 0.0 111.02 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.63 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.4 m-85 -86.56 -3.09 58.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.098 -1.001 . . . . 0.0 111.562 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -17.28 6.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.016 -1.053 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.89 ' HB3' ' CD1' ' A' ' 7' ' ' ILE . . . -70.87 -56.67 5.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.95 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.067 HG23 HG12 ' A' ' 13' ' ' VAL . 7.9 p -61.11 -27.79 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.969 -1.082 . . . . 0.0 109.469 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -64.57 -49.05 72.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.392 -0.817 . . . . 0.0 110.118 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 -137.2 14.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -48.67 -31.56 6.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -1.162 . . . . 0.0 109.889 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 54' ' ' SER . 8.6 m-85 -87.95 -177.83 5.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.006 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.547 ' HB3' ' CG1' ' A' ' 62' ' ' VAL . 46.8 m-85 -125.81 136.6 53.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.884 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.538 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 10.7 t -79.47 97.72 6.52 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.034 -1.041 . . . . 0.0 108.755 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 74.1 m -79.01 166.43 22.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.03 -1.044 . . . . 0.0 110.501 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.51 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 17.5 mtp180 -161.19 176.16 11.57 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.323 0.582 . . . . 0.0 109.83 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 78' ' ' SER . 11.5 p -108.08 104.53 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.505 -0.747 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.2 -179.812 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.35 161.07 45.41 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.968 1.51 . . . . 0.0 110.419 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -164.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.846 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.665 HG12 HD23 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -65.8 151.6 94.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.136 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.587 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.0 Cg_endo -74.86 164.73 32.92 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.144 1.602 . . . . 0.0 110.255 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.93 -23.27 28.9 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.443 -0.786 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.848 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -60.01 -38.23 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.687 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.511 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 9.7 m-30 -64.05 -18.79 64.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 9.4 mt -81.05 124.12 38.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.162 -0.961 . . . . 0.0 109.016 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 68.56 31.82 74.14 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -119.62 -163.08 0.96 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.468 -1.019 . . . . 0.0 110.752 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.728 ' H ' HG21 ' A' ' 69' ' ' VAL . 11.3 m -155.29 95.37 1.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.005 HG12 HG23 ' A' ' 69' ' ' VAL . 4.3 m -90.18 171.5 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.287 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 38' ' ' ALA . . . -83.77 -161.18 31.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.7 Cg_endo -74.26 -45.07 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.911 1.479 . . . . 0.0 110.407 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.1 m -66.75 -55.49 14.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.537 HG23 ' OD1' ' A' ' 41' ' ' ASP . 84.1 t -56.09 -45.56 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.728 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.814 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 22.8 t-105 -51.16 -62.99 1.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.19 -38.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.143 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.426 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.9 t80 -63.68 -60.21 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 110.106 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.807 HD13 HD13 ' A' ' 35' ' ' ILE . 1.2 tt -47.89 -55.37 9.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.625 ' HA ' HG21 ' A' ' 30' ' ' VAL . 41.3 t -44.15 -56.85 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.78 -42.74 47.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.149 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.665 HD23 HG12 ' A' ' 4' ' ' ILE . 11.4 tp -53.29 -42.94 67.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 109.988 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.099 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -127.99 -86.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 109.936 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.842 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.33 166.1 33.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -61.22 -19.93 62.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -1.145 . . . . 0.0 110.449 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -63.4 1.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.099 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.8 -20.17 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.185 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.649 HG22 HD22 ' A' ' 21' ' ' LEU . 29.6 t -77.85 -33.6 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.477 -0.764 . . . . 0.0 109.892 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -80.89 -33.16 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.52 -23.49 46.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.856 . . . . 0.0 109.85 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.28 4.88 11.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 59.4 t-20 60.78 63.98 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.654 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.814 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 54.8 mt -113.78 128.39 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.368 -0.832 . . . . 0.0 109.481 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -110.25 145.27 37.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 110.488 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.598 ' HG3' ' CD2' ' A' ' 18' ' ' TRP . 0.0 OUTLIER -90.31 154.38 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.413 -0.805 . . . . 0.0 109.761 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -129.54 171.0 13.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.253 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' HG ' ' A' ' 40' ' ' SER . 1.9 t -58.76 -33.3 70.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.533 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -159.92 178.94 9.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.567 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 41.6 m-20 -52.33 -33.31 42.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 52' ' ' CYS . 15.2 t-20 -82.71 99.81 9.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.89 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.7 p80 -136.25 177.01 8.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.409 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -75.25 141.66 43.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.977 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 10.9 p -131.79 178.78 6.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 44.16 44.88 6.71 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.229 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.03 -156.75 51.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' ASN . 22.9 t30 -84.33 41.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.963 -1.316 . . . . 0.0 109.959 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.35 -33.36 3.89 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.149 -0.969 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.533 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -121.19 173.84 15.68 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.483 -1.341 . . . . 0.0 109.831 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 16.5 m95 -150.73 161.35 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.424 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 86.4 m -96.5 104.57 16.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.12 . . . . 0.0 109.971 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 6.0 mtt180 -120.23 151.5 39.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 109.976 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.493 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -57.56 -52.84 63.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.094 -1.004 . . . . 0.0 109.122 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -128.38 172.98 10.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 94.6 m -149.5 168.09 24.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.785 -1.197 . . . . 0.0 110.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -79.91 176.22 9.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.731 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -75.34 -44.5 44.88 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.276 -0.89 . . . . 0.0 110.366 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -48.01 -21.73 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -118.3 174.29 6.32 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.417 -0.802 . . . . 0.0 109.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 11.2 p90 -134.4 -167.65 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.975 . . . . 0.0 110.227 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.797 HG13 ' HB3' ' A' ' 74' ' ' PHE . 17.9 t -113.97 89.83 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.73 . . . . 0.0 109.981 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.1 t0 -39.82 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.363 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -52.91 -23.34 6.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.446 -0.784 . . . . 0.0 110.591 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.08 -44.01 55.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 111.171 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.733 ' CD1' HD11 ' A' ' 7' ' ' ILE . 20.3 m-85 -89.83 -9.93 47.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.151 -0.968 . . . . 0.0 111.622 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -22.17 3.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.787 -1.196 . . . . 0.0 109.049 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.511 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -68.91 -52.62 27.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.488 -0.757 . . . . 0.0 110.645 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.005 HG23 HG12 ' A' ' 13' ' ' VAL . 9.7 p -60.0 -34.33 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.887 -1.133 . . . . 0.0 110.32 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 75' ' ' CYS . 61.6 m -60.4 -51.68 68.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.955 -1.091 . . . . 0.0 109.682 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.93 -102.78 2.91 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HD2' ' OD2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -76.57 -5.27 46.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -1.151 . . . . 0.0 109.881 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.65 178.09 4.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 110.077 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.797 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.1 m-85 -120.5 137.85 54.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 109.755 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 11.3 t -79.69 94.29 5.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.967 -1.083 . . . . 0.0 109.352 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 99.5 m -77.78 170.75 16.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.717 -1.193 . . . . 0.0 109.003 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.9 mtp180 -160.27 -177.5 6.3 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.244 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 m -110.19 91.15 3.54 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.192 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 10.3 tpt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.532 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 5.0 m-20 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 1' ' ' ASN . 46.2 Cg_endo -72.17 160.33 47.57 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.858 1.452 . . . . 0.0 110.466 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER 55.89 160.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 110.364 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 21' ' ' LEU . 2.6 mm -56.81 144.12 67.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.181 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.642 ' HG2' ' CD1' ' A' ' 8' ' ' TYR . 50.4 Cg_endo -72.86 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 124.243 1.654 . . . . 0.0 109.835 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.29 -41.33 3.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.627 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.766 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -57.64 -38.19 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.451 -0.781 . . . . 0.0 110.443 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.925 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 45.2 m-85 -62.71 -25.04 67.97 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.149 -0.97 . . . . 0.0 110.282 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 61.3 mt -73.4 143.72 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 49.51 36.58 24.4 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.23 -164.32 1.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.523 -0.986 . . . . 0.0 110.549 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.848 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.2 m -152.1 91.77 1.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.032 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.869 HG12 HG23 ' A' ' 69' ' ' VAL . 2.7 m -89.14 162.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.049 -1.032 . . . . 0.0 110.111 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.65 -166.68 9.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.1 Cg_endo -73.37 -39.41 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.999 1.526 . . . . 0.0 110.448 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.69 -51.25 43.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.285 -0.884 . . . . 0.0 110.38 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 48.0 t -57.62 -46.5 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.742 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 35.2 t-105 -49.8 -61.14 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.45 -44.3 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.283 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 79.0 t80 -58.12 -66.81 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.849 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.992 HD22 HG22 ' A' ' 30' ' ' VAL . 5.7 tt -40.52 -56.19 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 110.12 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 21' ' ' LEU . 47.2 t -42.44 -55.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.878 . . . . 0.0 110.061 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.18 -44.85 33.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 24' ' ' LEU . 12.9 tp -57.27 -49.94 74.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.15 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.973 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -117.02 -88.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.821 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.82 165.71 32.16 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.73 -20.13 63.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -1.129 . . . . 0.0 110.54 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.13 -63.29 1.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.149 -0.969 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.973 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.91 -19.14 62.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 109.223 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.992 HG22 HD22 ' A' ' 21' ' ' LEU . 10.9 t -75.09 -39.83 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.48 -0.762 . . . . 0.0 109.743 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.5 m -77.8 -28.8 50.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.4 -24.22 42.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -80.0 5.55 13.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.487 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.1 t-20 58.79 69.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.742 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 11.0 mt -119.3 135.65 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mtp180 -115.42 149.84 37.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.957 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 10.8 mtp85 -98.46 143.96 28.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 109.839 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -115.57 164.11 14.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.8 p -48.35 -27.79 2.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 110.395 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 39' ' ' SER . 4.4 m -165.01 -168.32 1.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 78.9 m-20 -64.32 -22.14 66.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.296 -0.877 . . . . 0.0 110.166 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 1.6 t30 -88.58 110.54 20.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 110.029 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.777 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.0 p80 -148.72 175.92 10.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.4 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.619 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -79.99 139.07 37.15 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.632 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -130.47 176.93 7.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 110.439 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.36 39.45 12.5 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.554 -0.716 . . . . 0.0 109.219 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.76 -151.98 46.86 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -87.44 24.17 1.72 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.171 -1.193 . . . . 0.0 109.972 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -105.65 -28.83 10.49 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 110.797 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.39 164.53 15.39 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.002 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.619 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 9.3 m95 -142.52 174.41 10.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.44 -1.035 . . . . 0.0 109.701 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.6 t -109.23 113.16 25.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 110.786 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 2.3 mtt180 -133.43 143.99 49.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -46.61 -39.31 10.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.971 -1.081 . . . . 0.0 108.766 179.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 4.7 tttt -135.86 171.1 14.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.779 ' SG ' HG22 ' A' ' 62' ' ' VAL . 6.3 m -119.73 177.06 5.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.18 -169.16 2.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.189 -0.944 . . . . 0.0 110.466 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -84.45 -42.46 15.59 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.422 -0.799 . . . . 0.0 110.215 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -72.2 -1.2 14.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.338 -0.851 . . . . 0.0 109.857 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 77' ' ' ARG . 17.9 mt-10 -126.65 -179.92 5.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.917 . . . . 0.0 110.02 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.55 ' CD1' ' HB2' ' A' ' 79' ' ' ARG . 8.1 p90 -139.74 -162.93 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.07 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.779 HG22 ' SG ' ' A' ' 56' ' ' CYS . 47.8 t -110.87 88.09 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 110.034 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.1 t0 -40.71 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.581 -0.699 . . . . 0.0 110.25 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 4.3 p -57.69 -34.64 69.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.378 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -63.54 -46.38 86.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.695 ' CD1' HD11 ' A' ' 7' ' ' ILE . 18.1 m-85 -86.57 -6.88 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 111.059 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -50.33 -22.29 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.951 -1.093 . . . . 0.0 109.064 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -67.59 -71.59 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.549 -0.72 . . . . 0.0 110.579 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.869 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -44.75 -29.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.01 -65.76 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 110.354 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.96 -115.81 5.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -61.6 -49.98 74.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -1.203 . . . . 0.0 109.915 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.475 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 21.6 m-85 -80.0 -177.22 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.926 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.668 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.7 m-85 -121.3 142.27 50.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.483 -0.76 . . . . 0.0 109.096 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.515 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.5 t -79.59 100.88 8.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.006 -1.059 . . . . 0.0 109.429 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 33.3 m -78.94 165.87 23.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.536 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -157.13 176.67 12.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.341 -0.85 . . . . 0.0 110.344 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.43 96.59 6.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.204 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.775 0.322 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.25 118.42 5.52 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.998 1.525 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.6 -175.96 2.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 110.148 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CD1' HD21 ' A' ' 21' ' ' LEU . 1.9 mt -74.89 144.47 79.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.249 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.62 ' HB2' HG22 ' A' ' 7' ' ' ILE . 48.6 Cg_endo -79.5 165.44 22.97 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.142 1.601 . . . . 0.0 109.859 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.16 -36.75 34.65 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.386 -0.821 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -50.7 -47.88 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 0.0 110.717 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.646 ' O ' HD13 ' A' ' 35' ' ' ILE . 7.8 m-30 -50.68 -34.93 28.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 110.301 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 43.4 mt -69.9 115.6 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.88 28.61 58.59 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.923 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -115.94 -162.65 0.85 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.557 -0.967 . . . . 0.0 110.71 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.752 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.0 m -153.35 93.78 1.74 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.18 -0.95 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.044 HG12 HG23 ' A' ' 69' ' ' VAL . 3.9 m -93.41 169.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 110.201 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -79.43 -154.95 9.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 49.1 Cg_endo -76.8 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.007 1.53 . . . . 0.0 110.441 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 t -53.21 -50.89 63.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.47 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 21.9 t -59.91 -46.73 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.118 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.624 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 11.3 t90 -49.47 -65.5 0.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.517 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.02 -41.55 2.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.395 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 36.6 t80 -59.33 -62.45 1.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.221 -0.924 . . . . 0.0 109.87 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.958 HD22 HG22 ' A' ' 30' ' ' VAL . 1.7 tt -43.92 -52.73 6.68 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.393 -0.817 . . . . 0.0 109.811 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' HG21 ' A' ' 30' ' ' VAL . 40.5 t -52.4 -42.67 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.786 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 20' ' ' TYR . . . -50.86 -45.11 59.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.369 -0.832 . . . . 0.0 109.342 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD23 HG13 ' A' ' 4' ' ' ILE . 4.6 tp -71.86 -27.38 62.84 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.488 -0.757 . . . . 0.0 109.673 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -124.18 -91.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.682 . . . . 0.0 110.293 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' H ' HG23 ' A' ' 25' ' ' VAL . . . 167.26 -170.57 41.61 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.87 -52.65 9.88 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.32 . . . . 0.0 110.306 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.58 -36.56 74.16 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.943 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . . . -69.45 -49.93 50.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.274 -0.891 . . . . 0.0 109.782 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.958 HG22 HD22 ' A' ' 21' ' ' LEU . 25.0 t -62.88 -21.77 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 110.252 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.2 m -79.78 -40.62 28.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.139 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.08 -17.21 60.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.96 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.19 25.05 2.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.9 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.448 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 46.0 t-20 41.87 67.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 8' ' ' TYR . 16.2 mm -110.21 112.5 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.659 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 12' ' ' THR . 5.3 mtt180 -97.6 139.47 33.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.893 . . . . 0.0 110.295 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.624 ' NE ' ' CE3' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -89.52 155.69 19.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 110.053 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -133.73 157.98 44.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.04 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 t -45.1 -33.27 2.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.545 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -166.92 -156.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 110.262 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD2' ' HD3' ' A' ' 72' ' ' ARG . 59.6 m-20 -71.73 -5.86 37.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.507 -0.746 . . . . 0.0 110.044 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 2.3 t30 -102.57 102.57 12.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.777 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.2 p80 -146.03 -175.46 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.454 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.1 p -86.95 129.49 34.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.443 -0.785 . . . . 0.0 109.568 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.45 177.63 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 110.426 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 48.03 45.35 19.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 -156.01 52.79 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 19.7 p30 -86.24 34.94 0.63 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.013 -1.286 . . . . 0.0 110.009 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -115.9 -30.6 6.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.131 -0.98 . . . . 0.0 110.788 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -117.92 163.74 12.82 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.483 -1.342 . . . . 0.0 109.773 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 7.5 m95 -140.23 177.06 8.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.0 109.367 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 6.2 t -114.55 115.07 26.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.831 -1.168 . . . . 0.0 110.928 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -131.91 159.28 39.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 55' ' ' LYS . 5.9 p -57.89 -52.67 64.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.988 -1.07 . . . . 0.0 108.965 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' N ' ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -140.69 139.69 34.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -105.05 163.6 12.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.235 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.63 -164.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' HIS . 8.9 ttp180 -80.64 -43.74 19.99 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.445 ' C ' ' HG2' ' A' ' 60' ' ' GLU . 1.3 m-70 -45.78 -24.49 0.38 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.153 -0.967 . . . . 0.0 109.445 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 56' ' ' CYS . 1.8 mm-40 -125.91 179.56 5.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.385 -0.822 . . . . 0.0 110.023 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.0 p90 -137.86 -163.11 1.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.594 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.727 HG13 ' HB3' ' A' ' 74' ' ' PHE . 25.4 t -113.77 87.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.431 -0.793 . . . . 0.0 109.927 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 15.3 t0 -38.26 90.6 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.694 -0.629 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -55.98 -25.34 43.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.545 ' O ' HD12 ' A' ' 7' ' ' ILE . 8.4 t80 -70.8 -51.32 27.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 110.737 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.63 ' O ' HG12 ' A' ' 69' ' ' VAL . 10.9 m-85 -81.44 -6.45 58.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 111.23 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -18.93 2.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.967 -1.083 . . . . 0.0 109.824 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.042 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.11 -47.02 63.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.9 . . . . 0.0 110.988 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.044 HG23 HG12 ' A' ' 13' ' ' VAL . 7.9 p -71.54 -24.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 109.501 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -66.99 -57.33 7.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.452 -0.78 . . . . 0.0 110.267 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 93.31 -125.75 8.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HD3' ' OD2' ' A' ' 41' ' ' ASP . 5.2 mpt_? -52.51 -36.65 55.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.84 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' C ' ' CD1' ' A' ' 74' ' ' PHE . 39.5 m-85 -90.87 -173.42 3.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.727 ' HB3' HG13 ' A' ' 62' ' ' VAL . 3.0 m-85 -129.65 142.34 50.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 10.5 t -79.6 99.32 7.28 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.556 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 77' ' ' ARG . 8.0 t -79.05 165.41 23.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.129 -0.982 . . . . 0.0 109.976 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 5.4 mtp180 -157.5 171.93 19.48 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.784 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 79' ' ' ARG . 1.1 m -107.55 76.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.172 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 78' ' ' SER . 6.6 ttt-85 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.152 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.522 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.9 t30 . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 1' ' ' ASN . 48.0 Cg_endo -75.91 -176.59 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.872 1.459 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.56 HD23 ' H ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER 52.12 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -0.849 . . . . 0.0 110.279 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.724 ' CD1' HD23 ' A' ' 24' ' ' LEU . 2.1 mm -89.87 144.71 31.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.838 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.9 Cg_endo -78.05 162.78 28.73 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.098 1.578 . . . . 0.0 110.028 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -80.44 -21.97 41.62 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.511 -0.743 . . . . 0.0 110.403 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.838 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -52.57 -54.25 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.608 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.66 -28.88 3.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 17.3 mt -64.86 123.91 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.75 29.34 74.47 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -116.92 -162.77 0.87 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -1.009 . . . . 0.0 110.429 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.844 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.2 m -151.95 95.09 2.04 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.0 110.012 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.739 HG12 HG23 ' A' ' 69' ' ' VAL . 3.2 m -88.87 179.25 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.936 -1.103 . . . . 0.0 110.118 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -94.52 -161.81 34.86 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.31 -45.68 0.42 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.016 1.535 . . . . 0.0 110.318 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -53.1 50.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG23 ' OD1' ' A' ' 41' ' ' ASP . 10.7 t -58.55 -47.24 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.187 -0.946 . . . . 0.0 109.856 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.636 ' CH2' HG12 ' A' ' 30' ' ' VAL . 59.6 t-105 -48.09 -66.83 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.96 -38.35 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.27 -49.66 76.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.174 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.823 ' CD1' HD13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -60.38 -28.13 67.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . 48.5 t -66.79 -48.75 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 110.0 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.98 92.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.838 . . . . 0.0 109.914 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.724 HD23 ' CD1' ' A' ' 4' ' ' ILE . 10.8 tp -61.45 -41.94 97.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -130.52 -50.87 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.254 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 30' ' ' VAL . . . 137.02 163.99 9.93 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -66.2 -9.41 31.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -1.182 . . . . 0.0 110.856 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.98 -67.64 0.66 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.968 -1.083 . . . . 0.0 109.707 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.025 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.77 -20.08 64.63 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.161 -0.962 . . . . 0.0 108.668 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.788 HG22 HD22 ' A' ' 21' ' ' LEU . 14.4 t -70.82 -37.23 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.606 -0.684 . . . . 0.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.7 m -85.04 -25.03 27.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.339 -0.851 . . . . 0.0 109.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.36 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.866 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -90.05 25.92 2.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.41 -0.806 . . . . 0.0 109.771 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 5.8 t-20 40.21 75.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 0.0 110.6 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.823 HD13 ' CD1' ' A' ' 21' ' ' LEU . 64.3 mt -124.34 118.34 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.472 -0.768 . . . . 0.0 109.455 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.482 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.3 mtt180 -96.91 156.68 16.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 110.512 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 8.9 mtp180 -107.27 139.47 41.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.508 -0.745 . . . . 0.0 109.645 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.554 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -117.73 164.56 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -42.7 -26.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.356 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.503 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -172.34 -162.42 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' OD1' HG23 ' A' ' 17' ' ' VAL . 54.2 m-20 -66.61 -8.44 27.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.882 . . . . 0.0 110.302 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 1.2 t-20 -94.7 101.99 13.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.516 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.802 ' CE1' HG22 ' A' ' 69' ' ' VAL . 2.6 p80 -143.55 -179.78 6.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 110.513 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.548 ' OG ' ' CH2' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -88.1 120.92 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 109.66 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 9.3 p -116.51 -178.75 3.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.103 -0.998 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' CZ ' ' A' ' 77' ' ' ARG . . . 49.13 41.58 19.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.457 -0.777 . . . . 0.0 108.957 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.57 -153.74 51.0 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.96 36.55 0.67 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.057 -1.26 . . . . 0.0 109.771 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -117.77 -30.74 5.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' HG3' ' A' ' 77' ' ' ARG . . . -124.64 160.23 19.25 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.893 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.548 ' CH2' ' OG ' ' A' ' 44' ' ' SER . 25.2 m95 -132.18 174.68 9.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.318 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 53' ' ' ARG . 7.7 t -107.44 112.53 25.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.421 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.3 mpt_? -127.77 143.2 51.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 0.0 109.894 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -49.52 -46.45 48.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.978 -1.076 . . . . 0.0 108.624 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -125.67 -175.84 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 55' ' ' LYS . 86.6 m -150.9 160.32 43.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.992 -1.067 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -80.56 171.53 14.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 110.365 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -38.97 67.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.228 -0.92 . . . . 0.0 110.258 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -13.68 11.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.733 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -120.88 169.93 9.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 109.557 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 15.5 p90 -132.09 -178.01 4.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.913 -1.117 . . . . 0.0 111.102 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 64' ' ' THR . 75.6 t -99.61 94.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.294 0.568 . . . . 0.0 109.777 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -47.96 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -50.46 -25.4 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 111.027 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.03 -48.6 43.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.169 -0.957 . . . . 0.0 111.17 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.706 ' CD2' HD11 ' A' ' 7' ' ' ILE . 32.0 m-85 -89.79 -4.86 57.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.07 -1.019 . . . . 0.0 111.41 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -49.91 -22.89 1.67 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.942 -1.099 . . . . 0.0 109.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -70.99 -65.44 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.447 -0.783 . . . . 0.0 110.541 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.844 HG21 ' H ' ' A' ' 12' ' ' THR . 9.3 p -46.69 -26.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.948 -1.095 . . . . 0.0 109.59 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -68.63 -64.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.12 179.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.38 -124.14 8.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.76 -24.36 22.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -1.147 . . . . 0.0 109.953 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 12.2 m-85 -102.0 -179.41 3.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 110.143 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 8.9 m-85 -123.57 130.84 53.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.131 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.526 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 7.5 t -79.81 105.99 11.5 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.037 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 66.6 m -102.09 170.07 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.168 -1.013 . . . . 0.0 110.666 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 16.7 mtp180 -149.73 -172.8 4.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.348 0.594 . . . . 0.0 109.559 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 79' ' ' ARG . 5.6 p -115.73 80.42 1.44 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.424 -0.797 . . . . 0.0 110.131 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.79 0.328 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.07 135.47 21.02 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.021 1.537 . . . . 0.0 110.493 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -172.18 3.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.998 HD11 HD21 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -54.9 160.15 3.18 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.94 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.4 Cg_endo -75.35 166.57 28.51 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.86 -27.73 20.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 110.413 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.8 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -54.36 -49.65 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -0.894 . . . . 0.0 110.442 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.571 ' H ' HG23 ' A' ' 7' ' ' ILE . 8.5 m-30 -46.6 -29.46 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.317 -0.864 . . . . 0.0 109.946 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -66.91 113.83 3.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.211 -0.93 . . . . 0.0 109.547 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 73.13 27.81 67.65 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -110.65 -164.77 0.94 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.527 -0.984 . . . . 0.0 110.619 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.745 ' H ' HG21 ' A' ' 69' ' ' VAL . 54.9 m -155.01 100.09 2.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.166 -0.959 . . . . 0.0 110.034 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.041 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -97.5 163.85 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.104 -0.998 . . . . 0.0 110.036 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.19 -164.73 11.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.2 Cg_endo -73.69 -47.5 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.989 1.52 . . . . 0.0 110.4 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -54.02 51.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 81.6 t -60.59 -50.71 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.593 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 26.8 t-105 -45.17 -66.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.119 -0.988 . . . . 0.0 109.626 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -41.55 -42.33 2.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.6 t80 -60.73 -65.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.376 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.998 HD21 HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -41.75 -44.33 3.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.446 -0.784 . . . . 0.0 110.356 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' VAL . 84.9 t -54.69 -49.52 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.81 69.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.606 HD23 HG13 ' A' ' 4' ' ' ILE . 6.7 tp -60.65 -46.22 91.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.997 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -120.13 -87.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.825 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.16 170.21 39.29 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.8 -22.62 67.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -1.102 . . . . 0.0 110.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.39 -61.94 1.58 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.997 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.17 -26.49 68.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.303 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 26' ' ' GLY . 33.9 t -71.42 -34.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.751 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.9 m -85.32 -20.47 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.905 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -20.52 31.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.85 25.01 2.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.831 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 49.0 t-20 41.5 74.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.397 -0.815 . . . . 0.0 110.445 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 21' ' ' LEU . 13.5 mt -118.43 120.34 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.667 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 7.3 mmt180 -99.09 147.85 24.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 110.474 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.593 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 17.5 mtp180 -101.38 136.58 40.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.409 -0.807 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -110.44 160.06 16.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 110.233 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.404 ' C ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -48.62 -25.7 1.88 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.917 . . . . 0.0 110.313 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.413 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -160.07 -176.6 5.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD1' HG23 ' A' ' 17' ' ' VAL . 56.9 m-20 -62.17 -16.65 54.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 73' ' ' TYR . 19.8 t-20 -90.4 107.62 19.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.891 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.6 p80 -143.77 175.54 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 110.561 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.2 p -78.68 130.41 35.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 109.736 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.57 179.34 4.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 47.7 41.76 14.33 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.159 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.56 -153.22 51.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 1.8 m-20 -84.47 41.33 0.83 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.164 -1.198 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.96 -36.51 3.4 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.234 -0.916 . . . . 0.0 111.043 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -122.71 166.3 15.21 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.094 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 11.1 m95 -135.74 172.07 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -1.033 . . . . 0.0 109.649 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.7 t -105.35 111.62 24.42 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 1.2 mtt180 -129.14 145.14 51.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 109.478 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 73' ' ' TYR . 23.5 m -46.68 -40.44 13.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.033 . . . . 0.0 108.614 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.83 168.52 19.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 62' ' ' VAL . 7.8 m -117.22 173.67 6.55 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.899 -1.125 . . . . 0.0 110.144 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -79.62 -169.85 2.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.074 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -87.57 -42.47 12.71 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.09 -1.22 11.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.229 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 9.2 mt-10 -121.65 -170.88 2.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.084 -1.01 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.7 p90 -150.26 -162.94 1.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.889 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 56' ' ' CYS . 53.9 t -120.35 94.37 2.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -51.88 89.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.739 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -42.77 -25.18 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.691 -0.631 . . . . 0.0 110.598 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.499 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.9 t80 -66.55 -50.07 64.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 111.287 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 7.9 m-85 -87.0 -5.76 58.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 111.761 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 t -55.27 -18.27 5.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.854 -1.153 . . . . 0.0 109.663 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.8 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -70.25 -49.33 51.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 111.044 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.041 HG23 HG12 ' A' ' 13' ' ' VAL . 7.0 p -68.47 -27.93 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.133 . . . . 0.0 109.224 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -60.97 -53.58 55.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.415 -0.803 . . . . 0.0 109.858 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.52 -123.37 6.88 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -42.79 71.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -1.106 . . . . 0.0 109.971 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 22.6 m-30 -85.96 -178.19 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.947 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.633 ' HB3' HG13 ' A' ' 62' ' ' VAL . 10.3 m-85 -121.05 143.23 49.17 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.447 -0.783 . . . . 0.0 109.236 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 t -79.28 99.72 7.21 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.131 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.7 m -79.3 162.87 25.34 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.145 -0.972 . . . . 0.0 110.153 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 60' ' ' GLU . 1.6 mtp180 -159.2 -176.21 5.69 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.512 -0.742 . . . . 0.0 110.275 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -118.31 83.59 2.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.756 . . . . 0.0 110.27 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.27 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.39 -160.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.927 1.488 . . . . 0.0 110.495 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.906 ' CD2' HD21 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -159.57 41.93 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.538 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.482 ' CD1' HD23 ' A' ' 24' ' ' LEU . 1.7 mm -51.72 145.87 15.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.326 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.0 Cg_endo -77.04 163.87 30.29 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.066 1.561 . . . . 0.0 110.041 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.16 -27.17 30.27 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.506 -0.746 . . . . 0.0 110.425 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.792 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -56.04 -38.03 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.211 -0.931 . . . . 0.0 110.582 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 10.8 m-30 -64.93 -27.29 68.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 110.281 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.09 129.18 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.255 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 63.16 32.02 82.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.792 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -123.06 -162.14 1.01 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 110.555 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.75 ' H ' HG21 ' A' ' 69' ' ' VAL . 8.4 m -153.2 101.05 2.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.038 HG12 HG23 ' A' ' 69' ' ' VAL . 3.2 m -99.84 157.43 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.94 -1.1 . . . . 0.0 110.284 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -71.87 -162.0 5.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.7 Cg_endo -74.57 -40.54 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.018 1.536 . . . . 0.0 110.428 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.3 m -62.81 -58.93 5.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 84.5 t -59.26 -50.53 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.776 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.801 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 23.7 t-105 -45.09 -64.14 0.78 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.868 . . . . 0.0 109.745 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.15 -44.55 5.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.719 . . . . 0.0 110.387 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 62.4 t80 -57.81 -62.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG22 ' A' ' 30' ' ' VAL . 2.0 tt -44.28 -56.16 4.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.813 . . . . 0.0 109.998 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' LEU . 84.7 t -43.07 -44.55 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 20' ' ' TYR . . . -57.78 -56.31 23.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.906 HD21 ' CD2' ' A' ' 3' ' ' LEU . 13.5 tp -49.44 -46.45 47.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.945 . . . . 0.0 110.028 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.99 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -116.37 -89.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.424 -0.797 . . . . 0.0 110.079 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.831 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.28 165.27 29.9 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.79 59.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 110.626 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.05 -62.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.105 -0.997 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.99 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.21 -21.38 66.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.788 HG22 HD22 ' A' ' 21' ' ' LEU . 24.8 t -74.62 -35.37 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.471 -0.768 . . . . 0.0 109.885 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -83.57 -26.32 30.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.92 -15.75 38.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 110.01 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.02 25.1 2.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.773 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 50.0 t-20 47.36 68.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.552 -0.718 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.801 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 57.6 mt -122.62 126.15 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.415 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 73.1 mtt180 -109.1 146.75 33.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.493 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.633 ' CG ' ' CE3' ' A' ' 18' ' ' TRP . 0.9 OUTLIER -93.32 144.37 25.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.513 -0.742 . . . . 0.0 109.647 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -116.39 155.0 29.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.969 . . . . 0.0 110.401 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -45.66 -27.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.339 -0.85 . . . . 0.0 110.192 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -165.07 -163.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -70.45 -12.69 61.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.946 . . . . 0.0 110.332 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.514 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.4 OUTLIER -94.57 103.75 15.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.425 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.816 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.7 p80 -143.42 177.0 8.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 110.336 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.598 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 84.9 p -82.37 131.89 35.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.44 -0.788 . . . . 0.0 109.569 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.9 p -124.27 175.68 6.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 110.62 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 51.11 36.51 15.71 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.17 -150.36 51.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -84.25 42.64 0.89 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.263 . . . . 0.0 109.827 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.2 mtt180 -117.23 -38.31 3.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.243 -0.911 . . . . 0.0 111.084 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -127.44 171.38 18.91 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.398 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 7.2 m95 -137.33 172.78 12.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.535 -0.979 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -106.46 110.69 22.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.847 -1.158 . . . . 0.0 111.024 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -128.46 145.45 51.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 0.0 109.4 179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 30.1 t -53.09 -53.16 54.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.884 -1.135 . . . . 0.0 108.316 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -124.87 178.4 5.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.455 0.645 . . . . 0.0 110.047 178.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' SG ' ' CD ' ' A' ' 53' ' ' ARG . 5.3 m -155.63 171.22 20.34 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.817 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -79.72 178.31 8.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.689 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -47.3 15.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 110.29 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -48.59 -21.04 0.51 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 109.64 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -110.5 178.17 4.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.352 -0.842 . . . . 0.0 109.705 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 3.5 p90 -144.18 -164.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.054 -1.029 . . . . 0.0 110.297 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 64' ' ' THR . 39.3 t -127.82 98.02 4.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -50.03 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.782 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -41.6 -26.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.674 -0.641 . . . . 0.0 110.458 -179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.5 t80 -66.79 -49.39 66.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 111.04 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.728 ' CD1' HD11 ' A' ' 7' ' ' ILE . 12.4 m-85 -85.77 -8.15 58.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 111.15 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.7 p -49.08 -22.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.921 -1.112 . . . . 0.0 109.017 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -65.36 -70.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.523 -0.735 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.038 HG23 HG12 ' A' ' 13' ' ' VAL . 9.8 p -47.43 -29.46 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.907 -1.121 . . . . 0.0 109.845 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -63.95 -46.19 85.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.32 -132.82 11.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.1 mmt85 -57.07 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -1.19 . . . . 0.0 110.132 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 8.8 m-85 -84.26 -173.26 4.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 15.9 m-85 -128.39 134.49 48.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 110.078 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.0 t -79.73 97.11 6.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.081 -1.012 . . . . 0.0 108.635 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 70.9 m -79.21 166.29 22.35 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 110.581 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 13.6 mtp180 -160.77 177.56 10.31 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.217 0.532 . . . . 0.0 109.666 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.8 t -106.94 106.58 17.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.783 0.325 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.19 124.69 9.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.973 1.512 . . . . 0.0 110.395 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.08 -164.78 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.852 HD11 ' CD2' ' A' ' 21' ' ' LEU . 4.2 mm -79.84 144.41 59.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.965 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 4' ' ' ILE . 45.6 Cg_endo -72.27 -159.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 124.072 1.564 . . . . 0.0 109.805 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.72 -35.61 5.7 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.356 -0.84 . . . . 0.0 110.036 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.923 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -53.01 -50.28 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.57 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.587 ' H ' HG23 ' A' ' 7' ' ' ILE . 15.9 m-30 -48.58 -31.76 7.06 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.887 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 41.7 mt -67.31 113.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.361 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 76.75 27.14 61.33 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -113.11 -164.4 0.92 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.552 -0.969 . . . . 0.0 110.6 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.678 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.0 m -155.89 103.08 2.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.073 HG12 HG23 ' A' ' 69' ' ' VAL . 4.0 m -98.62 -175.82 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 110.242 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' TRP . . . -96.21 -160.32 32.5 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.84 -43.64 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.01 1.532 . . . . 0.0 110.391 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.9 p -65.44 -53.75 38.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 ' OD1' ' A' ' 41' ' ' ASP . 60.1 t -59.9 -48.81 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.093 -1.004 . . . . 0.0 109.968 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.721 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 14.3 t-105 -48.58 -60.38 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.858 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.07 -42.47 13.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.256 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.4 t80 -59.69 -65.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.0 110.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.852 ' CD2' HD11 ' A' ' 4' ' ' ILE . 3.9 tt -42.58 -43.94 3.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 110.28 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 18' ' ' TRP . 40.1 t -54.34 -50.08 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.96 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.5 -45.66 66.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.425 -0.797 . . . . 0.0 109.837 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.0 tp -58.27 -41.66 84.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.362 -0.836 . . . . 0.0 109.898 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.007 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -125.64 -88.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.975 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.831 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 172.51 163.99 27.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -18.32 53.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.7 1.07 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.05 -1.031 . . . . 0.0 109.821 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.007 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -61.22 -25.64 67.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.921 . . . . 0.0 109.12 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.836 HG22 HD22 ' A' ' 21' ' ' LEU . 37.3 t -68.75 -33.27 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.491 -0.756 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -77.5 -46.67 21.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.26 -17.77 64.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -88.27 23.31 2.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 35.5 t-20 40.69 69.84 0.3 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.721 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 21.2 mt -118.34 122.04 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 19.1 mtp180 -104.15 148.79 25.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 110.59 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.606 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 5.5 mtt85 -91.93 154.3 18.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.546 -0.721 . . . . 0.0 109.771 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.552 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -133.34 160.62 36.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 110.297 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -44.42 -35.03 2.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 0.0 110.557 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -164.17 -165.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.404 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' HG23 ' A' ' 17' ' ' VAL . 70.3 m-20 -64.37 -11.38 32.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 0.0 110.165 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' HB2' ' CD2' ' A' ' 73' ' ' TYR . 24.2 t-20 -97.6 104.37 16.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 110.111 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.887 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -144.16 177.61 8.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.487 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.596 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.5 p -76.32 131.36 39.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -0.778 . . . . 0.0 109.699 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.51 173.96 8.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.985 -1.072 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.54 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . . . 49.83 38.79 16.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.596 -0.69 . . . . 0.0 109.179 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.64 -149.44 51.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -85.14 40.91 0.85 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.098 -1.237 . . . . 0.0 109.706 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.9 mmt180 -113.77 -37.2 4.61 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.341 -0.849 . . . . 0.0 110.843 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -130.86 173.6 20.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.128 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.596 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 9.4 m95 -140.17 171.43 14.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.397 -1.061 . . . . 0.0 109.223 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.2 t -106.38 120.5 42.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.791 -1.193 . . . . 0.0 111.287 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 3.4 mtt-85 -132.95 156.21 47.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.464 -0.772 . . . . 0.0 108.922 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -48.53 -50.05 33.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 107.964 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.66 179.86 5.89 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.488 0.661 . . . . 0.0 110.11 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.806 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.1 m -127.64 159.92 33.2 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.789 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -79.97 -177.0 5.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.41 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.48 -39.13 32.88 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.898 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -12.87 13.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.367 -0.833 . . . . 0.0 109.554 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' CD ' ' O ' ' A' ' 77' ' ' ARG . 5.3 mt-10 -124.56 -164.83 1.3 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.427 -0.796 . . . . 0.0 109.933 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.8 p90 -155.44 -162.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 109.709 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.806 HG22 ' SG ' ' A' ' 56' ' ' CYS . 78.4 t -119.86 95.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -53.04 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.294 -0.962 . . . . 0.0 109.334 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.3 OUTLIER -44.17 -24.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.672 -0.643 . . . . 0.0 110.627 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.562 ' O ' HD12 ' A' ' 7' ' ' ILE . 11.8 t80 -66.81 -50.85 61.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 111.164 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.611 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 8.0 m-85 -86.69 -5.6 59.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.108 -0.995 . . . . 0.0 111.724 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 t -54.68 -18.29 4.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.875 -1.141 . . . . 0.0 109.573 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.923 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -69.33 -51.81 33.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.073 HG23 HG12 ' A' ' 13' ' ' VAL . 8.1 p -66.71 -26.84 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 109.414 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -65.26 -44.5 87.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.871 179.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.08 -128.04 8.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -53.01 -34.02 54.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -1.097 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.555 ' CD2' ' HB2' ' A' ' 42' ' ' ASN . 4.4 m-30 -88.46 -174.62 4.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 110.001 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HB3' HG13 ' A' ' 62' ' ' VAL . 25.2 m-85 -130.17 135.97 48.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 109.957 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 11.3 t -79.36 101.25 8.0 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 108.958 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.0 m -83.09 162.31 21.38 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.054 -1.029 . . . . 0.0 109.817 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.423 ' CG ' ' HA3' ' A' ' 50' ' ' GLY . 10.0 mtp180 -157.14 -175.84 5.64 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.366 -0.834 . . . . 0.0 110.27 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -119.58 81.38 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 110.142 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 78' ' ' SER . 1.8 mtm-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.167 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.775 0.321 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.41 -174.46 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.13 1.595 . . . . 0.0 110.487 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.16 -166.36 1.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.544 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mm -72.3 145.19 87.84 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.914 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.6 Cg_endo -78.54 163.57 26.77 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.18 1.621 . . . . 0.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.97 -20.86 32.15 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.914 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -51.84 -57.54 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.391 -0.818 . . . . 0.0 111.119 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.681 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.2 m-85 -48.07 -27.28 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.063 -1.023 . . . . 0.0 110.236 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 12.4 mt -69.1 128.72 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 57.47 32.05 63.96 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.65 -163.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.526 -0.985 . . . . 0.0 110.431 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.818 ' H ' HG21 ' A' ' 69' ' ' VAL . 25.4 m -151.81 94.46 1.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.133 -0.979 . . . . 0.0 110.291 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.656 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.3 m -86.24 -168.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.854 -1.154 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.19 -161.46 24.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.0 Cg_endo -74.13 -45.63 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.805 1.423 . . . . 0.0 110.142 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 p -65.71 -49.3 68.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.02 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 41.3 t -59.34 -48.63 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.827 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.509 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 52.4 t-105 -48.42 -65.63 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.76 -33.2 4.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.408 -0.808 . . . . 0.0 110.382 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 47.8 t80 -67.95 -70.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 30' ' ' VAL . 1.5 tt -43.65 -30.25 0.59 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' GLY . 30.6 t -63.29 -57.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.77 -31.56 39.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.374 -0.829 . . . . 0.0 109.963 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 4' ' ' ILE . 10.1 tp -66.08 -51.74 55.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.308 -0.87 . . . . 0.0 110.43 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.722 ' CG2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 m -114.99 -49.0 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.208 -0.932 . . . . 0.0 109.766 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 147.1 163.83 10.77 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.36 -48.3 35.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.239 . . . . 0.0 110.68 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.71 76.24 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' CG2' ' A' ' 25' ' ' VAL . . . -61.36 -52.13 65.92 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.333 -0.855 . . . . 0.0 109.317 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 21' ' ' LEU . 24.1 t -50.02 -31.55 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.724 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -41.63 71.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.108 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.83 63.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 110.148 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -78.98 5.0 12.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.196 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.487 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.0 OUTLIER 59.05 69.09 0.75 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.36 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.531 ' CD1' HG13 ' A' ' 30' ' ' VAL . 34.3 mt -119.37 134.56 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.391 -0.818 . . . . 0.0 109.451 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.478 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 0.5 OUTLIER -109.04 146.04 34.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 110.59 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 7.7 mtp180 -95.18 142.34 27.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -118.5 156.58 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.6 t -42.17 -27.08 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 25.4 m -164.83 -170.59 2.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.28 -8.38 24.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.085 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 38.7 t-20 -96.52 104.9 16.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.889 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.6 p80 -143.45 -176.64 5.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 110.496 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.631 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -95.94 146.88 24.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.446 -0.784 . . . . 0.0 109.567 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.621 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 7.8 p -136.36 -177.71 4.84 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 47.31 37.93 6.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.089 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.97 -158.77 46.78 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.34 44.21 1.01 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.1 -1.235 . . . . 0.0 109.709 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -119.14 -34.63 3.82 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.18 -0.95 . . . . 0.0 111.388 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -116.09 163.99 12.31 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.425 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.631 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.7 m95 -137.64 173.57 11.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.439 -1.036 . . . . 0.0 109.505 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.7 t -116.09 118.01 31.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.923 -1.11 . . . . 0.0 111.366 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 0.2 OUTLIER -133.81 159.0 41.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.488 -0.758 . . . . 0.0 109.13 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -45.12 43.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.95 -1.094 . . . . 0.0 108.88 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 3.1 tttt -138.12 176.8 8.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.703 ' SG ' HG22 ' A' ' 62' ' ' VAL . 7.1 m -122.4 171.99 8.66 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.905 -1.122 . . . . 0.0 110.271 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -85.63 -178.6 6.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -44.0 41.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -67.51 -4.06 10.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.352 -0.842 . . . . 0.0 110.21 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -123.37 176.48 6.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 6.2 p90 -139.41 -160.73 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 0.0 110.24 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.703 HG22 ' SG ' ' A' ' 56' ' ' CYS . 76.4 t -125.26 103.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.559 -0.713 . . . . 0.0 109.899 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 9.5 p30 -53.44 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -45.53 -25.34 0.43 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.439 -0.788 . . . . 0.0 110.742 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 10.7 t80 -73.51 -47.41 41.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.812 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 69' ' ' VAL . 32.2 m-85 -85.18 -7.21 59.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.905 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -49.66 -23.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 109.156 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.511 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . -70.96 -66.13 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.516 -0.74 . . . . 0.0 110.64 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.889 HG22 ' CE1' ' A' ' 43' ' ' HIS . 13.0 p -44.25 -31.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -63.92 -67.86 0.4 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.453 -0.779 . . . . 0.0 110.186 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.54 -124.08 7.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -57.94 -32.18 67.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -1.191 . . . . 0.0 110.042 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 21.3 m-30 -94.38 175.03 6.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.292 -0.88 . . . . 0.0 110.462 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB3' HG13 ' A' ' 62' ' ' VAL . 22.0 m-85 -115.79 133.25 56.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.522 -0.737 . . . . 0.0 109.168 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.23 102.55 8.61 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.916 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 7.8 m -79.26 161.87 26.04 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 0.0 109.948 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 63' ' ' ASP . 24.3 mtp180 -155.78 -169.7 3.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 110.339 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.23 114.93 29.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 110.298 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.292 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.769 0.319 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.58 161.72 43.29 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.977 1.514 . . . . 0.0 110.597 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.03 -169.86 1.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.018 HD11 HD21 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.18 158.9 43.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.409 -179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.5 Cg_endo -75.76 167.97 25.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.172 1.617 . . . . 0.0 110.369 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -88.11 -26.12 22.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.429 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.881 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -51.86 -51.59 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.2 -0.938 . . . . 0.0 110.855 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.473 ' H ' HG23 ' A' ' 7' ' ' ILE . 14.4 m-30 -51.84 -29.21 18.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 21.2 mt -69.1 131.52 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.183 -0.948 . . . . 0.0 109.732 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 55.74 33.17 59.43 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.436 -1.865 . . . . 0.0 108.436 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.881 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -119.31 -163.06 0.95 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 110.93 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.778 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.9 m -152.22 95.86 2.11 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.013 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.958 HG12 HG23 ' A' ' 69' ' ' VAL . 2.6 m -92.3 174.93 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.274 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.92 38.81 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.7 Cg_endo -73.75 -48.43 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.987 1.519 . . . . 0.0 110.402 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 1.1 p -59.94 -51.09 71.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.894 . . . . 0.0 110.17 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.48 HG23 ' OD1' ' A' ' 41' ' ' ASP . 96.6 t -61.24 -52.1 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' CZ3' HG22 ' A' ' 35' ' ' ILE . 32.1 t-105 -44.59 -65.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.71 -41.21 3.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 11.4 t80 -61.46 -65.67 0.66 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.878 . . . . 0.0 110.241 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.018 HD21 HD11 ' A' ' 4' ' ' ILE . 1.7 tt -42.81 -36.8 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 64.9 t -60.47 -51.99 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.943 . . . . 0.0 109.819 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.83 51.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.713 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 24' ' ' LEU . 9.5 tp -63.73 -38.6 91.71 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.053 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -131.99 -87.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.331 -0.856 . . . . 0.0 109.989 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.825 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.08 169.06 36.49 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -1.129 . . . . 0.0 110.63 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.61 -63.14 1.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.149 -0.969 . . . . 0.0 109.968 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.053 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.01 -21.94 66.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.166 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 26' ' ' GLY . 27.9 t -73.3 -30.99 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.842 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -85.41 -32.05 22.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.07 -24.76 58.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.165 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -79.64 5.98 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 58.3 t-20 58.41 72.77 0.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.611 HD13 HD13 ' A' ' 21' ' ' LEU . 35.5 mt -122.51 129.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.548 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' THR . 13.8 mtt180 -108.97 140.37 42.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 1.2 mtm105 -84.2 156.93 21.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -130.92 164.79 24.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.42 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -50.85 -27.69 7.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.509 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 4.4 m -172.38 -170.8 0.75 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.48 ' OD1' HG23 ' A' ' 17' ' ' VAL . 6.8 m-20 -58.37 -15.3 10.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.893 . . . . 0.0 110.129 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -95.13 106.21 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.903 ' CE1' HG22 ' A' ' 69' ' ' VAL . 5.7 p80 -147.64 177.01 9.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 110.339 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.622 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.2 OUTLIER -80.14 147.85 31.18 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.457 -0.777 . . . . 0.0 109.841 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.12 173.89 11.05 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.334 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HB1' HH11 ' A' ' 77' ' ' ARG . . . 51.08 36.52 15.63 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.38 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.94 -153.64 48.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -85.65 36.16 0.64 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.066 -1.255 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.23 -30.52 5.59 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 110.87 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.485 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.52 164.58 15.49 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.484 -1.341 . . . . 0.0 109.767 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.622 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 7.9 m95 -143.47 172.64 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -1.133 . . . . 0.0 109.572 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 4.6 t -108.38 112.7 25.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.788 -1.195 . . . . 0.0 110.863 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 2.0 mtt-85 -128.4 153.38 47.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 109.679 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 1.0 OUTLIER -52.35 -46.15 65.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 0.0 109.033 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.06 147.85 49.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.805 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.0 m -97.44 163.25 12.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -79.69 -179.25 6.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.244 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -38.26 51.14 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.218 -0.926 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -68.69 -6.48 26.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.264 -0.898 . . . . 0.0 109.77 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' OE2' ' C ' ' A' ' 77' ' ' ARG . 5.9 mt-10 -126.63 -176.6 3.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.329 -0.857 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -140.76 -166.74 2.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 110.366 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.805 HG22 ' SG ' ' A' ' 56' ' ' CYS . 54.7 t -108.92 90.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.526 -0.734 . . . . 0.0 109.975 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 23.7 t0 -41.49 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.1 p -57.53 -31.02 65.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -0.833 . . . . 0.0 110.568 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 15.0 t80 -67.29 -48.29 68.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.722 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.637 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 28.3 m-85 -86.28 -6.9 58.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.212 -0.93 . . . . 0.0 111.089 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -21.45 4.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.858 -1.151 . . . . 0.0 109.164 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.55 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -69.95 -66.84 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.597 -0.689 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.958 HG23 HG12 ' A' ' 13' ' ' VAL . 14.1 p -46.65 -31.05 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.917 -1.115 . . . . 0.0 109.333 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -59.95 -69.72 0.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.398 -0.814 . . . . 0.0 109.949 179.361 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.66 -106.41 2.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -53.31 56.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -1.095 . . . . 0.0 110.06 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 42' ' ' ASN . 23.7 m-85 -83.94 -169.25 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.687 ' HB3' HG13 ' A' ' 62' ' ' VAL . 7.3 m-85 -126.95 141.95 51.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -0.835 . . . . 0.0 109.476 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.4 t -79.62 97.75 6.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.363 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 16.5 m -78.85 164.14 24.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.161 -0.962 . . . . 0.0 109.672 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.663 HH11 ' HB1' ' A' ' 46' ' ' ALA . 9.3 mtp180 -154.35 -177.16 6.26 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 110.406 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 p -101.37 89.63 3.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.13 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 24.3 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.797 0.332 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 46.8 Cg_endo -72.78 172.12 15.94 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.054 1.555 . . . . 0.0 110.415 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -174.68 42.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.183 -0.948 . . . . 0.0 110.596 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.794 HG12 HD23 ' A' ' 24' ' ' LEU . 1.9 mm -64.04 145.84 97.7 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.823 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.6 Cg_endo -76.73 166.47 27.05 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.118 1.589 . . . . 0.0 109.744 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -82.87 -20.94 34.54 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 110.36 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.823 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -53.7 -53.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 111.042 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 22.9 m-85 -49.13 -26.27 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 110.341 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 51.2 mt -69.65 136.16 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.143 -0.973 . . . . 0.0 109.489 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' ' CG ' ' A' ' 34' ' ' ASN . . . 52.04 33.28 36.75 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.74 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.31 -159.56 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.55 -0.971 . . . . 0.0 110.497 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.815 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.2 m -154.19 95.54 1.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.302 -0.874 . . . . 0.0 110.307 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.895 HG12 HG23 ' A' ' 69' ' ' VAL . 3.0 m -91.47 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.956 -1.09 . . . . 0.0 110.147 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -162.09 28.39 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 47.4 Cg_endo -74.08 -51.18 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.944 1.497 . . . . 0.0 110.415 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 2.3 p -60.66 -49.2 78.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.155 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.496 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 26.7 t -59.41 -46.67 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.892 . . . . 0.0 110.079 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -50.29 -62.77 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.58 -36.82 7.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.063 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 17.7 t80 -60.63 -55.06 37.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 109.994 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.677 HD22 HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -55.23 -36.12 65.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HA ' HG21 ' A' ' 30' ' ' VAL . 25.9 t -60.06 -52.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.2 -40.43 67.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.129 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.794 HD23 HG12 ' A' ' 4' ' ' ILE . 10.2 tp -61.73 -38.82 89.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -128.92 -88.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.17 164.94 31.69 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -21.81 62.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -1.149 . . . . 0.0 110.675 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.27 -62.79 1.27 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.083 -1.011 . . . . 0.0 110.057 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.995 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.24 -21.81 66.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.389 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 26' ' ' GLY . 44.8 t -74.46 -33.29 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 0.0 110.068 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.7 m -88.8 -21.4 23.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 110.094 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.28 -25.23 31.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.868 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -80.59 7.46 9.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 110.201 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 52.2 t-20 58.43 74.96 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.27 -0.893 . . . . 0.0 110.534 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.868 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 2.7 mt -124.38 110.41 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.868 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.484 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 2.3 mmt85 -87.3 157.24 19.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.402 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.5 mtm180 -102.17 150.7 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 110.018 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.99 154.55 39.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' ALA . 50.9 m -43.82 -26.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 110.208 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -166.23 -162.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.202 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 0.8 OUTLIER -72.28 -11.88 60.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 52' ' ' CYS . 36.0 t-20 -94.75 106.16 18.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.821 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.2 p80 -145.85 175.22 10.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.177 -0.952 . . . . 0.0 110.454 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 51' ' ' TRP . 2.4 p -80.96 124.45 29.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.366 -0.834 . . . . 0.0 109.823 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.0 p -115.3 -177.59 3.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.115 -0.991 . . . . 0.0 110.612 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.543 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.93 39.36 5.47 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.452 -0.78 . . . . 0.0 109.301 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.71 -150.08 48.94 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 48' ' ' ASN . 14.4 p30 -87.29 31.38 0.73 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.095 -1.239 . . . . 0.0 110.012 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.92 -28.96 6.86 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.251 -0.905 . . . . 0.0 110.701 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.97 162.64 14.03 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.925 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 44' ' ' SER . 8.4 m95 -139.55 167.42 22.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.449 -1.03 . . . . 0.0 109.325 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 6.3 t -107.79 108.92 20.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.868 -1.145 . . . . 0.0 111.1 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.7 OUTLIER -130.06 158.96 38.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.836 . . . . 0.0 109.06 179.113 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.85 -48.4 51.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.946 -1.097 . . . . 0.0 108.249 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -124.28 -171.24 2.29 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.686 0.755 . . . . 0.0 110.525 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.865 ' SG ' HG22 ' A' ' 62' ' ' VAL . 11.4 m -131.52 164.33 26.03 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.958 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 4.0 m-85 -79.63 164.76 23.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 110.153 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -63.56 -44.62 93.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.82 -4.77 13.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.868 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 17.1 mt-10 -123.0 -178.51 3.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.915 . . . . 0.0 110.145 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 8.4 p90 -139.65 -163.57 1.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.865 HG22 ' SG ' ' A' ' 56' ' ' CYS . 70.9 t -111.38 89.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 29.9 t0 -40.63 91.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.762 . . . . 0.0 110.185 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.542 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -57.27 -30.51 64.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.563 -179.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -67.81 -48.61 65.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 110.818 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 7' ' ' ILE . 22.9 m-85 -83.88 -8.76 59.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.92 . . . . 0.0 111.12 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.94 -24.35 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.974 -1.079 . . . . 0.0 109.415 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.591 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.22 -71.36 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 110.603 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.895 HG23 HG12 ' A' ' 13' ' ' VAL . 9.9 p -44.18 -29.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.116 -0.99 . . . . 0.0 109.841 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -61.41 -64.93 0.78 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.57 -116.07 5.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -60.8 -50.98 71.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 12.4 m-30 -79.91 -175.16 4.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.966 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.66 ' HB3' HG13 ' A' ' 62' ' ' VAL . 5.9 m-85 -122.31 144.83 48.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 t -81.59 97.05 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 109.382 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HD2' ' A' ' 53' ' ' ARG . 21.8 m -79.39 164.09 24.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.194 -0.941 . . . . 0.0 109.753 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.2 mtp180 -151.16 -179.25 7.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 0.0 110.53 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.435 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 54.4 p -116.59 87.35 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.269 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.509 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 1.4 t-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 1' ' ' ASN . 48.3 Cg_endo -75.34 141.09 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.901 1.474 . . . . 0.0 110.473 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -129.51 -169.26 2.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.185 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm -62.42 144.32 95.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 46.2 Cg_endo -72.4 -158.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.183 1.622 . . . . 0.0 109.701 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -113.48 -29.82 7.06 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.771 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -51.97 -55.28 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.367 -0.833 . . . . 0.0 110.815 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 21.2 m-85 -48.15 -29.33 3.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -0.991 . . . . 0.0 110.278 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 33.1 mt -68.57 129.22 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.422 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 59.66 32.01 72.74 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -122.42 -162.81 1.03 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.983 . . . . 0.0 110.583 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.778 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.0 m -153.79 100.07 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.939 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -93.73 173.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.115 -0.991 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -161.44 35.11 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 46.8 Cg_endo -74.27 -49.67 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.964 1.507 . . . . 0.0 110.39 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -50.19 74.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.23 -0.919 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.516 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 55.4 t -61.59 -51.0 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.776 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.1 t-105 -44.56 -65.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 109.703 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -43.53 -43.27 5.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 0.0 110.267 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 67.2 t80 -56.89 -64.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.867 . . . . 0.0 110.083 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.813 ' O ' HD23 ' A' ' 21' ' ' LEU . 2.1 tt -44.08 -38.61 3.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 110.06 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 18' ' ' TRP . 15.6 t -54.99 -55.97 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.095 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.1 -43.56 64.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.084 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD23 ' CD1' ' A' ' 4' ' ' ILE . 12.1 tp -55.28 -43.82 75.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.248 -0.908 . . . . 0.0 110.157 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.014 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.6 -88.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.238 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 177.08 166.83 34.61 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -61.22 -20.88 63.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -1.148 . . . . 0.0 110.588 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.06 -63.62 1.1 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.031 -1.043 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.014 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.45 -18.49 63.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.174 -0.953 . . . . 0.0 109.208 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.74 HG22 HD22 ' A' ' 21' ' ' LEU . 24.2 t -75.98 -32.02 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.468 -0.77 . . . . 0.0 109.729 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.0 m -93.03 -17.1 24.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.34 -24.0 23.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.073 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -83.18 10.36 8.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.178 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.485 ' ND2' ' HA2' ' A' ' 10' ' ' GLY . 61.9 t-20 58.81 74.07 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 110.603 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.643 HG22 ' CZ3' ' A' ' 18' ' ' TRP . 7.0 mt -125.1 125.27 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.858 . . . . 0.0 109.605 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 1.9 mtt180 -107.2 146.35 31.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 44.0 mtp180 -89.63 154.24 20.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -126.71 161.53 27.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 110.368 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -51.7 -26.71 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 110.392 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 39' ' ' SER . 3.7 m -165.32 -177.18 4.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 110.112 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.9 m-20 -56.41 -24.57 45.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.574 ' OD1' ' CD2' ' A' ' 73' ' ' TYR . 4.0 t30 -86.81 110.94 20.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.881 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.2 p80 -147.85 175.25 11.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.126 -0.984 . . . . 0.0 110.318 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.626 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -77.69 138.79 39.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.347 -0.846 . . . . 0.0 109.689 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.3 p -131.37 178.8 6.44 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 110.503 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.83 36.43 8.1 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.509 -0.744 . . . . 0.0 109.518 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.28 -147.74 46.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -87.13 31.6 0.71 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.164 -1.198 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -115.03 -31.84 5.93 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.236 -0.915 . . . . 0.0 111.032 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -122.81 165.75 15.4 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.162 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.626 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 5.7 m95 -144.74 169.71 17.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.461 -1.023 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 73' ' ' TYR . 5.8 t -109.61 113.33 26.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.829 -1.17 . . . . 0.0 111.065 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' CZ ' ' CB ' ' A' ' 51' ' ' TRP . 0.8 OUTLIER -132.52 160.96 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 109.126 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -50.84 -50.5 56.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.859 -1.151 . . . . 0.0 108.269 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -124.72 -178.98 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.528 0.68 . . . . 0.0 110.492 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.842 ' SG ' HG22 ' A' ' 62' ' ' VAL . 12.4 m -125.05 166.33 16.57 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.975 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -79.7 171.37 15.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.11 -0.994 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -39.41 71.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.207 -0.933 . . . . 0.0 110.17 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -71.21 -2.99 17.85 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 78' ' ' SER . 13.0 mt-10 -126.39 -172.35 2.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 110.14 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 6.2 p90 -144.52 -164.15 1.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.842 HG22 ' SG ' ' A' ' 56' ' ' CYS . 54.3 t -110.3 89.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.502 -0.749 . . . . 0.0 109.969 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 30.1 t0 -41.86 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -58.21 -28.67 65.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 110.465 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -68.86 -49.23 60.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 110.526 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.636 ' CD2' ' CD1' ' A' ' 7' ' ' ILE . 17.7 m-85 -82.91 -8.56 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.301 -0.874 . . . . 0.0 110.825 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.3 t -51.09 -21.71 2.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.987 -1.07 . . . . 0.0 109.115 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.681 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.49 -68.97 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 110.294 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.939 HG23 HG12 ' A' ' 13' ' ' VAL . 10.8 p -46.35 -30.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.022 -1.048 . . . . 0.0 109.35 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -60.15 -70.93 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.451 -0.78 . . . . 0.0 110.415 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.2 -115.5 5.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -61.0 -39.8 91.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.22 -1.165 . . . . 0.0 109.995 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.574 ' CD2' ' OD1' ' A' ' 42' ' ' ASN . 29.3 m-85 -92.26 -177.69 4.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.877 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.6 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -122.3 145.87 47.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.905 . . . . 0.0 109.642 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 8.7 t -85.08 99.24 10.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.64 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 18.3 m -78.36 163.89 25.29 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.15 -0.969 . . . . 0.0 109.667 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 22.0 mtp180 -154.09 -175.58 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 110.658 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -111.87 102.08 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.149 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.272 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 t30 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' HG2' HD11 ' A' ' 24' ' ' LEU . 46.2 Cg_endo -73.05 93.77 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.904 1.476 . . . . 0.0 110.367 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -52.54 139.68 24.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.363 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.494 HG23 ' HD2' ' A' ' 5' ' ' PRO . 1.4 mm -57.64 147.23 62.05 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.865 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.7 Cg_endo -76.36 164.34 31.02 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.035 1.545 . . . . 0.0 109.921 178.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.679 ' HB3' ' OH ' ' A' ' 65' ' ' TYR . . . -80.62 -20.96 42.01 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.417 -0.802 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.865 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -53.92 -56.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 110.9 -179.643 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.624 ' H ' HG23 ' A' ' 7' ' ' ILE . 22.3 m-85 -47.6 -25.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.064 -1.022 . . . . 0.0 110.004 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 8.3 mt -69.15 125.49 27.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' HA2' ' ND2' ' A' ' 34' ' ' ASN . . . 60.2 31.41 73.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.72 -160.92 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.447 -1.031 . . . . 0.0 110.759 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.731 ' H ' HG21 ' A' ' 69' ' ' VAL . 5.8 m -156.26 104.33 2.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.031 HG12 HG23 ' A' ' 69' ' ' VAL . 3.4 m -99.03 169.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 110.154 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.66 -163.89 21.54 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 47.5 Cg_endo -73.73 -46.1 0.35 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.051 1.553 . . . . 0.0 110.281 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -52.43 56.51 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.865 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 59.6 t -57.63 -41.36 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.727 ' O ' HG23 ' A' ' 22' ' ' VAL . 43.0 t-105 -54.22 -66.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.14 -0.975 . . . . 0.0 109.633 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.27 -33.97 1.77 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.707 . . . . 0.0 110.334 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 74.2 t80 -65.13 -65.59 0.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -0.891 . . . . 0.0 110.117 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.786 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.6 tt -44.7 -35.8 2.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.739 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 18' ' ' TRP . 21.7 t -60.96 -48.24 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.43 -42.21 73.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.459 -0.776 . . . . 0.0 109.968 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.8 tp -60.71 -42.98 98.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.017 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -121.7 -88.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 0.0 110.163 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.804 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 175.64 165.77 32.16 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.32 -19.25 61.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -1.132 . . . . 0.0 110.486 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -63.11 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.884 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.017 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -63.4 -19.7 64.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 26' ' ' GLY . 38.2 t -75.78 -32.03 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.442 -0.786 . . . . 0.0 109.856 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.2 m -89.37 -23.21 22.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.18 -24.9 32.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -81.07 8.38 8.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 61.2 t-20 59.21 74.73 0.43 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.663 HD13 HD13 ' A' ' 21' ' ' LEU . 67.9 mt -125.19 128.4 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.437 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.7 mmt180 -109.99 146.32 35.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.585 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 6.6 mtp180 -92.79 148.86 21.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -123.82 173.69 8.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.097 -1.002 . . . . 0.0 110.328 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 t -51.29 -37.02 45.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.33 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.535 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 1.2 m -161.2 -162.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.346 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 1.2 m-20 -67.47 -18.55 65.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.405 -0.809 . . . . 0.0 110.344 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -91.75 92.19 8.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.273 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.886 ' CE1' HG22 ' A' ' 69' ' ' VAL . 2.7 p80 -127.49 -178.6 4.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.87 . . . . 0.0 110.159 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.629 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -88.95 117.64 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.972 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.422 ' HB2' ' CD2' ' A' ' 66' ' ' TYR . 21.4 p -104.11 -175.47 2.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.439 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HB2' ' HD2' ' A' ' 77' ' ' ARG . . . 43.98 39.57 2.8 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.446 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.63 -150.23 50.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 34.43 0.61 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.153 -1.204 . . . . 0.0 109.969 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -117.93 -28.63 5.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.319 -0.863 . . . . 0.0 110.924 -179.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.536 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -126.53 165.17 19.83 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.165 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.629 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 30.2 m95 -138.61 176.16 8.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.426 -1.044 . . . . 0.0 109.956 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 m -105.66 102.41 11.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 110.216 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 5.3 mtt180 -122.21 137.71 54.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.147 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.559 ' O ' ' CE2' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -49.25 -41.2 36.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 108.977 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.44 144.13 51.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.826 ' SG ' HG22 ' A' ' 62' ' ' VAL . 4.4 m -103.62 166.8 10.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.038 -1.038 . . . . 0.0 110.048 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -79.9 167.8 20.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.417 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -41.03 90.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.371 -0.831 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.22 -6.18 17.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.27 -0.894 . . . . 0.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 15.5 mt-10 -126.18 178.04 6.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 109.887 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.6 ' CE1' ' HB2' ' A' ' 77' ' ' ARG . 12.6 p90 -133.49 -170.32 2.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.277 179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.826 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -107.48 87.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 32.0 t0 -40.49 91.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.617 -0.677 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -56.2 -27.73 55.69 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.43 -0.794 . . . . 0.0 110.572 -179.523 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.679 ' OH ' ' HB3' ' A' ' 6' ' ' ALA . 19.7 t80 -70.43 -50.35 39.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.293 -0.88 . . . . 0.0 110.886 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.654 ' CD2' HD11 ' A' ' 7' ' ' ILE . 24.0 m-85 -82.7 -8.0 59.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 111.065 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 -21.39 3.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.017 -1.052 . . . . 0.0 109.308 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HB3' HG21 ' A' ' 7' ' ' ILE . . . -69.96 -51.16 34.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.031 HG23 HG12 ' A' ' 13' ' ' VAL . 7.6 p -64.24 -31.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.95 -1.094 . . . . 0.0 110.495 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 75' ' ' CYS . 57.8 m -62.74 -52.3 63.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.944 -1.097 . . . . 0.0 109.466 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 -119.56 5.09 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.09 -23.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 110.11 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 25.7 m-85 -116.67 178.44 4.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.676 ' HB3' HG13 ' A' ' 62' ' ' VAL . 1.6 m-85 -115.73 147.22 41.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 66' ' ' TYR . 8.8 t -79.5 95.91 5.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 0.0 109.58 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 77' ' ' ARG . 31.3 m -78.66 160.98 27.24 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.957 -1.09 . . . . 0.0 109.355 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.602 ' HD2' ' HB2' ' A' ' 46' ' ' ALA . 43.4 mtp180 -157.83 -172.52 3.97 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.359 -0.838 . . . . 0.0 110.591 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 7.6 t -114.87 96.31 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.611 -0.681 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.49 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.533 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 7.1 m-20 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.728 0.299 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 1' ' ' ASN . 46.2 Cg_endo -72.89 84.29 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.929 1.489 . . . . 0.0 110.507 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.09 HD13 ' N ' ' A' ' 4' ' ' ILE . 3.1 tm? -96.74 150.98 20.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.09 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.09 ' N ' HD13 ' A' ' 3' ' ' LEU . 3.6 mm -40.91 145.44 0.55 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.851 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.626 ' HG2' ' CD2' ' A' ' 8' ' ' TYR . 45.6 Cg_endo -71.37 -158.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.125 1.592 . . . . 0.0 109.615 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -116.24 -21.49 9.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.781 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.731 HD11 ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -56.09 -44.9 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.454 -0.778 . . . . 0.0 110.807 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.3 m-85 -55.86 -24.17 35.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.987 . . . . 0.0 110.758 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 54.3 mt -61.18 127.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 54.7 32.58 54.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -112.29 -170.83 1.73 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.504 -0.997 . . . . 0.0 110.645 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.814 ' H ' HG21 ' A' ' 69' ' ' VAL . 17.2 m -145.75 90.13 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' A' ' 69' ' ' VAL . 3.1 m -82.99 175.95 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.04 -1.038 . . . . 0.0 109.826 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.83 -166.49 42.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' CD ' ' HA ' ' A' ' 40' ' ' SER . 44.0 Cg_endo -72.21 -46.49 0.51 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.976 1.514 . . . . 0.0 110.185 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -47.57 82.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 57.1 t -59.5 -51.81 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.594 ' CE3' ' HG3' ' A' ' 37' ' ' ARG . 36.4 t-105 -44.43 -66.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 109.824 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -42.71 -39.76 2.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.844 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 38.9 t80 -62.44 -64.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.363 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.763 ' CD2' HD11 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -42.74 -52.0 5.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG22 HG21 ' A' ' 30' ' ' VAL . 73.2 t -47.65 -50.89 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.78 -46.53 59.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 24' ' ' LEU . 10.6 tp -60.58 -38.87 86.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.349 -0.844 . . . . 0.0 110.036 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.043 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -126.99 -89.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.805 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 173.55 171.25 37.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.38 -19.18 65.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -1.169 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.95 -63.13 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.07 -1.018 . . . . 0.0 109.945 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.043 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -62.84 -21.87 66.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' HD12 ' A' ' 35' ' ' ILE . 24.6 t -74.0 -33.48 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.726 . . . . 0.0 109.929 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 m -85.31 -27.01 26.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 110.009 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.02 -25.93 48.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.948 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.695 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -81.46 3.25 25.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 110.025 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.2 t-20 58.73 77.95 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.59 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.695 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 2.6 mt -121.43 140.76 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.456 -0.777 . . . . 0.0 109.505 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 5.5 mtt180 -117.49 153.82 32.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.567 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.594 ' HG3' ' CE3' ' A' ' 18' ' ' TRP . 19.0 mtp-105 -109.04 134.3 51.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 109.977 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -109.44 173.82 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -49.58 -27.48 4.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.3 -0.875 . . . . 0.0 110.36 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.538 ' HA ' ' CD ' ' A' ' 15' ' ' PRO . 39.0 m -167.71 -166.08 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.942 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' OD1' HG23 ' A' ' 17' ' ' VAL . 97.9 m-20 -65.83 -10.17 35.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 2.8 m-20 -96.31 105.58 17.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.868 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.9 p80 -145.71 -179.85 6.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.136 -0.977 . . . . 0.0 110.647 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.625 ' N ' ' CZ3' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -91.64 148.31 22.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.443 -0.786 . . . . 0.0 109.521 179.627 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.636 ' HB2' ' CD1' ' A' ' 66' ' ' TYR . 9.3 p -141.27 -177.32 5.07 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.062 -1.024 . . . . 0.0 110.611 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 45.3 43.54 8.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.27 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.69 -161.04 53.92 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -83.82 41.33 0.79 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.031 -1.276 . . . . 0.0 110.113 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -119.38 -31.16 4.71 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.177 -0.952 . . . . 0.0 110.967 -179.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.64 158.76 14.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.223 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.625 ' CZ3' ' N ' ' A' ' 44' ' ' SER . 4.1 m95 -140.05 169.05 18.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -1.028 . . . . 0.0 109.189 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.6 t -112.45 115.91 29.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.786 -1.197 . . . . 0.0 110.893 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 0.9 OUTLIER -132.44 161.38 33.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.349 -0.844 . . . . 0.0 109.25 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -46.08 66.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.985 -1.072 . . . . 0.0 108.856 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.52 163.19 30.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.662 ' SG ' HG22 ' A' ' 62' ' ' VAL . 10.9 m -103.73 170.22 8.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.935 -1.103 . . . . 0.0 110.265 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 57' ' ' PHE . 21.5 m-85 -87.39 -178.88 6.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.2 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -75.23 -38.47 60.62 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.333 -0.854 . . . . 0.0 110.008 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.54 0.74 13.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.813 . . . . 0.0 109.888 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -132.36 177.9 7.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 9.7 p90 -138.89 -168.83 2.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 74' ' ' PHE . 26.2 t -104.07 89.63 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.64 -0.663 . . . . 0.0 109.828 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.489 ' OD2' ' CD ' ' A' ' 77' ' ' ARG . 16.8 t0 -42.64 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.8 p -58.08 -32.74 68.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.659 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -44.89 80.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.769 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.731 ' CD1' HD11 ' A' ' 7' ' ' ILE . 37.8 m-85 -89.1 -5.99 57.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.963 -179.347 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 t -50.51 -22.5 1.97 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.013 -1.055 . . . . 0.0 108.766 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HB1' ' CZ ' ' A' ' 8' ' ' TYR . . . -70.61 -67.78 0.48 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.868 HG22 ' CE1' ' A' ' 43' ' ' HIS . 12.9 p -44.71 -28.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.018 -1.051 . . . . 0.0 109.671 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' HA ' ' NE2' ' A' ' 43' ' ' HIS . 1.1 m -67.08 -62.93 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.453 -0.78 . . . . 0.0 110.449 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.7 -114.81 4.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -69.04 -34.0 74.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' CG ' ' OD1' ' A' ' 42' ' ' ASN . 61.7 m-85 -87.79 179.72 6.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.979 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.663 ' HB3' HG13 ' A' ' 62' ' ' VAL . 7.0 m-85 -121.89 129.55 52.65 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -0.853 . . . . 0.0 109.495 179.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -79.46 99.61 7.3 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.04 -1.038 . . . . 0.0 108.816 179.376 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 12.9 m -78.38 163.83 25.33 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.903 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 10.1 mtp180 -148.02 176.55 10.09 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.37 -0.831 . . . . 0.0 110.31 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 t -103.93 88.5 3.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 6.7 ttm180 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.248 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.813 0.339 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.2 100.36 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.032 1.543 . . . . 0.0 110.48 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -93.44 155.02 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.616 ' CD1' HD23 ' A' ' 24' ' ' LEU . 2.4 mm -54.56 144.97 41.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.338 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.876 ' HB2' HG22 ' A' ' 7' ' ' ILE . 45.4 Cg_endo -76.89 163.59 30.98 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.063 1.559 . . . . 0.0 109.828 178.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HA ' HD12 ' A' ' 9' ' ' ILE . . . -80.22 -22.48 41.77 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.467 -0.77 . . . . 0.0 110.307 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.876 HG22 ' HB2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -51.37 -55.11 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -0.853 . . . . 0.0 110.937 -179.663 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CD2' ' HG2' ' A' ' 5' ' ' PRO . 23.0 m-85 -48.25 -30.76 5.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 6' ' ' ALA . 65.0 mt -67.99 135.23 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.213 -0.929 . . . . 0.0 109.429 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.478 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 54.43 33.55 53.69 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -179.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -125.51 -160.28 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.513 -0.992 . . . . 0.0 110.417 -179.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.821 ' H ' HG21 ' A' ' 69' ' ' VAL . 3.6 m -155.18 92.57 1.44 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.952 . . . . 0.0 110.451 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.737 HG12 HG23 ' A' ' 69' ' ' VAL . 2.9 m -84.21 -147.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 110.28 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -125.58 -161.31 10.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.22 -47.27 0.32 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.992 1.522 . . . . 0.0 110.542 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -55.64 11.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 110.318 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 64.2 t -53.71 -39.74 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.601 ' CD2' ' HD2' ' A' ' 37' ' ' ARG . 25.9 t90 -55.99 -61.87 2.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' TRP . . . -43.76 -38.23 3.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -66.16 -44.2 84.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.258 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.915 HD22 HG22 ' A' ' 30' ' ' VAL . 1.3 tt -65.1 -27.89 69.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 110.27 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.628 HG13 ' CA ' ' A' ' 27' ' ' ALA . 85.9 t -71.37 -42.22 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 110.248 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.05 72.75 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 110.281 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.616 HD23 ' CD1' ' A' ' 4' ' ' ILE . 8.7 tp -72.92 -69.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 110.794 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.005 HG22 ' CB ' ' A' ' 29' ' ' ALA . 14.9 p -88.43 -26.48 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 110.702 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.787 ' O ' HG23 ' A' ' 30' ' ' VAL . . . 119.72 161.37 11.57 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.628 ' CA ' HG13 ' A' ' 22' ' ' VAL . . . -63.42 -63.2 1.25 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -1.121 . . . . 0.0 110.318 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.2 -34.25 31.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.992 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.005 ' CB ' HG22 ' A' ' 25' ' ' VAL . . . -63.6 -43.67 96.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.915 HG22 HD22 ' A' ' 21' ' ' LEU . 49.8 t -60.84 -39.76 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 m -71.47 -23.45 61.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.19 -20.8 31.75 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.213 -0.929 . . . . 0.0 110.391 -179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' ' CD1' ' A' ' 35' ' ' ILE . . . -90.11 9.14 29.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 110.513 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.478 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 1.3 t-20 59.13 68.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.383 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.766 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 3.3 mt -120.13 110.81 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.652 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 12' ' ' THR . 1.1 mtm105 -92.04 160.11 15.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.555 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.601 ' HD2' ' CD2' ' A' ' 18' ' ' TRP . 8.4 mtp-105 -110.54 151.52 27.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -119.83 -172.46 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 4.9 t -71.92 -2.76 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 170.65 -165.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.076 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -71.24 -9.65 58.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 110.216 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 36.7 t-20 -97.39 100.48 11.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 110.133 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.805 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.0 p80 -142.22 176.78 8.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.112 -0.993 . . . . 0.0 110.501 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.584 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.5 p -78.51 129.74 35.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.16 175.64 6.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 110.536 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.81 42.74 20.49 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.73 -150.65 49.74 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -86.17 38.57 0.77 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.103 -1.234 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 1.3 mtm-85 -116.96 -35.35 4.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.171 -0.956 . . . . 0.0 111.013 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 77' ' ' ARG . . . -125.45 165.49 18.58 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.501 -1.333 . . . . 0.0 109.931 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.584 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.9 m95 -136.77 175.0 10.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.443 -1.034 . . . . 0.0 109.673 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.6 t -107.97 120.09 41.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.976 -1.078 . . . . 0.0 110.602 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.0 OUTLIER -139.02 144.89 39.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.534 -0.729 . . . . 0.0 109.36 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' A' ' 55' ' ' LYS . 1.4 m -45.78 -38.73 7.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.954 -1.092 . . . . 0.0 108.479 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HD3' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -132.8 -162.83 1.27 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' SG ' HG22 ' A' ' 62' ' ' VAL . 20.7 m -143.4 179.06 7.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.928 -1.108 . . . . 0.0 110.37 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.93 -176.12 5.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 110.028 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -84.26 -38.46 20.46 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 9.58 7.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 110.068 179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 11.1 mt-10 -124.06 -168.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 2.6 p90 -154.4 -160.09 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.896 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.638 HG13 ' HB3' ' A' ' 74' ' ' PHE . 66.2 t -122.5 96.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.683 -0.636 . . . . 0.0 109.376 179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -52.69 89.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.245 -0.91 . . . . 0.0 109.796 -179.63 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 62' ' ' VAL . 0.5 OUTLIER -43.08 -24.96 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.58 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 63' ' ' ASP . 26.6 t80 -67.32 -55.13 15.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.83 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.643 ' CD1' ' CD1' ' A' ' 7' ' ' ILE . 17.3 m-85 -81.95 -9.92 59.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.195 -0.941 . . . . 0.0 110.982 -179.286 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 t -48.25 -23.73 0.97 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.094 -1.004 . . . . 0.0 109.215 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.675 ' CB ' HG21 ' A' ' 7' ' ' ILE . . . -67.54 -71.5 0.2 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.544 -0.722 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.821 HG21 ' H ' ' A' ' 12' ' ' THR . 9.3 p -43.33 -29.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.053 -1.029 . . . . 0.0 109.668 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -62.44 -58.67 6.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.471 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.69 -136.91 12.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.47 -27.69 4.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -1.166 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -93.71 179.18 5.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 110.152 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.638 ' HB3' HG13 ' A' ' 62' ' ' VAL . 10.9 m-85 -122.68 137.29 54.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 178.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 5.8 t -78.76 103.35 8.65 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.969 -1.082 . . . . 0.0 108.818 179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 19.5 m -79.58 163.06 24.94 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 -179.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.524 ' HD2' ' CB ' ' A' ' 46' ' ' ALA . 26.3 mtp180 -160.08 -170.24 2.78 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.534 -0.729 . . . . 0.0 110.274 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.69 114.9 21.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.379 -0.826 . . . . 0.0 110.22 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.174 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.771 0.32 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.3 86.76 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.023 1.538 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -153.38 167.89 27.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 110.115 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.828 HD11 ' CD2' ' A' ' 21' ' ' LEU . 2.1 mm -58.7 145.27 78.36 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 110.247 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HB2' HG22 ' A' ' 7' ' ' ILE . 46.4 Cg_endo -77.68 164.79 27.71 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 124.03 1.542 . . . . 0.0 109.88 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -83.95 -28.44 27.81 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.785 HD13 ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -54.75 -50.47 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 110.366 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.584 ' H ' HG23 ' A' ' 7' ' ' ILE . 9.9 m-30 -46.97 -27.24 1.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 49.1 mt -64.19 118.55 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.562 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 65.06 30.65 78.5 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 -178.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -106.52 -161.57 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.51 -0.994 . . . . 0.0 110.809 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.762 ' H ' HG21 ' A' ' 69' ' ' VAL . 4.3 m -156.35 92.28 1.31 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.037 HG12 HG23 ' A' ' 69' ' ' VAL . 3.4 m -93.74 169.75 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.074 -1.016 . . . . 0.0 110.288 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.97 -161.68 36.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 46.6 Cg_endo -74.09 -38.79 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.024 1.539 . . . . 0.0 110.414 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.94 -53.96 22.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 110.142 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 95.6 t -58.48 -46.86 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.986 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 19' ' ' ALA . 28.3 t-105 -49.06 -65.2 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.646 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 22' ' ' VAL . . . -42.48 -40.91 2.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 110.263 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 54.0 t80 -59.24 -58.0 10.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.969 HD22 HG22 ' A' ' 30' ' ' VAL . 2.8 tt -51.73 -36.2 46.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 110.226 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 40.8 t -58.4 -49.29 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.085 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.16 82.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.399 -0.813 . . . . 0.0 110.178 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.0 tp -57.14 -44.71 83.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -125.39 -88.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.265 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.841 ' N ' HG22 ' A' ' 25' ' ' VAL . . . 176.02 166.93 34.16 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.09 -20.34 63.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.173 -1.192 . . . . 0.0 110.637 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.57 -64.24 0.96 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.081 -1.012 . . . . 0.0 109.779 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.025 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -60.76 -23.5 65.02 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.277 -0.889 . . . . 0.0 109.024 179.173 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.969 HG22 HD22 ' A' ' 21' ' ' LEU . 21.9 t -67.43 -37.02 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.443 -0.786 . . . . 0.0 109.533 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.2 m -85.26 -23.85 28.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 109.961 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.22 -23.05 54.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -89.6 24.76 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 30.7 t-20 41.23 75.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 110.579 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.697 HD12 ' O ' ' A' ' 30' ' ' VAL . 53.1 mt -117.2 126.47 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.496 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 3.6 mtt180 -100.78 146.06 27.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 110.564 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -91.5 146.91 23.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.83 . . . . 0.0 109.693 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.662 ' HB1' ' HB3' ' A' ' 43' ' ' HIS . . . -124.45 152.91 42.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 110.258 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' ALA . 18.2 t -42.27 -27.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.211 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m -171.65 -165.03 0.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.888 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -65.23 -12.91 56.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.892 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 30.9 t-20 -95.8 103.38 15.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.575 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.758 ' CE1' HG22 ' A' ' 69' ' ' VAL . 4.5 p80 -145.77 -179.9 7.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.363 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 1.4 p -84.66 133.33 34.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 109.694 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.0 p -122.06 174.78 6.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.323 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . . . 50.0 33.09 6.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.323 -179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.47 -144.93 43.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.87 40.65 0.82 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.025 -1.28 . . . . 0.0 109.976 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -113.11 -40.37 3.96 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 110.989 -179.412 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -131.6 172.37 20.9 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.271 -1.443 . . . . 0.0 110.573 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 14.3 m95 -136.22 177.18 8.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.895 . . . . 0.0 109.356 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 4.7 t -107.62 115.07 29.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 1.6 mtt180 -132.16 142.95 49.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.464 -0.773 . . . . 0.0 109.729 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 2.1 t -48.1 -43.15 30.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.883 -1.135 . . . . 0.0 108.834 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.11 50.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.881 ' SG ' HG22 ' A' ' 62' ' ' VAL . 6.3 m -101.85 162.2 13.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.952 -1.092 . . . . 0.0 110.331 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -79.98 167.34 20.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.887 . . . . 0.0 110.478 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -67.01 -39.55 87.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -63.91 -9.89 17.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.918 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 13.3 mt-10 -126.48 179.15 5.45 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.212 -0.93 . . . . 0.0 109.817 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 77' ' ' ARG . 13.4 p90 -130.58 -169.45 2.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.164 -0.96 . . . . 0.0 110.34 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.881 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.9 t -111.08 88.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 77' ' ' ARG . 3.7 t70 -38.56 91.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.43 0.633 . . . . 0.0 110.477 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -56.85 -29.54 62.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 110.049 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.544 ' O ' HD12 ' A' ' 7' ' ' ILE . 51.2 t80 -68.48 -53.51 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.435 -0.79 . . . . 0.0 110.462 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 11.6 m-85 -80.09 -4.26 52.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 111.489 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.53 -16.62 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.944 -1.097 . . . . 0.0 109.626 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.785 ' HB3' HD13 ' A' ' 7' ' ' ILE . . . -73.19 -45.99 53.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.003 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.037 HG23 HG12 ' A' ' 13' ' ' VAL . 10.0 p -71.63 -26.28 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.935 -1.103 . . . . 0.0 109.343 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.5 OUTLIER -65.28 -50.91 63.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.467 -0.77 . . . . 0.0 109.83 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.12 -131.04 10.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -33.67 9.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -1.074 . . . . 0.0 109.798 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' CYS . 8.9 m-85 -92.83 -177.63 4.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.857 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.688 ' HB3' HG13 ' A' ' 62' ' ' VAL . 6.8 m-85 -126.69 140.77 52.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.844 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.52 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 8.6 t -79.48 97.25 6.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.568 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 14.2 m -79.23 163.26 25.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.13 -0.981 . . . . 0.0 110.069 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.636 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 6.5 mmm180 -153.59 -172.43 4.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 110.242 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 29.3 p -120.17 81.03 1.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.491 ' HB2' ' CD1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.169 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' LEU . 46.5 Cg_endo -73.83 153.12 47.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.73 HD23 ' C ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -55.39 -162.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.308 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.539 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.3 mm -87.62 143.37 33.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 109.972 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 7' ' ' ILE . 47.2 Cg_endo -79.29 162.11 25.58 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.151 1.606 . . . . 0.0 110.166 178.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.49 -20.31 37.05 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.547 -0.72 . . . . 0.0 110.22 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.835 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -57.73 -39.18 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.879 . . . . 0.0 110.457 -179.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CE1' ' HB1' ' A' ' 68' ' ' ALA . 12.8 m-30 -63.14 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.518 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.8 mt -72.44 126.55 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.148 -0.97 . . . . 0.0 109.281 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' HA2' ' OD1' ' A' ' 34' ' ' ASN . . . 63.79 31.01 79.36 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -118.54 -163.08 0.93 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.501 -0.999 . . . . 0.0 110.711 -179.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.832 ' H ' HG21 ' A' ' 69' ' ' VAL . 1.8 m -154.85 99.54 2.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -0.894 . . . . 0.0 109.835 -179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.886 HG12 HG23 ' A' ' 69' ' ' VAL . 3.1 m -94.72 178.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.991 -1.068 . . . . 0.0 110.445 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.12 -161.74 37.8 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 40' ' ' SER . 45.6 Cg_endo -73.33 -46.52 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.985 1.519 . . . . 0.0 110.509 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -47.78 74.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.317 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 13' ' ' VAL . 14.9 t -58.8 -46.05 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.447 ' CE3' ' NE ' ' A' ' 37' ' ' ARG . 7.7 t90 -52.66 -55.67 20.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.355 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.55 59.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.605 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.19 -59.06 4.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.92 . . . . 0.0 110.302 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.844 HD22 HG22 ' A' ' 30' ' ' VAL . 1.6 tt -52.04 -36.31 49.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.791 . . . . 0.0 110.366 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 26' ' ' GLY . 46.8 t -62.73 -48.58 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.11 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.85 -34.76 68.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.482 HD23 ' CD1' ' A' ' 4' ' ' ILE . 6.4 tp -69.54 -39.15 77.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.376 -0.828 . . . . 0.0 110.371 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.123 HG21 ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -128.71 -52.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.425 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 22' ' ' VAL . . . 134.85 164.19 10.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -65.2 -7.99 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -1.087 . . . . 0.0 110.884 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.947 -1.096 . . . . 0.0 109.817 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.123 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -64.74 -19.25 65.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.855 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.844 HG22 HD22 ' A' ' 21' ' ' LEU . 18.2 t -75.21 -32.83 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.545 -0.722 . . . . 0.0 109.807 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.9 m -87.26 -27.01 23.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 110.044 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.94 -19.91 36.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' ILE . . . -84.57 9.18 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 110.156 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.473 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 0.7 OUTLIER 59.05 72.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.345 -0.847 . . . . 0.0 110.624 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.617 HD13 HD13 ' A' ' 21' ' ' LEU . 38.0 mt -124.96 114.54 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 109.692 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 12' ' ' THR . 19.8 mtt-85 -98.67 152.11 19.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.956 . . . . 0.0 110.606 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 4.1 mtm180 -93.68 159.59 15.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.838 . . . . 0.0 110.113 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 43' ' ' HIS . . . -134.52 164.02 28.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.865 . . . . 0.0 110.261 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.18 -25.31 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 110.303 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -179.54 -161.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.293 -179.865 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 62.1 m-20 -65.97 -10.45 39.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 110.319 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -98.33 100.19 11.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.351 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.764 ' CE1' HG22 ' A' ' 69' ' ' VAL . 3.0 p80 -143.25 175.04 10.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.943 . . . . 0.0 110.451 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.569 ' HB3' ' CH2' ' A' ' 51' ' ' TRP . 5.7 p -80.38 125.63 30.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.439 -0.788 . . . . 0.0 109.403 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.97 177.44 4.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . . . 48.07 44.03 18.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.47 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.42 -152.13 51.49 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -86.75 36.14 0.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.061 -1.258 . . . . 0.0 109.989 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -31.2 5.11 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.225 -0.922 . . . . 0.0 110.859 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.521 ' HA3' ' HG2' ' A' ' 77' ' ' ARG . . . -118.78 163.46 13.17 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.061 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 44' ' ' SER . 8.1 m95 -140.84 165.92 26.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -1.082 . . . . 0.0 109.839 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . 5.5 t -104.37 107.95 19.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.009 -1.057 . . . . 0.0 110.787 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 51' ' ' TRP . 0.6 OUTLIER -128.29 149.93 50.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -0.898 . . . . 0.0 109.622 179.351 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' PHE . 65.8 p -55.99 -49.87 72.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 109.035 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -130.49 173.57 10.72 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 55' ' ' LYS . 57.1 m -148.6 172.04 15.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -79.54 -170.29 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 110.506 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -45.28 10.69 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.338 -0.852 . . . . 0.0 110.332 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.7 -20.31 1.2 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.147 -0.971 . . . . 0.0 109.517 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -113.58 170.77 8.0 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.395 -0.816 . . . . 0.0 109.832 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 77' ' ' ARG . 10.9 p90 -133.85 -168.33 2.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 0.0 110.145 179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.72 HG13 ' HB3' ' A' ' 74' ' ' PHE . 62.6 t -111.76 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.546 -0.721 . . . . 0.0 110.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 20.2 t0 -40.21 91.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.582 -0.699 . . . . 0.0 110.19 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' VAL . 2.8 p -55.13 -33.98 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 110.505 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.93 -46.79 83.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 110.78 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.734 ' CD2' HD11 ' A' ' 7' ' ' ILE . 27.4 m-85 -87.2 -6.48 58.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 0.0 111.021 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -21.96 2.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.053 . . . . 0.0 108.904 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 8' ' ' TYR . . . -69.67 -66.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.605 -0.684 . . . . 0.0 110.53 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.886 HG23 HG12 ' A' ' 13' ' ' VAL . 9.7 p -48.54 -26.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.077 . . . . 0.0 109.603 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -65.39 -63.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 110.231 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -114.94 5.17 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -61.06 -47.98 83.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -1.181 . . . . 0.0 110.027 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.484 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 22.5 m-85 -82.69 -178.45 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.72 ' HB3' HG13 ' A' ' 62' ' ' VAL . 2.0 m-85 -121.23 138.82 54.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 7.7 t -79.68 98.49 6.98 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.762 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 96.1 m -79.06 173.16 12.86 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.955 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 2.5 mtp180 -160.55 179.88 8.22 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.482 -0.761 . . . . 0.0 110.276 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.68 117.49 34.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 110.288 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.159 -179.929 . . . . . . . . 1 1 . 1 stop_ save_